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Abstract 
 
Beyond the brute pain of depression, individuals enduring this problem also commonly face a 
more subtle, added burden related to both societal and personal confusion about the basic nature 
of depression and its appropriate resolution.  This dissertation study seeks to better understand 
diverging interpretations or narratives at play in the experiences of those facing depression by 
examining the language of actual survivors.  In particular, the complexity of individuals’ 
decisions regarding possible medication use is investigated.  Through fourteen in-depth 
interviews with survivors reflecting diverse (both positive and negative) psychiatric experiences, 
three specific questions are explored:  1) How exactly do individuals come to adopt a particular 
narrative of depression and its treatment?  2) What are the most meaningful differences between 
varied narratives that arise?  3) After being adopted, how do particular narratives appear to be 
maintained over time?  The first section of the report describes basic patterns across survivor 
accounts—first, in reviewing individual synopses of each narrative (Ch. 3), and second, in 
documenting key interpretive themes across all interviews (Ch. 4-5).  The second section moves 
into more direct analyses of these narratives, taking up explicitly the three empirical questions in 
turn.  Chapter 6 identifies multiple resources that individuals draw upon in the adoption of 
distinct treatment narratives (e.g., intense levels of confusion and urgency; comments from 
friends/family; drug effects).  Ensuing moments are proposed as powerfully cementing and 
galvanizing specific interpretations of both depression and associated medication use.  Chapter 7 
explores several issues underlying some of the most meaningful differences between narratives 
(how participants interpret the role of biology, agency, medication and surrounding relationships).  
In Chapter 8, strategies that appear to be associated with the maintenance of particular treatment 
narratives are examined.  Among other things, analysis of patterns across accounts points to a 
striking role for diverging narratives in the unfolding treatment experiences of those facing 
depression.  Since such individuals typically have little awareness that their treatment experience 
can be interpreted in fundamentally different ways—nor that these distinctions may have 
substantial implications for how their experience ultimately unfolds—a more thoughtful and 
broad-based deliberation involving both professionals and those facing depression is subsequently 
proposed.    
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Chapter 1 
Introduction 
 
I have had . . . beatings to the point of unconsciousness--ripped, broken, arms taken out 
of the socket and that compares nothing . . doesn‘t even begin to be the pain that became 
every day, just right here (pointing to chest)--this thing that wouldn‘t come off—that 
made it hard to breathe . . like, I would rather have every day, just hours and hours of 
people beating the shit out of me than to [have] been where I was just inside.  It hurt that 
bad. . . . there were times I thought it would kill me—all on its own, that I wouldn‘t have 
to do anything. (6) 
 
As its victims can attest, the experience of depression can be agonizing to a terrifying 
degree.  The woman cited above compares her recent depression encounters with earlier vicious 
child abuse.     
Indicators suggest that in a given year, serious depression affects 14.8 million Americans 
ages 18 and older--approximately 6.7 percent of the U.S. adult population (Kessler, 2005).  
According to a 2004 World Health Organization report, depression is the ―leading cause of 
disability in the U.S. for ages 15-44‖ (see National Institute of Mental Health, 2009).  On an 
international level, Hyman and colleagues (2006), report that depression is now the fourth highest 
source of the ―global disease burden‖ and the ―leading cause of disability worldwide.‖ It was the 
assault of depression on one of my own dear ones that motivated my attention to the questions 
explored below.    
In 2002, lymphoma took the life of my 22-year-old brother.  Sam looked forward to a 
promising career in filmmaking and was well-loved by everyone who knew him—most especially 
his high school sweetheart and then fiancé, Mary
1
.  Soon after his passing, Mary fell into severe 
emotional challenges that included depression.  At the time, as a new graduate student in 
psychology at the University of Illinois, I joined others in actively encouraging her to get help 
and seek treatment from psychologists and doctors.  Over the next three years, I watched as Mary, 
in spite of both therapeutic and medical help, faced deepening pain and distance from us all.    
During this period, I began to notice how difficult it was to tell what was really going on.  
Her eating disorder and depression continued, and I started to wonder what impact her treatment 
was having—particularly, the combinations of anti-depressant and anti-anxiety medications being 
tried.  As I learned some of the latest insights on the brain, I started raising questions with family 
members on trips home to Utah:  Did the medications seem to be helping?  How were the side-
effects affecting the situation?    Once, I attempted to engage some of her treatment providers at 
                                                 
1
 Mary, who has become in every important sense my sister, has given her permission for her name and this 
story to be shared.   
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an inpatient facility around the same questions.  In literally every case, I was most struck by their 
response to questions.  When I wasn‘t ignored, individuals either minimized the concerns I raised 
or acted defensively.   
Back in Illinois, I met with Wendy Heller, a neuroscientist who would eventually become 
my dissertation chair.  After hearing my expressions of frustration, she emphasized that certain 
mindsets or ways of thinking carried great power and that, from her own observations and 
experience, they were not always readily open to serious questioning.  She told me to be patient 
and encouraged me to keep exploring.   
It was in the weeks that followed that I came across a notice for a conference in Chicago 
sponsored by the International Center for the Study of Psychiatry and Psychology (ICSPP).  I 
knew this organization was infamous for its persistent criticism of traditional medical treatment 
for emotional problems.  The psychiatrist Peter Breggin, a long-time critic within his field, would 
be presenting at the conference.  In spite of what I had heard, I decided I needed to hear these 
concerns for myself—dropping my plans that weekend to get in the car and head north.  My 
response to the conference was mixed.  Although it was refreshing to hear others directly 
examining the kinds of questions I had been wondering about, very often their rhetoric reflected 
sharp attacks on entire institutions and challenges to the motives of those involved in treatment.  
At the same as I was introduced to credible research from people such as David Cohen and 
Jeffrey Lacasse, I found myself distancing myself from many of the others for their fierce anti-
psychiatry rhetoric. 
From this vantage point, I decided I wanted to try to deliberately position myself in the 
middle of the conversation so I could try to listen and better understand both sides.  I was struck 
in an uncomfortable way at how certain and absolute both proponents and critics of psychiatric 
treatment seemed to be—both citing scientific evidence and deconstructing the ―faulty studies‖ 
on the other side.  How could each side be so convinced that they were right?  What lead 
individuals to such polarized views—and why was there such emotional intensity and anger 
associated with these questions?   
I decided I would have the best chance of finding some answers if I went to the real  
experts—those with first-person, front-line experience of depression itself.  It had been the 
experience of my sister that had raised so many questions for me in the first place.  While curious 
about depression accounts generally, my primary interest came to be exploring what underlay the 
polarized views about treating depression—especially medical interventions, given the particular 
research debate on that issue.  In my continued observations of Mary‘s situation, I began to notice 
a significant confusion in our family when treatments failed to resolve the problem.  While the 
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pain of severe emotional problems is frightening enough for individuals and families, I wondered 
if the confusion and even panic regarding what to do? (linked to the surrounding 
research/professional confusion) wasn‘t, at times, even harder to bear.  Once again, I asked 
myself, where do the competing treatment views originate?  And what does the debate and 
controversy mean for the experience of those individuals actually facing depression?    
In what follows, these questions will be explored across in-depth accounts of multiple 
depression survivors.    
 
Stepping Back:  Where Do Diverging Treatment Views Originate?   
From the outset, I realized that one of the most common explanations for diverging views 
regarding medical treatment for depression emphasized physiological differences—―drugs work 
for some, and not for others . . it just depends on your biology.‖  Clearly, as a logical explanation 
for variation in treatment outcome, biological difference may also play a role in diverse opinions 
on medical treatment for depression. 
One problem I saw with this explanation, however, is that other conditions also involving 
physiological variability do not reflect the same degree of public and professional discord.  While 
biological differences also lead to variation in cancer treatment, for example, there is no 
comparable ―anti-oncology‖ consumer movement.  Cancer survivor groups?  Yes.  Cancer-
treatment survivor groups?  No.  What leads citizens and consumer groups involved in mental 
health to such strong feelings in relation to treatment?  While a meaningful role for physiological 
differences seems obvious, this factor alone does not seem to explain clashing views about 
treatment entirely. 
In light of this, my own early hunch was that there had to be something significant 
beyond physiological differences that contributed to the public and professional confusion.  At the 
Chicago ICSPP conference mentioned earlier, the influence of pharmaceutical companies on 
research and practice was a frequent topic of discussion.  Indeed, recent years have seen big 
business interests in health care and pharmaceutical companies come under increasing scrutiny 
from watch-dog groups and researchers alike, including sociological examinations of associated 
power structures (McCubbin & Cohen, 1996; Cohen, McCubbin, Collin, & Perodeau, 2001; 
Williams, Birke & Bendelow, 2003).   
While concerns with both pharmaceutical companies and psychiatry itself made sense 
overall, as noted previously, I was hesitant and uncomfortable with some of the rhetoric.  While 
many of the arguments were fair and measured, in other instances these institutions were 
portrayed by critics as something of an ―evil empire‖ deliberately causing pain and ignoring the 
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well-being of those facing depression.  For instance, the Citizen‟s Commission on Human Rights 
has commissioned DVDs that include ―Psychiatry's Prescription for Violence‖ and ―Psychiatry: 
An Industry of Death.‖  In a recent one entitled ―Making a Killing:  The Untold Story of 
Psychotropic Drugging,‖ the American Psychological Association‘s DSM (Diagnostic and 
Statistical Manual) is essentially claimed to reflect ―made-up‖ categories created to convince 
people they need medication.   
  From my own personal experience with those involved in medical treatment for 
depression, I had observed what is perhaps obvious—doctors with sincere interest in their 
patients‘ well-being.  Similarly, I came to believe that most of those involved in developing and 
marketing drugs also maintained an authentic desire to help others.  In short, accusations of 
sinister motivations permeating both pharmaceutical and medical institutions and driving all their 
actions did not ―add up‖ for me.  Similar to physiological differences, then, the influence of 
institutional profits, while also clearly relevant, did not seem to explain all the polarization and 
confusion.  In my mind, a more comprehensive and satisfactory explanation for the confusion 
regarding medical treatment for depression would need to account for generally beneficent 
motivations among its primary stakeholders.  Rather than simply accuse one side of being 
malevolent or completely ―biased,‖ the question became how are we to understand individuals 
equally interested in depression recovery holding such intensely and deeply disparate (even 
mutually exclusive) views on what to do?   
At this point, I began to discern the contours of some other possibilities—namely, that the 
polarization might have something to do with divergent interpretative frameworks or narratives.
 2
 
In my undergraduate work at Brigham Young University, an early mentor, Brent Slife, had made 
me aware of subtle implications ensuing from distinct assumptions or interpretations operating 
throughout the social sciences (Slife & Williams, 1996).  In my first year at Illinois, Julian 
Rappaport taught me how narratives could be seen as ―community resources‖ upon which 
individual citizens drew in the creation of their own personal stories (Rappaport, 1998).  Could 
diverging interpretive frameworks for treatment have something to do with the competing 
professional/research certainties and associated confusion?  Whether for doctors, scientists or 
distressed individuals themselves, what role did one‘s interpretive framework or overall narrative 
play in the conclusions eventually reached?  If competing narratives were, in fact, significant 
                                                 
2
 While there are meaningful nuances in formal definitions between words like interpretive framework and 
narratives (see discussion below), throughout the manuscript, these words are essentially used 
interchangeably:  interpreting, narrating, perceiving, receiving, approaching, responding, making sense, 
understanding (as well as their noun forms: interpretation, narrative/narrative, perspective, way of thinking, 
perspective, view, approach, response, understanding).   
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overall—how especially did those facing depression navigate and negotiate differences in their 
own situation and arrive at a particular view?   
Preliminary curiosity:  Why hasn‟t science settled these issues already?  As I found in 
my own preliminary conversations with people, many individuals had come to believe that 
science had already settled on answers to questions about treatment and etiology in a conclusive 
and definitive way.  If this was the case, then the study I was planning would seem to be a 
distraction from the more important work of simply spreading the established ―truth‖ about 
depression and its treatment.  
My chance to spend six years as a graduate student in one of the leading psychology 
departments in the nation, however, left me with no illusions on this issue.  In particular, I was 
influenced by my interactions with three neuroscientists, Greg Miller, Janice Juraska and Wendy 
Heller.  Each made admissions about ongoing, fundamental questions still contested in their 
fields.  More than simply technical details or nuances of interpreting a particular physiological 
state, they highlighted fundamental distinctions in underlying interpretations and portrayals, such 
as how reports on the physiology of emotion itself were being framed (e.g., Miller, 1996).  
These interactions confirmed my own observations of clashes in the larger discourse that 
science had not, in fact, settled many fundamental questions in this area.  The more I explored the 
research on depression and its treatment, in particular, I found the conflict striking.  In addition to 
debates on the framing of biological contributions (Valenstein, 1998; Joseph, 2000; Miller & 
Keller, 2000; Slife, Burchfield, & Hedges 2002; Leo & Cohen, 2003), the general effectiveness of 
psychotropic medication had also become deeply contested (e.g. Kirsch & Sapirstein, 1998; 
Kirsch, Moore, Scoboria & Nicholls, 2002; Cohen, 2003; Breggin & Cohen, 1999; Moses & 
Kirk, 2005).  Even on the tangible question of whether medication increased or decreased suicide 
risk associated with depression, researchers remained in disagreement (Healy & Whitaker, 2003; 
Harris, 2003; Gibbons et al., 2006).   
It was thought-provoking to see scientists who presumably applied objective, fair 
methods coming to such widely divergent conclusions.  While celebrities, businesses and social 
pundits would be expected to disagree intensely, that it was happening so often among scientists 
initially puzzled me.  Laying aside the issue of whether or not science had reached conclusive 
answers, my curiosity came to center on why they had not? With so much collective research 
attention, how and why did so much confusion remain?  Answers to this broader question 
affected how I eventually designed my own specific study of depression narratives. 
Two studies, in particular, gave me insight on this larger issue—each a major and 
influential randomized controlled trial (RCT) of depression treatment published in the last ten 
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years.  In spite of being seen as a ―gold-standard‖ for establishing valid conclusions in 
psychology, fundamental problems were discovered with each study that reaffirmed some of my 
hunches about the ongoing contest between researchers.   
In 1997, Emslie and colleagues published a study that was received as the first evidence 
that antidepressants work for children—making a dramatic and almost immediate impact in 
justifying expanding these prescriptions for children.  After parents began to report adverse 
effects such as suicides to the FDA, however, the data were reanalyzed.  This lead to the 
discovery that although five different measures were made in the study to compare medicine and 
placebo (three self-report--parent and child--scales and two clinician ratings), Emslie‘s original 
conclusions were largely drawn from clinician ratings, which were notably different from 
parent/child ratings, but judged to be more reliable.  A reanalysis giving equal weight across 
measures reached more guarded conclusions (see Safer, 2006).   
In another recent study published in the Journal of the American Medical Association, the 
―Treatment Adolescent Depression Study‖ (TADS) (2004) compared Prozac and Cognitive-
Behavioral Therapy (CBT) separately and with a combination of Prozac/CBT in treatment for 
depression.  Among other things, the well-publicized study concluded that ―medical management 
of Major Depressive Disorder with flouxetine, including careful monitoring for adverse events, 
should be made widely available, not discouraged‖ (p. 819).  Once again, however, in the wake of 
parental complaints to the FDA, another team of researchers reviewed the same research findings 
and by interpreting the measures differently, reached different conclusions.  The second team 
noted that in the study‘s primary outcome measure—change in Children‘s Depression Rating 
Scale-Revised Total score--Prozac alone resulted in minimal benefit over placebo, with placebo 
effects 86% of Prozac (change of 19.4 compared to 22.6 points).  At the same time, other 
measures showed Prozac causing significantly higher rates of harm-related events—suicidal 
ideation, physiological effects (diarrhea, insomnia, sedation)--compared with placebo or CBT 
alone, as well as higher rates of psychiatric adverse effects (irritability, mania, and fatigue).  
Based on this re-analysis, one research team recommended that psychotherapy treatment, rather 
than drugs, be offered as the first line treatment for adolescents (Antonuccio & Burns, 2004).   
On one level, of course, it is unsurprising that interpretations differ between different 
researchers.  Ongoing testing and the differential interpretation of findings is a well-
acknowledged basis upon which the community of researchers seeks to advance theory.  That 
findings within the same RCT allowed such diverging interpretations and conclusions, however, 
raises some important issues—especially in light of the ensuing public response.   
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The initial report of the 1997 Emslie study was uncritically received by the media and 
general public as exciting evidence that ―Prozac worked for kids.‖  According to subsequent 
indicators, prescriptions of anti-depressants to children shot up in the years that followed.  It was 
only years later, after reports of problems to the FDA that the data were reanalyzed as described 
above.  In light of later implications, the uncritical embrace of one RCT as presumably ―settling‖ 
a question is an evident problem in the way science is viewed.  While the high level of control 
may offer certain benefits as one method of studying treatment outcomes, this control obviously 
does not eliminate the critical role of researcher interpretation.  At a minimum, this suggests more 
cautious portrayals of conclusions from any one study or type of studies (see Jacobs, 1999).  
While this problem is certainly most pronounced in media portrayals of research, scholarly meta-
statements across the RCT literature can also be benefited by simultaneous considerations of the 
quality and nature of the evidence itself.   
While RCTs remain one helpful way of gaining insight into these kinds of questions, 
their limitations thus suggest a need for supplementation with additional methodologies.  Beyond 
simply more methodological controls against bias-intrusions, I became intrigued by another 
methodology operating from an entirely different basis.   
 
Studying Interpretation:  A Case for Qualitative Methods   
Over recent decades, qualitative researchers have begun to illustrate the potential of 
methods that investigate language and interpretation associated with depression and other severe 
emotional problems in a comprehensive, direct way via interviews, ethnography, archival 
analysis, and so on (e.g., Capps & Ochs, 1995; Drew, 1998; Gammell, 2004; Bilic & Georgaca, 
2007).  While still caring about objectivity in the basic sense of fairness, qualitative methods 
seemed distinct in two important ways:   
First, although striving for systematic and rigorous design similar to more conventional 
studies, qualitative research seemed to more readily acknowledge the bias and standpoint of the 
researcher as a meaningful starting point for the study to be openly acknowledged.  Rather than 
only seek to minimize or control a researcher‘s own bias, a-priori interpretations were 
acknowledged so that their ―play‖ in the study could be transparently observed by readers 
(Denzin & Lincoln, 2000)
3
. 
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 This explains why I have shared so much of my own narrative to this point.  While the following chapters 
explore challenging questions about medical treatment that reflect personal concerns regarding its role in 
recovery, it is important also to acknowledge openly that I am not ―anti-medication‖ nor am I opposed to 
biomedical explanation, per se.  Medical treatment saved the life of another brother who faced cancer—and 
I know there is value in it when used appropriately.  
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Second, more importantly, qualitative researchers saw diverging interpretation as a 
legitimate object of study in itself—including competing views and narratives of actual citizens 
facing depression.  Ten years ago, David Karp (1997), a sociologist at Boston College who has 
pioneered interviewing research for depression, commented that ―the essential problem with 
nearly all studies of depression is that we hear the voices of a battalion of mental health experts . . 
and never the voices of depressed people themselves.‖  In his review of the Journal of Affective 
Disorders over a period of several years, he noted that in twelve volumes of this journal, he could 
not find one word spoken by a person who lives with depression.  He concluded that ―research 
about a feeling disorder that does not get at people‘s feelings seems, to put it kindly, incomplete‖ 
(p. 12).  As further detailed below, until recently, first-person accounts of those facing severe 
emotional problems have received little systematic attention within psychology.  While 
autobiographies have been a historical outlet for these narratives, they have generally been seen 
as having little relevance to scientific knowledge and subsequently received little rigorous 
examination. 
This study aims to contribute to the growing literature on public interpretations of 
depression—specifically, to better understand conflicting evaluations of its treatment.  Going 
beyond autobiographical studies, this project joins Karp and others in examining themes across 
first-person accounts of the experience of depression and its treatment.  Participants with diverse 
treatment experiences were recruited with the help of advocacy organizations on contrasting sides 
of the debate (National Alliance of the Mentally Ill and MindFreedom Support Coalition 
International).  By comparing participant narratives, insight was sought on how people came to 
adopt such contrasting interpretations and evaluations of depression and its treatment.     
 Key terms:  Interpretation and narrative.  Before going further, it is important to say 
something more about how I understand my primary objects of study, ―interpretation‖ and 
―narrative.‖  As reflected in narrative theory (Bruner, 1997; De Rivera & Sarbin, 1998), the 
impulse to interpret or ―make sense‖ of one‘s life may be seen an inherent to humans—universal 
to one degree or another.  Rather than approaching interpretation as a static snapshot or mere 
―perception,‖ however, human beings are here understood to be continually interpreting or 
making sense of their experience, packaging and ordering thoughts as they navigate surrounding 
circumstances.  Naturally, these interpretive choices and adjustments take place in the flow of 
previous interpretations and predispose those that follow.  Furthermore, individual interpretations 
do not exist in isolation—but instead, link to other interpretations in web-like frameworks such as 
a story or narrative.         
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In the context of illness, Kleinman (1988) defines narrative as a ―story the patient tells, 
and significant others retell, to give coherence to the distinctive events and long-term course of 
suffering‖ (p. 49).  While coming in diverse forms, all narratives are characterized by a temporal 
ordering of events associated with change of some kind (Hydén, 1997).  As what one proposed as 
a new ―root metaphor‖ for psychology as a whole (Sarbin, 1986), narratives have also been 
argued to reflect ―the preferred mode for understanding how human intentions and desires get 
translated into human actions and how those actions play out over time‖ (McAdams,1999, p. 
480).   
Like the individual interpretations that make it up, narrative or ―narrating‖ may also be 
understood as a kind of holistic interpretive practice that is lived and continuously accomplished 
moment-by-moment (T. Schwandt, personal communication, 2006).  More than a ―subjective 
overlay‖ or ―perception‖ of experience, narratives thus have an existential quality to them.  In 
addition to telling stories, for instance, individuals are understood to be living them out in tangible 
ways (Fay, 1996, p. 178).  As Kleinman (1988) adds, ―the personal narrative does not merely 
reflect illness experience, but rather it contributes to the experience of symptoms and suffering‖ 
(p. 49).  
To further preface the study, the particular relationship between interpretation/narrative 
and other factors (physiology, environment, relationships) is also important to address.  More 
than simply ―interacting‖ with these conditions, both interpretation and narrative are proposed 
here to ―transact‖ with physiology and context.  In 1984, Altman and Rogoff proposed a 
―transactional model‖ that called for ―the study of the changing relations among psychological 
and environmental aspects of holistic entities‖—the unit of analysis being ―holistic entities such 
as events . . not composed of separate elements but a confluence of inseparable factors that 
depend on one another for their very definition and meaning‖ (p. 24).  A transactional account of 
the ―event of depression,‖ then, would attend to logically distinct elements--body, context, 
interpretation, time--as inseparable aspects of the same holistic entity.  From this perspective, a 
depressed person is understood to be ―always already‖ embodied (―biological aspects‖), 
embedded in an external physical and social context (―contextual aspects‖) and continually acting 
and making sense of the experience through time (―temporal‖ and ―interpretive/narrative 
aspects‖).   
This becomes an important theoretical backdrop for how interpretations and narratives 
are approached in what follows—namely, as intimately connected to a complex mixture of 
physiological and ecological context.  For instance, since interpretation is an embodied act, its 
study cannot be neatly abstracted from attention to known variation in physical phenomena.  
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Moreover without a particular context and community in which an embodied interpreter resides, 
there would be no interpretations in the first place.  On the flip side, of course, it might be 
similarly argued that without the ongoing, evolving interpretations of human agents themselves, 
particular contexts, communities and physiological experiences might have little meaning at all.   
In all these ways, this study attempts to investigate depression as a holistic event, 
constituted by biological and contextual aspects interpreted as they develop and change over time.  
Specifically, I attempt to examine the complex ways that human interpreters navigate through the 
host of these objectively diverse experiences via the lens of interpretations themselves.  In doing 
so, rather than minimize external factors, I seek to better understand the interpretive backdrop 
against which they become significant.   
 
Precedent in the Study of Depression Interpretations:  A Review of the Literature    
Interpretation associated with serious emotional problems has often been minimized in 
traditional psychopathology investigations--relegated to the realm of subjectivity that if to be 
studied, is to be done so only with tight methodological control.  Indeed, where human 
interpretation has been studied directly, it has typically happened through cognitive studies or 
surveys with high levels of control.  While interesting insights have been gained through these 
approaches, there are a variety of other ways to approach the study of interpretation.       
 On a general level, the broader discourse of depression has been explored in interesting 
ways.  For instance, large scale marketing studies examine the dissemination of dominant 
interpretations in the form of pharmaceutical company advertisements (Montagne, 2001; Cline & 
Young, 2004).   Large-scale survey studies have attempted to document community/public 
attitudes towards medical treatment for depression (e.g., McLeod, Pescosolido & Takeuchi 2004).  
Historical researchers have also examined the development of a variety of associated constructs 
in public discourse over time (see Healy, 1997 on psychopharmacology; Rousseau, 2000 on 
depression; Baldwin, Williams & Houts, 2004 on PTSD).    
 Beyond these examinations of general interpretation in public and corporate spheres, 
other studies have moved to investigate interpretations of those more immediately involved with 
depression itself—including doctors and mental health professionals; friends, family and 
caregivers; and those individuals facing depression.  When attention is paid to the voices of 
individuals facing depression, it has typically been through survey research--dating back to the 
―Custodial Mental Illness Ideology Scale‖ (Gilbert & Levinson, 1956) to the more recent 
―Reasons for Depression Questionnaire‖ (Addis et al, 1995) and ―Perception of Depressive 
Illness Questionnaire‖ (Manber, et al., 2003). 
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 Where qualitative research has been applied to depression in the past within 
psychology, it has been largely focused on case studies as a way to gain insight into therapeutic 
dynamics.  When attention is paid to the patient‟s views in this way, it has therefore often been 
conceptualized as an exploration of underlying psychopathological irrationality.  Cognitive 
researchers, for instance, have investigated disordered and irrational thought patterns underlying 
psychological problems in order to address these patterns in psychotherapy.  The psychiatric 
compliance literature, as well, attempts to understand the faulty logic of those who resist 
medication (Kirk, 2005; see Navon & Ozer, 2003).  In a recent review of medical compliance 
literature, for instance, Moses and Kirk (2005) note a consistent ambivalence towards medication 
in youth, with large numbers embracing medication and equal numbers resisting it.  Whereas 
some are extremely positive about its impact, others express concern about harmful side effects.  
Even those believing in positive effects often show other concerns about control and identity.   
The historical exception to this pathology-weighted study of patient perceptions and 
interpretations has been the rich autobiographical literature on severe emotional problems, 
including depression, noted earlier.  This literature is enormous, with one bibliography of mental 
illness autobiographies listing literally hundreds of titles (Hornstein, 2003).  Specific to 
depression, one search of Amazon turned up 17 biographical works in the year 2008 alone:   
 Shoot the Damn Dog: A Memoir of Depression, Sally Brampton  
 The Devil within: A Memoir of Depression, Stephanie Merritt  
 Out of Focus...Again: A Journey from Depression to Recovery Through Courage, Love and 
Commitment, Sandy MacDonald and Ann Kochenberger  
 Hide and Seek: How I Laughed at Depression, Conquered My Fears and Found Happiness, 
Wendy Aron  
 Blue Genes: A Memoir of Loss and Survival, Christopher Lukas  
 Gray and Red: An Internal Struggle of Depression and Self-Injury, K. A. Proveaux  
 My Life...Welcome to It: Living with Bi-Polar Disorder (also Known as Manic Depression), 
Ivy Berry  
 Moving On From Depression,  A. Brocklesby  
 Surviving Depression: My Agonizing Struggle with Sanity, Robert L. Hamlett  
 My Sisters Three: A Tiny Glimpse of Abuse and Neglect Viewed Through the Eyes of 
Someone Now Living with Major Depression, Dearis  
 Depression Saved My Life, Brian Michael Joyce  
 Madness: A Bipolar Life, Marya Hornbacher  
 The Other Great Depression: How I'm Overcoming, on a Daily Basis, at Least a Million 
Addictions and Dysfunctions and Finding a Spiritual (Sometimes) Life, Richard Lewis  
 Something In My Childhood: A Personal Journey with Depression, C. Gorrie and A. C. 
McKessock  
 Why I Jumped: A Dramatic Story of Finding Hope Beyond Depression, Tina Zahn and 
Wanda Dyson  
 Silently Suffering with Anxiety, Depression, and Agoraphobia, Julie Auriana  
 Forever the Fat Kid: How I Survived Dysfunction, Depression and Life in the Theater, 
Michael Boyd  
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Unfortunately, this literature continues to be largely dismissed by psychologists as not 
offering a legitimate grounding for knowledge; with one interesting exception (Clark, 2008 
―Depression and narrative: Telling the dark‖), I have seen no systematic attempts to analyze 
themes across autobiographies.  In that unique project, Clark, a professor of English, draws 
together contributors from a number of disciplines to examine ―the stories we tell about 
depression: its contested causes; its gendering; the transformations in identity that it entails; and 
the problems it presents for communication.‖  
On a more optimistic note, there is currently a flowering of interest and activity in diverse 
styles of qualitative research taking place across a variety of problems, including depression 
(Hurst, 1996; Curtis, 2001; Walker, 2001) attention-deficit hyperactivity disorder (Navarro & 
Danforth, 2004) post-traumatic stress disorder (Baldwin, Williams & Houts, 2004), agoraphobia 
(Capps & Ochs, 1995) and eating disorders (Malson, et al., 2004).  In addition, novel areas of 
interpretive investigation are being forged including ―phenomenological psychiatry‖ and 
―hermeneutic psychopathology‖ (Schmidt-Degenhard, 1997; Schmidt-Degenhard & Feldmann, 
2003; see also Mijuskovic, 1996; Hedelin & Strandmark, 2001).   
McAdams (1999) points to an upsurge of interest in narrative beginning in the mid-
1980‘s across multiple areas of psychology.  Figures 1 and 2, created by the founder of a 
narrative psychology clearinghouse on the internet (www.narrativepsych.org) illustrate the 
change over recent decades:    
 
 
Figure 1. Taken from Hevern, V. W. (2004). Introduction and general overview. Narrative 
psychology: Internet and resource guide. Retrieved [March 22, 2004] from the Le Moyne 
College Web site: http://web.lemoyne.edu/~hevern/nr-pbiog.html 
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Figure 2. Taken also from Hevern (2004). (see reference above).   
 
For depression research, in particular, one aspect of this development has been to reverse 
the past gender bias of autobiographical work, which was largely written by men.  Current 
interviewing research has been more directed at women‘s experience, including adolescent 
women (Hetherington & Stoppard, 2002; Gammell, 2004), middle-aged women (Hurst, 1996; 
Scattolon & Stoppard, 1999; Amankwaa, 2000; Scattolon, 2003) and elderly women (Hedelin & 
Strandmark, 2001).  Interviewing studies of depressed men exist, but are less common (Elder, 
1979).  Even with this upsurge in interest, however, the relative contribution of these approaches 
still remains dwarfed by the broader psychological literature on mental and emotional problems 
(Stoppard & McMullen, 2003).   
What is only now being ―discovered‖ in psychology, has long been embraced in the field 
of anthropology.  Medical anthropology, in particular, offers a rich literature about the role of 
diverse cultural interpretations in the experience and treatment of medical problems.  Arthur 
Kleinman (1988) has been a pioneer in his investigation of ―illness narratives‖ and the meaning 
around pain, sickness and healing.  While some dissertations on these issues exist in psychology, 
medical anthropology regularly produces volumes of this kind of investigation, with titles such as 
―medicine as culture‖ (Lupton, 1994) and the ―social and cultural lives of immune systems‖ 
(Wilce, 2003).  These studies explore the interpretive dimension of many physical and mental 
problems (see Hahn, 1995; Telban, 1995; Castillo, 1998; Skultans & Cox, 2000; Finkler, 2000; 
Mattingly & Garro, 2000), including depression.  Anthropologists perhaps also deserve credit for 
pioneering the investigation of professional accounts as narratives, rather than as reflections of 
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undisputed reality they are often taken to be (e.g. Thomas-MacLean & Stoppard, 2004).  Within 
psychology, cultural psychologists increasingly seem to reflect anthropological sensitivities in 
their research of different cultural portrayals of mental problems (see Angel & Thoits, 1987; Tsai 
& Chentsova-Dutton 2008; Amankwaa 2000; Walker, 2001).   
A common thread running across all these literatures—from psychology to anthropology, 
sociology and history—is the reminder of the situatedness of individual experience in these larger 
interpretive frameworks or discourses—called ―narratives‖ in this study.  Rappaport (1998) 
clarifies that narratives are not created ―whole cloth‖—but are, instead, drawn from the larger 
cultural narratives available in communities—called a ―dominant cultural narrative‖ when a 
particular narrative is shared by many people and institutionalized in policies and procedures.  
The biomedical model of understanding emotional problems could arguably be labeled a 
dominant cultural narrative (Crossley, 2003; Landers, 2004).   
As the interpretations of individual survivors of depression are investigated in light of 
this dominant narrative, insights emerge regarding their relationship—namely, the way a 
prevailing biomedical narrative might influence individual decisions and practice.  For instance, 
Gammel (2004) explores how adolescent girls draw on different discourses to make sense of their 
experience—including an ―adolescent girls‘ lives‖ discourse and a medical discourse.  She 
reviews how girls make different strategic decisions to reconcile contradictions between different 
understandings of depression—discarding one account in favor of another, combining 
explanations in seemingly contradictory ways, and sometimes pursuing an integration of ideas.  
She notes that a medical discourse is more likely to be adopted when the depression is judged to 
be severe and when life stressors do not seem to be relevant.  Given the potential implications of 
such narrative patterns for the actual experience of distressed individuals, research such as this 
deserves more attention.   
Stoppard and Gammell (2003) describe a feeling of relief accompanying diagnosis as 
individuals come to see difficulties as depression, rather than personality flaws.  This shift makes 
the depression experience more acceptable to some:  ―[It‘s] the same as any other illness.  You‘re 
depressed; well you‘ve got a bad heart so what‘s the difference . . it was a natural occurrence . . 
People aren‘t ashamed to walk around with diabetes or a heart attack. . It‘s the same thing (p. 51). 
The same authors go on to note that part and parcel of diagnosis for all interviewed was 
adopting a personal understanding of depression as largely a chemical imbalance in the brain.  
Stoppard and Gammell (2003) have explored ―medicalization,‖ the progressive translation of 
problems as diverse as child birthing, adolescent delinquency, homelessness, old age, menopause, 
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and race, into a biomedical language.  Medicalization has also taken place with most major 
psychological problems—including depression.  
This shift in explanation, in turn, has been linked with accepting medical prescriptions—
emphasized by many survivors as an important part of treatment.  Moses and Kirk (2005) note 
that many experience positive ―psychosocial side effects‖ with medicine, including increased 
self-confidence and the alleviation of guilt (pp. 392-393).    
On the other hand, a general reluctance to proceed with medical treatment has also been 
examined in the narratives of depressed individuals seeking help (Karp, 1997).  Through in-depth 
interviews, Karp explored the intense and ambiguous internal process of accepting new 
definitions of self accompanying diagnosis and treatment.  He portrays depressed people as 
engaged in a continuous process of trying to make sense of their experience:  ―the experience of 
taking antidepressant medications involves a complex and emotionally charged interpretive 
process in which nothing less than one‘s view of self is at stake‖ (p. 102).  Moses and Kirk (2005) 
cite a patient interviewed by Goldstein ―I need to know what is my personality and what is caused 
by the pill.  I don‘t know whether my feelings are what I feel or what the pill causes me to feel‖ 
(p. 391). 
Feminist researchers have investigated the way medical treatment and its implicit 
narrative may be potentially disempowering for women.  This includes the suggestion of 
conditions over which people have little or no control, the limited attention to social context, and 
the typical reliance on doctor judgments during treatment.  These qualities contribute to personal 
narratives of depression reflecting minimal personal power.  Moses and Kirk (2005) review 
conflicting conclusions in the literature examining learned helplessness within depression 
treatment, but note a consistent link between conventional treatment and notions of an external 
locus of control.  They explore how psychiatric treatment may undermine autonomy, control and 
a sense of efficacy.  Of course, the experience of depression itself is also experienced as 
disempowering.  A woman interviewed in Stoppard and Gamell‘s (2003) study said:  ―you‘re 
going to have to acknowledge that sometimes, you know, it is going to invade your life . . and at 
times like that you have to ride it out‖ (p. 52).   
Consistent with previous reviews of traditional outcome literature, patient anecdotes, and 
the medical compliance literature, these interview studies confirm a fairly consistent ambivalence 
about medical treatment for depression.  Karp‘s (1997) study examines how this ambivalence 
may change as attitudes shift.  In the majority of individuals interviewed, the initial reluctance of 
patients towards biomedicine is eventually overcome in a process he compares to religious 
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conversion.  He explores how the bulk of individuals experience later disillusionment in coming 
to understand the potential of medication more realistically.    
As reviewed above, those adopting the biomedical narrative often center their 
understanding on physiological responses to medication.  In contrast, those resisting a biomedical 
narrative often turn to the context of daily living as a consistent theme.  Stoppard and McMullen 
(2003) note that rather than seeing depression as an extraordinary event, most women interviewed 
naturally understand their depression as arising in the context of their everyday lives—a normal 
taken-for-granted consequence of life.  These researchers note the disjuncture between this 
indigenous commentary from women and the prevailing biological narrative of what underlies 
depression.   
A central part of a context of daily living, perhaps, is relationships.  For individuals 
experiencing depression, this often includes disconnection and isolation—even when social 
connection is earnestly desired (Karp, 1997).  Susan Hurst (1996) has investigated ―profound 
betrayals‖ from close figures as prompting a demoralization process constituting depression.  
Also common are narratives of families not talking about ―the problem‖—simply not 
acknowledging it.  Individuals hide ill feelings at home, put on a mask, play a role and exhibit 
two sides.  In this case, a professional is welcome relief in order to be able to talk to someone 
about feelings—since it has been too difficult with family or friends.  Finally, those seeking relief 
are rarely made aware of other sources of help—having to request such help or seek it out 
themselves (Stoppard & McMullen, 2003).  
While the literature offers important initial insights into the interpretations of depressed 
individuals generally, there is still relatively little attention being paid to interpretive research on 
medical treatment overall.  There have only been rare investigations, for instance, of the more 
subtle effects of psychiatric treatment on meanings and relationships (e.g., Nevins 1990).  Moses 
and Kirk (2005) lament: 
We know comparatively little about the overall experience of being treated with 
psychotropic drugs. In addition to symptomatic physical changes produced by 
medications, what is the subjective experience . . of taking psychotropic drugs? Are there 
direct or indirect social and psychological effects on esteem, identity, and other views of 
the self?  (p. 387).  
 
For these reasons, additional research on these questions appears to be justified.  Calls 
have even been made to employ qualitative studies as a formal part of the outcome research for 
psychiatric treatment (Crawford, et al., 2002).   
As the dominant biomedical narrative has grown in power, so also have counter 
narratives.  These alternatives vary in how sharply they break from dominant explanations and to 
 17 
what degree they are critical of these explanations; likewise, individual narrators vary in how they 
draw on different, sometimes contradictory narratives.  For instance, many women interviewed 
have positive judgments of medical treatment while also leveraging non-medical ―everyday life‖ 
explanations—including poor interpersonal relationships, difficulty coping with a job, school 
related stress and heavy workload contributing to depression (Stoppard & McMullen, 2003).  
Other individuals, however, adopt fierce anti-psychiatry narratives that rebel against any kind of 
medical explanation.  While variation in narratives across cultures is studied within anthropology, 
there seems to be less research on why narratives within a restricted locale can be so remarkably 
diverse.  The current project aims to understand interpretive differences existing even within one 
cultural location (two states in the U.S.) at one time period.     
 
Theoretical Questions 
As noted above, on a broad theoretical level this study aims to better understand the 
―transactions‖ accompanying the development of diverse accounts of depression and its 
treatment.  Awareness of the relations between narrative and biological/contextual variability 
constitutes an important backdrop for three specific empirical questions described below.  In 
short, each aspect of this transaction is understood as a potential prompt for the active interpreter 
or narrator, who is necessarily encountering and making a constant, ongoing flow of decisions.  
By examining more carefully how narrators adjust their interpretations and larger stories over 
time in the face of evolving conditions, the project aims to gain insight into how narratives come 
to be polarized so sharply.  Furthermore, the way individuals make sense of their experience via 
hypothetically distinct narratives was theorized as having potentially tangible consequences for 
the actual experience of depression—i.e., how are emotional problem experienced and treated 
differently when interpreted and narrated in distinct ways?  Better understanding of these 
interpretive processes is thus proposed as potentially offering further insight into the nature of the 
larger transactions involved in depression, as well as its basic nature and appropriate treatment.  
In all these ways, a more complex social scientific understanding of the ―interpretive event of 
depression‖ is sought.   
 
Empirical Questions 
As a dynamic activity over time, interpretation can be studied in different time periods 
across distinct contexts.  Given this, the research will center around three empirical questions:   
  1. Narrative arrival/creation.  How do these narratives arise?  What resources do 
participants appear to draw on in the initial adoption or formation of a personal narrative?  How 
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are different features of past experiences (physiological responses to medication, reactions of 
surrounding community) taken up to prompt an evolution or disruption of previous 
understandings?  How might narrators adjust differently to these common experiences?   
The process of arriving at a particular narrative was anticipated to be complex—if only 
by virtue of the amount of time preceding it and the possible contributors available.  Sheer 
number of contributors multiplied by the time of life prior to the interview means the amount of 
contributing events may literally be infinite.  While impossible to research, this becomes an 
important acknowledgment to make.  Each individual interviewed has been immersed in a sea of 
emotional states and messages for the duration of his or her life.  These promptings as a whole 
constitute the available ways of thinking, making sense and approaching their ongoing 
experience.  From these available ways of thinking, they have made choices throughout their lives 
of ways to make sense of their current experience.  Sometimes these choices have been made 
explicitly, in a deliberate way.  More often, however, I believe they have been made implicitly as 
a function of living.  Over time, these choices—deliberate or otherwise—have led to their current 
state of thinking and being.  After reviewing the content of participant narratives in Chapters 3-5, 
Chapter 6 will focus explicitly on an analysis of how particular stories appear to be created and 
arise over time.   
2.  Narrative constitution.  What is the nature of differing narratives of depression?  This 
question includes a focus on both what is presented in the narrative and how it is presented:  what 
is the content of these narratives and how is this content structured differently across narratives?   
Once again, after reviewing content of our participant narratives in Chapters 3-5 and briefly 
exploring structural patterns in Chapter 3, I focus in Chapter 7 more explicitly on key issues that 
appear to underlie the most meaningful content differences between narratives.   
3.  Narrative maintenance.  Given adoption of a particular narrative, how is it maintained 
over time?  Once a personal story has formed what are the processes or strategies that contribute 
to its continuity as a narrative?  This question goes beyond the structural nature of narratives 
(how are narratives presented) to ask what particular actions appear to help perpetuate the 
narrative over time.  When narratives are challenged, what strategies are employed to preserve 
the story?  What constitutes these strategies and how do they function to sustain narratives?  
Chapter 8 examines the maintenance of narratives over time.   
On one level, all three activities (narrative creation, constitution and maintenance) appear 
to be inseparable—each fundamental acts of narrating life experience.  On a finer level, however, 
given the dynamic and temporal quality of ―narrating,‖ each may be separated by temporal 
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progression—early events leading to the creation and adoption of a narrative, with later events 
accompanying the present narrative presentation and perpetuating its maintenance over time.     
 The following chapter lays out the methodological design of this interviewing study of 
depression survivors.  Following this discussion, analysis begins with a brief synopsis of each of 
the sixteen participant narratives (Ch. 3).  Next, the text moves to an overarching review of key 
themes across narratives relevant to the three empirical questions.  This thematic review is 
divided into two chapters:  one taking up themes relevant to how individuals come to define and 
interpret the problem of depression (Ch. 4), a second focused on how individuals come to frame 
and interpret depression treatment, with a particular focus on medical treatment (Ch. 5).  
Interview excerpts across this section are arranged in a roughly linear temporal sequence to help 
make sense of the themes more broadly.  Although addressing empirical questions implicitly, this 
section aims to be primarily descriptive— a walk through of interview excerpts relevant to these 
questions.  In the following section (Chs. 6-8) empirical questions are taken up more explicitly:  
how do narratives arise (6), what major differences are evident across stories (7) and how are they 
maintained over time (8).  Each of these final chapters includes more deliberate discussion of 
previously reviewed narratives and themes for both empirical and theoretical questions taken up 
in the study.  In the final chapter (9), implications of findings for the larger discussion on 
depression treatment are explored.     
In order to connect with the rich vein of related investigations, findings will be presented 
alongside insights from other research teams in a way that highlights salient and re-occurring 
themes across the growing literature (Chs. 6-8).  In this way, the presentation also aims to 
contribute to synthesizing of findings from the literature—a need emphasized as critical within 
the qualitative study of medication experience (Pound et al., 2005). Finally, by better 
understanding in what ways depression and its treatment are being interpreted differently, this 
study aims to facilitate a more thoughtful collective deliberation regarding severe emotional 
problems and their treatment (see Schwandt, 1996).             
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Chapter 2 
Methods & Analysis 
 
Methods 
In order to examine interpretive processes associated with depression treatment, this 
study investigates the language of actual depression survivors through the method of 
interviewing.  Interviewing is here approached from within a narrative/interpretive methodology 
that highlights the ―dialogic process of communication‖ and the ―joint construction of accounts of 
social life in conversation and reflection‖ (Schwandt, 2007, p. 195). 
Sampling and recruitment.  The aim of sampling was to recruit those with diverse 
experiences of depression and its treatment, ranging from very positive to very negative 
evaluations of traditional psychiatric treatment.  The key sampling characteristic was diversity of 
treatment experience. I aimed for participants with glowing testimonials of treatment and 
recovery, those with tragic rants against the treatment system, and those in between.  In doing so, 
I sought to explore the broad scope of the continuum of how people evaluate their treatment 
experiences.  My research questions did not necessarily call for differences across other 
demographics, so there was no particular recruiting strategy to gather men versus women, 
particular ethnic groups, and so on (also unnecessary without a goal of generalization across 
groups).  The exception to open recruitment was avoiding interviewing children, youth and 
adolescents (due to both ethical difficulties and sharp developmental differences that were not at 
issue in this study).  I requested permission to recruit subjects in both Illinois and Utah, given 
opportunity and multiple connections in both locations.  Although religiosity was also not 
deliberately selected or queried, ten of the participants, to my knowledge, identified with the 
Church of Jesus Christ of Latter-day Saints (Mormons), with three identifying with other 
Christian groups (Catholic, Evangelical and Pentecostal) and three reflecting no explicit religious 
identification.  As a whole, then, the sample was highly religious and Christian
4
.  (See comment 
at the end of this section on how religion was understood in relation to this study‘s questions).   
Broadly, recruitment was aimed at anyone who had experienced depression at some time 
in his/her life, regardless of degree of exposure and involvement in the system (with no 
requirement that participants had received formal diagnosis or treatment for depression).  Severity 
or exact nature of experienced depression according to official diagnostic criteria was not a 
                                                 
4
 Since Mormons do not consider the orthodox view of God‘s nature or the Trinity to be true, many 
orthodox Christians do not consider Mormons to be Christian.  This demographic statement assumes the 
existence of different viable ―narratives‖ of Christianity.   
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determining factor.  In this way, anyone who self-reported to have experienced ―depression‖ of 
some kind was recruited—both long and short durations and multiple kinds.  My rationale for 
such a broad inclusion protocol was to not exclude individuals who self-identified as ―depressed‖ 
but who, under more exclusive criteria, would have been excluded from sharing their experience.  
This ensured the desired diversity of voices.  Although such diversity may be an obvious 
hindrance in other studies, my own research approach and questions required it.   
The primary criterion for inclusion in the research was thus having  
experienced depression at some point and in some degree.  Reported experience was typically, 
but not necessarily, in the past.  Although participants continuing to fight depression in mild 
degrees were not excluded, when the current distress was of a serious degree, the person was 
excluded from the study (see exclusion protocol listed in ―ethics‖).  Consistent with this protocol, 
I declined interviews with people in several instances who were undergoing intense treatment for 
depression.   
In order to reach a fuller range of stories, organizations advocating for and dissenting 
from psychiatric care were contacted—including the National Alliance of the Mentally Ill (NAMI) 
and to the Alliance to Stop the Influence of Psychiatry in Religion and Education (ASPIRE).  
[ASPIRE is a now-defunct group of lay persons concerned with psychiatry‘s influence in 
dominant institutions of society (see www.aspire.us).  The organization was headed by a Utah 
mother, Cassandra Casey, whose teenage boy killed himself soon after starting Prozac].  Leaders 
of each organization were contacted and informed of the research, with subsequent letters of 
support written for the project (see below).  The purpose of each organization is to educate the 
public about its particular perspective on mental health treatment.  Organization leaders were 
invited to contact possible participants in their networks, briefly describe the research and invite 
their participation.  Flyers were provided with information about the study and contact 
information of the primary investigator.   
In seeking this purposive sample, pluralistic recruitment strategies were employed—
posting flyers at the local public libraries, posting notices to psychology listservs and asking 
acquaintances if they ―knew someone with a story.‖  I anticipated some reluctance as health and 
disease issues are often reported to induce hesitancy in interviewing research (Adler & Adler, 
2003).  For this reason, I sought to ―snowball‖ with every contact—―who else do you know that 
may have a story to tell about this?‖  This became a form of continuous ―sponsorship‖ 
recommended in cases where there is not time for extensive relational groundwork (as would be 
the case in ethnography) (Adler & Adler, 2003).  While doing so, I avoided interviewing persons 
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with close relationship to myself—friends or family.  Most referrals for the study came from the 
help of personal acquaintances (see Appendix A:  Recruitment protocol and flyer).         
While recruitment progressed, I began interviewing participants.  The plan was to 
interview approximately 15-25 persons or until the diversity of experience I aimed to understand 
had been adequately explored.  While there was no pre-set number assumed to be necessary for 
validity (samples in similar studies have ranged from 1-50 interviewees, depending on the goals 
and research approach of the investigators), I planned on regularly assessing whether there was 
―sufficient coverage of experience‖ by analyzing interview data as I went along.  Data generation 
and analysis thus overlapped, with transcription and review of interviews proceeding 
simultaneously with ongoing efforts in conducting further interviews.   
Given the prevalence of depression, finding subjects for this study was not difficult.  
However, in light of the prevailing biomedical view of depression, these snowball recruitment 
strategies were not anticipated to yield as many accounts critical of medication.  While the 
director of the Utah chapter of the NAMI was extremely helpful in putting me in touch with 
participants, it remained remarkably difficult to find individuals from an alternative perspective—
even with ASPIRE‟s help.  Indeed, after conducting 9-10 interviews, I was having difficulty 
encountering the broader diversity of perspectives, and so took steps to deliberately pursue 
greater contact with additional referral sources.  The director of ASPIRE referred me to Anne 
Blake Tracey, leader of another anti-psychiatry organization centered in Utah, the International 
Coalition for Drug Awareness (http://www.drugawareness.org).  When Tracey had no referrals, I 
turned to a third source, Mind Freedom International (www.mindfreedom.org), a prominent ―anti-
psychiatry‖ group across the nation.   After sending an e-mail to their listserv in Illinois, I got in 
touch with two people living in Chicago who were willing to participate.   
As a result of this broad sampling approach, the sample turned out to be notably complex.  
While some participants came from abusive families, others spoke of happy childhoods; while 
most described what appeared to be classic unipolar depression, a few reported clear bipolar 
tendencies.  In spite of these benefits, it is important to clarify that not all depression accounts 
were included.  While not verified through diagnostic criteria, two individuals shared accounts 
that seemed distinct and not of the same fundamental kind as the others—i.e., not serious enough 
to be classified as clinical depression, reflecting ―passing blues‖ easily shaken off.  To have 
included these accounts, I judged, would have pushed the ―diversity‖ of depression narratives so 
far that ―depression‖ would cease to have a common meaning.  For this reason, these accounts 
were only peripherally included in analysis as exemplars of sadness narrated-as-depression 
(leaving the total number of narratives fully analyzed at 14). 
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On the most important criteria—diversity of treatment experience—the sample was 
generally sufficient, although more participants critical of treatment would have strengthened the 
study.  While four participants eventually refused medical treatment, only two of these were 
expressly critical of that treatment.  The majority of participants were either strongly in favor of 
medications, generally in favor, or ambivalent.  As a result, the sample tended towards a 
generally favorable position on medications (much like the general population).  Even among this 
majority expressing favorable leanings towards medications, however, most expressed significant 
ambivalence.  Consequently, the sample could be understood as ranging between 2 
unconditionally in-favor of medical treatment for depression, to 8 ambivalent, but generally in 
favor, to 2 ambivalent, but generally opposed, to 2 unconditionally opposed.  
Two other demographic characteristics deserve some further mention:  gender and 
religious faith.  As noted previously, the sample is fairly religious—especially Christian 
(Catholic, Presbyterian, Evangelical and Mormon).  Although faith clearly matters for how one 
narrates any experience, I did not believe initially that faith would necessarily have much bearing 
on my three main empirical questions nor did I deliberately sample individuals to select for a 
particular variety of faith.  Instead, I assumed that any human being facing depression would 
narrate depression and its treatment in varied ways that could be compared and from which 
interesting insights would come.  That individuals also believe in God (or not), while obviously 
reflecting an interesting aspect of individual narratives, was not presumed to be so influential that 
it prompted wholly different forms or patterns of narratives.  (Another reason for this belief was 
my privileging of questions regarding how psychiatric treatment was narrated—a cultural 
experience fairly universal across other differences).   
Having said all that, it is important to acknowledge that this is a highly religious 
(especially Mormon) sample.  With one major exception, I think analysis bears out my general 
initial assumptions.  As reflected in descriptions of recovery in Chapters 3 & 5, individuals 
referenced God‘s hand and help in multiple ways during their narratives—especially in guiding 
them to healing.  Chapter 8 summarizes the potential role of this faith as a strategy for 
maintaining individual narratives, and later, as an explanation for the high rates of anti-depressant 
use in Utah (moderated by a trust in doctors).  Perhaps the most likely pattern is that conservative 
religion seems to make people more likely to adopt and maintain a biomedical narrative of 
depression—a pattern that has obvious relevance to the study and that I believe deserves further 
attention (my own explanation is included in Chapter 8).  This becomes a notable exception for 
the rationale to disregard religion as a crucial sampling variable.  In spite of this qualification, my 
broader observations to date (hearing and reading many other accounts) lead me to believe that 
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the general findings and patterns presented in what follows would likely be seen across many 
other demographics. 
Given the value on transparency in qualitative research, I would mention my own 
identification as a member of the Church of Jesus Christ of Latter-day Saints (―Mormon‖).  On 
many levels, the Church of Jesus Christ has instilled and shaped what I have come to view as 
important in ways that I value—including, no doubt the questions involved in this study.  Having 
said this, while active in my faith, I have some concerns with how many of my religious brothers 
and sisters have come to approach questions discussed in this study (see Chapter 8).  In terms of 
the interviews, although I did not always reveal my religious faith, those who knew of it perhaps 
spoke more openly of their own spiritual experiences.      
Moving on to other demographics, I similarly did not believe gender would 
fundamentally skew data that aims to document how medical treatment is narrated.  Of the 
original 16 participants, 13 are women.  Although women have well-documented higher rates of 
depression and also seem more willing to talk and share, the kinds of patterns and dynamics I saw 
in male participants like Kyle and Peter did not differ significantly, in my mind, from those I saw 
in female participants, Esther and Sarah, respectively (pseudonyms are used throughout).  Of 
course, if my questions were focused on attending to unique ways men and women narrate 
depression, I believe interesting patterns would definitely emerge.  For questions attending to 
medical treatment, however, I did not assume meaningful differences would necessarily vary by 
gender.    
Ethics.  Multiple steps were taken to minimize potential discomfort or distress—
especially through recruiting procedures carefully designed to exclude individuals who were 
experiencing serious depression.  The goal of my inclusion/exclusion protocol noted earlier was 
to only include participants who were currently stable.  Although persons recruited for research 
may have incidentally been in contact with professionals recently regarding their depression 
(doctors or counselors), when this contact constituted a regular ongoing treatment for depression, 
the person was excluded from the study.   
While formal criteria are limited and no official diagnosis of depression is needed, the 
following basic protocol was used to systematically exclude persons who were currently 
experiencing depression to a significant degree.  While not identifying as a clinical psychologist, 
as part of graduate training in a combined clinical/community doctoral program, I took a class in 
basic psychological assessment and received specific training in assessment for suicide risk.  At 
the time of initial contact, potential participants were asked the following basic screening 
questions prior to confirming their inclusion in the study: 
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“Before confirming your participation, I need to first ask you some basic questions about 
your current situation related to depression before we start.  The reason for this is that 
this research does not apply to all circumstances—and I need to make sure the study fits 
your situation.  There is a chance this study may not be a good match for you.  Will that 
be okay to ask a few general questions about your situation?     
 
(If ―yes‖): “Are you currently receiving any treatment for depression?” 
(If ―yes‖):  “Can you describe how regularly your treatment visits take place?”   
[If treatment was on a fairly regular--weekly/bi-weekly basis--(such as intense 
psychotherapy or psychiatric supervision)--the participant was told the 
following]—―In order to make treatment a priority--as it should be—I won‟t be 
able to include you in this current research study.  Let me assure you that this 
will in no way harm the research, and thank you for being willing to participate 
regardless!‖]   
[If treatment was infrequent or sporadic—such as monthly visits to a primary 
care physician to monitor medication or follow up visits to a counselor twice a 
year—the participant was told the following]—―I want to be careful not to 
interfere with any treatment—which should be seen as the priority.  It looks like 
this won‟t be a problem—but I want to check in with you to make sure.  Do you 
feel okay about participating?‖  [More details about what the study entails were 
reviewed in the informed consent at a later point; this simply functioned as an 
initial, general screening question for those in light contact with professional 
services (typical of many stable Americans and not be interpreted as evidence of 
instability unless further signs indicated otherwise).]  
(If ―no‖—the person did not currently receive treatment for depression, the person was 
asked the following):  Have you been experiencing any significant increase in symptoms or 
struggles with depression currently? [This question represented a secondary screening precaution 
beyond whether the person is in intensive treatment or not, since it is known that a good number 
of people fighting depression do not receive or seek any treatment or help.‖]   
(If ―no‖—there was no significant increase, I confirmed details of their  
participation) 
(If ―yes‖—there was a significant increase in symptoms, I informed them I 
wouldn‘t be able to include them in the research, but thanked them for their 
willingness to participate.  At this point, I explained that getting better is a more 
important focus than research.  I also asked participants if they had considered 
getting help and presented them with information on basic referral sources (the 
same information leveraged in the case of any distress during the interview; see 
Appendix B:  Additional plans in case of distress during interview).   
 
 As a result of this screening, participant stories were largely expected to be chronicles of 
experience in participants' past (with the exception of mild ongoing struggles
5
).  Because 
recruiting naturally targeted people more interested and willing to ―share their story,‖ it was not 
                                                 
5
 While being careful about these exclusion criteria, I sought to avoid the other extreme which would 
unnaturally limit my sample.  Specifically, I sought permission in my protocol to contact individuals who 
were still mildly depressed currently (a vulnerable population).   The goal in doing so was to allow my 
interviewing sample to include voices of these individuals.  Especially given the commonality of relapses 
and the difficulty in defining when depression is actually gone, it seemed important to obtain permission to 
be able to speak with these individuals.   
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anticipated that serious discomfort would be a regular aspect of sharing for participants.  Still, 
participants were monitored throughout the interview to assure that they were comfortable.  Since 
recruiting procedures could have failed to detect a person currently fighting serious depression 
and because even recounting past or mild depression is not without the possibility of real 
discomfort, plans and steps were put in place in case they were needed (see Appendix B).   
The only other risk of note was basic privacy (particularly since experiencing depression 
can be viewed as stigmatizing by some).  In addressing confidentiality, participants were assured 
that recordings made during these interviews would be confidential and secured in a locked office 
when not in direct possession of the investigator and that any publication, report or presentation 
of research that may result from this inquiry would not identify him/her or any other participant. 
Beyond the avoidance of seriously depressed participants, additional basic ethical 
protocols were followed for everyone—including voluntary consent obtained from each 
participant prior to beginning an interview.  Consistent with Adler and Adler‘s (2003) 
recommendation for sensitive interviews to ―be overt about intentions but remain oblique or 
vague about their specific purpose‖ (p. 163), I did not go into detailed description of the exact 
research questions within the informed consent (see Appendix C:  Informed Consent).  Because 
important aspects of informed consent documents often remain obscure to participants, however, 
I made sure the consent procedure functioned as a conversation—verbally highlighting significant 
issues and probing for any questions or concerns.  As noted on our university IRB site, the 
consent process also aimed to "involve answering questions that arise before, during, and after the 
subject's participation.‖  Copies of the consent forms were given to participants for their records.    
While participants gave consent for their own sharing to be recorded and used as data, 
other kinds of data also became relevant.  Several participants offered written material as a 
supplement to their verbal sharing—including pictures from a book that had been influential and 
writing they had done about the subject.  Each gave their permission for the written material to 
likewise be included in the research.  In one instance, family members spontaneously entered the 
interview, adding important elaborations to and exchanges with their mother‘s narrative.  These 
family members also gave their verbal consent for their comments to be included.      
While denying that I was offering any immediate benefit, I acknowledged a general 
benefit of potentially improving the way we respond to depression in communities by better 
understanding how and why people narrate their experiences so differently.  A ten dollar bill was 
offered at the beginning of each interview, alongside an emphasis that remuneration was not 
compensation for their time after the interview is over, but a simple expression of appreciation for 
assistance in the first place.   
 27 
In making follow-up calls, I once again sought to be careful about emotional stability of 
participants, since there was a possibility that participants originally screened for interviews had 
lapsed back into depression in the interim.  Anticipating this possibility, the following three 
safeguards were in place as an expansion of my original protocol for distressed participants:        
a) General screening:  Given the brevity and generality of the call, it was not necessary or 
appropriate to do a more in-depth screening (as done previous to interviews).  Rather, the 
goal was to specifically assess whether a person currently felt well enough to speak.  
Following an explanation of the purpose of the call, I would ask “are you feeling up to 
answering these questions?”  This would function as a general screening which served its 
purpose for the purpose and nature of the call.     
b) Maintaining summary nature of the call:  Importantly, as reflected in the phone script, this 
follow-up call explicitly avoided delving into experiences to the depth of the original 
interview—remaining general enough that it did not elicit very emotional descriptions.     
c) Preparation for worst case scenario:  In the worst case scenario that a past participant had 
now lapsed into a bout of serious depression, I planned to apply step four of the plan for 
distressed participants from the original IRB protocol:  “if responses indicate significant 
challenges in recent experience or increasing level of depression, I will recommend 
immediate contact with a health care professional or some other support in their 
community—for additional assessment and assistance.  If they have no previous contact or 
have interest in additional resources, I will provide information on the following resources as 
well as any additional resources that appear to be relevant” (See Appendix B:  Additional 
plans in case of distress during interview for further details including provider names and 
numbers).     
 
 In spite of these risks, it was concluded that the potential benefits of improved ways of 
understanding and responding to depression were significant enough given the increasing human 
toll of depression in our society.  These benefits outweighed the minimal, inherent risks 
associated with disclosing personal information (discomfort, assuring confidentiality). While 
participants were regularly emotional in recounting their experiences, it never reached a level of 
serious distress which made the emergency protocol necessary.    
Audio files, written notes, and electronic files of transcription were kept secure on a flash 
drive in a locked office when not in direct possession of the investigator.  Digital audio files of 
interviews were coded numerically and kept on a secure flash drive prior to transcription.  Written 
―memos‖ from the interviews were also kept secure.   Data collection was confidential, but not 
anonymous, since I still had the ability to trace responses to subject identities—and retained the 
ability to contact participants at a later date.  These transcribed files, however, were coded with 
numbers replacing names, and thus only identifiable to me.  The identity key was stored in an 
office separate from the files.  Signed informed consent documents were stored in third secure 
location separate from both audio files and identity key.  Once all files were transcribed, these 
electronic text files were also kept secure on a flash drive.  All undergraduates assisting in the 
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transcription process were trained on the importance of confidentiality and the specific ways to 
protect this throughout the research.   
 
Interviewing. An IRB protocol was approved the year prior to the formal launch of the 
dissertation study in order to do piloting of my interview questions.  The interview schedule was 
subsequently refined during this preparatory time through both practice interviews and exchange 
with committee members.  The interview schedule became increasingly unstructured as it 
developed, anticipating that once participants felt comfortable sharing openly, they would need 
only intermittent prompts in relaying their story.  After the initial main question, ―tell me your 
experience of facing depression,‖ possible probes were listed as needed to prompt further 
elaboration into the three central empirical questions.  These probes included: a) questions to 
further investigate events or features contributing to the adoption/formation of a narrative; b) 
questions that prompted further exploration into the nature of the narrative, including probes 
targeting both the content and structure of individual narratives; c) finally, a few probes to prompt 
further discussion of how an individual has maintained their narrative over time.  In practice, 
depending on how much individuals shared from the initial open-ended question, only a subset of 
probes were used for any given interview (See Appendix D:  Interviewing schedule).  
My interview with participants constituted only two short hours of their lives—only a 
brief, concentrated period in which I was able to directly inquire into their current understanding 
of their past experience with depression.  As such, I engaged as best I could to understand how 
they currently thought of their experiences.  As part of my inquiry, I sought to investigate how 
individuals arrived at their current understanding by asking individuals themselves to select 
among past experiences and share relevant contributors to their current understanding.  In 
multiple ways during the interview, participants were asked to comment on influential events, 
persons and aspects of their past experience (medication outcomes, media), as well as to respond 
explicitly to how their perspectives had shifted relative to the past.  Combined, this set of 
questions probed (as much as possible within the limitations of a two hour interview) into that 
individual‘s current perspective on how he/she arrived at his/her current understanding.  
In my IRB protocol, I reserved the option to modify the schedule as the interviews 
proceeded since I expected unexpected dynamics to emerge (Kvale, 1996 p. 100).  After several 
interviews, I saw a better organization for the questions and laid them out in a more linear way.  
As interviews progressed, I also found several questions that were not working and either revised 
them or dropped them entirely.   
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Given the subject matter, it felt especially important to be sensitive to rapport issues.  
Seidman (1991) recommends avoiding extremes of too much versus not enough rapport, arguing 
for appropriate distance on sensitive topics in order to assure answers have sufficient autonomy 
and to avoid a therapeutic relationship.  This caution seemed particularly important with 
interviewing about depression experience.  Indeed, one woman quipped after the interview, ―It‘s 
good to talk, you don‘t charge me.‖ I answered in good humor, ―No, I‘m actually paying you.  Is 
it alright to ask a few more questions?‖ 
  Overall, the tone of participants‘ voice spanned a surprising range both across and within 
interviews--from talking very, very slowly or in a monotone way, to exquisite emotion evident in 
a pained voice, or one that was happy and content.  While selection criteria required the person be 
stable and not currently in intense treatment, pain was still evident in most interviews; the 
intensity of emotion and feeling across stories was striking and humbling to witness.  As 
interviews progressed, I reflected on how participant stories were a real gift; the more I learned, I 
realized that it was a real honor to witness them.   
After passing my preliminary examination Wednesday, May 11, 2005, I submitted a final 
IRB proposal in order to receive approval to begin formal research by June.  In the meantime, I 
revised my dissertation proposal based on feedback from the dissertation committee—structuring 
it around the three empirical questions reviewed earlier in the introduction.  In August of 2005, 
after receiving approval from both the IRB committee and my dissertation chairs on the revised 
proposal, I began conducting narrative interviews in Utah.  Participants were contacted directly 
by the investigator and invited to participate in an interview at a time and location convenient to 
them.  Half of the interviews took place at an individuals‘ place of residence, with the remainder 
happening at multiple locations, depending on what was most convenient for the participant.  
Two interviews happened at work sites, one at a park, one at a church, one at a library and two at 
the psychology building.   Individual interviews took place face-to-face and were audio recorded.  
For the main interview, I decided to try to avoid phone exchange, believing the costs would 
outweigh their benefits for the questions I was asking.  One interview, however, had to be 
finished on the phone when face-to-face time ran out.  All original interviews took place between 
July and December of 2005 in Utah and Illinois.  Nine interviews were conducted by the end of 
the summer before returning to Champaign.  Six more interviews took place over the coming two 
months in two Illinois cities—Champaign-Urbana and Chicago.  One more interview took place 
in Utah in December, 2005.  
As noted previously, the decision to stop interviewing was connected to my early, 
ongoing analysis of the interviews to date.  As interviews progressed, I monitored the tenor and 
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themes of interviews and attempted to adjust additional recruiting to target more areas not yet 
sampled.  While this led to a broader diversity of stories, there was a growing realization that the 
variety of stories was literally endless—realizing that my goal was not to make sure my sample 
was broad enough to capture as much of the variety as relevant to my questions.  When, in my 
last cluster of interviews, I found three individuals with views more critical of traditional 
treatment, I concluded my sample had reached sufficient qualitative diversity.  Even in a sample 
of fourteen individuals, I came to realize that powerful insights could be gained from even just a 
few stories.   
There were sixteen participants:  10 participants from Utah and 6 from Illinois.  There 
were 10 interviews in the Salt Lake Valley, 3 interviews in Champaign and 3 interviews in 
Chicago.  The average interview time was 1 hour, 31 minutes, with a range from 39 minutes to 
3:05 hours (a mode of between 1 and 2 hours).  The total time across interviews was 24 hours, 23 
minutes.   
Interviews were tape recorded for transcription purposes, which took place beginning in 
fall of 2005 over the next nine months with the help of six undergraduate students:  Diana Brahm, 
Mary Moore, Kim Brookens, Nate Walsh, Jesse Taylor and Asma Siddiqi.  There were 199 single 
spaced pages of transcription (average of 12.5 pages per interview).  In supervising the 
transcription, students were instructed with the following basic guide:  ―Aim for a transcription to 
be quality in really capturing what was said:     
 In general, try to capture everything said on the transcript—including significant silences  
or gaps.     
 Record these meaningful gaps with a series of periods.  
 Example:  “The thing about my father is he . . . I don‟t know, you know?”   
 Record significant emotions heard on the transcript in brackets [sigh] [crying] . . use 
whatever word seems to describe the emotion!  (;  
 Use periods to naturally reflect the endings of their thoughts (rather than the 
„grammatically correct‟ endings)—i.e. follow the flow of their thoughts.” 
 
As I read through transcribed texts to code them, I simultaneously listened to the 
interview through headphones.  In this way, I was able to conduct a general quality check on the 
transcription itself—correcting it in places where significant errors were made.   
Personal memos were also recorded throughout the process of interviewing.  Schwandt 
(2007) describes memoing as an ―analytic procedure . . for explaining or elaborating on coded 
categories . . captur[ing] the thoughts of the inquirer while he or she is engaged in the process of 
analysis.‖  He adds specifically that ―memos are conceptual in intent, vary in length and are 
primarily written to oneself.  The content of memos can include commentary on the meaning of a 
coded category, an explanation of a sense of pattern developing among categories, or a 
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description of some specific aspect of a setting or phenomenon‖ (pp. 188-189).  My memos 
included notes of possible themes, key issues based on participant insights, aspects of interviews 
that stood out and excerpts of verbatim quotes from interviews—as well as beginning hypotheses 
and conclusions to test in later analyses.  These were transcribed for use in an early phase of 
analysis, suggesting avenues to pursue in more comprehensive analyses (see analysis section for 
details below).    
 
Analysis 
Fundamentally, I view analysis as a continuation of the interview conversation—a 
seamless extension of the exchange with participants‘ words.  Rather than just asking questions 
and listening once, qualitative research is constituted by multiple waves of listening, hearing and 
thinking about responses.  In this way, it makes sense to think of ―waves of analysis‖—with the 
first wave of analysis happening during the interview itself (see ―memos‖ above), with multiple 
waves following.   
Broadly, I take a philosophical hermeneutic approach to analysis, which sees 
interpretation and language as inseparably connected to the observable, empirical world.  From 
this perspective, as delineated in the introduction, humans are understood to make sense 
continually of their experience as they navigate surrounding circumstances—in this case, active 
engagement in interpreting encounters with depression (Lewis, 1995).  As meaningful 
physiological and contextual conditions change over time, individuals make ongoing choices in 
how to think and be, adjusting overall interpretations in the process.  In contrast to strong 
constructivism or realism, however, hermeneutics sees language as neither ―reflecting‖ nor 
―producing‖ experience, but instead partially constituting it (Taylor, 2002).  As a viable 
alternative to both essentialist realism and anti-realist relativism, a hermeneutic approach to 
research—including within qualitative inquiry—has become increasingly common within 
psychology (Martin & Sugarman, 2001).   
Consistent with these portrayals, a hermeneutic analysis of depression narrative moves 
beyond an attempt to grasp the ―objective experience‖ of depression itself (i.e. ―factors 
contributing to the problem‖) to understand how individuals frame and interpret/narrate the 
experience.  In this way, rather than seeking a reality ―behind‖ the narrative—i.e. ―what really 
happened‖ (whether medication works or recovery is possible), understanding is sought for the 
way individuals come to make sense of happenings through distinct interpretive frameworks. 
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This analysis section is divided into two sections—first, an explanation of the 
analytic plan established before the study and second, a summary explication of how the 
actual analysis played out over time. 
 
 Analytic plan: Seeking answers to the three empirical questions.  
Overall analysis for the research project involved careful exploration of the three 
empirical questions reviewed earlier:  How are distinct narratives created (or how do they 
arise)?  What constitutes the essential nature of narratives (including meaningful 
differences between them)?  And how do these narratives appear to be subsequently 
maintained by individual interpreters? 
    1.  The creation of stories:  How do these narratives arise?   Before inquiring into the 
nature of narratives, assessment first targets how current narratives came to be—exploring 
evidence for what led to the creation or adoption of the narrative.    How did individual narrators 
speak of arriving at their current understanding—including any events (with doctors, biology, 
community or media influence, etc.) that ―had an impact‖ on them or ―taught them‖?  How did 
different narrators make sense of various physiological and contextual aspects of experience 
(starting medication, family interactions) and how might these aspects have contributed to the 
overall evaluation of the experience they adopt?   The anticipation was that many factors would 
be involved in the adoption of a personal narrative—interaction with community members, 
professional helpers, good or bad physiological responses to drugs, and so on.  Given this, 
analysis aimed to investigate how narrators navigated through multiple (often conflicting) 
prompts in settling on their current account of depression and its treatment—the ―complex and 
emotionally charged interpretive process‖ Karp (1997) highlights in studies of individuals 
seeking to understand their depression experiences (p. 102).  In this process, were there episodes 
that appear to have galvanized the current narrative—turning points leading to the adoption of the 
narrative?  How do some narrators come to portray their experiences in medical terminology 
while others reject the same? (and vice versa)  Were there conditions that seem to make adoption 
of a medical narrative more likely than others, such as the severity of depression?  (see Gammel, 
2004).      
 Implicit in understanding how a particular narrative arises is grasping what came 
before it.  This includes both previous understandings that may have been modified or rejected 
and critical events that may have prompted these decisions.  To what degree were current 
narratives preceded by other articulated ways of understanding experiences? (i.e. did participants 
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describe their interpretations changing over time as their experience developed?).  Were there 
episodes that appeared to have unsettled these past narratives--perhaps prompting evolution 
towards its current state?  If so, what were these turning points like?  In light of these past 
understandings, how did individuals appear to embrace their current narrative?   
 Importantly, this analysis also aimed to attend to both cognitive and emotional 
experience.  Was the process of narrative acquisition primarily characterized by reluctance and 
ambivalence, relief and excitement, or perhaps a mixture of emotions?  A special focus of 
analysis was investigating the adoption of particularly polarized (and emotional) narratives of 
participants.  Were there patterns in how these narratives are adopted or rejected—perhaps similar 
to Karp‘s (1997) articulations of conversion and disillusionment in his interviewees?   
After reviewing memos from interviews, several themes were selected in ―how did they 
arrive at their current understanding‖?  Particular attention was then given to these themes in 
coding—such as events where an individual was influenced by a particular community member, 
by a book or other media, by events related to their biology (with doctors or medicine) and by 
traumatic events.  After illustrating trends in actual verbatim text across Chapters 3-5, Chapter 6 
examines explicitly themes in how stories appear to arise over time.   
 2.  The nature of stories:  What is the nature of differing narratives of depression?   
After examining how a particular narrative appears to arise over time, this question focuses on 
how participants are currently thinking about and framing their experience.  Clearly, any 
narrative itself is complex and may be analyzed in a variety of ways.  As reflected in interview 
questions, the following aspects of individual narratives were examined:  Where most basically 
do individuals see depression as coming from?  How is the role of biology seen by individuals?  
What is the role of abuse/traumatic experience?  What reportedly leads to recovery?  What does it 
mean to ―get better‖?   
 More broadly, analysis relevant to this question included attention to both the content and 
structure of the narratives—moving from a basic content analysis of ―what is being said‖ 
(narrative content) to a more sensitive narrative analysis of ―how this is being said‖ (narrative 
structure).  The following questions were important from the outset of the study:   
   a. Story content. First, were there patterns in the content of narratives?  Three areas—
biology, agency and context--were of particular interest: 
    i) The interpretation of biology and depression.  This refers to how participants speak of 
biological aspects of their condition and how this changed over their experience of depression.  
This may range from a full adoption of a language of biological bases for depression, to a mixed 
reception of this language, to a complete rejection of this language.  Alternatively, there may be 
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multiple ways of talking about biological contributors—with meaningful differences between 
them.  In cases where psychiatric drugs are used, the following issues were earmarked as 
important to analyze:      
 How often do narrators attribute improvement or deterioration to a primarily biological 
change (response to the drugs) versus something else (life experience, relationships, the 
depression itself)?   
 How are uncomfortable effects of the drugs portrayed in the narrative—especially the milder 
discomforts such as numbness?   
 What is the person‘s lay definition of ―getting better‖?  What is their personal definition for 
when a medication ―works‖?   
 
ii) The interpretation of agency and depression.  This refers to how individuals generally 
speak of having capacity to manage, resist, or be free of depression in the course of their 
experience (and how this changes over time).  This includes biology talk, but goes beyond it—
ranging from an ―intrinsic locus of control‖ highlighting their personal agency, to an ―extrinsic 
locus‖ emphasizing external determinants (as well as to middle ground combinations of agency 
and constraints) (see Stoppard & McMullen, 2003).  This quality will be reflected in how they 
talk about what depression is, how it began and whether or not it ever ultimately ends.  Are 
improvements and downturns in depression attributed to areas within their control or outside of 
their control?   
iii) The interpretation of context and depression.  This refers to how the person generally 
talks about surrounding contextual factors.  I was particularly interested in how participants 
would speak of their community context.  Sarason (1974) called on community psychologists to 
make ―sense of community‖ a central focus of research and practical attention.  This sense 
encompasses feelings of ―belonging, identity, emotional connection, and well being‖ (Fisher, 
Sonn, & Bishop, 2002).  I sought to understand how participants interpret their sense of 
community over the course of the depression—including feelings of belonging, identity and 
emotional connection.  Do they report relationships growing stronger or weaker through the 
experience of depression?  Did taking a medication affect their relationships at all?  Where has 
the individual gone for support over the course of their experience?  Whom has he/she trusted and 
relied on (and how has this changed over time)?  To what degree does the person rely on 
professionals versus the natural community?  How well do they judge members of their natural 
community as understanding and empathizing?  
b. Story structure. Besides examining basic narrative content, I also planned to 
investigate the structure of stories—how each individual presented and framed his/her experience.  
This would include attention to structural elements in how the story is organized or ―packaged‖ 
and how the tale is developed—i.e. plot, characters and themes (Coffey & Atkinson, 1996, p. 57-
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58).  Where is primary attention focused in the narrative—to ‗everyday life,‘ to biological 
changes, to professionals?  Who are the main characters and how do the basic ―plots‖ compare?   
After illustrating trends in actual verbatim text across Chapters 3-5 and briefly reviewing 
structural patterns, Chapter 7 examines more in-depth meaningful differences in the nature and 
content of differences across participant stories.  (As reflected in this Chapter 3, direct 
examination into the narrative structure itself was much less extensive than other types of 
analysis.  For reasons described there, investigation of narrative structure across accounts 
ultimately remained only at a most basic level).   
 3. The continuity of stories:  How are narratives maintained?  I was lastly interested in 
exploring what processes contribute to the narrative being maintained over time.  This analysis 
extends the previous exploration of narrative structure (how narratives are presented) to examine 
how particular presentations function to perpetuate the narrative over time.  What constitutes the 
active strategies that reinforce or cement particular narratives and how do they function to sustain 
them?  These may include denial, reliance on authority, resistance, and intense dedication 
characteristic of ―conversion‖ (Karp, 1997)—as well as basic choices in whether to discard one 
account in favor of another, combine them in seemingly contradictory ways, or pursue some kind 
of integration (see Gammel, 2004).   These strategies may become especially evident when 
participants discuss events that challenged their understanding.  In these instances of challenge, 
how did narrators interpret experience to preserve their stories?  What aspects of narratives serve 
to immunize narratives against change or further entrench them?   
As noted in the literature review, individual engagement in experience is not solely a 
cognitive affair.  Analysis of this question thus addressed emotional aspects of narrative 
maintenance.  For instance, how might emotional ―clinging‖ (Karp, 1997) to biomedical 
interventions cement a particular narrative?  On the other extreme, how might fierce anger against 
psychiatry stabilize a certain counter-narrative?  Beyond structural aspects of the narrative, 
analysis on this point has aimed to address contextual and biological aspects of the experience 
that may be contributing to maintenance. Are there patterns of physiological or contextual 
experiences (particular responses to medication or family reactions) accompanying the sustaining 
of a particular narrative over time?  How are ensuing experiences taken up to reinforce 
narratives?  After illustrating trends in actual verbatim text across Chapters 3-5, Chapter 8 
examines explicitly themes in how stories appear to be maintained over time.       
To be clear, any themes identified in these questions areas are not reflective simply of the 
objective occurrence of events or experiences, as would be the case if analysis had centered on 
event-based questions such as ―how many resisted medication?‖  Neither, however, are these 
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themes mere interpretive patterns, as would be the case if analysis had exclusively centered on the 
question, ―how are participants framing/interpreting their experiences?‖  While both of the above 
questions play into the overall analysis, themes identified in the upcoming chapters largely center 
on the interplay between interpretation and experience across accounts.  In addition to asking 
how varied experiences are being interpreted across accounts, analysis explores the 
circumstances, contributors and processes associated with these interpretations arising and being 
maintained over time.  These latter questions require attention to nuanced patterns in the interplay 
between common experiences and interpretations over time.  In this way, the themes identified in 
upcoming chapters systematically articulate evidence of salient patterns in how particular 
interpretations arise and are maintained by participants over time.   
 
Analytic process:  Phases in the examination.  Moving on from the analysis plan, how 
did examination actually proceed?  After completing interviews and transcription, analysis began 
gradually over the coming year, with an analytic structure for chapters beginning to coalesce late 
in 2006.  During this period, I listened to the interviews while reviewing the transcripts, then 
coded the interviews (as detailed below).  Finer-grained analysis of these codes began in 
November and December, with follow-up clarification/update calls to participants taking place 
one year later in early 2008.  During this time, I finished writing up results, submitted a draft to 
my co-chairs, and revised this draft based on their feedback towards preparation for my defense.     
As noted earlier, analysis proceeded in ―waves‖—ranging from memos in the interview 
itself, to early analysis of the memos transcribed to produce a preliminary coding tree, to 
comprehensive analysis of the interview text based on this coding tree.  Descriptions below 
review early- to mid-analysis and writing decisions, then finally the summative decisions made 
on how to analyze and frame the results.     
            1. Initial analysis:  Making and examining memos.  Memos recorded during interviews 
were transcribed and analyzed for each participant, including first of all, salient patterns and 
themes within each individual.  Next, I identified ―things to look for‖ more broadly across 
accounts, including preliminary conclusions on salient differences and commonalities in stories.   
Many of the specific ―codes‖ used in the formal coding tree were generated in this initial analysis 
of memos.   
 2. Main formal analysis:  Coding of transcribed interviews, followed by analysis within 
codes.  As a rough initial coding ―tree‖ was organized, the second formal wave of analysis began 
as this framework was applied to the transcribed interview text.  Rather than remain ―set,‖ this 
coding tree evolved throughout the analysis as additional codes were generated and some initial 
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codes were abandoned—expanding and elaborating upon the rough initial coding frame.   In 
addition, I would record additional memos as I coded—keeping a blank document open where I 
would write additional insights, comment on particular verbatim excerpts coded, or make note of 
anything not fitting in the current set of codes (and not calling for the creation of an additional 
code).   
 Since there are many ways to approach coding, it is important to clarify how I 
approached the actual task of coding.  For a sample of participants selected randomly or in a way 
representative of the larger population, very often coding centers on identifying the frequency of 
particular ideas or themes.  As noted earlier, however, rather than aspiring to general 
representativeness, my sample was purposively selected to maximize variation.  While the range 
of views was consequently diverse, certain views were not reflected as much as others; only two 
participants (of 14), for instance, were strongly concerned with psychiatric treatment, with the 
majority generally favorable to medical treatment or ambivalent.  Given this set of views in the 
sample, basic frequencies did not appear to be as valuable a part of analysis.     
 For this reason, more than the frequency of particular themes, coding primarily aimed to 
capture the variety of themes available—exploring the nature and qualitative differences between 
accounts.  For instance, I sought to explore varied reasons cited for resisting medicine and 
wanting to taper it.  Overall, I found different participants offering unique insights and lessons 
across accounts.  While one individual elaborated on her sharp ambivalence about treatment, 
another shared exquisite detail about his growing conviction of the importance of medication.  As 
a whole, this group of participants offered a rich variety of views and emphases—a smorgasbord 
which seemed a good match with a thematic, qualitative approach. This kind of an approach to 
thematic inquiry is consistent with the way Karp (1997, 2006) has analyzed his interviews with 
depression survivors.  
To concretize the approach I have taken, a tangible comparison is helpful.  If depression 
treatment interpretations were African wildlife, this project would be an attempt to identify the 
kind and varieties of species (and perhaps glimpse something of how they came to be different), 
rather than an attempt to ―chart the prevalence‖ of different species.  I looked to other kinds of 
studies—large-scale surveys of public attitudes, for instance—as more well-positioned to assess 
the quantitative scope of a particular interpretation.  (As evident in Chapters 6-8, many of these 
broader survey studies form an important backdrop for my final analyses as well). 
Throughout analysis, I sought to be careful of perhaps the greatest danger of qualitative 
research:  over-eager self-narration of others‘ stories —―using them‖ to justify the researcher‘s 
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own views.  Was I really listening to what experience means to them, or just ―overlaying‖ my 
initial analysis?   
Typically, this danger is addressed through attempts to be objective and control one‘s 
own subjectivities in different ways.  In this case, rather than seek to escape my a priori views, I 
sought to acknowledge my own interpretations as a critical and inescapable backdrop for analysis.  
Specifically, I began this project with concerns with the general societal confusion about medical 
treatment, and questions about whether the medications were really helping or not.  I also 
wondered as to whether medical treatment might potentially prolong depression in the long-run.       
While acknowledging the role of researcher pre-understandings in this way, they need not 
set the ―agenda‖ for analysis.  That is, the fact that I began with these pre-understandings did not 
mean my analysis had to center around finding evidence to fit my views.  On the contrary, 
acknowledging researcher views at the outset, allowed, I believe, a more transparent and public 
accounting of whether and how these views were open to being tested and challenged in the study 
itself.  In other words, if an audience knows what a researcher‘s general inclinations are, they 
may adequately judge whether the study was an honest and fair examination of the subject matter 
(in spite of these biases).     
As another way of holding myself open to being contradicted, I adopted a particular way 
of engaging text in which expectations are held ―gently‖ enough to allow the text to jump out and 
teach the researcher—a kind of ―dialogue with the text.‖  As noted in the introduction, this project 
centers on both theoretical and empirical questions.  Overall, transcripts were analyzed in a 
dialectic fashion—moving back and forth between ―tracks of analysis‖ theoretically and 
empirically (Alford, 1998).  In other words, as I examined how data informed my empirical 
questions (nature, adoption and maintenance of narratives), I ―zoomed out‖ to explore 
implications for larger theoretical questions (nature of depression transactions; nature of 
depression).  From this perspective, analysis was about letting go of rigid pre-categorizations in 
my immersion in text—letting myself be taught.   
My specific methods of doing so varied.  Sometimes I would cut and paste a paragraph of 
text that puzzled or challenged me into a blank document, then begin writing my thoughts and 
questions in an attempt to find an interpretation-of-their-interpretation that was satisfying.  Other 
times, I would actually dissect a piece of text, getting close up and taking it apart, looking at its 
parts.  As noted previously, throughout analysis, I continued to memo about ideas that came to 
me during the process—both in direct encounters with the text (interview events, coding 
transcripts) and in random moments unassociated with the dissertation.  
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Preliminary themes were created from this preliminary analysis of memos, with 
additional ones added as coding continued.  Eventually 30 coding categories were created and 
classified into clusters to facilitate the progression of the coding process.  There were 648 coding 
references total, and 16 possible sources cited.  A detailed description of nodes, their meaning and 
the number of references and sources for each node is elaborated in Table 1: Meaning and 
frequency count of interviewing nodes.  After coding was completed, analysis moved to a more 
fine-grained analysis within codes, examining the various patterns across comments.  The 
following five chapters (3-7) are all dedicated to the sharing of resulting patterns and conclusions 
from interview analysis.   
           3. Final analysis:  Examining the broader meta-story.  As part of this final analysis, I 
wrestled with how to make sense of diverse interviews of people with such remarkably complex 
and variable experiences.  Originally, my intention had been to compare whole narratives.  Since 
accounts were so diverse, however, and limited to 14 people, I opted against comparing them 
exclusively or primarily on the level of ―whole narratives,‖ relying more centrally on thematic 
analyses instead.  The exceptions to this are Chapter Three‘s synopses of all narratives and a short 
section in Chapter 7 examining overall narrative structure.  In this way, most of the analysis of 
narratives is carried out in a thematic way, rather than a traditional structural/functional approach.  
Eventually, I settled on two primary ways of trying to capture and present my understanding of 
this complexity:   
First, I sought to identify themes of major events highlighted within participants‘ 
narratives, especially those that seemed relevant to the formation and perpetuation of those same 
narratives.  These ranged from vignettes of initial confusion at facing depression and early 
influential encounters with friends and family, to moments of personal crisis and varied 
experiences of medical treatment.  After identifying these patterns or themes associated with 
events, I decided to order them (in Chapters 4-5) within a general temporal framework according 
to what point in time they seemed to be relevant to the adoption and maintenance of particular 
depression interpretations (rather than merely listing them thematically with an arbitrary 
ordering).  In this way, glimpses of broader patterns could be seen across stories.  Although in a 
sense, the contours of a ―meta-narrative‖ across stories may be evident, I resist claiming to 
identify an underlying, essential ―story of stories.‖  Instead, this chronological, linear structure for 
presentation serves as a helpful backdrop to organize and make sense of the most salient, 
meaningful characteristics of individual stories and patterns across accounts (both similarities and 
differences).     
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Once again, to be clear, it is important to emphasize that the themes which follow do not 
reflect the ―full story‖ across participants.  As explained above, this was not my aim.  Instead, 
since my particular questions relate to the experience and interpretation of medical treatment for 
depression, I gave preference in analysis to any events, circumstances and interpretation that 
seemed relevant to this area.  I decided that an attempt to address ―all interesting themes‖ at once 
would distract and dilute from the central line of questioning.  Given this, other more peripheral 
themes, such as the role of community, are addressed in other places, such as the broader 
discussion of the nature of narrative/interpretive differences in Chapter 7.     
Since a central value of this research is the richness and power of stories themselves, the 
central chapters (3-5) focus primarily on accounts of participants themselves—serving as a 
platform for individual narrators to largely
6
 speak for themselves.  As will be observed in these 
chapters, the complexity, diversity and richness of individual accounts is remarkable.   
Even while attempting to maximize interview text and minimize my own interjections in 
these early chapters, of course, my own voice as a researcher is never absent.  I alone made 
decisions about which text to include, how to order it in general themes and present it in a 
temporal ordering.  In this way, my own research voice comes through in this first section as the 
narrator of the skeletal ―meta-narrative‖ across accounts, a counterpoint voice walking through 
this meta-story like a tour-guide.  
 To be clear, however, little effort is made in these initial three chapters (3-5) to explore 
and parse out explicitly what these key events and narrative aspects have to say about the broader 
empirical questions.   Instead of analysis and deliberate discussion, this first section centers more 
on the text itself, aiming to offer a felt and concrete sense of individual narratives in both close-up 
examination of two whole accounts and then across narratives.  Although empirical question are 
each addressed within this section, possible answers remain largely implicit, allowing explicit 
attention to remain largely focused on the actual narratives themselves.  The presentation of 
individual synopses within narratives (Ch. 3) and themes across narratives (Ch. 4-5) becomes a 
dual platform for the analytic chapters that follow.   
Subsequently, later chapters explore insights relative to empirical questions more 
explicitly.  In individual chapters, the adoption (Ch. 6), constitution (Ch. 7) and maintenance (Ch. 
8) of stories are addressed, with overt attention to what key events and aspects across individual 
narratives might mean for each of these issues.  It is in these chapters that the implications of 
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 I say this while acknowledging that a goal of having participants speak for themselves completely is 
impossible, unless I deny the role of my own interpretations (even in these first descriptive chapters, they 
underlie the design of the study, the formulation of its questions, the choice of which comments to 
highlight, how to cluster quotes, how to order them, etc.) 
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narrative patterns for the broader empirical questions are examined in an explicit way.  In these 
later chapters, findings from this study are juxtaposed with insights from the broader literature on 
treatment interpretations/perceptions in a montage or ―patchwork of voices‖ (Rich, 2006, p. 286).   
This structure reflects roughly the ―results‖ and ―discussion‖ format of traditional 
research reports.  The first section (Ch. 3-5) largely centers on the ―showing‖ of narrative 
excerpts relative to the adoption and maintenance of particular narratives both thematically and 
within individual accounts.  The final section (Ch. 5-8) moves to a more overt ―telling‖ of what 
these excerpts might mean for the adoption, constitution and maintenance of depression 
narratives.  ―Discussion‖ in the traditional sense thus emerges in the latter section, culminating in 
the final conclusion section (Ch. 9).      
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Chapter 3 
Summarizing Individual Narratives of Depression and its Treatment: 
“So tell me your story. . .”   
 
This and the subsequent two chapters describe the actual narratives themselves.  This 
review is carried out in two ways.  First, in this current Chapter 3, a brief synopsis of each 
participant narrative is presented--a summary sketch of how each individual essentially sees 
his/her experience with depression and its treatment.  Second, in Chapters 4 and 5 salient themes 
across participant narratives are presented.  Subsequent analytic chapters draw on these three 
more descriptive chapters in discussing more overtly how narratives arise and are maintained 
over time.  
To preface this chapter, three qualifications are noted.  First, rather than summarizing 
what a person ―experienced,‖ these synopses attempt to summarize how each individual generally 
packages or narrates what they experienced.   Second, rather than convey an in-depth, detailed 
narrative analysis, the following chapter simply reviews synopses reflecting basic sketches of 
individual accounts.  The reasons for this are that a sample of 15 felt too small to form the basis 
for very compelling comparisons across whole narratives.  Also, I thought that thematic analysis 
across accounts (the focus of Chs. 4-5) would better capture the insights needed to inform my 
main empirical questions.  Third, because diverging interpretations for the medical treatment of 
depression are central to this study‘s questions, how individuals see medication within their 
overall narrative is privileged in what follows (relative to how they see all kinds of other aspects 
of their depression experience).  This was an additional reason for relying on thematic analysis 
more than that of full-narratives, with the latter arguably more appropriate when equal emphasis 
is given to all possible aspects of a narrative (i.e., how individuals narrate psychotherapy, 
surrounding friends and family, etc).         
While some stories were relayed in a coherent, flowing narrative, others shared their 
experience in disjointed bits.  Among other things, this difference may have reflected how often 
individuals had received the opportunity to share their story previously (with several admitting 
they had shared their story in forums on multiple occasions).  Another difference was reflected in 
the amount of insight and self-understanding individuals seemed to have into and about their own 
story.  While some individuals offered a running commentary of serious contemplation on the 
events being relayed, others primarily conveyed details of the events themselves, with much less 
self-interpretation.   
 43 
Pseudonyms are given to each person.  Since a great deal of verbatim from each person 
will be shared, and since these excerpts are scattered across seven chapters, I hope names may 
also assist readers in discerning individual story-lines across chapters.  In order to protect their 
identities and maintain confidentiality, I also avoid sharing too many details of demographics or 
extraneous background information of participants.  Instead, synopses reflect summaries of key 
themes and highlights from each participant‘s narrative.  To conclude this chapter, a brief analysis 
of the narrative structure across accounts is given (with a more extensive analysis of narrative 
content awaiting Chapter 7).   
 
Individual Narrative Synopses 
 Laying aside two individuals excluded from analysis (see section below, participants 1 
and 14), the following summaries reflect snapshot accounts of individual narratives of depression 
and its treatment.   
 (2) Elaine:  This married woman in her 50s, with grown children, spoke very slowly with 
dramatic, emotional language and deep pain still evident in relating her account of facing bipolar 
depression and anxiety.  Much of Elaine‘s depression narrative referred to a mixture of ebbing, 
but ongoing confusion and fear.  To begin, she elaborated at great length on the intense confusion 
she experienced at what she was initially experiencing when depression first hit.  This included 
reports of personal perplexity at no seeming explanation for the emotional paralysis of 
depression, as well as emphasis on the confusion of surrounding friends and family as a burden 
for her as well.  The pain and confusion got so bad that she joked to her brother that she wanted to 
get in an accident—prompting family pressure to seek treatment.  The doctor‘s explanation of 
chemical causes for depression relieved her confusion and she experienced an almost miraculous 
initial effect of her first anti-depressant in helping her cope with and handle her emotions, as well 
as sleep well for the first time in a long time. 
 After this climax, she related the effects of medication fading and the long search to find 
the right next medication and dosage level that would duplicate the earlier effect.  She also 
expressed intense fears about the future—especially what she would be like without the 
medications.  Although recounting her first encounter with depression as a time of intense stress 
(raising seven children, running two businesses and going back to school), her external 
environment remained largely in the background of her narrative of facing depression—with her 
attention given to how she came into contact with doctors, what the medications had or hadn‘t 
done, and what she hoped they would do for her in the future.  Although still searching for a 
 44 
return of the treatment relief, frustrated with the number of current medications and expressing 
some interest in tapering, her story remained one of general redemption
7
 by treatment.     
 (3) Camille:  This middle-aged married woman with younger children also spoke slowly 
and quietly about her experience with anxiety and unipolar (seasonal) depression.  Similar to 
Elaine, Camille spoke frequently of the emotional burden on her, associated with surrounding 
family members‘ confusion.  In her case, she was directly challenged as to the reality of her 
experience—including insinuations that she was just lazy and should ―snap out of it.‖  Camille‘s 
account seemed to center more around the trauma of these kinds of comments—reflecting a story 
of being a victim of this surrounding stigma.   
Similar to Elaine, Camille found the biomedical explanation to be deeply relieving—even 
prompting her to travel to California to receive a SPECT scan providing visual evidence of her 
biological deficit.  If there was a protagonist/hero figure in the story it was this practitioner, 
effectively addressing the antagonists (those critical of her behavior).  Although having mixed 
results with medication, she was largely comfortable continuing treatment.  In the face of 
surrounding stigma, it was biomedical diagnosis, rather than medical treatment itself, that seemed 
to function as Camille‘s major vindication and redemption.    
(4) Sarah:  This middle-aged woman with older children spoke in an animated, energetic 
way about her experience facing and managing post-partum depression and occasional anxiety.  
The beginning of depression in Sarah‘s story was a period after a pregnancy.  Like Elaine, Sarah 
recounted poignant moments of confusion both personally and for loved ones about what she was 
facing.  Similar to Camille, Sarah highlighted being questioned by her ex-husband about the 
nature of depression—and contrasted this with unconditional support from friends and other 
family members.  A first turning point came when a neighbor friend introduced the idea that 
depression could be caused by a chemical imbalance.  Though initially fearful of the related 
notion of chemically treating depression, this ongoing relationship was mentioned multiple times 
throughout the narrative.  Sarah emphasized her own surprising aggression toward her children as 
a climactic, crisis moment prompting her to seek treatment.    
A spiritual experience in the hospital was a turning point in accepting medical treatment 
and believing she was called to help others facing depression learn to do the same.  This was a 
second turning point in her story—reporting that it galvanized her commitment to continue 
treatment.  Although her initial experiences on medication were not as dramatically positive on 
                                                 
7
 As detailed in Chapter 6, ―redemptive‖ sequences have been defined by narrative researchers as ―an 
affectively negative or bad life-narrative scene . . . followed by an affectively positive or good outcome‖ 
with ―the good ultimately redeem[ing] or salvag[ing] the bad that precedes it‖ (McAdams & Bowman, 
2001).     
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others, she vividly recollected the first really good sleep she had after starting a second drug.  In 
addition to her family, the influential neighbor was the major protagonist in her account—helping 
to reassure her and help her stay the course after experiencing difficult states concurrent with 
treatment (her ex-husband being the major antagonist).  Although Sarah also spoke of learning 
major lessons as part of her recovery, it was her evolving openness to and relationship with 
medication that occupied the foreground in her narrative.  Sarah‘s story centered on the process of 
overcoming her own resistance and fears regarding anti-depressant medication through a series of 
events that gradually cast away her ignorance in the process of coming to a personal acceptance 
of medication as key to her recovery.  A major part of that embrace was becoming an advocate to 
help educate others.  Along with Peter‘s story related below, Sarah‘s account went beyond the 
typical pattern of redemption to an especially vivid account of conversion to medical treatment.   
  (5) Victoria:  This middle-aged married woman with one small child spoke quietly and 
deliberately of her experience with unipolar depression.  Like others, Victoria highlighted the 
confusion of depression and initial struggle to explain it.  A first turning point came, like Sarah, in 
a conversation with a friend who encouraged her to seek medical treatment.  Although 
acknowledging some difficult side-effects, her emphasis was on dramatic initial improvements in 
emotional control on the medications.  At a point where side-effects led her to consider tapering, 
she spoke of a second turning point/defining moment of being taught by a doctor that she should 
be grateful that she could be on medications the rest of her life.  In a pattern seen with Sarah and 
Peter as well, Victoria spoke of learning to deal with major life changes, while retaining a major 
focus on medication itself.   
She spoke often of her husband‘s amazing support for her.  He, along with an influential 
neighbor, were cast as protagonists in the story—with God being emphasized as the main 
protagonist throughout (no major antagonists).  In a way very similar to Sarah, Victoria spoke of 
a divine hand she saw as guiding her first to diagnosis, and then to the right doctors and treatment 
levels.  Like Sarah, she also emphasized a sense of calling to share what she had learned with 
others.   Two climaxes of her account both involved painful moments emotionally and physically 
where, in both instances, help came that she saw as miraculous.  Although not as intense as Peter 
and Sarah‘s telling, Victoria spoke of a redemption through treatment that included a long process 
of conversion as well.   
(6) Lucy: This younger married woman in her twenties shared an especially painful story-
-spanning vicious abuse as a child, to a terrifying burden of depression and other severe 
emotional problems later on, including auditory hallucinations, attention problems, obsessive-
compulsive disorder (OCD) and bipolar depression.   In the middle of her early abuse, she 
 46 
recounted being taken to the doctor and put on Prozac.  Although critical of her doctor for not 
picking up on the abuse, Lucy herself also consistently downplayed the role of past abuse in her 
ongoing emotional problems.  Instead, Lucy‘s story centered on the experience of seeking a 
correct diagnosis and finally receiving better treatment support.   
A turning point was when she was introduced to a mental health advocacy organization 
that helped educate her about depression.  Subsequently, a major theme of her story was the 
failure of surrounding professionals to accurately identify her correct diagnosis and supply 
adequate treatment (mentioning several friends who killed themselves due to a lack of treatment 
as well).  In different ways, then, bad doctors were the antagonists of the story. Three times 
during the interview, Lucy mentioned the lack of a proper diagnosis and consistently emphasized 
her suffering as needlessly resulting from not ―getting med levels right‖ in the last three years.  
The experience of receiving a correct diagnosis, although described as rocking her identity in 
profound ways, was clearly a defining moment of her account.  One good doctor and her mother 
were mentioned as protagonists of the account—offering her the support she needed at the right 
times.  A climax of the story was her mother rushing home at the right time to find her after she 
had cut her wrists.  Although Lucy acknowledged difficulties with the medications and questions 
about biomedical explanation, she also became an advocate for the medical treatment of 
depression and had frequently shared her story with others to encourage them to seek help.  In a 
way similar to Elaine, although Lucy had some ambivalence at the level of treatment relief, her 
story remained one of general redemption by treatment.     
 (7) Jill: This middle-aged married woman with older children related an account of 
facing unipolar depression for many years.  In spite of a ―dread‖ at being tied to pills, the 
combination of a local woman killing herself and aggressive behavior to her children lead her to 
become fearful and reach out for help.  Like Elaine, Jill spoke of receiving a diagnosis as 
comforting--especially being able to offer an explanation to surrounding family members.   
Although mentioning a positive impact of her anti-depressant, she spoke even more of 
sexual side-effects and her lack of being able to ―feel deeply‖ in a spiritual sense (the latter, a 
theme that arose several times).  Overall, Jill‘s narrative reflected striking ambivalence about 
treatment.   At the same time she expressed conviction that recovery wasn‘t possible without 
medication and encouraged psychiatric treatment for others in her family, she struggled to justify 
the same for herself and remained, in her words, ―sitting on the fence.‖   
Like Victoria, Jill recounted a doctor encouraging her to be thankful she could be on 
medication for the rest of her life.  In contrast to others, however, Jill‘s initial resistance to 
medication did not appear to abate.  Rather than a long process of conversion, Jill‘s account 
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reflected a long process of limbo-like ambivalence and tension.  In a way similar to Elaine and 
Lucy‘s lingering frustration (but more intense), Jill‘s story seemed to have less of a definitive 
end—instead, remaining open-ended in the presence of ongoing worries, questions and resistance.  
Among those who spoke of medication as having lifted them to some degree, Jill‘s redemption 
account was the mildest.  As she started feeling better, her desire to taper would frequently return, 
although failing in her occasional reported attempts to do so.   
Aside from a brief criticism of public figures (Tom Cruise) who criticize those taking medication, 
there were no major antagonists.  Encouraging family members, including children and her 
husband, were protagonists.   
(8) Debbie:  This middle-aged married woman with children recounted a long fight 
against dysphoria and anxiety associated with challenging times.  After being offered Prozac as 
part of a study, she tried it and reported feeling like ―Superwoman‖ with energy to do everything 
she wanted (a climax to her story).  After these initial effects faded, she joined Elaine in detailing 
a journey of trying to find a drug and dosage to duplicate Prozac‘s original effect.  Similar to Jill, 
Debbie‘s narrative of depression treatment largely centered around ambivalence—wondering out 
loud at one point why she could convince others of the importance of antidepressant medication, 
while struggling with the notion herself.  Also parallel to Jill, Debbie related desires to taper that 
ended in failure.  For her, one such attempt was another turning point, as she saw emerging 
turbulent emotions as a return of depression; subsequently, she went back on her medication, 
convinced by the experience that her depression was undoubtedly chemically-based.  Although 
not as intense in her questioning as Jill, Debbie‘s account was almost nearly as centered on 
ambivalence and reflected the second weakest story of redemption via treatment.   
 (9) Robert:  This married man in his twenties described facing emotional downs his 
whole life—particularly unipolar depression and anxiety during times of great stress.  Although 
struggling with blues much of his life, it was during his religious ―mission‖ that he started to be 
especially bothered by it and was recommended by his religious leader to try medication (a first 
turning point).  After a scary period of considering suicide (second turning point/climax), Robert 
recounted his family pressing him to begin treatment.  A series of these difficult, stressful 
experiences were emphasized as prompting the emotional turbulence he experienced.   
Compared with his reported skepticism regarding early treatment, it was the noticeable 
impact of a later medication that began to change Robert‘s mind (third turning point).  In the 
pattern of Sarah, Peter and Victoria (but to a much less intense degree), Robert‘s story reflected a 
redemption via treatment following a conversion process of coming to embrace his crucial and 
ongoing need for medication.  Although Robert continued to highlight the role of stressful 
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situations, like others, the medication was emphasized as the major solution.  Aside from a 
supportive family, no major protagonists or antagonists were mentioned.   
 (10) Peter:  This single man in his twenties had also faced emotional problems his whole 
life—including challenges with panic, anxiety and unipolar depression, as well as some attention 
difficulties. Peter was the only participant that emphasized early confusion with depression as 
much as Elaine—―why was I feeling this way!?‖  Like Sarah, Elaine and others, he subsequently 
experienced significant relief from biomedical diagnosis.  He remained, however, reluctant to try 
medication until a major break-down at his workplace lead him to a willingness to ―try anything.‖  
This break-down moment was both the climax and turning point to Peter‘s story.   
After commencing treatment, he reported experiencing huge improvement—with 
improved emotions directly correlated with an increase in dosage and coming to feel his best on 
its maximum dosage.  Peter spoke of remarkable support from protagonists such as friends and 
family, and highlighted help from God multiple times as well (like Sarah, Kellie and Victoria).  
Although also reflecting on personal changes involved in recovery, for Peter, medication was 
clearly emphasized in the foreground as the basic building block on which other components of 
recovery rested.  Alongside these other changes, it was the results of finally giving medication a 
chance and the process of coming to an acceptance of treatment (like Sarah & Robert) that 
occupied the centerpiece of Peter‘s narrative.   With Sarah, Peter‘s account likewise went beyond 
the typical pattern of redemption to an especially vivid account of conversion to medical 
treatment.   
 (11) Fern:  This older divorced woman with grown children spoke of long-term 
dysthymia associated with stressful occasions—especially, the serious marital trauma of her 
husband‘s unfaithfulness and eventual abandonment after many years (major antagonist/climax).  
Unlike many other accounts, the grief and pain of this stressful experience for her children and 
herself occupied the foreground of her story.  While generally ―not a medication person,‖ Fern 
spoke of betraying her ―personal code‖ at one point and seeing if anti-depressants would help.  
After experiencing some benefit in avoiding negative thoughts for a period, she started to feel 
out-of-body and less control.  This upset her enough to stop medication for good.  This whole 
experience was related as a minor, secondary event, compared to the tremendous emotional cost 
of her husband‘s betrayal on the family.  While there were major turning points related, she did 
speak of finding help and some degree of redemption in spiritual experiences.     
 (12) Kyle:  This middle-aged married man with children recounted relatively recent 
experiences with bipolar emotional challenges—severe bouts of depression accompanied by 
manic episodes during stressful times.  Like Elaine, Kyle recounted his first bout with depression 
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as having a defined beginning, being ―smacked‖ by depression in the middle of a busy period 
where he was trying to complete renovations on his home by himself.  During a period of mania, 
his wife signed papers to forcibly commit him to a hospital for treatment.  Combined with 
negative psychiatry encounters prior to entering the hospital, this uncomfortable experience was a 
climax that raised many critical questions in his mind.  Although Kyle recounted a period where 
he tried medications with some degree of success, a turning point came when he experienced 
fairly severe side-effects and went to consult with a psychiatrist.  When the doctor suggested they 
add Wellbutrin to the current treatment, Kyle felt uncomfortable and said, ―I‘m not going to be a 
poly-pharmacy experiment.‖  He left the appointment and began to read literature from those 
critical of psychiatry.  While challenged by family members in his rejection of treatment (wife 
and father were antagonists), Kyle reported growing interest regarding non-medical treatment 
options (in her support to introduce him to alternative sources, his mother was a protagonist).   
Similar to Michelle, a turning point for Kyle was coming across a professional who 
believed he could recover.  After adding Omega-3s and adjusting his life-style to prioritize good 
sleep, Kyle‘s depression subsided.  Ending up as a volunteer advocate to educate people on the 
harms of psychiatry, Kyle‘s story reflected a kind of mirror opposite to Sarah‘s account, above.   
That is, rather than overcoming resistance and fears regarding anti-depressant medication, Kyle 
related a series of negative experiences with medication that galvanized growing and deepening 
opposition to psychiatric treatment.  Similar to Sarah, Kyle‘s account likewise reflected a story of 
having ignorance gradually cast away through learning experiences, albeit in the opposite 
direction and with an outcome of increasingly resisting medical advice.  In contrast to many other 
redemption accounts, Kyle essentially saw his redemption in avoiding psychiatric treatment, 
alongside his embrace of non-medical interventions for his depression.  Like Esther, the primary 
narrative plot was the learning process following negative treatment experiences—with personal 
research leading to a rejection of the system and the embrace of an alternative.   
(13) Michelle:  This older divorced woman recounted facing severe recurring depression 
and other delusional problems after a long, abusive marriage.  Similar to Lucy, Michelle 
mentioned little or nothing about the previous abuse in her account—instead focusing on the 
nuances of treatment and overall recovery.  Alongside several suicide attempts, her long process 
of treatment included multiple hospitalizations and electro-convulsive shock therapy (ECT), with 
doctors eventually concluding she had no chance of ever living independently.  She spoke of that 
moment as a defining moment, that lead her and her family to believe for many years that 
recovery was not possible (the doctor who told her she would not live independently was an 
antagonist).  A climax of her account came at an in-patient facility that showed some trust in her 
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to choose whether she could leave.  This was followed by another defining moment/turning point 
of later hearing the story of a woman in a state even worse than she was, who had nonetheless 
come to live independently again thanks to a recovery program.   
Michelle went on to emphasize her experience in the same Copeland ―Wellness Recovery 
Action Plan‖ program as her literal redemption to regain the capacity to live again independently.   
Like Kyle, simply hearing that recovery was possible was a major turning point in her account.  
Those individuals who introduced her to the possibility of recovery were the clear 
protagonists/heroes of the story.  Rather than coming to an acceptance or rejection of medication, 
the primary plot of Michelle‘s story was coming to an acceptance of the idea of true recovery.  
While medication continued to be seen as important to her stability, it was the recovery program 
alongside other physiological changes (e.g., stabilizing her blood sugar) that were emphasized as 
the thrust behind her improvement.  From this backdrop, the central theme and overall emphasis 
of her account was the importance of remaining open to recovery for those facing severe 
emotional problems.  Like others, she had become an advocate for those struggling with 
depression; rather than advocating regarding medical treatment specifically (for or against), her 
educational efforts centered on spreading the message that recovery was possible.   
 (14) Esther:  This middle-aged woman spoke during a brief interview of depression 
emerging with life stressors.   From the beginning, her encounters with medical treatment for 
depression were recounted as categorically negative—especially in having labels imposed, her 
questions dismissed and medication pushed.  A climax in the story was when doctors decided her 
concerns were a sign of her mental illness and sought to contact her family to assist them in 
medicating her.   
It was during this time, she reported starting to research on the internet for herself.  She 
described recovery from depression as happening fairly easily—with no specific source of 
redemption, per say, except for a vivid emphasis on escaping ―the system‖ in which she had been 
―ensconced.‖  Overall, these experiences were related as explanation for why she had become 
actively involved in advocacy efforts to educate others about the harm and abuses within the 
conventional mental health care system.  Medical professionals and, indeed, the entire treatment 
system were framed as the antagonist within her account.  Like Kyle, the primary narrative plot 
was the learning process spurred by negative treatment experiences—with personal research 
leading to a rejection of the system and an embrace of alternatives (see participant #15 at the 
end).     
 (16) Kellie:  This single woman in her early 30s spoke of experiencing symptoms of low-
level depression for much of her life.  Like other participants, Kellie spoke of initial confusion 
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personally and in terms of explaining her feelings to her family.  Also like several others, she 
related a process of coming to accept that she had a problem and needed help.  Although 
expressing some appreciation for the legitimization of diagnosis, Kellie was unique in reporting 
never following that diagnosis to accept any medical treatment.   
In spite of relating intensive encouragement from her brother in medical school to begin 
medical treatment, she resisted based on negative previous experiences with hormone medication 
and a feeling that depression would eventually resolve over time.  Like Fern‘s account, 
medication thus remained largely in the background.  With the support of a remarkably trusting 
and supportive family, Kellie sought to understand other reasons for her depression and reported 
gradual healing over time.  Similar to Sarah and Victoria, Kellie emphasized divine support as 
key in her recovery—although, in her case, God‘s guidance never directed her towards medical 
treatment.  Rather, Kellie spoke of learning major life lessons at different points throughout her 
experience that were critical in her recovery.  Her family and God were major protagonists 
emphasized in the story.  The overall theme of her account was the gradual, unfolding nature of 
recovery.  Given the consistency of her views over time and relative stability of her recovery, 
there were no major climaxes or turning points recounted.   
 
Individual Narratives Not Used in Analysis 
 (1) Veronica:  This divorced woman in her late twenties shared an account of difficulties 
associated with the death of her father and other challenging transitions in her life.  Many aspects 
of the narrative suggested the ―depression‖ she faced was non-clinical and qualitatively different 
than other depression accounts.  For this reason, as explained in the previous chapter, her account 
was eliminated from formal analysis.  
 Although recounting difficult events such as her father‘s death and a divorce, her 
comments never pointed towards depression invading her life as in other narratives.  Instead, she 
spoke of ―getting depressed‖ almost casually.  The pain expressed in her account, compared to 
the others, seemed qualitatively different—as did the challenge of getting better (her recovery 
occurred fairly rapidly and easily—like a cold).  In other accounts reviewed below, by contrast, 
life events almost necessarily remain in the background given the intense pain of something else 
concrete and terrifying occupying the foreground.
8
    
                                                 
8
 Beyond the simple confirmation that ―depression‖ means different things to different people, this 
illustrates on a deeper level, a critical qualification in the study:  a reaffirmation of something existing 
clearly ―beyond the narratives‖—i.e., that depression is not something made by interpretations alone.  
Among those critical of mainstream psychology, it is popular to emphasize discourse or surrounding 
institutions as ―making people sick‖—and sometimes suggest mental illness is a ―myth‖ (Szasz, 
 52 
(15) Alicia:  This single woman in her twenties spoke more of her experience facing 
eating disorder than that with depression, which was relatively brief and associated with one 
traumatic event.  Different aspects of her story suggested her depression was likewise not 
clinical—and did not seem to appropriately compare with other participant narratives.  Along 
with the first participant, her account was also eliminated from formal analysis.   
 
Basic Narrative Structure Across Accounts  
As a first basic way of examining the nature of narrative differences across individuals, 
we turn to basic patterns in how each individual presents and frames his/her experience—i.e., 
structural elements in how the story is organized or ―packaged.‖  
As reviewed in Chapter 3, the themes and overall plots of narratives differed in 
interesting ways.
9
  Since the invited focus was their experience facing depression, stories were 
naturally oriented to their journey facing and seeking to overcome this problem.  Most every 
account subsequently reflected some kind of general ―redemption‖ sequence (McAdams & 
Bowman, 2001)—although the source of this deliverance varied in striking ways.   
For the majority of participants, their account emphasized medical treatment as the 
central player in redemption.  This emphasis ranged from the strong, enthusiastic testimonials of 
Peter, Sarah and Victoria to milder endorsements from Jill, Lucy and Debbie.   
For a few participants, acceptance of such treatment was fairly easy.  For the bulk of 
others who reported experiencing resistance, their accounts could be seen as variations around 
one similar plot:  the journey towards fully accepting medication—translated for some as ―finally 
giving treatment a chance.‖   While most had reached that point, those who had not were still 
aiming for that goal.  Against this broad theme, the details of barriers varied—from personal 
                                                                                                                                                 
1960/1994).  While attending to surrounding cultural factors and raising critical questions are both 
important, I believe this should be done without questioning depression itself.  There is an external reality 
to depression without which the surrounding interpretations explored in this study would be irrelevant.  
While the way we frame this reality is one of my questions, this inquiry should not be confused with 
contesting the reality of depression itself.  Amidst an exploration of diverging ways of interpreting 
depression, the entity of depression itself need not be seen as just a construction of these interpretations—
―merely a construct‖ or a ―figment‖ of the discourse.  On the contrary, it is very real and tangible—so much 
so, that when other individuals such as Veronica and Alicia who have experienced a sorrowful time come 
to label and narrate this same event as ―depression‖—it simply does not fit.  While drawing on similar 
language and terms, these personal narratives do not succeed in transforming a different experience into the 
kind of experience related by others.  To conclude, this becomes an illustration of how interpretation is 
being approached in this study:  inescapably linked to the ―brute‖ reality of surrounding context, bodies and 
depression itself.   
9
 Note:  As outlined elsewhere, my study design and specific questions lead me to conclude that thematic 
analysis would reveal answers better than whole-narrative comparisons.  For this reason, only brief 
analyses are made below in how different tales are developed (see Chapter 7 for more extensive look at key 
issues underlying meaningful narrative differences).    
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resistance to family resistance and from improper diagnosis to incorrect prescriptions.  In spite of 
such differences, a primary theme of these narratives was the growing acceptability and centrality 
of medications in resolving the problem of depression.   
 In addition to accepting and receiving medication as a primary solution, related themes 
included seeing the warning signs quicker (prevention) and spreading the truth about mental 
illness to the general public and families who misunderstand.  Many participants also spoke of the 
importance of making changes to one‘s thinking, learning life skills and the importance of loving 
community. 
 A small sub-sample of participants likewise spoke of redemption, but as coming from 
other primary sources.  For Fern, it was healing from an abusive relationship with God‘s help 
(11); for Kellie, it was receiving divine help to learn key lessons and make changes contributing 
to her depression (16); for Kyle it was tapering off medication and changing his lifestyle in terms 
of stress, nutrition and sleep; for Michelle, it was finding those who believed she could recover 
and getting her blood sugar stabilized (13); for Esther, it was largely becoming free of the mental 
health and medical system itself (14).  Beyond the general theme of resisting the medical system, 
other related themes included personal changes, learning skills and the importance of loving 
community, as well as additional physical treatments that may impact depression.   
Across accounts, the main actors ranged widely, with roles often portrayed in either a 
positive or negative light.  Overall, those largely favorable towards medical treatment for 
depression spoke of positive ―hero‖ figures that included a religious leader and mother 
encouraging treatment (Robert); friends and neighbors encouraging treatment (Victoria & Jill); a 
brother who is a doctor (Camille), good doctors (Lucy), validating, supportive parents (Sarah, 
Victoria & Peter), and a friend who faced depression before (Sarah).  For this same cluster, 
negative ―villain‖ figures included an apathetic husband (Elaine & Sarah), others critical of 
psychiatry—i.e., Tom Cruise or surrounding family/friends (Camille, Sarah & Jill), bad doctors 
seen as not giving competent treatment (Lucy, Michelle), an abusive husband (Michelle) and an 
abusive father (Lucy).   
In contrast, for those generally unfavorable towards biomedical treatment, positive ―hero‖ 
figures included critics of psychiatric treatment (Kyle), family members who introduce alternative 
interventions (Kyle) and supportive family open to the individual thinking for herself (Kellie). 
Negative ―villain‖ figures included those encouraging treatment (Kyle & Esther), professionals 
pressuring individuals into treatment (Lucy, Kyle & Esther), patient advocacy groups 
encouraging treatment (Kyle), and a neglectful/abusive husband (Fern).   
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Chapter 4 
Interpreting the Problem:  Making Sense of the Monster.  
 
            The previous chapter reviewed brief synopses of each individual narrative.  
Accompanying this within-narrative review, I now turn to thematic results across-narratives.  
The following two chapters begin to orient the study more explicitly towards the main empirical 
questions—exploring key experiences and events across accounts standing out as especially 
relevant to the adoption, constitution and maintenance of particular depression interpretations.   
Narratives of depression reflect characteristics similar to any story.  Just as any tale 
involves an antagonist and protagonist, so also depression stories may be approached in two 
parts:  the development, engagement and interpretation of the foreboding challenge itself 
(―problem definition/interpretation‖) and the ensuing engagement and interpretation of helpful 
answers (―solution definition/ interpretation‖).   This chapter examines key events associated with 
interpreting the problem of depression itself, while the next explores events associated with 
interpreting possible solutions for depression.  More specifically, this chapter includes the 
following areas and events identified as critical to the formation of narratives, called ―problem 
interpretation‖ themes:  1) The brutal reality of depression; 2) The added burden of confusion; 3) 
Answers offered; 4) Formal diagnosis & 5) Moments of climax.  
Rather than list these key experiences only thematically, they are presented below 
temporally in a way that highlights similarities and differences in helpful way.  Once again, with 
the focus on offering a felt and concrete sense of individual narratives, no effort is made in these 
chapters to explore and parse out explicitly what these aspects have to say about the broader 
empirical questions—leaving this task to the overt analytic chapters which follow (Chapter 6-8).  
With ―results‖ remaining largely implicit here, the attention in the next two chapters remains 
focused on the nuances and richness of experience reflected in the actual narratives.        
Furthermore, whereas later chapters hone in more directly to contributors and strategies 
in the adoption and maintenance of narratives, these chapters take up themes across accounts in a 
broader fashion.  That is, themes range from basic snapshots of reported experience to specific 
patterns of how these experiences appear to be interpreted.  In this way, while these chapters are 
largely focused on what participants reported to have happened in their stories, subsequent 
chapters focus more exclusively on the nature, contributors and implications of how these 
happenings are variously framed or narrated.    
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Theme 1. The brutal reality of depression:  “ I thought it would kill me—all on its own.” 
 The terrifying pain that hijacks and saps its victims constitutes the basic backdrop against 
which individual narratives unfold.  On average, participants spoke of facing some form of severe 
depression for an average of 9 years (range from 1-18 years).  Reports often centered around 
states of overwhelming paralysis—―like I was trying to swim through mud‖ (7);  ―Day to day 
tasks like putting the wash from the floor into the washer . . . overwhelmed me and I would just 
start bawling‖ (2);  ―indescribable effort to force myself to do anything‖ (4); ―even simple tasks, 
uh, just become . . . terrible, just unbearable (9).  Elaine specifically linked this inability to 
accomplish anything to mental chaos—―My thinking at the time was really log jammed I mean I 
couldn‘t produce coherent sentences practically and I had ideas that were just . . coming from 
everywhere; I couldn‘t put rational thoughts together. . . [I felt] totally out of control as a person.‖  
She continued, ―I just felt sick. I just felt like I was just wired just, totally, like I was just coming 
totally unglued all the time. Like I just couldn‘t handle it, you know . . . and I was just spending 
days just bawling too, you know, just crying my eyes out and just totally, totally, totally stressed 
out‖ (2).   
Two individuals spoke of lashing out at others—―I‘ll say just about anything to just about 
anybody‖ (10); ―Everything would make me frustrated . . I would snap, start snapping at 
everybody and irritated all the time. . You cry all the time; you‘re snapping all the time, hateful 
(laughs), you‘re tired, it‘s just a terrible thing. Terrible‖ (7).  Elaine commented on another 
common response:   
Just a desire to..to just bury yourself… To just get away from everything . . . To escape 
life, to escape thinking about what . . . needs to be done, what could happen, what… what 
is happening that I should be doing something to help with. . .What‘s going on in 
life...just be…away, away from everything. And not have to think about anything, and 
not have to interact with (sigh) people . . . you kind of almost wish you weren‘t there at 
all. . . .
10
 I feel like, I mean, I could sleep for days when I was going through the worst of 
it--just to get away, to not have to think about life.‖ (2) 
 
 Three others spoke of escaping the pain through sleep or watching television— ―Crying 
comes easily, sleeping all the time‖ (7); ―I didn‘t want to get out of bed ever‖ (9).  I forced myself 
to get out of bed . . . I‘d come home from work, I‘d eat some dinner, and I‘d just go lay down 
(16).  Peter said, ―I was shutting myself off from everything.  I would watch TV, but not really, 
you know.  It was just noise in the background; I was not taking anything into my mind; my mind 
                                                 
10
 Throughout, I have sought to be precise and consistent in my use of ellipses.  Reflecting prevailing 
standards, four ellipses (. . . .) suggests material removed between two sentences (in a few rare cases, one 
sentence has been reordered to come before another to reflect a more coherent overall statement); three 
ellipses (. . .) indicates material removed within one sentence and two ellipses (. .) generally reflects a 
natural pause or break by the speaker himself or herself.  Italics reflect the emphasis of the speaker as well.   
 56 
was so locked down in depression‖ (10).  Peter further related his deliberate attempts to isolate 
himself and avoid attention from surrounding friends and family:   
As I got older, I learned not to lash out but I learned to turn inward . . and so what I 
would do is I would walk around with my sweatshirt on and my hood pulled down, you 
know . . .I‘m a big guy and I‘m easy to pick out of a crowd.  But you‘d be amazed how 
easily a person can disappear if they want to . . . the right combination of clothing . . 
colors and keeping your head down you can become a ghost and I did and I got very, 
very good at it. (10) 
 
Others likewise spoke of ―faking‖ it to friends (16)-- ―There was still part of me that was 
struggling all the time.  Um, even though sometimes on the outside it seemed like I was doing 
pretty well‖ (9).  The true pain, however, was readily acknowledged—called ―hopelessness‖ (11), 
a ―black hole‖ of ―no hope for the future‖ (12) and ―free falling‖ into a ―a bottomless pit‖ (13).  
Robert said, ―it numbs you and becomes the point that… you forget what being happy is like‖ (9).  
Camille said, ―It‘s like being enveloped in this thick darkness that no light can penetrate. . . . I 
would call it hell, like being in hell. There‘s no joy, there‘s no…no matter what you do you can‘t 
find happiness.  Who wants to live that way?  I wouldn‘t wish that on my worst enemy‖ (3).  The 
most graphic depiction came from Lucy, as repeated earlier, a younger single woman who 
compared depression with her early encounter with vicious child abuse:      
I have had very bad beatings to the point of unconsciousness, ripped, broken and arms 
taken out of socket and that compares nothing . . doesn‘t even begin  to be the pain that 
became every day, just right here . . like this thing that wouldn‘t come off—that made it 
hard to breathe . . like, I would rather have, every day, just hours and hours of people 
beating the shit out of me than to been where I was just inside.  It hurt that bad.  It hurt so 
bad that there were times I thought it would kill me—all on its own, that I wouldn‘t have 
to do anything. (6) 
 
 
Theme 2.  The added burden of confusion:  “I couldn‟t figure out why” 
  While the brute pain described above is an inescapable starting point for these stories, it 
is an aspect of depression fairly well-acknowledged.  At closer-view, there is another burden 
evident across accounts that is more subtle and far less recognized generally, namely,  intense 
personal confusion at what one is facing.  Not everyone mentioned confusion, such as those who 
had felt blue for so long they assumed it was a part of life (Kellie & Robert) and others who had 
experienced obvious reasons to be depressed (Fern, Lucy).  7 of 15 participants, however, spoke 
of some kind of confusion faced at the outset of their experience with depression.  Said Peter, 
―The thing that made it so frightening (pause) and so . . difficult to handle was that I couldn‘t find 
where it came from.  It seemed to come out of nowhere . . I would wake up feeling sad . . or wake 
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up feeling angry and I couldn‟t figure out why.  How can you be sad when you wake up?  Nothing 
caused you to be sad!‖ (10).  Elaine similarly recounted:   
It‘s always the same thing, you know. There‘s nothing really to say.  There‘s no 
explanation; there‘s no reason that you‘re depressed really, I mean, like. . . I know that 
when I lost my little grandson, when we went through that [Sudden Infant Death]--and 
that‘s the most horrific kind of thing in the world, I mean, my daughter put him down for 
a nap at nine a.m. and he was gone at quarter after ten, you know--and I had all these 
daughters that were just heart-broken and I was heart-broken and that was a very 
depressing thing, but I‘ve been far more depressed over absolutely nothing, you know, 
just in this place.  I can‘t explain what it is. (2) 
 
Peter and Victoria highlighted the personal challenge ensuing from this confusion:   
That‘s part of the reason that the depression hit me so hard. I would always say to myself 
―I‘m a smart guy, why can‘t I control this?‖ You know, ―I‘m an intelligent person‖--I had 
good morals and I take care of myself; ―why can‘t I handle this?  I should be able to 
handle this!‖ (10) 
You have a brain, you have a body, you know what needs to be done around the house, 
you know what needs to be done . . .  to take care of your family and it‘s just like, there‘s 
no reason on earth you shouldn‘t be able to do it. . . .  I just kind of felt like someone had 
put a hundred pounds on my shoulders.  I . . . couldn‘t see any reason why I felt this 
way.‖ (5)  
 
 Others expressed similar frustration with the discrepancy between normal desires and 
expectations for life and one‘s ability to reach them.  After commenting on her lack of 
―backbone‖ to do anything during her depression, Elaine went on to describe how she felt like a 
―failure as a human being--because I had just really been knocked off my feet and I just couldn‘t 
do anything.   . . . I just had to be the most worthless person; I had been so active and strong for a 
long time (2).‖  Kellie said ―I just lay there feeling terrible about yourself and wondering, ―what 
is my problem?‖ You know, ―why can‘t I just make myself shape up and do something?‖  She 
spoke of forcing herself to get out of bed, ―I got to the point where I‘d just have to get angry with 
myself. It was the only way to get something accomplished.‖ (16).   
 In addition to not being able to feel normal sorrow, Elaine went on to highlight the 
perplexing contrast with positive life experiences as well.  ―And I have a wonderful life too. I 
mean I have what most people would consider the ideal, perfect kids and you know perfect 
(laughs) what most people would consider a really great life so that‘s what‘s so stupid. 
Everybody‘s, ―what in the world could you be depressed about?‖ (2).  Others pointed to the 
contrast between their dark feelings and a positive ambience--―Even though the flowers were out 
and . . . the warm sunshine it was ...doom and gloom‖ (4); ―[it] doesn‘t matter how many lights I 
turn on in the house . . . I still feel like it is so dark‖ (5).   Elaine further commented on her 
previous joy of Christmas and Disneyland as a grandmother—―if it was something that I used to 
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find fun, there was just no fun in it and I just would feel so bad that I really couldn‘t enjoy those 
things that normally you just (laugh/cry) are supposed to enjoy so much.‖   
 Beyond the individual confusion, the puzzlement of surrounding family and friends also 
appears to have a significant impact in ―ramping up‖ the urgency for an explanation.  As Kellie 
said, ―It‘s hard for family and friends to understand that you really, really, really are not doing 
this intentionally‖ (16).  Elaine recounted, ―[My mother] feels like [depression is] something that, 
you know, you wouldn‘t have if you‘ve really been living right . . but I really have tried pretty 
hard (laughs)‖ (2).  
 While many friends and family provide helpful support, their behavior was often 
described as complicating things, ranging from being resistant, questioning, and challenging one 
to exercise more will-power, to being annoyed, angry, exasperated and believing treatment is evil.  
When asked, ―Has your current understanding of depression ever been challenged?‖ Camille said, 
―Yes by people who‘ve never … who don‘t understand, who think that you can just decide to be 
happy and snap out of it. . . . I tell (laughs) them, ‗do you think anybody would choose to live this 
way?  Don‘t you think if I could just snap out of it and decide to be happy I would have done that 
a long time ago?‘‖ (3).  Elaine related wishing there was some kind of video tape she could show 
her husband designed to ―teach families that it‘s not this huge character flaw (laughs) that it‘s not 
just laziness and um…orneriness… that you could bring home and just ask your family to sit 
down for thirty minutes and say, you know, this is normal to expect‖ (2).    
 After describing her own struggle with misunderstanding of others and her initial fear 
that she was ―going to lose it,‖ Lucy noted, ―you need a place to point your finger to where, 
who‘s making it happen or what situations made you get to that point . . because. at first, you just 
need someone—it needs to go somewhere‖ (6).  Referring to her own period of ―overwhelming, 
slogging . . .tiredness,‖ Jill recollected wondering, ―what‘s wrong, something must be wrong with 
my body for me to feel like this? (7).  Sarah spoke of her initial desire for answers so great that 
even the possibility of a serious physical deficiency felt like a relief, ―Why am I crying all the 
time?  Um, you know, just the confusion of what‘s going on with me. . . . I mean, I even thought 
maybe I have a tumor . . . if I have a tumor then they can put a name to it and I can get it fixed‖ 
(4). 
 
Theme 3.  Answers offered: “Let me help you . . ”   
A third salient theme across accounts was the prevalence of early moment of influence 
from friends or family, with 6 of 14 participants recounting some kind of initial moment of 
influential counsel by a friend or family member in their early stages of decision-making about 
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how to respond.  For others, messages came from a medical professional or through television or 
books.  Sarah offered the most vivid example in recounting the following experience after her 
negative feelings first arose:   
I had a very dear girlfriend that lived up the street that saw the warning signs in me. And 
Emily came to me and explained her story of depression which started for her when she 
was a teenager. . . She said, ―let me help you.  I really feel like you are exhibiting the 
symptoms that I suffer. . . . I‘ve been down this road; let me help you.‖. . . She said, you 
know, ―let‘s get you in to see a good psychiatrist, get you e-valed and start you on 
medicine.‖  
 
While resisting this suggestion, Sarah described the pain getting worse and becoming  
more confused.  Her neighbor offered further assistance:   
And Emily [said] to me, ―Sarah (sighs), it‘s the lack of serotonin in your brain‖ and I go 
―serotonin what in the heck [is that]?‖  And so she described it in a really simple way that 
our brain has neurons that will fire up each morning.  So on this side, one says ―Okay, 
Sarah time to wake up [and] get the kids off to school‖ and it will swim across the 
serotonin bridge to a receptor, a connector and when it gets there that enables you to get 
up and, you know, go on with your day. Well when that serotonin bridge is broken, 
there‘s no, I mean, it can‘t get to that connector.  So they‘re swimming around and so the 
confusion in my brain was like ―Wahhaha,‖ you know, and I thought, ―okay that makes 
sense.  I can understand that.‖ And then she said, ―and no matter how hard I tried to think 
positive it was only negative and, I mean, that‘s the only door that was open‖. . . . And I 
loved it because she had been there and she could put it in simple words to me, you 
know, to make it click.   
 
A later experience helped reassure Sarah even more about the serotonin imbalance theory  
of depression:   
So a friend of mine who knew I had really been suffering sent me a book. . . . and it had 
pictures in each chapter and there was this picture of this Mom and she was sitting at the 
kitchen table and she was frazzled.  There were dishes on the table; there were piles of 
laundry behind her; her kids are throwing the laundry, and I went ―that‘s me‖ and that 
was my first connection, like ―oh my gosh.  That is what I‘m feeling.‖  So, boy did I read.  
I was hungry you know. . . . it was actually the picture in the book that I saw of that 
woman.  You know, I was reading through and I was going "yea . . that sounds like . . 
yea, okay!" and [it] has really simple pictures of the sero- . . the neurons, and the 
serotonin bridge and just and I‘m going ―ooh, that's what Emily was trying to say to me.‖. 
. .  So then, when I saw the picture of that woman I went ―ah ha . . . yup, that‘s what I 
have.‖  Then, I read on to the part about medications and it showed that same mom.  Now 
her hair is done; she‘s pushing her little daughter and it‘s saying people can lead, you 
know, go back to their normal everyday life.  So that gave me, you know, more concrete 
hope . . . it was like, ―okay, I wanna look like her.  I mean, I wanna look like me again 
and I wanna be able to do those things.  
 
Other accounts reflected similar moments of influential counsel.  Camille related, ―It was  
actually my mother who put things together . . . long before doctors were actually recognizing it, 
my mother had already pretty much diagnosed it (laughs) in me and. . . . Yes she read me the 
 60 
article and we‘re going, ‗ok yeah. That‘s me; that‘s me; that‘s me.‘‖ (3). Victoria described a 
dinner party with a friend in the days following a crisis experience involving suicidal thoughts:   
It was just about 3 or 4 days after that, in which some friends had invited us to dinner. . . . 
She and I were sitting in the kitchen and I just felt, just kept feeling like [I should] tell her 
about this, you know, tell her about what happened.  It was persistent, I mean, I just, I 
couldn‘t hardly think of anything else. And so I just said, ―Anne, you know, could I talk 
to you about something?‖ And she says, ―sure.‖ I told her about this experience and umm 
(sniff), she‘s a psychologist. She said, ―Victoria, you need to get in and see the doctor 
since you got depression,‖ you know. ―You gotta go, and you gotta see him right away.‖ 
And umm she said, ―the two things you need to do is you need to get on some medication 
and you need to get into some counseling.‖ And umm I said, ―well I umm . .‖ you know, 
I brushed it off but I did promise her I would go to the doctor. So I made an appointment 
for the next day, went in, saw him and he says ―Oh yeah your depressed‖ and they start 
me on Prozac. (5)   
 
Kellie spoke at length about the efforts of her brother, who was enrolled in medical 
school, to first educate her about the nature of the problem she faced:  
My sweet brother, he realized that I was--I don‘t know if you want to call it stubborn . . .  
that I wasn‘t taking action--and he was worried about me, so he talked to me once and 
took me aside, and tried to help explain to me what different drugs were available to help 
me . . said he was concerned about me and he wanted me to maybe think about trying 
some medication. He said ―Kellie, You‘ve been depressed almost your whole life!‖ 
 
When she resisted, he sought to detail the medical school rationale for the treatment:   
One time he took me aside and wrote on the white board and explained things, like you 
know, what goes on in the brain with serotonin, you know, taking the different tracks. . . . 
He was just trying to help me, explain to me, what happens chemically in the brain when, 
see, I don‘t even know enough about it to explain it now.  But at the time he explained it, 
and I understood. But, um, yeah, he just explained what happens when there is a, I don‘t 
know if it‘s a chemical that‘s not present, I‘m not exactly sure how it works, but he 
showed me what medication would do, and how it would help, um you know, persons 
who are depressed; it would help reverse that, that process, so. (16) 
 
In addition to the influence of friends and family reviewed previously, participants 
mentioned doctors‘ advice as meaningful.  Jill related, ―Well my family practice doctor‘s the one 
who put me on [medication] in the first place, and so he was quick to . . . he was the one who 
picked up that it was depression right off the bat‖ (7).  Media messages were also referenced. 
Sarah said:   
You know, I remember, you know actually it was the Zoloft commercial . . . it's the little 
blobs, you know . . . and it‘s sad and it was raining on him and it was gray and then he 
went [and became happy] . . . I went ―Ahh that‘s the first commercial‖. .  I remember 
saying, ―that‘s the first commercial I‘ve seen . . . on anything that addresses depression.‖ 
(4)  
 
Debbie spoke of a news report on an athlete who killed himself, and added:  
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You hear radio ads, you know, always doing the sampling for research studies, 
medications, commercial on the TV that say, ―okay, do you have this and this--all these 
symptoms?‖ and you think, ―well, I‘ve got (laughs) ten out of the fifteen so I must have 
something,‖ so whatever. (8) 
  
 Jill spoke of her relief to hear of media figures sharing about their experience with 
depression:  ―There have been celebrities that have written about there own depression.  I 
remember when Rosie O‘Donnell wrote in her magazine came out that she had depression.  Um, 
there‘s been, like Patty Duke and uh, what‘s the gal that played prince- Carrie Fisher are bipolar, 
both of them.‖  She reflected, ―I think that helps ‗cause you start to feel like, ―well, now 
everybody else will understand it more because this celebrity person has come out about.‖  There 
was actually . . . a news anchor . . . that recently has written about his depression and Brooke 
Shields just wrote her big book on post-partum depression.‖  She continued, ―In 2001, a book 
came out called ‗The bipolar child‘ which I think opened up a lot of [us]--especially for those of 
us that had kids.  You read in that going ‗Wow,‘ you know, ‗that‘s my son‘‖ (7). 
 
Theme 4.  Formal Diagnosis:  “I was kind of relieved. . .” 
A fourth theme in all accounts was how the experience of formal biomedical diagnosis 
was variously interpreted.  Although true ―objective diagnosis‖ was not a main question of 
interest, a rough attempt was made to verify the general ―objective‖ conditions faced among the 
participant sample (whether from formal diagnoses received by participants or from what formal 
diagnostic criteria individuals appeared to most closely resemble based on their accounts).  Based 
on this analysis, across fourteen participants, seven either reported or appeared to have faced 
some kind of major depressive disorder, three individuals bipolar depression, three post-partum 
type depression, two seasonal-type depression and three low-level depression (dysthymia).  Six 
other participants expressed simultaneously facing severe anxiety (OCD, Anxiety Disorder, Panic 
Attacks), two serious attention problems and two, hallucinations.  It was contrasting ways of 
responding to and evaluating the experience of being labeled with one of these conditions, 
however, that revealed the patterns of interest.  While some had difficulty recalling diagnosis 
experiences and three were largely neutral with little to say, most participants made some kind of 
evaluative comments about diagnosis (including those who generally avoided doctors and 
diagnoses altogether).  Of these twelve, responses to diagnosis varied widely—from reports of 
intense relief, to persisting ambivalence, to deep reservations.    
The largest subset of participants spoke of diagnosis as being a relief, ranging from 
intensely positive evaluations (Elaine, Camille, Sarah, Jill and Robert), to a mostly positive 
 62 
response (Victoria), to a mixed evaluation including both positive and pained feelings (Lucy).  
Several spoke of the satisfaction and comfort of having a ―name and explanation for something 
you know is going wrong‖ (Robert/9):  ―just to have a name to call it was almost comforting, you 
know . . . in the idea that enough people have it that they bothered to give it a name . . . so that 
was actually quite helpful to me‖ (Peter/10).  Elaine, who expressed a burden of significant 
confusion previously, related:    
I remember when the doctor told me that she felt like I was bipolar . . . I actually felt like, 
you know, it explained . . . um, I don‘t know, like she was telling me that it this is 
something that was treatable--that it was an illness; that it was something that had to do 
with my brain not working the way it was supposed to work.   
 
Although ―not pleased with the idea that I was mentally ill,‖ Elaine spoke of feeling  
encouraged with the idea she was facing ―something that was treatable‖ via medication to 
―stabilize my moods and hopefully clear up my thinking.‖  She added, ―so I was pretty scared in 
one way but I was also kind of relieved in another,‖ grateful that her doctor ―was encouraging 
that I could live a fairly normal life if I could stick with my medications and stay on them.‖ In the 
face of her mild ambivalence, Elaine told of later encounters that helped her emotionally accept 
the diagnosis further, starting with a religious leader comparing depression to being hit by a car—
―if your arm had been cut off, we wouldn‘t tell you to go read your scriptures and pray more 
(laughs); you [would] need to get to a doctor and get the help you need (laughs).‖  She added:   
I‘ll just never forget when I read a book that said telling someone with depression to pull 
themselves up by their bootstraps and ―just do it,‖ is like telling somebody who‘s had a 
heart attack to run to the top of a mountain. You know, there‘s really no difference. 
There‘s something physically wrong and . . . something wrong with your brain and it‘s 
not working and you can‘t force your brain to do something it can‘t do anymore than you 
can force yourself to run to the top of the mountain just after you‘ve had a heart attack.  
 
She concluded emphasizing how reading this made her feel ―a little bit better about  
myself‖ since she had an explanation for not being able to make herself do something while 
depressed.  Others who felt similar to relief with diagnosis expressed similar interest in seeking 
further validation.  Debbie said:   
I know I‘ve read things on how they can actually see [the brain] and I‘ve often thought, 
―now why can‘t I get into this or why does it cost so much?‖--where they can look at the 
brain and see how things are formed and different areas and then be able to prescribe 
medication. Is that true or have you heard?  I‘m thinking I‘ve seen Dr. Phil or you know 
different shows that they‘ve had specials on that and, or I just wish there were a blood 
test. (8) 
 
Camille recounted the following experience: 
I went to California and saw a Dr. Daniel Ayeman who does what‘s called a SPECT scan 
and mostly it‘s done to diagnose patients with ADHD and when we got the scans back, it 
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showed um there was an area that was just totally grey meaning that there wasn‘t . . that 
part of the brain had kinda shut down.  And he explained to us that that part of the brain 
was the part that managed time--not only being able to get places on time, but organizing 
your time and accomplishing things, managing money, and all those kinds of things were 
controlled by that part of the brain that was not functioning (laughs). It was great for me 
to have a picture of my brain that showed, ―Hey look! This isn‘t working.‖ (3) 
 
In addition to offering relief for one‘s personal confusion, biomedical explanation and  
diagnosis thus helped legitimize the struggle before individual‘s friends and family as well.  Jill 
reflected: 
For the most part, people know that it‘s a real thing now. . . . One thing that was nice is I 
found a booklet--I think I got it from the NIMH (National Institute for Mental Health).  It 
was a little booklet for children about ―why is mommy so sad,‖ and I loved that because 
it helped me sort of explain to my older kids at the time why I was so sad all the time and 
crying and tired and I liked that.  (7) 
 
Not everyone, however, experienced such thorough relief with a biomedical diagnosis.  
In spite of her relief to be diagnosed and ―know that I wasn‘t alone,‖ she added, ―I just didn‘t like 
what she was telling me, that I‘d have to take medicine and I‘d have to stay on it for the rest of 
my life.  You know, it was a relief to go ―oh, okay, I can grasp that but don‘t tell me I‘m going to 
have to stay on meds‖ (laughs). You know what I‘m saying?‖ (4).  For Lucy, the conflict was 
striking:     
Two really combative emotions came up when I was diagnosed—one was ―God, thank 
you!‖ . . you know, ―I‘m not insane—this is a real thing.  It‘s in a book somewhere . . we 
can start working on it.‖  There was a relief that I wasn‘t alone, totally, anymore.  And . . 
. . it didn‘t feel so stuck anymore.‖  But then . . . . in a way, it made me feel more alone 
too, cause I was like ―oh, it‘s not a cold that‘s just going to go away or I can‘t take some 
penicillin and look back and go, ‗oh, that was crappy‘‖—so it . . . makes you realize that 
this is something that‘s going to be with me for [good].  
 
 She continued:  
It might be crappy, but at least I know everything.  But then on the other hand, it was so 
defeating, you know, ―it‘s not going away--this is me,‖ you know—and that‘s sad.  You 
feel like you lose yourself, almost.  Like a part of you dies when you‘re diagnosed. . . .  
*J:  It‘s a relief, but a part of you dies?   
It‘s almost like a grieving period realizing that the person that was faking it for so long--
she wasn‘t real.  And she kind of did die and that we had to reinvent and restructure this 
new being, almost.  That we didn‘t have any information on what would make it better . . 
it was almost like we were constructing a new being, you know?  Giving her the tools and 
the revenues, making sure she had insurance all the time, you know?  I mean, it‘s hard . . 
. . [you] do feel a detachment from everything you thought you were when this becomes 
where you‘re at, because this is not who I was suppose to be. 
 
Two individuals referred to diagnostic explanation as demeaning and misguided in 
various ways—expressing hostility to their experiences.  Esther, a younger single woman, said: 
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I‘ve had a multitude of labels . . and most of them I didn‘t pay much attention to . . 
because only once . . did my psychiatrist actually sit down and actually do the whole 
interview you‘re suppose to do.  Every other time I got labeled it was just guesswork—
and I was . . a couple of times labeled by professionals when they went back and got my 
medical records and I had never met them and they had never met me. (14)  
 
 Kyle, who had once been diagnosed with manic depression at one point, said:  
It‘s too easy to say, ―You‘re bipolar.  Take either Depacote, Zyprexa, Lithium, Geodon, 
Topomax‖ (laughs), you know, it‘s too easy.  But the way health care is now, you know, 
maybe a doctor doesn‘t have time to check to see if you maybe have an underlying Lyme 
disease, maybe you have an allergen, maybe you have, you know, thyroid condition, um.  
That‘s my, that‘s the problem I see, it‘s too easy to, to put a label on someone without 
digging deeper.  
 
He later added, ―To be fair with the doctors, how can they have time in 10 minutes to  
figure this stuff out?‖  He related the following experience during a meeting of the Depression,  
Manic Depression Association (DMDA) support group:   
They had a special night where they had a psychiatrist come in and, and, and it was ―ask 
him anything you want.‖ . . . And one woman said. . . . ―My son was just diagnosed with 
ADHD last week and, this was her first appointment with him and it was only a fifteen 
minute appointment and he was diagnosed with ADHD and prescribed . . . Ritalin,‖ and 
she goes, ―can you really diagnose ADHD in fifteen minutes?‖ And he goes, ―Well it is 
possible in fifteen minutes.  It maybe takes longer, but yes, it is possible.‖  And I raise my 
hand and go ―Excuse me.‖  I go, ―You‘re willing to say that in fifteen minutes you can 
stigmatize this kid for life and give him a schedule two drug, um, and you didn‘t even 
check his thyroid?  You didn‘t check for allergy, you did nothing but, but, but write in 
your little prescription pad . . You‘re willing to do that to a kid?‖  And he goes, ―Well 
maybe it would be okay to take a thyroid test.‖  But, I mean, this crap is happening all 
over!  Um, so that‘s frustrating to me.   
 
Kyle concluded, ―Any kind of diagnosis like that is not liberating…at all. . . . Just putting  
a label on a, on a behavior, um it doesn‘t do any good, it‘s not gonna help find root causes, not  
gonna, you know . . 'take your meds, you know ..  for life' and some people do that and that‘s 
fine, um, it‘s not the way I want to live life.  He further added ―once someone is diagnosed they 
say "it‘s a lifetime illness.  Lifetime.  Never get better‖ (12).  
 As here reflected, concerns about biomedical diagnosis naturally extend to biomedical 
treatment as well.  Once again, some did not reflect any initial resistance to suggestions of 
treatment.  After being told by her doctor about a depression medication study, Debbie related 
thinking, ―well, okay.  I‘ll give it a try and if it does anything . . . we‘ll just see‖ (8).  At least 
initially, however, most participants reported experiencing some degree of resistance to the 
thought of beginning psychiatric treatment.  Robert, for instance, who was grateful for a diagnosis 
said, ―Medication, that‘s for babies.  That‘s ridiculous. . . . I don‘t want that.‖  Fern said, ―I have 
always been a person who dislikes taking medication. . . I just have never taken drugs at all on a 
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regular basis.  I even have arthritis now and it‘s difficult to decide to take some Tylenol even 
when it hurts a lot‖ (11).  Kellie, the one participant who never accepted medication, mentioned 
past experiences underlying her hesitance—specifically, an extremely negative encounter with 
hormone medication that wreaked ―havoc‖ on her body:  
There are a lot of good medicines out there, but there are some that basically just mask 
symptoms and do not actually heal the body, and because I have had to deal with such 
issues myself from, you know from taking those hormone pills, I think it was kind of like, 
―Nope!‖ It was like, ―No way! Before I ever take anything like that again, no matter what 
it‘s for, I‘m going to be very cautious and find out everything I can about it.‖  
 
Kellie went on to mention the expense of medication as an additional factor, as well as 
concern with ―that mentality, too, of ‗I don‘t want to be tied to a drug to keep me going‘‖ (16).   
While reflecting varied degrees of reluctance with medical treatment, it is worth pointing 
out that interviews did not confirm the broad stereotype of people ―looking for easy answers‖ 
with medication.  On the contrary, participants showed great care and caution in their exploration 
of this option and evidence that this is a difficult decision to make.  After being encouraged to 
start Prozac, Fern recollected thinking, ―okay [is] this is just going to be a crutch?  What‘s going 
to happen to me? Am I going to be dependent on this forever?‖ (11).  Jill and Peter spoke of their 
own similar initial concerns:      
I saw my grandmother, you know, for years and years and years tied to her pills and I 
dreaded that.  I really dreaded having to (sigh) think that for the rest of my life, I‘ve got 
my pharmaceutical cocktail that I take every day, you know (laugh). (7)    
Well that‘s originally the reason that I put off going to uh a doctor for so long, you know 
. . . I don‘t want to be dependent on something (pause), you know, I want to be 
independent and I want to be, you know, ―I can take care of this myself,‖ you know.  
That was my outward stance and my inward frustration you know that I couldn‘t . . . I 
really, really didn‘t want to take medication. . . . I told him, ―I‘d like to avoid drugs if at 
all possible.‖ (10) 
 
 
Theme 5. Moments of climax: “I‟ve got to get some help” 
A final theme documents some early moments of significant drama that appear to have a 
notable impact on individuals‘ course of action (and associated interpretations).  Seven of 
fourteen participants spoke of some kind of early traumatic moment as reinforcing the seriousness 
of the problem and stimulating their interest in seeking medical treatment.  These included 
difficult break-ups (Camille, Sarah, Robert & Kellie), betrayals from intimate partners (Fern), 
major stressful changes (Robert, Elaine), thoughts of suicide (Victoria, Jill), actual suicide 
attempts (Lucy, Michelle) and panic attacks (Peter).   
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It was in the middle of raising seven children, going back to school and working as a 
nurse while running several businesses, that Elaine eventually had a ―complete mental physical 
emotional breakdown.‖  During this time, she spoke to her brother, who was a medical doctor:    
[I told him] that I found myself trying to figure out a way to get into a car accident that 
would be just bad enough to put me in the hospital for a few weeks so I could get some 
rest, you know, without hurting anyone else . . . and so he immediately hooked me up 
with a psychiatrist and said, ―you know this isn‘t funny. You know, this isn‘t something 
you can play around with any longer.‖ (2) 
For Jill, a tragedy in the local community heightened her own urgency:  
When I got really bad in 1993, I just, I was afraid.  About the same time this lady in [our 
city]--they found her body, she had had depression and she had taken her life and they 
didn‘t find her for six months.  So I was afraid that this would happen to me and I knew 
that I wouldn‘t want to do that, but it‘s like the depression takes over; and I was afraid it 
would do that and I didn‘t want that to happen.  I reached out for help. (7)  
 
In addition to possible violence towards self, others are pressured by the possibility of 
harming others.  Peter faced regular, lengthy panic attacks associated with his depression; after 
another one hit him on the way home from teaching school, he decided he was putting children in 
his classroom in danger by not seeking help:  ―So that moment that I made that choice (pause) 
was a huge turning point. . . . I called my mother and my father I called them both and I said uh 
―guys I‘m coming home‖ . . . At that point I decided to seek help‖ (10).   
Others are impacted by their own actual (surprising) outbursts towards others.  Jill 
described a distressing moment of kicking her child (7).  In addition to the conversation with her 
brother, Elaine said, ―the things that sent me into the doctor was I hauled off and smacked one of 
my kids. I‘d never done anything like that before in my life. . . . I‘d had a little bit of experience 
of that with my own mom . . . and I just wasn‘t gonna do that, so I ran right to the doctor and said 
‗okay now. I can‘t be like this‘‖ (laughs) (2).  Finally, Sarah related two crises events that 
impacted her powerfully: .   
[My husband] was out of town and I thought, ―okay, I can make pancakes‖--but it was 
like . . . indescribable effort to force myself to do anything. . . . So I gathered the kids up 
to the kitchen bar and I‘m whipping up pancakes.  … and I started making them and they 
were just chit chatting among each other—Not fighting or bickering or anything, but it 
was so loud to me.  It just, I was frustrated and I took a Corelware . . . and uh I slammed 
it on the counter and . . . it went into . . . slivery thousands of [pieces] and I just 
screamed; and I was not a screamer or a yeller and I yelled, ―will you kids just shut up!‖  
And . . . they all just sat there and I started bawling and Lisa said, ―what is wrong with 
you Mom?‖   
 
She later related a second experience of giving her baby a bath and wanting her to be 
quiet, when she started crying—―I just, you know, I just needed her to, I mean, to be quiet… and 
at that point I knew a little bit of what some of these moms feel who, for one reason or another 
 67 
drown their babies.‖  That thought ―scared her to death‖ and prompted her own crying; she called 
her neighbor immediately and said ―Come get my baby. I can‘t take care of ‗em; I can‘t take care 
of my family‖ (4).   
Among other things, these rock-bottom/climactic moments seem to ―ramp up‖ even 
further both personal and collective urgency towards some kind of decisive action.  After his 
panic attack after school, Peter related: 
Things had gotten so bad for me that I said, ―I‘ll do anything . . . I will do anything if you 
tell me that it will make me feel better.‖. . . you know.  If you told me the problem lived 
in my finger and I had to cut it off, I would really, I would have done anything to make 
that go away and so . . . I said, you know, ―let‘s try some medication.‖. . . The physician 
said, ―well . . . . it‘s generally well-tolerated--no side effects . . low side effects‖--
whatever, I mean, I didn‘t know the . . you know, I just knew I wanted to feel better. (10)  
 
While such experiences lead many to a readiness for medical treatment, Lucy described  
hurting ―so bad‖ that she initially used illegal drugs and cutting to stop it—since there was ―No  
other way to hurt less‖ (6).   Robert, who described contemplating killing himself, related the 
impact of this event on both him and his family:   
Well, I think that from the first big episode … it scared me.  I think it really, really, really 
scared me because here I was at a point where I could have killed myself, I could have 
done it. . . . And at that point my mom decided, she‘s like, ―We have got to do something 
about this.  We‘ve got to.  And it‘s just . . it‘s hanging on too long, and you‘re just, you‘re 
gonna . . you‘re having trouble with this.  And we just, we just have to do something.‖ 
And so she… um, took me to a doctor. (9)  
 
The combination of painful experiences and surrounding family encouragement lead 
many to reach a point of willingness to try medications—including some who were deeply 
resistant.  Fern, who was quoted above as not being a medicine person, said that her own painful 
crises lead her to ―succumb to breaking down my own personal code and taking something for it‖ 
(11).  A handful of participants, however, continued to resist.  After describing her medical 
school brother‘s continued encouragement to start treatment, Kellie said, ―I was to the point 
where I was going to take something, even if it was just to take for a few months to see how I 
feel. It doesn‘t mean I have to stay on it forever.‖ She continued:       
But I didn‘t. I just felt like in time, usually your wounds heal. So I just figured ―I‘ll 
wait.‖. . . I think it was because I really felt that I wanted to do everything in my power 
first to help myself . . . to try everything to exhaust all possibilities before I went ahead 
and took the medication. . . . [and] feeling like I would eventually find answers. . . . I just 
thought that everything would somehow work out, and I‘d get through it.  . . . I just had 
this feeling that everything was going to be okay. . . . I didn‘t know how or when, but I 
knew that somehow it would. (16)  
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For some who remained resistant to medications, they encountered threats and attempts at 
forced treatment from surrounding friends or family.  After refusing treatment from his 
psychiatrist, Kyle was forcibly admitted to a hospital by his wife (12), while Esther described 
doctors attempting to bypass her resistance and apply pressure via her family (14).  In contrast, 
Kellie‘s situation was unique in the way her family‘s response:    
[My parents] knew I was struggling with knowing what to do as far as having to take 
some form of medication, or just to get through it somehow.  They didn‘t want to be 
forceful and I don‘t know, take my agency away and say ―We‘re going to take you to see 
a doctor, and you‘re going to do this, and take this so that you can have a normal life 
again,‖ but still [were] very supportive in me and trusted me that I would be able to find a 
remedy, whatever that remedy was, to be able to heal eventually.  
 
Kellie elaborated, ―Some people might look at the situation and say, ‗when you are  
depressed you are mentally sick and you can‘t think reasonably for yourself.‘ And so, some 
people would say it would be appropriate for . . .  a parent to even say, ‗I love you, I care about 
you, I‘m going to you know, I‘m going to take you in; I‘m going to get you this appointment with 
the doctor and get you some help.‘‖  She reflected, ―but I think my parents and my family, my 
parents . . . when we go to them for counsel, they have tried to listen, and, if we ask for their 
advice, or what they think, they will tell us, and, but, they have tried to let us make our own 
decisions and figure things out for ourselves. And so I think, that probably played a big role in 
them not just coming to my rescue and saying, ‗You need some help, and we think you need to do 
this, so we‘re going to go do it.‘‖  She concluded, ―you know, it‘s that rescuing syndrome. . . . 
Their attitude was just, ‗You know, Kellie, we trust you, we know that you need to find a method 
that you feel good about that you‘ve prayed about.‘. .  They were just praying for me that I would 
be able to be inspired to know what was the very best for me and my situation‖ (16).  
 
 In summary, the themes reviewed in this chapter help the reader understand some of the 
nuances associated with a decision to begin medical treatment for depression.  Rather than reflect 
either an easy acceptance of medical advice or a hasty grasp for a ―quick fix,‖ these accounts 
reveal subtle and intense interpretive struggles often accompanying the decision to accept anti-
depressant medication.  Initially, individuals frequently report a personal confusion with the 
nature of depression that appears to constitute heightened urgency for a tangible explanation.  
This becomes a meaningful backdrop to understanding the significance and impact of 
surrounding friends and family in their frequent role to introduce possible explanations.  
Although some are eager to embrace biomedical explanations, others remain ambivalent or flatly 
resistant—in part, for the associated implications for treatment.  For some of these, the additional 
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influence of especially traumatic events may augment the urgency of finding relief to a point they 
are willing to try an anti-depressant.  Not everyone reaches this level of desperation, of course, 
nor do all feel as driven or confused.  For those who eventually start taking medication, however, 
the preceding confusion, wrestling and crisis constitute a literal journey to a decision.   
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Chapter 5 
Interpreting Solutions: Fighting the Monster 
 
 This chapter centers on salient excerpts or moments across individual accounts standing 
out as especially relevant to the adoption, constitution and maintenance of particular depression 
interpretations.  Whereas the last chapter centered on varied interpretations of the problem of 
depression itself, this one explores key events associated with participant interpretations of 
possible solutions for depression.  This chapter includes the following ―solution interpretation‖ 
themes:  1) Starting medical treatment 2) Encountering ambiguous & evolving treatment effects; 
3) Interpreting states concurrent with medical treatment; 4) Encountering additional influence; 
5) Refusing treatment; 6) Previewing life without antidepressants; 7) Attempting to taper off 
medication; 8) Evaluating alternatives & 9) Considering prognosis and recovery.  We begin with 
attention to the well-recognized diversity of initial responses to medication:  the good, the bad 
and the ambiguous.   
 
Theme 1. Starting medical treatment: “Miracles” and “carbuncles” 
 In spite of aforementioned wide-ranging resistance, 13 of 14 interview participants ended 
up taking medication at some point.  Several had difficulty remembering the names, including 
one woman with memory impairments from electroshock.  All participants, though, listed 
whatever meds they could remember.  12/13 spoke of taking Prozac, most typically as the first 
anti-depressant they tried.  8/13 took Wellbutrin, 4/13 took Zoloft, 4/13 took Paxil, and 2/13 each 
took Effexor, Celexa and Lexapro—alongside several ―mood-stabilizers‖ [Neurontin (2 people); 
Topomax (2), Lithium (1) Depakote (1), Lamictal (1)], several other anti-anxiety drugs [Xanax 
(2), Valium (1), Clonazepam) (1)], anti-psychotic meds in a few cases (Seroquel) and sleeping 
pills frequently.     
Obviously, the actual physiological/metabolic responses to these medications varied 
across both participants and time.  Partially
11
 linked to this diversity of biological response, 
personal/interpretive response to medication also varied, sometimes in dramatic ways, from 
dramatically positive accounts, to mildly uncomfortable/mixed reports, to those claiming little or 
no effects at all, to dramatically negative accounts.  Considering the initial experience of taking a 
particular medication:  How did participants respond to and frame these events?  While 
acknowledging the diversity of a) individual types of depression, b) medications prescribed and c) 
                                                 
11
 See introduction for a full discussion of why I view the diversity of personal/interpretive responses to 
medication only partially ensuing from the diversity of actual biological response to these medications.    
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metabolic responses to these medications, some meaningful patterns of general interpretation 
emerged across accounts.  In describing initial experiences with anti-depressant treatment, some 
individuals spoke of dramatically positive results.  Elaine said:   
I felt like it was a miracle . . . like I was in control of some kind of (sigh) . . . some kind 
of demon that just.. uh, I‘d been possessed by. . . . It was an absolute miracle because . . . 
I was calm enough to handle the situation and to cope with everything and then I was 
able to get some sleep, and I hadn‘t gotten sleep for years.  (2) 
 
Debbie recollected similarly:   
You know, the magic part of my life was taking that Prozac. It just seemed to do 
everything.  I had the energy, I was losing weight I could stay up (laughs) until 3 a.m. 
cleaning and everything was organized and it was just wonderful.  It was like the 
superwoman I wanted to be . . . . it helped me with my energy--it was just the magic pill 
that . . there‘s (chuckle) no such thing as a magic pill but that [it] was for me. (8) 
 
 After relating a similar ―huge difference‖ of her son starting Lithium, Jill similarly 
described Prozac as initially giving her more energy and helping her feel active and not tired all 
the time (7).  In relating her ―personal definition that a medication is working‖ Victoria said, ―I 
just, I feel good. I mean, you know, I get things done.  I have energy.‖  In spite of some 
accompanying sleep difficulties, she concluded, ―but I just wake up and I‘m ready to go, you 
know. Plus I‘m running around getting things done. You know, just feeling good, feeling happy, 
just content, you know, very much in control--just that kind of thing‖ (5).  Robert spoke of 
intermittently ―really, really have a lot of energy or really, really tired‖ on Effexor.  In spite of 
this vascillation, he added ―but… as a general rule, I felt more outgoing when I was on Effexor, 
like I didn‘t mind talking to people.  And usually I‘m kind of a reserved-type person, um, at least 
in a lot of social situations… and, uh…  So I – that that worked‖ (9). 
Beyond the sheer physical energy, then, others spoke of a heightened sense of confidence 
and capability, with Elaine noting being able to ―remember things and feeling more capable‖ (2).  
After starting Prozac, Debbie said that after a few weeks, ―I started liking myself, I didn't have 
the feeling of ‗I hate the world‘, and I felt I had some control of my outbursts.  Therefore I didn't 
resist taking medication because I liked this new person.‖  She later added, ―I like me better on 
the Prozac—felt better about myself, had confidence‖ (8).   
For some, this ―feeling better‖ had more to do with enhanced calm, than increased 
energy.  Elaine, who spoke of feeling ―SO MUCH better‖ with the ―blessing of medication‖ had 
previously described ―nerves as raw as they could be.‖  With psychiatric medication, she 
described an ―invaluable‖ new ―ability to deal with kids in a calm manner. . . I couldn‘t believe 
the difference the Xanax made in my ability to cope.‖  Referring to her current anti-depressant 
medication, Elaine concluded it ―seems to handle me really well‖ and effectively ―steadies‖ her 
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(2).  In these kinds of ways, several saw meds as ―maintaining a level of being able to function‖ 
(11).  Sarah recollected finally being able to rest: 
I remember the first good night sleep I got. When the Paxil, had kicked in, I can‘t 
remember if it was a month or you know four weeks or whatever when I had let‘s 
see…started on the medicine I can‘t remember, Jacob, if it was . . . but it was just like I 
could lay my head down and relax my body knowing that I wasn‘t fearful to get up the 
next morning.  That sounds so weird, but it was like it was a relaxed, sleep finally.  You 
know it was like ―Ooh.‖  (4) 
 
For some, this calming effect was related to particular ways the medication seemed to 
prevent negative thoughts from running amok.  Fern described Prozac as helping her ―not think 
about so many of the things that were going on‖:  ―if my brain was starting to focus on a negative 
thought that [Prozac] would divert me from that thought.  That‘s my basic understanding of what 
happened‖ (11).  Robert and Peter both mentioned less background noise and out of control 
(―spinning‖) thoughts.  On an emotional level, others spoke of less emotional static, ―downs‖ not 
as long, ―ups and down‖ not as intense, and more hope overall.  After initially speaking of rapidly 
shifting mood swings from ―one afternoon of bliss‖ to ―bam, right back into the dumps. . . my 
emotions were still just going out of control,‖ Peter shared one of the more dramatic accounts of 
starting medical treatment:   
I could feel it starting to get into my system . . . . and for the first time in my life (pause), 
once the medication started to kick in I would wake up calm. . . . and for the first time in 
my life, I was able to use logic and say ―you know what?  It‘s gonna be all right.‖ . . . . 
and then I could move on with life. . . After the medication came through it leveled me 
out.  
 
 He continued with descriptions of changes in his treatment: 
When I initially started the medication I started on a lower dose (pause) and all it 
produced was the sense of calmness just the sense that ―okay, my mind is not spinning 
anymore.  Now anything could still set me off‖ . . but I wasn‘t already going (pause).  As 
we upped my medication, um, I began to get that sense of confidence… that sense of uh 
―it‘ll be all right,‖ that sense of control over my emotions.‖  
 
 Peter continued, ―it didn‘t dull my emotions in any way it just controlled them you know 
it‘s not as if I‘m never sad it‘s just you know I‘m not always sad you know so for me it‘s been a 
very positive experience.‖  As reviewed earlier, he came to see increased control and confidence 
as directly proportional to the amount of medication, reaching the following climax:      
We finally brought me up to--there was actually a little while there, where I was taking 
more than the suggested amount.  We got our wires crossed--the doctor and I--and I 
ended up taking (the suggested max is 225mgs), I ended up taking 300 mgs a day and I 
felt invincible, I felt like a million bucks… I‘m on the maximum (safe) dose right now 
and I have to say my life has never been better.  
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 As individuals talk of feeling better, they also often mention how medications have 
helped them feel more normal or ―myself‖ again.  Peter, who had initially emphasized the pain of 
feeling out of control, further explained how medication helped ―clear away‖ the ―emotional 
static‖ in a way that ―made that person [his ideal self] accessible to me…and now I feel like I am 
that person or at least I‘m close‖ (10).  Sarah said, ―[I] found me again‖ (4), with Camille 
testifying that ―I finally feel like me again and even though I still experience the seasonal 
depression to some degree, it wasn‘t as bad as before‖ (3).  From only a small sample of thirteen 
participants who took medications, obviously the reported initial effects are dramatic and 
compelling.   
Not everyone, however, saw initial benefits from their experience with medication—with 
a range of negative reports as well.  Victoria, who eventually had better experiences on 
medications, said that medication initially ―weird[ed] me out something awful.‖  Although she 
had been recently promoted at work for her skill in improving a friendly atmosphere, she 
described her feelings after taking Prozac:        
I just felt angry all the time. I just thought, ―I can‘t do this . . . I‘m not an angry person, 
you know.‖. . . This was, ―I want to throw something.  I want to break something.  I want 
to, you know, just scream, just, just blah (laugh). . . . this crazy . . . weirded-out feeling. . 
. . It was really hard. It was hard to control umm when I was at work and not snap at 
people you know. . . . You just want to chew somebody‘s head off, you know (laugh). 
And that wasn‘t like me. (5)  
 
Fern, who had a positive initial experience with Prozac, reported the following account 
with Paxil:   
I began to feel distanced from myself. I felt like I was above my body looking at myself. . 
. . like I was viewing myself and I was not acting for myself. . . . like I was out of body 
observing myself. . . . And that just made me frightened. . it really frightened me.  I felt 
like I was out of control with myself .. and I didn‘t want that feeling at all.  (11) 
 
Kyle also experienced difficulties on medication:    
My regular GP gave me Celexa and achhh! Just, just I hated it, it just um, not only was I 
still depressed but now I felt like I had cotton balls in my head, you know.  And I‘m, [in 
my profession] I depend on being on the ball and thinking fast and this just was like 
cotton candy or cotton balls in my head, and just numb.   
 
 Referring to a second medication, Lithium, he later related:    
I gained fifty pounds in six months, I had boils and carbuncles that, I swear . . they were, 
you know, the size of a golf ball on my legs and even the doctor said ―you know, modern 
day, we don‘t see this.  This is what they saw in the, you know, middle ages,‖ you know.  
And I said ―Do you think it‘s the Lithium?‖  ―Oh no, no, no.‖. . . my eczema was horrible.  
Well it was making the eczema go bad and these boils and carbuncles, it was horri . . it 
was gross. . . . See I don‘t think . . . psychotropic medication has worked for me; it‘s only 
made things worse. (12) 
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Others interviewed noted a lack of motivation, inability to feel deeply, and other physical 
effects that included dry mouth, severe bloody nose, ―hands shaking really bad,‖ ―gaining a lot of 
weight‖ and sexual side effects (6, 7, 9).  For some who spoke of being energized by an anti-
depressant, it could also reportedly keep people up late and interfere with rest (9).     
In sum, the reported initial experience of a particular psychiatric medication can range 
widely, from dramatically positive to negative—as well as more mixed in effect.  As described in 
the next theme, these experiences often vary over time as well—with initially positive or negative 
experiences changing substantially over the course of months or years. 
 
Theme 2. Encountering ambiguous & evolving treatment effects: “We‟ll see how I feel 
tomorrow.”     
While these kinds of dramatically positive or negative accounts can often draw great 
attention, it was more nuanced and complex evaluations of medication that proved most 
commonplace in this sample, with most stories reflecting the well-known mixture of risks and 
benefits.  While 10 of 13 participants reported some medical experiences that were either 
dramatically positive or negative, that same number spoke of more mixed experiences eventually.    
In what follows, I explore details of the common-place ambiguity of medical treatment for 
depression that arguably receives less attention than the more dramatic accounts reviewed above.  
I focus on the ―brute‖ experience of treatment, highlighting the day-to-day experience of 
treatment, followed by reports on changing effects of anti-depressant treatment over time.   
Day-to-day experience of treatment.  To begin, Jill‘s account offers a rich vignette of 
some of the complexities of receiving medical treatment for depression:      
The second time [starting treatment] I was trying to find a different medication that didn‘t 
have the sexual side effects, and that‘s when I hit rock bottom ‗cause I wasn‘t even at a 
therapeutic level on anything at that point, ‗cause [the doctor] was trying me on this for 
six weeks to see how I did . . . I was kind of doing the ―guinea pig thing‖ and that‘s when 
I hit rock bottom.  And then when my dad died that year, then he upped me a little bit to 
get me through that.  And then a couple of years later is when I tried to go down, couldn‘t 
seem to do it, waited a year, went down another 20 mg, and I‘ve been fine since then.  
But lately, like I said, I haven‘t been, don‘t feel like I‘m feeling . . and I want to try again. 
(7)  
 
Victoria spoke of facing difficulties with her doctor‘s help:  
I guess, umm, partly the medication helps me think straight, helps me think straight 
because uh, in those times when I haven‘t had my medication it‘s almost as if life doesn‘t 
make sense. You know, I can‘t …and this has been times when they‘ve upped the 
medication. And this is times when I have gone in and I said, ―I can‘t seem to find a 
direction I can‘t seem to prioritize and figure out what I need to do during the day, you 
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know. And umm that has usually been a symbol that we need to up the medication a little 
bit or there is some or like I have said before some of the life changes that I‘m not aware 
of. (5) 
 
As reflected in these accounts, exchange with doctors can occur over years—playing an 
intimate role in both enabling and responding to life events.  After acknowledging her ongoing 
desire to taper, the Jill continued, ―I don‘t know what my doctor will recommend at this time of 
year, though, as we‘re going into fall….but I don‘t feel . .‖  I asked, to clarify, ―So there‘s one, 
like Cipro and then there‘s another...Wellbutrin.  And that is supposed to help you sleep?‖  She 
responded: 
No, Wellbutrin is just a second one he put me on to help me and then the one for sleeping 
is Pamilor.  It tends to make you drowsy and he said it would also boost the effects of the 
other two.  And he wanted to put me, add another ten, you know a second one of Pamilor 
at night to make me sleep all through the night, and I just, I don‘t want to be on that 
many.  In fact, I‘d like to. . he bumped me up to--five years ago my father died and then 
my grandmother who I was really close to--so then he bumped me . . I think I was on 
Paxil at that point, he bumped me up to like 75 on that, which is a pretty high dose.  And 
then I tried a couple of years later to come down and I couldn‘t, so I waited another year 
and I was able to go back down to like . . . 50-40, and then I tried to go from 40 down and 
I couldn‘t do that.  But I did get down from 60 to 40.  And you have to try that, like, in 
the spring and summer.  They don‘t like you to try that during the winter months just 
because winter‘s depressing anyway. (7) 
 
Elaine described some of her medical journey following the dramatically positive 
beginning:   
First I was on Zoloft. It aggravated my..um..manic thing. Then I went on to Wellbutrin. It 
aggravated it, so I just, I‘m not on an antidepressant at all.  I‘m just on the mood 
stabilizer. Uh so um and that seems to work the best for me. . . . .I did a lot better on the 
Topamax but then um… had a.. an experience where I had a.. kind of exciting thing 
happen that kind of got me a little bit manic and then found that the Topamax wasn‘t 
really holding me there so they.. put me on another mood stabilizer to . . . just keep me 
from being too manic, but not be as sedating as the Depacote had been.  And the 
Wellbutrin, I found, I felt like it aggravated--I just could not sleep.   
 
She continued, ―I‘ve thought a million times my family . . . . with the $500 insurance  
premium which I feel horribly guilty about (and that‘s every month). . . . I just feel like such a 
drain on my family‖ (2).  Michelle, who had been especially faithful in complying with treatment 
gave the following explanation of ―how her current drugs work together‖:   
Really well.  I‘ve just recently got off of, I had been on Seraquil 100milligrams three 
times a day and I noticed that taking it twice a day I‘m a lot bubblier, you know, more 
energetic.  The Seraquil in particular kinda has a sedative effect . . . you know, you kinda 
get that drowsiness mid morning with it and um you really have to kinda consciously . . 
work through that, you know.  Um, it‘s real easy in the early stages of recovery to just 
kinda give into it and go back to bed (laughs). (13) 
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Robert and Victoria related the mixture of increased energy and challenged sleep:    
Effexor especially seemed to… just it either made me really, really have a lot of energy 
or really, really tired.  But it wasn‘t really predictable as far as what I was gonna get.  
And so but… as a general rule, I felt more outgoing when I was on Effexor. . . and 
sometimes I noticed like extreme things, like it would keep me up… really late. . . . 
And… uh… I dunno, that‘s just kind of the way it was.  It was kind of erratic and 
unpredictable but definitely potent, definitely noticed differences.  (9) 
When the medication is working umm I just, I feel good. I mean, I ummm, you know, I 
get things done. Umm I have energy, I‘m and . . I‘ve had to sort this out because we 
recently figured out that (laugh) that what I lovingly refer to [as] my ―pharmaceutical 
cocktail‖ is preventing me from sleeping well. I sleep for about two hours and them I am 
awake. I sleep for another two hours. And so I have to I have to separate that, you know. 
But umm, I just wake up and I‘m ready to go, you know. Plus I‘m running around getting 
things done. You know just feeling good feeling happy. Just content you know umm very 
much in control you know. (5) 
 
Something of the complexity associated with changing medications, dosages and side-
effects are evident in these comments.  Jill commented that finding the right dosage and keeping 
her medication regimen stable had become a dominant theme of her experience, even an 
overriding goal: 
I guess a theme [of my story] would kind of be just . . . the constant struggle to find a 
balance. . . . so that you can be happy, so that you can have feelings, so that you 
can…have the energy that you need to engage in life and do things with your family and 
to be a productive member of society. To be medicated enough so that you‘re not a 
weirdo and embarrassing your kids, but to not be medicated so much that you can‘t 
engage in life. I think that‘s the whole thing; that‘s my whole goal. Just to find out where 
that medication line is. Where it is that I can be and still feel protected from the disease, 
but still be a little bit of myself at the same time. (7) 
 
Lucy spoke with some exasperation about her ―cocktail of drugs that I needed to take 
everyday just to maintain a kind of a balance‖—―It‘s very hard to get to, and it doesn‘t always 
remain, you know?  Sometimes it stops working, so you have to change them again.  So . . 
sometimes you‘re just like it—‗it worth it? (whisper)‘‖ (6). 
 Individuals were asked at the time of the interview how many years they had faced 
(serious) depression and how many of those years they received medical treatment.  Responses 
can be organized into three general categories.  Seven participants spoke of facing depression for 
a number of years and receiving medication that same amount of time (18/18 years; 16/16; 14/14; 
13/13; 12/12 & 10/10 years).  Three participants spoke of medical treatment over different ratios 
of their total years facing depression (14/16 years; 4/9 & 2/4 years) and a final group of four 
participants spoke of only briefly taking medications—from several months to a year and a half.  
Of the average experience of facing depression for 9 years (range:  6 months to 18 years), 8 years 
was the average time that participants had been treated with medication (range:  3 months to 18 
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years).  Across all 15 participants, this reflects an average coverage of 66% of depression years 
including some kind of medication use.  An intense weariness of long years of facing depression 
and navigating these kinds of treatment decisions was evident across interviews.  Kellie related, 
―I think it got to a point where I was just so tired of not knowing what to do . . so frustrated‖ (16).  
Robert said, ―The only lesson I can think of is just keep trying, just, just keep, keep trying . . . 
You just have to keep going.  You don‘t have any other choice.  You can kill yourself or you can 
keep going.  I mean, which one do you wanna choose?‖ (9).  Jill added:  
Things are going well enough in my life right now that I feel like I want to lower it again.  
I‘m always wanting to do that, I don‘t. . it‘s kind of . . you know, I‘m sitting on the fence, 
cause it‘s like ―yes I have to have meds‖ and I‘ve accepted that, but ―yes I‘d still like to 
get down off of them,‖ you know, if I can (sigh). . . . It‘s a roller coaster, sometimes you 
feel like, ―okay good, I‘m on meds, I‘m glad [that] I‘m on em,‖ other times it‘s like, I 
look at my pill case (laughs) and feel like a grandma--―I got this big old pill case!  I take 
all these meds‖ (laughs)! And you wish you didn‘t have to and you think ―oh man, what 
am I gonna do when there‘s this big earthquake someday and I don‘t have access to my 
meds, am I just, just going to disintegrate?‖ (7)  
 
Changing medication effects over time.  Beyond the common ambiguity of day-to-day 
experience, there was also a pattern of treatment effects changing over time.  For some, like 
Robert, positive effects started occurring after experimenting with several medications (9).  More 
often, it appeared the reverse was occurring, with initial positive effects eventually ceasing.  
Debbie, who spoke of experiencing Prozac initially as ―the magic part of life [that] seemed to do 
everything‖ went on to say, ―for a while--like maybe two or three years—[Prozac] seemed to 
work, and then all of a sudden, it just gradually did not work. . . . and I kept trying all these 
others.‖  She related her long search over the years for another medication or combination of 
meds ―to make me feel like I did when I first started taking Prozac‖ (8).  Camille also described 
Prozac ―working great for a year and then it just quit working‖:   
I started becoming depressed and they, my doctor increased the Prozac and it just didn‘t 
do anything, I continued to become more and more depressed and so I finally just--―this 
is not working.‖  And that‘s when I started to see the psychiatrist. . . . There was no 
explanation. . . . [I] said, ―I‘ve been taking Prozac for . . . a little over a year and it 
worked great, but it‘s not working anymore.  I‘m just getting more and more depressed.‖  
And we tried increasing the dosage and it didn‘t help, and he said, ―sometimes that just 
happens to people.‖  He said, ―we don‘t know why it happens; it just isn‘t effective 
anymore‖ (3).   
 
Elaine, who also had good initial experiences on anti-depressant medication noted a 
number of side-effects becoming troublesome, noting ―I thought [it] was a wonder drug when I 
went on it.  But, after I‘d been on it for quite awhile,‖ she related emerging side-effects such as 
emotional ―jitters‖ and a ―hard time putting sense together‖ that forced her to give up writing 
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poetry (2).  Robert, who spoke of Effexor helping him feel more energetic and social, later 
related:   
There was one point . . . . I just noticed that, um. . . I started to feel really nervous, even 
when I was taking my medication--it was just a different feeling. . . . And so I wondered, 
―Well, you know, maybe my medication‘s not working.‖  So I went and saw the doctor 
and he thought, ―Well, this is just anxiety,‖ so he gave me uh, I think it was Buspar, the 
uh anti-anxiety drug and then he also gave me a small of Atavan. . . He just said, ―Those 
are for the bad days.‖ (9)  
 
To summarize, individual response to medication can evolve in different directions over 
time.  For four participants, this meant that initial dramatically positive effects ceased or wore off, 
transitioning to a more mixed/positive response.  For two other participants, medication effects 
went from a good to mediocre/bad response.  On the other hand, two participants spoke of initial 
negative experiences eventually becoming positive, with a third describing no effect of the drug 
initially, followed by eventually noticing a difference.  Laying aside reported effects, the more 
interesting question was how individuals came to think about their worth and meaning.   
 
Theme 3.  Interpreting states concurrent with medical treatment:  “What is going on now?” 
 The foregoing themes depict variation in largely the actual reported medical effects over 
time.  While such variation is interesting and has received insufficient attention in the research 
literature, this study proposes that such brute patterns cannot be fully appreciated when 
considered on their own.  Accompanying this variation in effects is evidence of striking variation 
in how such effects are interpreted and narrated across participants.  This theme takes up some of 
the more nuanced, subtle differences in interpretation evident in participants‘ continued 
experience with medication—ranging from ascertaining the source of particular good or bad 
states concurrent with treatment, to evaluating these same states, to making sense of states 
associated with an end to treatment.         
Ascertaining the source of a state concurrent with treatment:  “Where are these feelings  
coming from?”  In speaking of uncomfortable states arising concurrent with medical treatment,  
participants revealed some interesting deliberations about their source.  These states range from 
mild feeling of numbness and lack of motivation, to more dramatic and painful conditions.   Jill 
said, ―I don‘t feel like I‘m feeling. . . . I do have emotions but, it‘s just hard to explain. . . I don‘t 
feel you know, like I don‘t feel what everybody else feels (sigh).‖  She also said, ―I want to feel 
deeper. . . . those deep, you know, chest feelings that you get.  I don‘t want just the superficial 
happy, you know, ―I‘m happy today or that was fun to do or I‘m excited to read this,‖ I want to 
feel it inside‖ (7).   
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 Jill attributed the absence of feeling to medication, parallel to Elaine‘s explanation for her 
lack of motivation (2).  Debbie, however, who also complained of a similar lack of motivation, 
wondered about the possibility of another hidden condition that hadn‘t yet been diagnosed.  She 
was then asked, ―When you‘re going through something hard, do you ever struggle with whether 
it comes from depression or whether it‘s like a side effect from the drug?‖  She replied, ―I usually 
just think it‘s the depression‖ (8).  Sarah‘s early experience with Zoloft illustrates this same issue 
in a more dramatic way:     
One of the negatives of the Zoloft was I still was suffering quite a bit of anxiety and panic 
attack and I remember . . (nervous laugh) you ever had a panic attack?  I mean it truly 
feels like your heart is just jumping out of your chest . . and that, your breathing you 
know you start hyper-ventilating but you think you are having a heart attack. . .    
*J:  Was that something you had experienced [before]? 
Yea. Well before I had even gone on my med, you know, any meds.  Well actually, now 
that I think about it, I had anxiety but I had never really experienced a panic attack, I 
think, until I went on the Zoloft and I remember calling Emily saying ―this is making me 
have panic attacks!‖ . . . and she says Sarah ―it‘s not the medication, it‘s your anxiety that 
you want this to work so bad‖ and I kept saying ―are you sure?  Are you sure, Emily!?‖ I 
said, ―because, if I can‘t . . so the Zoloft it it it . . ‖ (4)   
 
Sarah wondered aloud whether, in fact, the Zoloft came before her panic attacks or not.  
Sarah related her doctor‘s conclusion that Zoloft didn‘t have enough anti-anxiety effect to pull her 
out of her own struggle with severe anxiety.  After being prescribed a replacement prescription of 
Paxil, she reported feeling calm again.   
This account illustrates a particularly tricky challenge with medications.   When negative 
states are experienced concurrent with medical treatment, how are they to be interpreted?  
Continuing the pattern in Sarah‘s account, three other participants likewise commented on fairly 
serious conditions, while questioning or minimizing their connection to medication.  While 
mentioning some serious memory loss concurrent with treatment, Camille wondered briefly 
whether it was ―a result of medication or simply the way my mind works,‖ before emphasizing 
the memory loss as inevitable:   ―You just deal with it. What else can you do? And I‘ve just 
figured well maybe those are parts of my life that I just don‘t wanna remember anyway, so it‘s 
okay‖  (3). 
Robert, who was happy with the energy boost he felt with Effexor was then asked about 
―side effects?‖  After saying initially, ―You know, not really any…  not really any that were too, 
too bad,‖ he added: 
I will say, you know, on Effexor, I almost think that it was maybe too much for when I 
would have the increases in energy or whatever.  Sometimes I felt like my heart raced a 
little bit, and I‘ve noticed ever since then . . kind of um… I get pains in my chest.  I 
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mean, I don‘t know if that has anything to do with it.  It could be something totally 
different, but I have noticed that.  So, I don‘t know…(9) 
 
Robert described confusion about other strange effects, ―It seemed like, and I and they 
never really… knew for sure, but I started breaking out in hives, um, just all over my body for no 
reason… It wasn‘t, you know.  I wasn‘t eating anything different, no… uh…  No changes other 
than, you know, possibly stress‖ (9).  Along the same lines, Victoria related the story of waking 
up nearly paralyzed, ―I woke up one morning and could not move. I mean literally I was just 
paralyzed. It scared me to death‖ (5).  She attributed this experience to a random physical 
reaction, ―What it was, was that it was just some kind of freak thing where the nerve endings just, 
for some reason, just kind of locked everything up and so it was really muscle relaxants and pain 
killers you know and it took an couple of days for everything to improve (laugh), you know, and I 
was fine.‖  When she raised the concern with her doctor, he reassured her, ―it‘s so rare you know 
that I really doubt that it will ever happen again‖ (5).  
 Evaluating states concurrent with treatment: “Is this what I want?”  In cases where a 
particular emotional state (whether positive and negative) is clearly linked to medication, a 
second question becomes relevant:  how exactly should that state be evaluated?  This constitutes a 
second subtlety in the process of interpreting medication effects.  In some cases, the emotional 
state associated with medication is judged as clearly positive or negative (see above, Theme 1).  
Even when this happens, there is not necessarily a one-to-one correspondence between 
challenging effects and negative evaluations—with many instances of difficulties concurrent with 
medication narrated positively (see Ch. 8).   
 More typically, the worth of a particular effect itself, however, remains especially 
challenging to judge and interpret.  For instance, just as a state of numbness presented difficulty 
in ascertaining its source, numbness may also entail particular challenge in evaluating its worth.  
Jill hinted that her personal evaluation of a numb-like state varied depending on how well she was 
feeling overall:   
When I was really bad and I knew I needed help, I wanted to be on it . . . and now maybe 
I‘m doing better--and that‘s why I‘m feeling like it‘s giving me the ―flat line.‖  ‗Cause 
when you really need it, I don‘t think you feel that [concern with side-effects] as much.  
You just feel good, you know, because you‘re not depressed anymore.  But I think when, 
like right now [when feeling concerned with side-effects], maybe I‘m emotionally doing 
alright and maybe it‘s keeping me too ―flatline‖:  I‘m not feeling much of anything. (7) 
 
More frequently, difficulty judging the worth of medication effects appeared to reflect 
more general questions about how to think about side-effects alongside the other effects of the 
drugs—i.e., deliberating the overall question of the worth of medication in their lives.  As with 
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initially starting medication, some reported no resistance to remaining on meds.  Camille said, 
―I‘m fine taking medications; if I have to be on medications the rest of my life [then] fine, [it] 
doesn‘t bother me‖ (3).  Debbie added, ―I didn't resist taking medication because I liked this new 
person.  I learned about chemical imbalances in my brain and the comparison to diabetics needing 
insulin. I looked at taking meds as a must‖ (8).   
 Others who had experienced initial resistance described how positive experiences later 
lead them to abandon former concerns about medication.  Peter, who had agreed to take 
medication after hitting ―rock bottom‖ said, ―I tried that medication and found out that it . . . 
didn‘t dull my emotions in any way it just controlled them . . . . I got used to the idea of taking 
medication and I saw how much good it did me um then I lost all my reservations about 
medication‖ (10).   
 Still others spoke of lingering or continuing reluctance to remain on medications—with a 
range of responses that resulted.  In the face of some difficult side-effects, some decided to quit, 
such as Fern‘s reflections on experiencing out-of-body feelings on the drug:  ―I‘m a very cautious 
person, and when I had that feeling it just frightened me and I just said, ‗this was enough‘ . . when 
the Paxil started doing these funny things with me, I just said ‗no, I need to have control‘‖ (11). 
Most other accounts reflect less decisiveness and more intense vascillation.  For Lucy, 
questions about particular side effects prompted some intense wondering about whether 
depression or the drugs effects themselves were to blame for her earlier dark moods.  Reflecting 
on a period of gaining weight on the medications during high school, she said:   
You don‘t know why at all, like—and it‘s not that you‘re eating a ton—a lot of the time 
you really didn‘t know the source anymore because you‘d be 200 pounds and you‘d want 
to kill yourself because you didn‘t want anyone to see you.  You wouldn‘t go to school, 
cause you hated yourself so bad, and I looked back and go ―was I depressed?‖ or was it 
just—―my doctor made me [a] frickin‘ 200 pounds?‖  
 
Jill, who previously spoke of ―dreading‖ being tied to pills and disliking their numbing 
effect, described further of the rollercoaster of emotions involved in her treatment—between 
acceptance at ―having to have medication‖ and ―always wanting‖ to decrease the amount of 
treatment:   
But still, you know, you don‘t want to be put on, be put on a med and have to stay on it 
and you want to go off of it, but it felt good to be on it.  When I did go on Prozac I had 
more energy and I liked that about it. . . . You know, like sometimes you‘re just okay 
with it, other times you‘re thinking ―no I‘ve got to, you know, I‘ve got to, I don‘t want to 
be on them.‖   
 
She added, ―my only two complaints right now are the sexual side effect that is severe  
and the fact that, you know, I don‘t feel like I want to feel.‖  After being recommended an  
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additional drug, Jill noted, ―I‘ve been so reluctant to do it.  And, and see, I‘m, I‘m, what‘s the 
word . . not a hypocrite, but I mean, I say, I need the meds, I‘m okay with taking the meds, but I 
don‟t want to be on the meds (laughs).‖  Speaking of her own eventual reconciliation, she 
commented, ―It took a mind change for me to finally get to where I could say ‗I‘m grateful that I 
was born in this day and age where I could get the medication that I need.‘. . . it took me a while 
to come to that.‖  Jill continued:  
You go through that, ―well I don‘t want to have to take a medication,‖ you know, yea, 
you go through that whole process in your mind of ―Oh I, you know, I don‘t want to take 
medication . . every day of my life‖, and then you take it and start to feel a little better 
and then you think ―okay, you only need to be on it a few months‖ and that didn‘t work.  
 
 She concluded, ―I wish I didn‘t have, you know . . . to have meds. . . . I had to just tell 
myself, you know, ‗It‘s okay.  You‘ll just be on these meds and it‘s okay to be on these.‘  You 
have to talk yourself into it, basically, you just have to talk yourself into it‖ (7).  Similar 
reconciliations over time were evident in other accounts.  Robert said, ―The idea that you can‘t 
live without these little pills is somewhat upsetting, I think.  But . . or was somewhat upsetting.  
To me, it‘s normal now‖ (9).  For some, this reconciliation included accepting difficult side 
effects as necessary.   
Not all who continue their treatment reach such a personal reconciliation.  Debbie, who 
spoke of medication ceasing to work after initially feeling like ―superwoman,‖ later commented:       
I hate taking pills daily. . I keep thinking, what if I forget or what if I double take it? . . . I 
just hate it.  I hate remembering to have to bring [my pill box] wherever I go and . . . to 
worry about it, the schedule of it, you know, in the morning, ―do I take it with food?--do I 
have to not take it with milk or take a full glass of water with this one?” or whatever . . . 
all those little things.  
 
She was then asked, ―do you see yourself accepting it more in the future?‖:  ―Hopefully 
or I‘m in big trouble--(laughs).  Oh everyday.  I‘ve got to convince myself. I can convince others 
but accepting it myself, I just . . I struggle with that . . . it‘s easier for me to tell somebody else, 
‗oh yeah you need, you need it, you need to accept it‘. . . even though they say it‘s just like 
diabetics. I can tell that to somebody else but for me to accept it, I don‘t.‖  Debbie later said, ―I 
have to keep telling myself it‘s a chemical imbalance‖ (8).   
Ultimately, participants ranged in their general opinion of medication at the time of 
interview — from 3 unconditionally in-favor, to 8 ambivalent, but generally in favor, to 2 
ambivalent, but generally opposed, to 2 unconditionally opposed.  In a rough split, there was one 
group largely favorable (Elaine, Camille, Sarah, Victoria, Lucy, Jill, Debbie, Robert, Peter, 
Michelle) and a second largely unfavorable (Fern, Kyle, Esther & Kellie) to traditional 
biomedical treatment.   
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More interesting than overall participant disposition towards medication, of course, was 
evidence of how they arrived at that point.  While Chapter 6 examines this question in detail 
based on key narrative resources, here we can trace characteristic ―trajectories‖ of personal 
interpretations and evaluations of medication evident over time (only those nine participants who 
spoke of changing perceptions are included here).  Four participants reported miraculous initial 
effects, and held onto a belief in the potential of medication even when these positive effects had 
lessened or ceased (Elaine, Sarah, Jill & Peter).  Two participants who had reported good initial 
effects, in contrast, began questioning the potential of medication when the effects had become 
mediocre or bad (Fern & Jill).  Among those who reported initial negative or neutral effects, two 
eventually came to embrace the potential of meds when their effects had improved (Victoria & 
Robert) and two rejected them outright when their effects remained ambiguous (Kyle & Esther).   
By emphasizing patterns of resistance, these trajectories may be framed in a slightly 
different way.  Attitudes of resistance over time may be organized in a continuum of five 
groupings, as follows:  On one end, two individuals were seemingly never resistant to medication 
and remained openly accepting of their current medication at the time of interview (Robert & 
Michelle).  A second group was initially resistant to medication, but had changed their feelings 
after starting to embrace medication they were taking at the time of the interview (Elaine, Sarah, 
Victoria & Peter).  A third group (of one person), was likewise initially resistant, and while 
remaining on medication at the time of the interview, remained deeply hesitant (Jill).  A fourth 
group, likewise reflected enduring resistance and had followed it to cease medication by the time 
of the interview (Fern, Kyle & Esther).  A final group (of one) had experienced enduring 
resistance and never started medication (Kellie).   
  Interpreting states associated with a cessation of medication:    “What is going on 
now?”  Here, I focus on diverging interpretations of states associated with a temporary cessation 
of medical treatment.  Previously, a tendency was reviewed among some participants to attribute 
negative states concurrent with medical treatment to depression itself.  A similar pattern is 
reflected in the manner that negative effects arising concurrent with a decrease in medical 
treatment are typically judged.  This interpretation, which also arguably plays a significant role in 
participants‘ eventual treatment decisions, is reviewed in two parts:  the interpretation of 
temporary, accidental cessations examined here and the interpretation of deliberate, planned 
tapering reviewed in Theme 7 below.   
Some participants report getting to a point where they mostly experience no side-effects 
as medication regimens are constant, but notice considerable turbulence when it changes.  For 
instance, as reviewed earlier, Jill described hitting ―rock bottom‖ during a transition between 
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medications, ―‗cause I wasn‘t even at a therapeutic level on anything at that point‖ (7).  Victoria 
spoke of ―those times when I haven‘t had my medication‖:   
It‘s almost as if life doesn‘t make sense. You know, I can‘t …and this has been times 
when they‘ve upped the medication. And this is times when I have gone in and I said, ―I 
can‘t seem to find a direction I can‘t seem to prioritize and figure out what I need to do 
during the day, you know. And umm that has usually been a symbol that we need to up 
the medication a little bit or there is some or like I have said before some of the life 
changes that I‘m not aware of.. (5) 
 
Similarly, an increased dosage was the natural response when the Jill faced her own  
difficult period—―And then when my dad died that year, then [my doctor] upped me a little bit to  
get me through that‖ (7).   
Two additional accounts further illustrate both the nature and implications of 
interpretations in the accidental/temporary cessation of medication.  When asked, ―Have you ever 
had any uncomfortable side effects on the medication?‖ Peter answered, ―I‘m trying to think 
(sigh) no not really, I mean only when I don‘t take it.‖  He went on, however, to speak of negative 
emotions from the absence of medication: 
Well, I know that (pause), I can tell when I haven‘t taken a medication . . . there are 
physical and personality aspects that come out when I haven‘t taken my medication…um 
I get a lot more moody, and by that I mean I‘ll tend to take something very personally. 
Someone will say something, and I‘ll say, you know, ―boy that really‖ and, you know, it 
will make me very angry.  You know, I‘m generally a very even tempered person but 
[without medication], I‘ll get angry really quickly . . . . I don‘t feel in control of myself, 
you know, I, you know, I just, I‘ll snap and I‘ll say just about anything, to just about 
anybody (pause) you know (pause) and, you know, I hate that--I don‘t like it, you know, 
I like being in control.  
 
 Peter related the following explanation of uncharacteristic behavior: 
A couple weeks ago I was at home and uh (pause) my mom and I started talking about 
something, and it was, I hadn‘t taken my medication. I didn‘t remember um (pause), and 
without even thinking I just mouthed off to her.  And I don‘t do that, like that‘s not, I just, 
I just mouthed off I said, ―you don‘t know what you‘re talking about so you better just be 
quiet‖ you know.  And, you know, that‘s not me, like I don‘t do that. I mean our 
relationship is such that I don‘t have to do that.  We can speak honestly one another…and 
as soon as I said that I sort of reflected on it, and I knew I said, ―oh yeah I haven‘t taken 
my meds today.‖ (10) 
 
Others mentioned noticing greater physical repercussions of not taking medications—
dizziness, upset stomach, light headed.  Robert commented:    
As far as Wellbutrin is concerned … I noticed, I guess I noticed that it was working when 
I didn‟t take it.  If I would miss doses, and I‘m bad – I‘m horrible with consistency, um… 
then I‘d start to just feel… kind of jittery and on edge . . . And so…  that‘s really how 
I‘ve noticed that. . .   
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*J: So, when you don‘t it, you notice you‘re jittery or on edge, and when you take it 
again, and that goes away? 
Yeah… 
 
 Robert shared further thoughts about the jittery and ―on edge‖ feeling ―kind of the way 
that I felt in my earlier years when I was knew something was wrong, didn‘t know exactly what it 
was, you know, as far as having racing thoughts and stuff that would end up, you know, pulling 
me down into a cycle of depression‖ (9).  As will be reviewed in the later tapering theme, how 
exactly individuals come to interpret negative emotional states during an accidental cessation or 
deliberate tapering of medication may have significant practical consequences for ultimate 
decisions about treatment. 
 
Theme 4.  Encountering additional influence:  “As my doctor explained to me. . .”   
In navigating different treatment issues reviewed above, individuals clearly do not 
deliberate alone.  In the case of difficult emotional states concurrent with medication, participants 
appear to be significantly influenced by surrounding relationships (similar to initial treatment 
decisions described earlier).  These range from additional encounters with family and friends, to 
doctors and other health professionals.  Similar to the earlier theme exploring surrounding 
community influence on initial problem definition, this theme examines and reflects the same 
influence relative to interpreting treatment.  4 of 12 participants who had received medical 
treatment spoke of some kind of significant influence from surrounding relationships in their 
continued decisions about that treatment.  Once again, this influence ranges from informal helpers 
(family and friends), to that encountered with medical professionals.  Since this influence plays 
an obvious role in the formation of positive convictions about medication, this theme ends with a 
brief review of some of these favorable treatment conclusions reached by participants.   
To begin, friends and family appear to play an influential role in helping individuals think 
through and process difficulties and ultimately maintain compliance.  After being helped by her 
friend and doctor to resolve fears about drug-induced panic attacks, Sarah later referred to the 
general influence of her surrounding community:   
It‘s the people around you that . . they can tell you‘re not you; it was the people at work. . 
. I was teary again and finally . . . [my coworker] said, "I am calling your doctor right 
now something, your medicine is not right‖ and I go ―I haven‘t changed.‖. . . it‘s the 
people around you that see it more than you really do, actually see your mood change, 
your appearance change. (4) 
Similarly, Victoria recollected: 
And so, you know, [my friend] would check up with the medication, ―how are you 
feeling?‖ She is kinda the one that, umm she got me through this because, you know, she 
would be the one that said ―umm Victoria, your fuse is really short; tell me how you are 
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feeling,‖ you know.  ―It‘s the Prozac…go get something else,‖ you know.  And then she 
would say ―how is this [medication] doing?‖ and [I would say] ―well, I feel this way; I 
feel that way.‖ And then, that‘s when she said, you know, ―I want you to try this Zoloft 
go ask your doctor if they will give you some.‖ (5)  
 
Debbie related that ―another way [that] you know medication‘s not working, is people  
around you tell you. ‗Have you taken your medication today?‘ (laughs) or whatever so, people 
around you notice things‖ (8). 
Jill, whose ―daily life‖ account of medication was reviewed earlier, later spoke of her 
efforts to help two sons who faced emotional struggles.  After petitioning her psychiatrist to 
diagnose and treat her first son, she spoke of her efforts to educate him:   
I‘ve had to teach that to my, my son that‘s bipolar; I‘ve had to teach him that it‘s just like 
anybody else that has to take medication.  It‘s like someone with, you know, diabetes or 
someone with a cardiac problem, your body needs this medication to function.  You have 
to take it. . . . From the beginning when he was diagnosed, I said ―this is something for 
life, you‘ll have to be on these medications for the rest of your life.‖   
 
Jill continued, ―My husband‘s become the alarm clock basically, ‗Did you take your 
meds today?  Did you take your afternoons?  Did you take your night pills?‘‖  Relating the 
experience of her other son, she said, ―They tried him on Ritalin.  It was too strong for him; he 
just had that glazed- over look, you know.  But it would calm his temper down.  And the summer 
before eighth grade he just begged me, ‗can I just not be on it?‘‖  This son eventually stopped 
medication and managed the problem himself.  Jill‘s other son, however, continued treatment in 
the face of similar resistance, ―He would just never want to take ‗em.  And even in the early 
stages of taking the mood stabilizers, he, you know, would sometimes throw out ‗I‘m never going 
to take my meds again!‘ you know.  He got mad at us, but as he‘s matured, he‘s accepted it and 
he forgets.  He has a hard time remembering‖ (7).  
In addition to the influence of friends and family in reinforcing a course of treatment, 
interviews consistently illustrated an important role for doctors in guiding people through the 
resolution of complex evaluations, a theme evident in earlier vignettes as well.  Indeed, while 
friends and family seem to play the greater role initially, once individuals are in the system, 
doctors seem to play an increasing role.  As always, these experiences varied across participants.  
While four individuals spoke of resisting encouragement from medical professionals (see Theme 
5 below), three participants spoke of encounters with doctors as making a significant impact on 
their decisions to continue treatment—the focus of this part of the theme.  After mentioning her 
co-worker insisting on calling her doctor, Sarah continued:    
So anyway, I was able to go in right then.  I talked to Dr. Maxwell and she said ―you 
come in, Sarah, I want to see you today.‖  And she said, you know, ―I‘m going to add 
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some Wellbutrin to your Paxil‖ and I said, ―well I don‘t want any more meds.‖  And she 
explained to me, she said, ―Sarah. .‖  I said, ―how come it‘s not working?‖ and she said 
―there are other little neurons that need a reboot from time to time‖ and I said (sigh), you 
know, again, I didn‘t want to take more meds.  And she said ―let‘s just try it and see.‖  
And so she added 100 in the morning and 100 at night. (4) 
 
In the face of patient concerns about being on many medications, doctors can play a 
major role in shaping people‘s decisions and often prompting individuals to move forward.  
Elaine spoke of feeling hesitant to start Xanax, not seeing how it would help since she could not 
get out of bed as it was.  In visiting with her doctor, however, he convinced her ―this stuff will 
help you be able to function.‖  She went on to confess, ―I thought I knew more than the doctor 
did‖ and described a critical process of ―learning to not be smarter‖ (2).  
Victoria recounted a time she began to feel better, prompting hopes of being able to get 
off the medication: 
Once I was doing well--the business and work was going along fine—I decided, ―okay, 
(laugh) you know, I can get off this medication,‖ you know. And I tried and tried and 
tired. And my doctor very wisely sat me down and scolded me and said, you know, you 
will probably be on this medication for the rest of your life. And you have to come to 
terms with that. And he said, ―I don‘t think you‘re looking at this the right way. He said 
you should be the way ….he put it thanking god that he has brought this medicine that 
you can live a good life and have a way to accomplish that.‖ (5) 
She called that encounter a ―major shift‖ for her—recollecting again, later:  ―I had that  
conversation with my doctor where I said ‗I‘ll never be off this medication‘—him just saying, 
‗you now what?  Be grateful. This is out of your control.  But you know it‘s all alright‘‖ (5).  
Ultimately, such reinforcement from family, friends and doctors appears to contribute in many 
cases to a loss of hesitancies about medication.  After her own evolution, Sarah reached a 
conviction that medication was necessary to have a clear mind, for its help towards her ―serotonin 
and chemistry being balanced‖ (4).  Several other participants shared similar convictions.  As 
Victoria noted, ―The medication really helps me have a life. . . . I mean . . . if life is sailing along 
smoothly and I didn‘t have my medication, the days would just be gloomy and gray just lack 
luster.‖  Speaking of therapy, she continued, ―they definitely have to work together because I 
can‘t do it without the medication‖ (5). 
Jill, who spoke of previous resistance to meds in her interview, similarly concluded, ―I‘m 
a firm believer in medication . . . .  for me it‘s pretty dramatic, with and without meds.‖  She later 
added, ―like I said, I don‘t, you can‘t get better without medication.  You can talk and talk and 
talk but you can‘t get better without if your chemicals are messed up‖ (7).  Michelle, whose story 
reflected impressive faithfulness to medical treatment, was asked, ―other people have struggled to 
be compliant in treatment and instead, go on and off of medication.  How have you been able to 
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stick with it?‖:  ―Because I see the difference in the quality of my life, my ability to function. . . 
You know if this is what it takes in order to have the life I do today I think that‘s a small price to 
pay, so . . . But a lot of people don‘t see it that way‖ (13). 
 
Theme 5.  Refusing treatment.  “It‟s only made things worse. . .  
 As reflected below, not everyone reaches such conclusions--nor are all individuals 
responsive to professional assurances to continue treatment.  Some participants had less positive 
experiences with drugs and medical professionals, in particular.  While participants commonly 
spoke of an uncomfortable exchange with a doctor, two individuals, specifically, spoke of 
extreme dissonance during interactions with medical professionals.  Kyle and Esther‘s narratives 
provide especially vivid illustrations.   
 Esther had initially entered treatment for depression with openness to medical treatment, 
but also with many personal questions.  Her first difficulty came from the general professional 
response to these concerns:     
When I initially went into the system . . .  I was kind of frustrated--confused would be the 
best word, because I was sitting there saying ―these are the kind of services and support 
that I want‖ and the system was saying ―no, no, no you‘re going to take whatever we‘re 
giving you.‖   
Esther said, ―I just felt like . . they didn‘t really care if I had any questions or concerns.‖   
She continued, ―Just so many times that I was sitting there saying, you know, ‗here are the things 
in my life that are bothering me‘ and having a majority of the people that I dealt with in the 
system saying, ‗well, that‘s great—but I really don‘t care now. . . . take the drugs.‘‖  While 
initially showing a willingness to try the medications, she added:  
A lot of times I wasn‘t getting a lot of information—they would, you know, give me list 
of like four or five side effects and then I‘d go on the web and I‘d find that there were 
like sixteen and I would ask why they hadn‘t mentioned the other twelve?  
 Esther continued:   
What I was always told when I was in the system was . . ―well, you know you have this 
chemical imbalance in your brain and if you just take this medication it would fix it.‖ . . . 
They had a really narrow way of defining the problem. . . ―we can fix it; just take this and 
you‘ll be fine‖ . . and I wouldn‘t do that.  . . . I was this thing that they felt I had to fix 
and the way that they could fix me was to force me to take medication which I wasn‘t 
really interested in doing.  
 During this time, she also researched alternative resources on her own and brought them 
to the attention of doctors:   
I found generally across the system that when someone‘s first idea didn‘t work they 
didn‘t have a lot of interest in researching what else might be out there. . . . When I would 
find resources . . . I found the system was fairly closed to even looking at any of the other 
alternatives. . .  [I found] some article about alternative treatments and I remember 
bringing it to one of the practitioners I was working with, and him just basically handing 
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it back to me and telling me that he didn‘t even want to look at it because he was certain 
he already knew what was.  He didn‘t want to look at it—gave it right back.   
 
 Ultimately, she spoke of ―realiz[ing] that I had the strength to stand up and say no.‖  
Esther describes the doctors‘ response to her resistance:    
They didn‘t know what to do. . . . They saw the person who they had labeled with any 
number of things . . and, then they saw this [same] person who was sitting there saying 
―no, I don‘t want to take these drugs you‘re giving me.‖. . .   They didn‘t want to deal 
with it—and you know, it was the old, kind of, ―shut up and take your drugs‖ you know, 
they‘re expecting you‘re not going to get by if you don‘t get the drugs (laugh).  
 
 As she persisted in her refusal to take medication, Esther recounted other doctors‘ 
responses:     
It would vary—some would just flat out tell me, ―It can‘t be.  You don‘t know what 
you‘re talking about.  Of course, you‘re mentally ill and you‘re in denial that you‘re 
mentally ill‖. . . . And a lot of times they would just start bypassing me and go right to my 
family, sort of like, ―we don‘t really agree what you‘re saying, so we don‘t want to deal 
with you.  We‘re just going to talk with your family who understands what we‘re 
saying.‖  
 
 Since her family was willing to force her to get treatment, she agreed to see a psychiatrist 
to ―keep them off my back.‖  For a short time, she tried medication at their request:  ―I was 
initially forced to—it wasn‘t very much, very long. . They were just pushing it and pushing it.‖  
Referring to family concerns when she quit, she added, ―Luckily, it was a time when laws were 
not favoring forced compliance . . compared to current laws making it easier for family members 
to forcibly commit family members‖ (14).   
 Kyle‘s story reflected similar discomfort with medical advice.  In spite of uncomfortable 
side effects, reviewed earlier, he initially tried to work with his doctor, ―I stayed with it and then 
he said ‗well now double it and then back off and then double it again‘ or something like that.  So 
I tried that.‖  After experiencing weight gain, blunted emotion, boils and carbuncles, he 
concluded ―it just, uh . . . it wasn‘t working‖ and asked his doctor, ―‘Do you think it‘s the 
Lithium?‘  ‗Oh no, no, no.‘‖ It was at this point the doctor suggested adding another medication:    
He goes ―well, we‘re going to add Wellbutrin to the mix.‖  And I said, ―you know what?  
I don‘t want to take that rollercoaster ride with you.  It‘s making me nervous, I have 
problems with my sleep anyway, I‘ve heard Wellbutrin is, you know, can cause 
insomnia.‖  He goes ―well then we can add something for that.‖  And I go ―I‘m not going 
to be a poly-pharmacy experiment.  It just . . that just doesn‘t work for me.‖ And he 
raised his eyebrows and he goes ―I‘m, giving you the script, you know, talk to me next 
week.‖  
 
 Kyle went on to research medication profiles for himself and conclude that the drugs had 
become a part of the problem.  At the end of his interview, Kyle raised concerns that as new 
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problems arise, doctors were inclined to simply adding more medications in a ―rollercoaster of 
med after med after med.‖   
 Other treatment accounts also reflected a similar response to worsening symptoms:  either 
increasing dosages or adding new and different medications (poly-pharmaceuticals).  Of the 13 
participants who had tried medication, 77% (10/13), were administered more than one psychiatric 
medication—ranging from four individuals who spoke of taking a combination of three drugs 
(e.g., anti-anxiety, anti-depressant and anti-psychotic), to six taking two medications at a time.  In 
addition to the 2-3 psychiatric/psychotropic medications, participants also spoke of concurrently 
taking other medication to address side-effects (e.g., sleep aids) and medications for other 
independent physical conditions.  Of the other three individuals who never experienced poly-
pharmaceutical treatment, two took medication for only a short time, while the third (Kyle) was 
encouraged to add an additional medication, but refused.   
Other accounts reflected similar poly-pharmaceutical concerns.  Referring to a period of 
taking several medications including Depacote and Xanax, Elaine described problems with 
weight gain, muddled thinking, fatigue and diabetes.  After her internist asked her to bring in all 
her medications so he could review them, he said ―how in the world . . . you walk through that 
door I will never know‖ (2).  In contrast, other individuals‘ response to similar poly-
pharmaceutics was often quite positive.  Jill spoke favorably about her doctor saying, ―well, it 
wouldn‘t hurt to just try it and see if anything happens‖ as he added another medication to ―boost 
the effects‖ of other medications (7).  Camille said: 
My psychiatrist has been absolutely fabulous.  He‘s willing to try combinations of 
medications that probably wouldn‘t normally be put together or um, you know, dosages 
that that my regular doctor never would‘ve even thought to prescribe. Not dangerous 
dosages by any means but he‘s been practicing for quite a long time and is very 
respected. (3) 
  
 We have examined accounts of participants both strongly resistant and strongly in favor 
of medical treatment.  As mentioned previously, however, the bulk of participants lie in between 
these extremes:  with some satisfied with treatment, alongside some with real concerns.  In the 
next two sections, some additional aspects of more ambivalent experiences are detailed.  These 
individuals typically are neither willing to reject treatment nor embrace it entirely.  To begin, we 
listen in to how these individuals think about life without medication.   
 
Theme 6.  Previewing life without antidepressants: “The person off meds is scary. . .”   
 When participants spoke of times of considering tapering off medication, they expressed 
poignant emotions, ranging from aching fears at its potential dangers, to an adamant belief in its 
 91 
possibilities.  Several individuals expressed fear at the possible consequences of tapering off 
medications.  Victoria said, ―I really dreaded having to (sigh) think that for the rest of my life I‘ve 
got my pharmaceutical cocktail that I take every day, you know (laugh). But umm, it‘s better than 
the alternative, you know . .‖(5) 
 What is the ―alternative‖ to being on medication?  Unsurprisingly, many report expecting 
a return of difficulty in the absence of medication—from a lack of basic cognitive capacity, to 
more frightening prospects.  Jill reflected, ―I‘m grateful that I was born in this day and age where 
I could get the medication that I need so that I wouldn‘t be locked up in the attic somewhere, or 
indisposed all the time (laughs)‖ (7).  Elaine similarly commented, ―I‘d really like to be off the 
meds, but the person off the meds is scary.‖  She went on to elaborate her fears as specifically 
linked to her family:   
I don‘t know, I‘ve thought a few times I wish I could see a window of time where--and 
I‘d wanna talk to my doctor about this--where I could play around with my medications 
and see how I did going off of them, but my grandchildren (shaky, crying) I don‘t want 
my grandchildren to see me as this bitter, angry (laughs) . . you know, ‗cause all it takes 
is the screaming . . . and that‘s how they‘ll remember you for the rest of their life--so it‘s 
just not worth risking the relationships. . . . You know, it‘s not at all fun and games to 
take the stuff but it‘s, the alternative is really unpleasant . . . it‘s the difference between 
me and a normal person (or fairly normal person) and being the weird lady, you know, so 
I feel like the medications are worth it.  
 
Although the fear of others‘ appraisal of her actions while off medication reflected her 
primary concern, Elaine spoke further of another more basic fear:    
There‘s just nothing scarier . . . . really deep depression is about the scariest thing I‘ve 
ever experienced. And I just don‘t wanna be there. Um… and…so. . . it‘s something that 
I‘m scared to death of now. I‘m scared to death of going into a depression. (2) 
 
 Others spoke of the influence of their fear of depression and a real dread of its return.  
One woman spoke of the fear that comes when a worsening mood ―doesn‘t stop—when it doesn‘t 
just become a bad day‖ (6).  Speaking of the same potential return of depression, Kellie noted, 
―Every once and a while, I will feel that feeling. It may be a particular day where those feelings 
come back, and it‘s scary. And I think, ―Oh no!‖ (16).  Robert similarly commented, ―I mean, you 
just know what‘s coming. . . in the back of your mind since you‘ve been through the cycles a 
bunch of times, you know what‘s coming. . . . When things start to go wrong, I‘m just like, ‗Don‘t 
get depressed, don‘t get depressed‘ (9). 
Naturally, such fears of depression may lead individuals to avoid tapering off 
medication—with the fears of life without meds more broadly, playing a critical role in keeping 
individuals compliant.  Even Kyle, whose tapering was successful, said of it, ―I did feel nervous.  
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I knew if I didn't succeed and ended up wacko again I would lose a lot of freedom in how I lead 
my life‖ (12). 
Explaining her own commitment to stay on the medication, Sarah recounted, ―I just said  
there‘s, I‘m not gonna (sighs), I can‘t go back to what I was. . . . I can‘t because it scared me so 
bad‖ (4). 
 Once medication is embraced as central to fighting depression, the fear of depression may 
lead individuals to an intense attachment to this treatment, with Elaine summarizing her ―whole 
goal‖ as finding the right dosage level for her to be able to function (2) and Jill asking 
hypothetically, ―what am I gonna do when there‘s this big earthquake someday and I don‘t have 
access to my meds, am I just, just going to disintegrate (laughs)?‖ (7). This attachment was also 
reflected in another vignette from Sarah‘s account:  
I was on a low dose of Zoloft and, it needed to be bumped up a lot faster than it was. . . I 
remember calling Emily going, ―it‘s not gonna work for me, I know it‘s not gonna work 
for me‖ (very upset). And she‘d go, ―Sarah, honey, you know, it will; you know it will. 
Just give it a little time.‖  I‘d get the panic and the anxiety and fearful that I‘m gonna be 
in this state forever--this, this despair. (4) 
 
In spite of such fears, a desire to taper may persist for years.  Of 11 participants who took 
medication for an extended period of time, 5 spoke at some point of either tapering or having a 
desire to taper off meds.  As cited earlier, for instance, Elaine spoke of wishing for a ―window of 
time‖ where she could ―play around‖ with her medications and see how she did going off of them 
(2).  Jill also spoke of her long-standing hope of tapering off medication:    
And [my doctor] wanted to put me, add another ten, you know a second one of Pamilor at 
night to make me sleep all through the night, and I just, I don‘t want to be on that many.  . 
. . he bumped me up to, five years ago my father died, and then my grandmother who I 
was really close to, so then he bumped me up to like 75 on that which is a pretty high 
dose, and then I tried a couple of years later to come down and I couldn‘t so I waited 
another year and I was able to go back down to like whatever it was, maybe it was 50-40, 
and then I tried to go from 40 down and I couldn‘t do that.  But I did get down from 60 to 
40.   
 
Reflecting on her experience, she summarized: 
When I was really bad and I knew I needed help, I wanted to be on it.  And then, I was 
such a high dose, I wanted to go down off of it . . . And once I was doing well the 
business and work was going along fine I decided, ―okay (laugh) you know, I can get off 
this medication.‖  
 
Jill described her doctor‘s response: 
And my doctor very wisely sat me down and scolded me and said, ―You know, you will 
probably be on this medication for the rest of your life. And you have to come to terms 
with that.‖ And he said, ―I don‘t think your looking at this the right way.‖  He said, ―you 
should be thanking God that he has brought this medicine that you can live a good life 
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and have a way to accomplish that.‖ And I thought, ―well, I guess so,‖ you know 
(chuckle). (7) 
 
Against the counsel of relatives, doctors and their own frightening narratives of the 
future, some make the decision to try leaving medication anyway.   
 
Theme 7. Attempting to taper off medication:  “Damn the torpedoes--I‟m going to do it . .” 
 The following theme examines participant comments about actual efforts to taper off 
medications.  Of the 13 participants who started medication, 9 spoke of having a desire to taper or 
cease meds at some point (Elaine, Sarah, Victoria, Jill, Debbie, Peter, Fern, Kyle & Esther), with 
four never mentioning any interest (Camille, Lucy, Robert & Michelle).  This interest appeared to 
evolve and vacillate for many, with Debbie, for instance, moving from satisfaction in ongoing 
medical treatment to a growing desire to taper, and Peter the reverse—with a gradually 
decreasing desire to taper over time until he was content with ongoing treatment.  Among the 
nine participants who considered tapering, all but one tried it.  The following illustrates both 
outcomes and some of the difficulties encountered—including both emotional turbulence 
associated with tapering and particular interpretations of this emotional turbulence.  While the 
sub-theme‘s title implies boldness involved in decisions to taper, more often than not, accounts 
reflect a haltering nervousness accompanying this step.   
 The necessity of a gradual taper was not always something of which people had been 
aware.  Lucy said, ―I never . . no one told me that when you started taking them that you had to 
kind of withdraw from them—like you had to slowly go off of them‖ (6). 
For others, it was difficult for some to find a professional willing to supervise tapering off 
of medication.  Debbie spoke of being ―unable to find help to taper; nobody seemed to want to 
take me off Effexor‖ (8).  With previously reported significant positive and negative treatment 
experiences, she eventually spoke of her own attempts to taper off medication:    
The couple times I tried to get off, it‘s just not gonna happen. And you see the side 
effects of getting off and nobody likes me and I myself don‘t like me when I get off the 
medication. . . . I don‘t remember which one it would have been with. I would say Prozac 
or Paxil. . . . You feel good, you know, you‘re feeling so good and you just think ―this is 
wonderful I don‘t need this.‖ I mean, now I know but at the time you think I‘m just 
feeling so good everything‘s running nicely, you know, let‘s just try to get this so I‘m not 
dependent upon this medication. . . . But um usually about three to four weeks I notice 
that, okay, I‘m getting very nervous, very tense I can feel myself getting tense.  And then 
just, the wanting to stay in my little cage . . . and not wanting to go out to see people. . . . 
*J:  This is what you felt like with trying to wean yourself off, that‘s what you‘re talking 
about? 
Right. 
*J:  After you reach this point, then what happens? 
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Right. I think I stop myself completely, but then I start taking it and within like a week or 
two I‘m okay. (8) 
 
Others report similar experiences.  Elaine recounted:  
Every couple of years--I got to the point that I thought, ―I felt really good‖ and I did; I 
just cut down on the Topamax and actually ended up not taking it at all for awhile.  But 
then, I just felt everything coming back.  And so I had to get back on something . . and 
then [doctors] tried these other things.  (2) 
 
Jill described hoping to taper in the previous section had actually ―tried I tried and tried  
and tried‖ to decrease her medications:   
I‘ve seen when I‘ve tried to go off of them how hard it‘s been. . . . Like if I try to lower 
the dose I can see it starting to happen again, the symptoms, and I don‘t want that either 
so it‘s like I had to just tell myself, you know, ―It‘s okay.  You‘ll just be on these meds 
and it‘s okay to be on these‖; you have to talk yourself into it, basically.  
 
Even after being discouraged by her doctor‘s ―scolding,‖ she added: 
Lately . . . I haven‘t been, don‘t feel like I‘m feeling . . and I want to try again. . . . I think 
things are going well enough in my life right now that I feel like I want to lower it again.  
I‘m always wanting to do that, I don‘t. . it‘s kind of . .  you know I‘m sitting on the fence 
‗cause like, ―yes I have to have meds‖ and I‘ve accepted that but ―yes, I‘d still like to get 
down off of them,‖ you know, if I can (sigh). (7) 
 
In previous themes, the difficulty of interpreting negative states coinciding with a stable 
regimen of medication was evident.  Here, the added challenge of understanding turbulence with 
a changing dosage is evident.  As reflected in the aforementioned fears of participants, as these 
individuals began to encounter painful feelings concurrent with a decrease in meds, we see both 
reach the same conclusion:  the depression has returned.  Debbie concluded, ―I‘m pretty sure it‘s 
a chemical imbalance though because I‘ve tried to wean myself off the medication and it‘s just 
not a good idea--I don‘t like me.‖  She also said, ―So I have to keep telling myself it‘s a chemical 
imbalance--it‘s not gonna go away with . . you know, I can't, I‘m not one of those that could take 
it for a couple of years and then be good for five years. It‘s . . I‘m stuck.  I‘m always going to 
have to have medication‖ (8). 
 Similar to interpretations of active treatment, here we see evidence of consequences 
associated with the particular ways individuals interpret treatment cessation.  In both cases, how 
to interpret negative emotional states concurrent with treatment is the critical issue.  As noted 
earlier, among the nine participants who considered tapering, all but one tried it.  Of those who 
tried it, however, only three of eight individuals actually got off medications (Fern, Kyle & 
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Esther).  The rest were either dissuaded from trying again (Jill) or continuing to experiment, with 
some trying and failing multiple times (Elaine).   
Even after tapering, however, tension and struggle as to the appropriateness of treatment 
may continue.  Kellie recounted the experience of an acquaintance who had stopped taking 
medication, ―She is off of it now, but she is struggling and she is wondering if it is something that 
she needs, that she should have kept doing or that she needs to get back on.  It‘s that struggle . . . 
wanting to take it but not wanting to be tied to it‖ (16). 
 
Theme 8. Evaluating alternatives:  “What else could be done?”   
 Since interpretations of medical interventions for depression are the primary focus of 
inquiry, attention to views of alternative treatments has been limited.  The following theme 
captures comments about general openness to alternatives, followed by accounts of the recovery 
process and the role of family, friends and professional counselors.  While the focus here is on 
instances of support from friends/family, Chapter 7 breaks down patterns in difficulties during a 
depressive period for these same relationships.   
 Kyle began searching for alternative support when medical side-effects were becoming 
burdensome, but initially remained unaware of any other viable ways of addressing his 
depression.  After learning of some alternative interventions, he started considering the possibility 
of tapering off meds—an idea adamantly opposed by family members.  In spite of personal fears 
and the concern of his family, Kyle gradually tapered over several months and found eventual 
relief in major changes to his diet and sleeping habits, as well as his overall stress level.  
Reflecting on this experience, Kyle spoke at length about alternatives and articulated various 
perspectives more than other participants.  First, he noted that in some cases where medication is 
emphasized, ―There's very little talk of alternative treatment.  Reflecting on his wife‘s decision to 
forcibly hospitalize him, he asked:   
What else could she have done?  What else?‖  You know, I don‘t know and that‘s the 
problem.  . . . I think if something works for someone . . that‘s great, but there‘s got to be 
alternatives . . . for people when medication doesn‘t work and right now it‘s just not 
there.  And there has to be more than ―take meds and if that med doesn‘t work, well then 
try this med and then we‘ll try this med.‖  Well, there‘s got to be more.  (12) 
 
 Referring to the major impact that better management of her blood sugar levels had on 
her depression, Michelle remarked:    
No psychiatrist ever suggested to me in all this time . . . ―check this out‖ or ―maybe if you 
took this seriously you would improve over here,‖ you know.  . . I don‘t know how much 
research they‘ve done about that correlation between diabetes and depression.  (13) 
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 Kyle recounted a conversation with an acquaintance having difficulties on medication:   
She was not happy with what meds were doing and she was on this rollercoaster of med 
after med after med; she was having problems with her liver from Depacote, um, so she 
was asking me about going off meds . . . I said ―What else have you tried?. . . Have you 
tried this, have you Omega-3‘s, have you tried exercising, have you tried therapy? . . . I 
wrote to her, ―. . . I do advocate exploring other alternatives IF you feel your meds are 
doing more harm then good.‖  
 
Kyle, Fern & Kellie all commented on wishing individuals would try other things before  
medication (11, 12, 16).  Kyle went on to suggest that such alternative interventions could 
potentially duplicate any positive effects associated with the drug:  ―[Medication] did work to 
bring me down [from mania].  I think if I had been weaned off the Benzo and put in a nurturing 
environment, I know I would have done the same thing.‖  He subsequently called for research on 
viable environmental interventions:  
When they study twins, when one of them has been diagnosed with bipolar, the odds are 
60% that the other one will be diagnosed.  Well, that means four out of ten--even though 
they have the same exact genetic makeup--they‘re not ever going to be diagnosed.  That‟s 
what we should be studying, not the 60%.  Study the 40%, what they do different.  Was it 
something they weren‘t eating, something nurture [or] nature?  What was it?   
  
 Kyle paused to clarify:     
I‘m not anti-meds and anti-psychiatry either because it works for some people and some 
people, some people need it . . I guess.  I think it should be a last resort though.  I think 
unless, unless, there is a true crisis, someone‘s suicidal, someone‘s homicidal, someone‘s 
just trying to kill themselves.  Unless there‘s a true crisis like that ..  why not try some 
alternative like . . . exercise and therapy, rather than right away going into the 
psychotropic drugs . . .  Unless a person is in a crisis situation, I personally think Omega 
3‘s, diet, exercise and some kind of therapy should be first line treatment. 
 
 In spite of believing Omega-3 fish oil had helped him, Kyle discussed the typical 
response of doctors:    
I have been taking the stuff for five years now, my regular GP poo pood it, you know, he 
said ―What is this stuff?  Omega-3 fish oil?‖ . . . No doctor is gonna say, ―you know 
what?  Go to Sam‘s club and get a bottle of this and start taking six capsules a day..‖ It‘s 
the equivalent of having an eight once salmon filet a day. . . . and see what happens.‖ [or] 
―Start getting some exercise,‖ that‘s not going to happen.  Maybe it happens with some 
doctors, but the majority, it‘s not gonna happen.  They can get us a prescription for, you 
know, Prozac, Paxil and Celexa, Effexor, one of those.   
 
Esther similarly noted, ―I found the system was fairly closed to even looking at any of the  
other alternatives‖ (14).  Even when doctors are open to alternatives, Kyle pointed to a resistance 
regarding the notion that medication can be replaced:  
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I‘ve always seen [psychiatry] as being ―more meds, more meds, more meds, take your 
meds, take your meds, take your meds.‖  There's very little talk of alternative treatment 
and if they talk about alternative treatment, it‘s an added treatment on top of your meds.  
Never instead of. (12) 
 
Exploring alternative recovery pathways.  While not all participants had achieved a 
significant degree of recovery, there were some accounts of genuine progress and recovery.  In 
addition to comments about medication, participants also emphasized other components to 
recovery.  A number of people spoke of shifts in other physical conditions (beyond brain 
chemistry) playing a role in lifting the depression—including better treatment for hormonal 
problems (16), diabetes (13), losing weight (11), nutritional and sleep changes (12) and exercise 
(2).  Laying aside physical shifts, three individuals, in particular, spoke at length of life-lessons 
that had a significant impact on their recovery.     
 Peter, who loved his teaching job, spoke of feeling perpetually dissatisfied with his 
performance.  He then related this defining moment in therapy:   
I told [the counselor] one day in session, ―you know my goal is to be 100%--be the best 
teacher I can be every single day of every single year.‖ He said, ―you can‘t do that.‖ I 
said, ―what?  What do you mean I can‘t do that?‖  He said, ―you can‘t do that.  You‘re 
not always going to be your best.‖ He said, ―there a days when I am the best psychologist 
I can be. And there are days when I just stink for whatever reason.  Maybe I didn‘t get 
enough sleep.  Maybe I had a bad day at home.  Maybe I didn‘t eat breakfast or have my 
cup of coffee; there are days when I am just no good.‖  He said, ―you can‘t always be 
100% all the time.‖  And that stuck with me and it allowed me (pause) to have those 
failures and say, ―well I‘ll do better next time.‖ (10) 
 
 In further emphasizing an intense learning process associated with recovery, Peter linked 
much of it to a changed relationship with God:       
In many, many ways I feel like I‘ve been reborn.  I feel like I‘ve started a new life--like 
I‘ve started life over . . . I‘ve had to relearn all the things I thought I knew [like] 
socialization skills I had to completely relearn, you know. I had to change my 
assumptions about the people around me. . . and so I would, even rather than recovery, I 
might even call it rebirth . . . I have established a new and strong relationship with Christ 
in that time, you know, which has been (pause) there are no words for what that has done 
for me . . . so many things have changed I mean I grew more in that year than the 10 
years previous and it‘s really (pause) I‘m in a place where I find it exciting.  
 
Associated with this process, he attributed his recovery to addressing aspects of his life 
preventing him from being his true self—letting go of false aspects of himself:   
In my particular case, depression was about confronting these issues that had haunted me 
my whole life (pause) and figuring out a way to live with them so that I could be the 
person I wanted to be…because one of the things that was fueling my depression was I 
had this image in my head of a successful person…you know this is a picture of this 
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successful [me]… and I was so angry and frustrated that I couldn‘t get there…ultimately, 
I think (pause) if you if you want to look for a cure or a positive treatment for depression 
it needs to be about letting go of (pause), letting go of the idea (pause) I mean, you know, 
maybe what you thought is for you, isn‘t for you. Maybe you‘re depressed because you 
are in the wrong place or you are doing the wrong thing (10). 
 
 As a second major example of lessons learned on the way to recovery, Fern spoke of the 
emotional reprieve associated with being able to forgive her husband who had abandoned her:  
My religious foundation enabled me to turn over some of my grief and some of my 
depression to the Lord, because . . I had to exercise forgiveness with my husband. . .  I 
felt like I had to let the atonement work and it took a long time and I was mad at God for 
a long time when this happened . . . I had to come to a point in my life where I could get 
rid of that anger. . . . I had to forgive entirely and it took me awhile.  I am a very 
passionate person and I was still deeply in love with my husband in spite of all that he 
did.  It was difficult for me to get to that point where I could just let go and forgive him. . 
. . So I suppose that reading the scriptures, reading church books and different things like 
that had helped me to put a different perspective on my life so I could get beyond the 
depression.   
 
Referring to her darker periods, Michelle added:   
I have, again, used my religious faith to get through and turn things over to God and . . 
talk things over with Him .  . . I feel like my faith has gotten me through everything that 
I‘ve gone through and only because I have an understanding of what life is and why 
we‘re here . . . Because I‘m sure that if I didn‘t have that understanding I certainly could 
have considered suicide on many occasions just because my circumstances were so bleak. 
(11) 
 
It was Kellie, however, that said the most about learning lessons as central to her  
recovery.  In light of her decision to not take medication, Kellie reflected on her persisting belief 
that her recovery would eventually come—―I just thought that everything would somehow work 
out . . . that‘s what kept me going . . . . I‘ll get better, it just takes time, you know‖ (16).  She went 
on to describe emotional issues that ―kind of just worked themselves out‖ as she improved her 
overall physical health and came to ―see [herself] differently‖ and have a ―different outlook on 
my future, my life and my potential‖:   
Gradually, I started coming . . . out of it. . . . the symptoms started just kind of wearing 
off gradually (and so at that point, I didn‘t even think anymore about taking the 
medication). . . . I can‘t really explain how things happened. Things just started . . I really 
believe it was a combination of things: probably just time, and learning more about 
myself (which, when you can do that, that brings a freedom, I think).  
 
In continuing, Kellie focused on details of the change over time:  
It has been a long process, a long time, probably over 15 years .  . . gradual, you know . . .  
something will happen and I‘ll realize something and it‘s like, it‘s kind of like, little by 
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little, you know.  It‘s kind of like you‘re carrying this heavy burden or heavy weight on 
your back that weighs you down physically and mentally and just in every aspect. It 
seems like it‘s just this burden, and then little by little I find, you know, I receive 
knowledge about myself, or, I gain more experience, time passes, my wounds heal, or 
whatever it is. It‘s like little by little there‘s just a little more lightness to my step.  A little 
more weight is lifted . . . it‘s a feeling of there being a sunshine back in your life, and um, 
probably the best way to describe it is probably, and also to say it‘s a feeling of freedom. 
. . . It was a little piece of knowledge and freedom . . .  like a burst of I don‘t know, a 
burst of . . . power, that‘s another word for it. It‘s power that I gained.  
 
She went on to describe learning ―truth‖ about her life situation as key to a freedom to 
move forward:   
It‘s a great feeling when you know the truth about something. You know you could have 
been involved in something terrible, you know, an accident, or you could have been 
abused, or any number of things and it doesn‘t change. You‘re still going to be someone 
who‘s scarred in some way. But having truth about the whole issue does bring a freedom, 
and it gives you, I think, the courage and the strength to move forward, and to just 
progress where you are, even though you feel like you‘ve lost years in your life with that 
depression. You know, ―Aw, I‘ve wasted my whole life, it‘s a waste because I‘ve been 
depressed and haven‘t lived up to my potential, and all these things,‖ but, you know, 
somehow it‘s okay. You just start where you‘re at.  You know, we have to start over 
again, probably at many points in our life. . . . starting over fresh every time. So yeah, I‘d 
say there‘s a freedom, there‘s sunshine again in your heart, and it‘s little by little there‘s 
just this heavy weight that‘s being taken off you.  
 
At this point, I clarified, ―So it kind of just like it went away?‖ 
Uh-huh. . . . Yeah, I think for me there were so many little issues that were causing it that 
I, I‘d find something and something would make sense, and it would click and I‘d say 
―ah-ha!‖ cool, you know, this is it.‖ . . . Basically it was just, it was a process. . . . you 
know, like if the depression was just because of this broken up relationship, then with 
time and understanding and more experience, then you know, your heart would heal. I 
could have gotten over it that much quicker, but because there were a lot of issues, it took 
a long time. . . . it‘s taken me this long, but I‘m getting to the point where I‘m 
understanding--I‘m learning a lot about myself, and reasons for why I feel the way I do, 
why certain situations scare me, why I react, why I do things, and so I‘m understanding 
me more, and so that has helped me more, I guess in a way, come out of the depression. 
(16)  
 
Understanding the specific “alternative” of family and friends.  As reviewed below, 
participants spoke of several variants of community support that had a significant impact—from 
people who ―knew just what to do,‖ to others who were ―just there‖ or perhaps just ―acted 
normally.‖  Sometimes helpful support was especially directive, while other times it was 
primarily trusting of the individual.  After reviewing how others‘ support benefited individual 
recovery, we turn to the reverse:  ways that a chance to help others reportedly benefited an 
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individual facing depression.  Finally, we briefly review ways that severe emotional problems 
may ―drain‖ and exhaust one‘s family support.   
 To begin, Debbie spoke of a family member with the special touch to ―to calm me down. 
. . Um but she just, I don‘t know what she does; she just has the magic of cheering me up (8). 
Victoria related the following experience on a dark occasion following her mother‘s funeral when 
she was looking through old family heirlooms:   
I remember . . . just umm feeling so overwhelmed about it and [my neighbor] came.   
And she just sat there with me and she (weeping) asked me to tell her about these things, 
what they were, and what they meant, and what part they had in my family. And then she 
asked me, ―what would your mamma do to make you feel better?‖ Oh that one is easy 
―she would brush my hair‖ and . . and she sent my daughter after my brush and just sat 
there and brushed my hair and helped me work through that particular day. (5) 
 
 Jill mentioned the influence of one neighbor‘s support, in spite of her lack of knowledge 
regarding depression:  ―I [had] one person say to me ‗I don‘t, you know, I don‘t understand 
depression, I don‘t know what it‘s like, but I can see that you‘re having a hard time.‘  So even 
though she didn‘t get it, she was still sympathetic about it and that was nice‖ (7).  Peter similarly 
described the response of friends:    
When the time came that I needed them (pause), they were supportive at a distance.  They 
were like many people I‘m sure would be:  they were unsure of how to help.  They didn‘t 
know what to say, what to do; they were uncomfortable, but they were helpful.  I mean . . 
. they would do what I asked, you know, and if I said, ―look don‘t be offended . . . I just 
need to be alone for a while,‖ they would say, ―okay‖ . . . And we all came through it, 
you know.   
 
 He continued:     
The best thing they ever did for me was just act normal around me, you know, I would go 
through all this intense stuff on my own and then I would come out and say ―hey lets go 
get a beer,‖ you know or something.  And they‘d say ―okay‖ and, you know, they would 
sit and talk about baseball or football or you know politics you know or whatever it is we 
talked about but they didn‘t treat me like I was diseased or different they still gave me 
that respect and that was what made all the difference, you know.  My parents were there 
in the trenches with me (pause) and my friends were there when I needed to get out of the 
trenches (laughs).  
 
 Speaking of his family, Peter remarked:  
Oh man, my family has been just unbelievable, just unbelievable.  They just stood behind 
me so much, uh just 100% and I know that it had to be very traumatic for them to watch 
me go through what I went through.  My parents . . . we were very tight and for them to 
watch me go through what I went through, um the feelings must have been . . . awful for 
them, but nonetheless they stood by me [and] backed me up.  They said anything you 
need, we‘ll get it.  I don‘t care how much it costs.  I don‘t care where we have to go . . . If 
you gotta fly to India to see the best doctor in the world, we‘ll go, you know.  And they 
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backed me up 100%.  They said, ―you know, whatever you gotta do to take care of this, 
we‘ll be there right there with you. 
 
 He concluded, ―I just thank God for that and I really pray and I hope that other people out 
there who have depression can have a similar support system people who will be there for them 
because really they‘re the only reason I made it through all this‖ (10).   
 Lucy similarly spoke of particular relationships as life-saving—―Two teachers . . they 
kept me alive .. some days they were the reason I was there the next day and they‘ll never know 
that . . Two people that never knew—they made or broke some of my days, you know.‖  
Referring to her mother, she added:      
My drugs cost, even with insurance, 600 bucks a month—and my Mom‘s got part time 
jobs, I mean two jobs . . and she‘s still there to try to help me out.  I mean, if that‘s not 
love, you know.  . . In one sense, it‘s amazing, knowing that that person will do anything 
to make your situation the best they can.  
 
 About these relationships, Lucy concluded that she could look at them and say, ―‗I‘m 
okay.‘  Because sometimes that‘s all you need—like during a humongous panic attack when you 
feel like it‘s all going to end.  If you can think just for one second, ‗I‘m okay because this person 
loves me. And they‘re there all the time.‘  You don‘t have to believe it . . ever.  But sometimes it 
keeps you around‖ (6). 
Sarah similarly spoke of her community as ―24-7 counseling any time I needed it.‖  She 
added, ―I don‘t know . . . that I would have made it honestly. . . It was truly my mom and dad and 
sister and my friends that kept me, you know, got me to the point I needed to be (4). 
 Victoria recounted a particularly poignant account of her husband‘s impact on her 
recovery—starting with a moment of crisis:   
I just got home and I thought, ―oh I just don‘t want to be here anymore.‖ I picked up that 
bottle of Valium and thought, ―I could just take all of these right now. That would be that 
and I wouldn‘t have to live like this.‖  And I could remember sitting in the kitchen just 
bawling [and] just thinking, what do I do. And the thought came to me to call Paul [my 
husband] and I did I called him. I said, ―I need you right now.‖  And . . . I don‘t know, he 
must have flown home a hundred miles an hour because he was there within minutes.  
And I just said, ―I‘m going to take my life.‖ And he said, ―let me give you a blessing 
first‖ and he did he gave me a priesthood blessing.12  And I will never forget that blessing 
because he just pleaded with Heavenly Father. And he didn‘t plead that I wouldn‘t leave 
him. He pleaded that Heavenly Father would have mercy on me so that I would not 
suffer, you know. And (sniff) I remember think that it occurred to me that he loved me 
enough that my suffering was more important than my being here. And it‘s kind of a 
weird thing but after that there was a real peace that came.  
                                                 
12
 This is a common occurrence in Mormon families, where an individual receives a blessing after being 
anointed with oil.   
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 Two additional vignettes depict the impact of Victoria‘s husband:   
I woke up one morning and could not move. I mean, literally I was just paralyzed. It 
scared me to death. And Paul said ‗we have to go to the doctor, we have to go to the 
doctor.‘ . . . And you know, I don‘t want a doctor. . . . And so this morning was just so 
horrible. And Paul just rubbed me and rubbed me; I could barely move, but I was in just 
such pain. And he said. . . ‗I‘m just going to call this other doctor and we‘re gonna go.‘  
We messed up the credit card buying medicine, but it‘s worth it. . . . and Paul has never, I 
mean he has been so supportive in that, you know, we will find a way even if we have to 
borrow the money. . . . Even when I say we can‘t afford it or go without (laughs) but, you 
know, he just laughs and he makes it happen, you know. (5) 
 
 In some cases, it appears that especially directive help is critical, as reflected in this 
vignette from Jill‘s narrative:    
When I had my [depression] episode a year ago, a friend of mine . . . she was persistent to 
get me to get help. And that‘s what you need, is someone that will not let you just . .―you 
can stay in bed today, but you‘re going to call the therapist,‖ is what she said to me that 
day.  ―I‘m going to let you stay in bed today, but you must promise me that you‘ll call the 
therapist and set up an appointment.‖  And that‘s what you need, someone who will just 
take the reigns and tell you, ―you‘ve got to…‖, you know, and she‘s the only one who‘s 
ever done that.  And that may have been why I did so well last year coming out of it.  (7) 
 
In other cases, less direction and more trust appeared especially powerful.  As detailed in  
Chapter 4, Kellie emphasized the space and trust received from her parents as critical—alongside 
their willingness to be present:  ―Even just to bounce ideas off of them. You know, and get their 
ideas, it‘s definitely helpful.  It‘s definitely helpful just to talk . . . Just get it out so you have this 
assurance that you‘re not crazy you know?‖  She continued:   
They knew I was struggling with knowing what to do as far as having to take some form 
of medication. . . . They didn‘t want to be forceful and, I don‘t know, take my agency 
away and say ―We‘re going to take you to see a doctor, and you‘re going to do this‖. . . . 
Their attitude was just, ―You know, Kellie, we trust you, we know that you need to find a 
method that you feel good about.‖. .They were just praying for me that I would . . . be 
inspired to know what was the very best for me and my situation. (16)  
 
 In addition to the impact of others‘ help, some mentioned the opportunity to help others 
as beneficial in their recovery.  Sometimes, this was a passing reference to others‘ as a kind of 
distraction, such as Fern, who spoke of life after her divorce--―I didn‘t have time to be depressed 
because I just had to function for my children‖ (11).  In other instances, the chance to care for a 
child seems to have a particular emotional impact.  Speaking of her baby girl, Jill remarked:   
She . . I don‘t know if she knows it but she has been like my little lifesaver, my little life 
preserver.  Uh, I know that the year my mom died when she was born that year.  Had I 
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not had her I probably wouldn‘t have gotten out of bed and gone through the days, you 
know, I had to get up and take care of that baby (7) 
 
Victoria similarly said about her young daughter:     
She is a cute girl; she is my joy. She keeps me going, you know. Anyway, when talking 
about depression there are days when I feel like, you know, I could just run away. . . . But 
to have her here you know keeps….Love can do that. You gotta stay here, you know, 
even though [there are] those occasional dark days when I feel like, ―ugh, it‘s not even 
worth living anymore,‖ you know, she‘s right there. . . She makes it worth living. (5) 
 
Lucy, still fighting the effects of severe abuse, similarly spoke of the impact of her  
own baby girl—―For the first time, I mattered‖ (6).   
 Finally, two individuals mentioned consequences of the unfortunate drain that severe 
emotional problems can be on a family unit.  Reflecting on the duration of her battle with 
depression, Elaine summarized her family‘s emotional response, ―Well, uh, I‘ve tried; it‘s been 
eight years and . . . I mean, it just gets old.  They just don‘t wanna hear about it anymore 
(laughs)‖ (2).  Michelle told of being called by her family in the hospital and told that ―I couldn‘t 
come home again.‖  She explained:  
And what they meant--what I understand now. . . I think one of the things with mental 
illness is that we do not do a good job of supporting families of the person whose 
mentally ill.  My, uh I didn‘t realize the toll, the responsibility I put on my sister and her 
family when I would be so suicidal and my sister drove me to ECT treatments. . . It takes 
. . a toll on your relationship with your family. It takes a toll on your relationship with 
your friends too.  You just I mean, how many times can they listen to you re-hash the 
same thing.  Um, I can remember during one hospitalization . . . calling this friend of 
mine and asking him if he would give the eulogy at my funeral and would he be able to 
forgive me if I ended my suffering.  You know, that‘s a lot for a friendship with 
withstand and, you know, this friend did.  He still was there, um but it‘s really hard.  
 
In light of this, Michelle spoke of the positive impact of professional assistance via a  
supported apartment program on her family relationships:   
That gave me the support of this agency and the support of a case manager and . . . what 
that did was that has allowed my relationships with my family to heal.  Now my sister 
only has to be my sister.  And my daughter and my son just have to be my kids.  And 
they know and I know that if I have a problem, that I have a doctor. . . So, that‘s been 
important in the healing process. (13) 
 
While participant accounts confirm a powerful reported benefit from positive 
relationships with friends and family, it appears there are times when talking with someone 
external to one‘s natural support system can be critical.   
Considering the specific alternative of psychotherapy.  As an important member of their 
support system and community, psychotherapists were also highlighted as a helpful alternative.  
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Comments ranged from an assortment of barriers and difficulties with counseling, to its potential 
when it goes well.  Robert reflected a classic resistance to counseling:   
I didn‘t talk to anybody; I think my mom had mentioned a couple times though, ―I think 
you need to go talk to a therapist‖ but I was not going to (laughs) go and talk to anybody 
because only crazy [people] went and talked to them. . . .  I thought that my problem was 
not that major. (9) 
 
Others spoke of more pragmatic concerns.  Camille described going to a counselor  
after ―resisting for a long time‖ because ―number one because of finances and second because I 
thought it was mostly a chemical thing, and what was a counselor going to do?‖ (3).  Similarly, 
Elaine initially felt encouraged to seek counseling, but arrived to find the counselor asking for 
$150 up front that she didn‘t have (2).  Peter related the following experience with his first 
therapist:  
Well the reason it wasn‘t helpful is because I very easily could have replaced him with a 
dead fish and gotten the same kind of response.  He would sit there and he would say, 
―well how are you feeling today?‖  ―Well, you know, doctor I don‘t feel very good and 
the reason I don‘t feel good is this, that and the other.‖ And he‘d say ―really well how 
does it make you feel?‖ ―I‘m not here because I‘m cheery; I‘m here because I am 
something is wrong‖ and, you know, we went through five or six session like that where 
it was just you know ―uh huh, uh huh‖ and he‘s writing furiously on this clipboard 
(pause) and he‘s not talking to me and he‘s not offering me . .  
 
He continued:  
I needed help; I needed tools; I needed something…and uh and he was offering me 
nothing.  You know, he never, he never asked me you know ―what do you want to do 
about this?‖ he never said . . he just sat there and listened. . . And the first session, I said 
―well, you know, well he‘s getting a feel for the problem.‖ And the second session I said 
―well, you know, maybe he‘s still trying to see how deep it goes.‖ And the third session I 
said ―boy, you know, he ought to be saying something‖ and by the fifth session I said 
―I‘ve had it. I‘ve absolutely had it. I can‘t handle this anymore. You know, I‘m reaching 
out for help and I‘m trying to be patient I‘m trying to be understanding and he just he‘s 
not helping me.” (10) 
 
Robert, whose resistance to counseling began this section, eventually acquiesced to see a  
therapist and related this experience:    
Counseling was okay, but for some reason – I don‘t know why – and maybe it‘s just 
because I‘m bull-headed and stubborn and I don‘t know… um.  I didn‘t like counseling 
because it seemed like every time I would go and talk to the counselor, it would bring 
back memories of things that made me depressed.  So, a lot of times I would walk out of 
there more depressed than I was when I walked [in]. (9) 
 
When counseling went well, it was often reported to be impactful.  Peter himself reported  
eventually finding another therapist that ―made a huge difference in my life‖:   
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All I ever wanted was a chance to try and dig myself out, but I know I needed help I 
needed tools I needed something… [the second counselor] was able to zero in on what 
was causing me to feel this way and what I could do to help myself… As soon as he 
knew what we were dealing with he started giving me tools right away . . . And 
immediately, I felt, even after the first session . . I had made some progress. ―Okay, I‘m 
not cured.  I‘m not, you know, whatever, but I have a couple of tools now. I have some 
tools in my pocket that whenever something starts to go wrong. . . I have something I can 
use.‖  
 
As reviewed in the earlier section, Peter spoke of specific lessons as critical to recovery:     
I got some tools. I got some help. I got some direction, you know, he . . . set me right on 
a lot of premises that I had wrong.  For example, he let me know that, ―no the whole 
world doesn‘t lose the ability to sleep before a big event, you know, and the whole world 
doesn‘t . . . feel this way about themselves when they don‘t get something right, and you 
don‘t always have to be perfect all the time.‖  
 
He concluded:  
The other thing is he never claimed to have a cure all. That was really good for me. He 
didn‘t say ―this is the answer you do this and you‘ll be fine‖ he said ―you know this 
works for some people and uh give it a try and if it doesn‘t work we‘ll come back and try 
something else‖…um and that that to me was terrific . . . . what was helpful was the fact 
that I was taking steps to alleviate my own pain. . . . (pause) I mean, all I wanted . . . from 
the first moment I knew I had a problem . . . was to (pause) to get in there and start 
working on it you know I wanted to be able to get in there and . . . to be able to battle it . . 
to stand my ground against it so I could you know (pause) so I could take back my life. 
(10) 
 
Fern spoke of being ―able to articulate what I was feeling to a counselor‖—to have ―an 
audience for my feelings‖ since she didn‘t ―have a spouse that you are use to unloading your 
feelings onto‖ (11).  Kyle specifically highlighted the potential impact of ―some kind of 
therapy‖—―I don‘t necessarily mean a paid Ph.D.  It could come from a book, a friend, a group . . 
The thought process needs to change somehow‖ (12).   Lucy described being touched by a 
psychologist who gave her his home phone: 
I don‘t even see him every week now, but if it‘s getting bad in my life, he will call me 
every day, or he will call me once a week.  And he just says, hold on till that next phone 
call, and that‘s all he asks me.  But he realizes, he doesn‘t take it further than that, or look 
at me differently, but he‘s available, he‘s made himself approachable, and not on a 
different level than me, which has made me open so much more of myself to him, and in 
doing so benefited myself so much more. (6) 
 
While the potential of therapy was well acknowledged, views on its relation to 
medication differed widely.  Even therapy advocates often emphasized its secondary place in 
relation to medication.  Jill noted: 
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I‘m a firm believer in medication, because I don‘t think, I mean, I think therapy is good, 
but it doesn‘t help if you‘re not calmed down.  It doesn‘t, I mean . . . You can‟t talk it out; 
it‟s chemical (emphasized).  Talking it out or going for a jog isn‘t going to help the 
chemical imbalance that‘s going on, and for me it‘s pretty dramatic, with and without 
meds. (7) 
 
In a similar spirit, Victoria added:   
The medication really helps me have a life. The therapy helps me not crash and burn. Not 
crawl up in a ball and cry every two hours you know what I mean. Or feel like I want to 
give up on life. . . I mean . . . if life is sailing along smoothly and I didn‘t have my 
medication, the days would just be gloomy and gray just lack luster. And that‘s not a bad 
thing but it‘s not the way I want to live my life. So I need them both. Medication always 
(laughs). (5) 
 
Theme 9.  Considering prognosis and recovery:  “Can I get better?”   
To conclude, we zoom out to examine participant interpretations of the broader horizon 
of prognosis and recovery.  In Chapter 7, attention is given to variation in participants‘ actual 
definitions of recovery.  Here, the focus is on a related question asked to all participants:  ―do you 
believe permanent improvement with depression is possible?‖  Elaine related, ―[My doctor] was 
encouraging that I could live a fairly normal life if I could stick with my medications and stay on 
them‖ (2).  Victoria reflected:   
Well, I resolved that it will never be better, okay?  My own definition of better would 
mean that I wouldn‘t have to take anymore pills—okay, that‘s not going to happen.  I 
mean unless some brilliant person comes up with a pill that just fixes it permanently.  
 
She suggested that the best recovery she could aspire toward was having more self- 
control in a changing environment.  Even while acknowledging some improvement, Victoria 
went on to similarly conclude:   
But, you know, there will always be life changes.  That‘s just part of living on this earth, 
you know. There are always gonna be things that are going to change and you know 
maybe from that perspective I will never be better that way, you know, but one can hope. 
(5) 
 
As Jill mentioned earlier said of her son, ―from the beginning when he was diagnosed, I 
said ―this is something for life, you‘ll have to be on these medications for the rest of your life.‖  
In extension of an earlier quote, this same woman remarked:   
I‘m permanently going to have depression and I‘ll be on meds my whole life and I had to 
take, it took a mind change for me to finally get to where I could say ―I‘m grateful that I 
was born in this day and age where I could get the medication that I need so that I 
wouldn‘t be locked up in the attic somewhere, or indisposed all the time‖ (laughs).  
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 Jill also noted, ―I just, like I said, I don‘t . . you can‘t get better without medication.  You 
can talk and talk and talk but you can‘t get better without, if your chemicals are messed up 
(emphatic)” (7).  
 Debbie, who spoke of being ―stuck‖ with a ―chemical imbalance,‖ responded similarly 
when asked, ―Do you ever talk about getting better from depression?‖:  ―I don‘t think that‘s 
possible. I just . . . . I want it to but I don‘t think that I . . I think, just a couple years ago, I just 
faced it that I‘m just always gonna have to have something‖ (8). 
 For others, a similar narrative of permanence is tied to long years of struggle.  To the 
same question of ―Do you ever talk about getting better completely—like a permanent 
improvement with depression?‖ Robert answered, ―No, not really.  I mean, I, uh… I just don‘t 
know. . . . I [have] fought with it so long that I just don‘t know that that‘ll ever happen‖ (9). 
From long experience, many simply conclude they are not getting better.  Kyle described 
speaking to his friend about recovery, ―I go ‗You are gonna get better.‘  And . . . she said ‗Am I?‘  
I go ‗well of course you‘re gonna get better.‘  She goes ‗I don‘t think I am, Kyle‘‖ (12). 
 In spite of such despair, one striking feature of many accounts was a common impulse to 
want to believe they could get better
13.  Robert, who had mentioned that he didn‘t ―know that 
recovery would ever happen,‖ later added:  
But I, I hope, I keep a . . .  a thought in my mind that, you know, life goes [on], you gain 
more experience, who knows what‘s . . . out there?  But I… there‘s also a part of me that 
says, ―You know, you may deal with this the rest of your life.‖ (9) 
 
Even with those currently seeing their condition as permanent, this impulse prompted a 
hope against hope.  Knowing of my exposure to ―latest findings‖ as a graduate student, Elaine 
asked me during the close of the interview:  
What are you learning?  Is there a getting better from this or not?  I mean, they told me in 
the beginning there wasn‘t . . [but] I‘m hoping that I can make improvements that are 
permanent and that I will.  I am getting better than I was certainly.  I don‘t know how 
much better, you know, I don‘t know if I can ever be what . . I probably can‘t be what I 
was when I was twenty but I think I can certainly get better than I was eight years ago, 
yeah. 
*J:  Who told you that you don‘t get better?  
Well my initial diagnosis--they said this is something permanent. This isn‘t something 
that you‘ll ever not have (2). 
 
                                                 
13
 Different recovery views seemed comforting for different participants.  Some were relieved in accepting 
depression as a lifetime challenge, other felt comfort in the hope of full recovery.   
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 Two participants spoke of the actual moment they heard about such an alternative view.  
As described in the other chapter, Kyle spoke of discovering the National Empowerment Center, 
a website run by a psychiatrist recovered from schizophrenia:  
The site is all about recovery--that recovery is real. . . . Until I got to that site, all you 
heard was drilled into people ―Lifetime, Lifetime, it‘s a lifetime illness, you‘re forever 
going to need meds; you got to stay on your meds.‖ Um . . . there‘s no hope there for 
recovery. (12)   
 
Michelle, who had faced both schizophrenic and depressive symptoms, spoke of 
participating in a recovery-oriented treatment program (Mary Ellen Copeland‘s Wellness 
Recovery Action Plan—mentioned by two participants in the study as helpful) during one of her 
many stays in a psychiatric hospital.  In one of the sessions, she heard the story of a woman who 
had faces similar difficult circumstances.   
Kate had been hospitalized in the late 50s out east in a state hospital.  The family was told 
that there was no hope for her recovery that they should just go and forget about her.  
And after eight years Kate started to get well, and the staff realized that she was having 
conversations with getting little groups of people together for conversation and she‘d help 
the staff with little things.  And they realized that Kate was well enough to go home.  
Kate went home she worked for 22 years as a school dietician in a kinda of inner-city 
type school.  She helped her son raise 7 children as a single parent and was never 
hospitalized again.   
 
Michelle continued: 
[This] was the first seed of hope. . . . I thought, ―if Kate could get well after 8 years 
maybe I could get well after 2 or 3.‖. . I remember a conversation with the psychiatrist 
out there saying ―I have faith the size of a mustard seed to begin rebuilding my life and if 
you can work with that little, I will try living one more time.‖ (13) 
 
Camille remarked similarly, ―The important thing is that I know that it won‘t last forever.  
Before I had no hope. I couldn‘t see a light at the end of the tunnel‖ (3).  After recounting 
gradually successful efforts to regain the capacity to take care of herself, Michelle spoke of a 
second turning point involving a seminar on tape (Pat Egan‘s Inside Outside Program):  
This particular video is finally what counteracted ―you‘ll never live independently again.‖  
It was that first conclusive evidence that people really do . . [there] really is something 
beyond ―you can never live independently.‖. . . There‘s a lot of people that don‘t 
understand that you can recover.  
 
This woman, who had first received a ―seed of hope,‖ reflected on an earlier treatment 
experience:  
This doctor told my family that I would never be able to live independently again. . . . 
Even though I have made progress over the last 4 or 5 years, there‘s still always that seed 
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of doubt that was planted . . . you know, ―can I really take care of myself?‖. . . That‘s a 
long time to have one remark. . but it was said by the doctor so it had so much power and 
so much influence.  And you know if you went back and asked him, he probably 
wouldn‘t even remember having said that and yet it‘s had all these ripples for the last 
several years.   
*J:  You said a seed of doubt in your family?   
In my family and in myself too. Um hmm.  
 
Michelle concluded about her experience, ―One of the things that I‘ve learned since then 
is that you can never predict the recovery of another individual‖ (13).   
             Before concluding this section, one qualification is important to mention.  While the hope 
of recovery seemed beneficial to some, for others this expectation could be almost offensive and 
stifling in its seeming naiveté.  Lucy, who had suffered perhaps the most intense depression 
suffering of any participant (over an extended period), said:     
Everybody makes that promise, ―it‘ll get better.‖  And when it‘s not getting better, you 
know, and . . . you‘ve been hurting alone for so long, that promise really . . holds no 
weight.  You know what I mean?  Because you‘re like ―no, I‘ve been dealing this for, you 
know, ten years by myself, and hurting that long for that bad, you think you can turn it 
around in a few months?‖  (6) 
 
Robert also claimed, ―one of the ideas that pushed me to be more depressed was the 
thought that I had to beat this problem.  And, uh… and that, that was [during a certain period], 
that was a motivating factor for the depression (9).  He went on to speak of gaining more realistic 
expectations in terms of his own recovery.   
 
In summary, this chapter helps the reader understand some of the nuances associated with 
the continued navigation of medical treatment.  Rather than reflect an easy acceptance of 
treatment compliance, these accounts reveal subtle interpretive aspects often accompanying the 
decision to continue (or cease) receiving treatment.  Overall, the above analysis highlights the 
degree to which individuals evolve in their self-understanding over time to a point where they 
fully embrace treatment or eventually give it up.    
Initially, many individuals report a dramatic experience with medical treatment, whether 
positive or negative, that appears to galvanize a particular way of thinking about medication 
generally.  Even while the bulk of other reported experiences tend to be more ambivalent, these 
initial experiences seem to have a lasting effect in the way individuals subsequently endure 
changing effects and other difficulties concurrent with the medication.  Interpreting these 
complex emotional/physiological changes and difficulties seems to be a particular challenge for 
individuals.  As was the case with the initial problem definition of depression, confusion 
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generated by these treatment questions becomes a helpful backdrop to understand the significance 
of friend, family and doctor in shaping the ultimate interpretations adopted.  Although some gain 
a resolve and conviction to continue treatment, others flatly reject medication—while still (most) 
others remain ambivalent, wrestling with their opinion about treatment.  In spite of significant 
doubts about life without anti-depressants, a good number of individuals eventually attempt to 
taper off medication.  As was observed during treatment itself, the interpretations of states 
associated with tapering are diverging and wide-ranging, with obvious consequences for what an 
individual eventually decides.  In addition, depending on differences in how overall treatment 
experiences are interpreted, views of both alternative interventions and recovery itself may 
likewise differ.  Once again, for all who have endured depression and experienced its dominant 
treatment, the associated confusion, hesitancies and conflicted treatment advice ensures, as with 
problem definitions, a veritable ―journey to an answer.‖ 
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Chapter 6 
Adopting Distinct Interpretations of Depression and its Treatment:   
What Resources are Leveraged in Narrative Formation? 
 
In the foregoing chapters, general themes across individual stories have been reviewed.  
Taken together, these themes inform the three empirical questions in an implicit way:  1) how do 
diverse narratives of depression and its treatment arise, 2) what constitutes meaningful 
differences between narratives and 3) how are they maintained over time?  In the following three 
chapters, insights and results relevant to each question are made more explicit, with evidence for 
each issue summarized and elaborated upon more directly.  Starting in this chapter, these findings 
are presented alongside insights from the broader literature on depression interpretations.   
While attending to a variety of aspects in the adoption of particular interpretations and 
stories, the focus in this chapter is on the narrative ―resources‖ that participants draw and rely 
upon in the creation of their particular story.  While a ―resource‖ is customarily seen as some kind 
of physical, concrete object, the word is used here more broadly to also refer to common mental 
and emotional states associated with facing depression (confusion, urgency, resistance).  
Resources may thus include physical objects (e.g., books, data, videos), programs, people, 
particular states associated with treatment and the treatment itself.  In each case, these entities 
may be engaged in experiences that are ultimately leveraged in the adoption/creation of a 
particular story.  This smorgasbord of narrative ―resources‖ is proposed to scaffold the formation 
of unique stories of depression and its treatment.  To begin, we set the stage by considering the 
role of pain and confusion itself as a fundamental narrative resource for the way it appears to 
heighten individuals‘ need for adopting some kind of concrete explanation for depression in the 
first place.  This urgency-for-explanation is proposed as a key state ultimately leveraged and 
‗drawn upon‘ in the creation of particular narratives.     
 
1.  The Pain of Confusion:  “I couldn‟t figure out why I felt that way. . .”   
Half of participants spoke of some kind of confusion early in their depression narrative, 
often centered on desires/expectations for life and their inability to reach them; for example, 
wanting to sleep but not being able to; wanting to enjoy life, but not being able to; wanting to 
experience relationships but not being able to.  For some, this entailed a battle between 
competing desires, such as wanting to participate in common activities, but also wanting to avoid 
them or yearning for people to be with, alongside an impulse to avoid them.  In addition to 
confusing clashes between internal desires, expectations and abilities, others spoke of the 
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perplexing contrast between their depressing feelings and external realities, including a happy, 
positive childhood, an otherwise happy family life or surrounding positive physical conditions 
like a sunny day.  Contrast with other surrounding individuals also became a source of 
confusion—both in comparisons with others‘ happiness and their more normal levels of sorrow.   
Confusion thus stems from the perplexing discrepancy between intensely negative 
feelings and surrounding signs they should be feeling differently (i.e., good weather, loving 
family, other people staying happy or experiencing normal sorrow in their own tough times)—
prompting questions such as, Where is this coming from?  Why does this hurt so bad?  Why can‟t 
I control or overcome this? Why does it come out of the blue?  Confusion has been noted as a 
common aspect of chronic pain narratives generally (Hydén, 1997).  Polkinghorne (1996) cites 
May‘s belief that ―major life events . . . often tear apart previously meaning-giving stories‖ and 
leave the person to face ―profound insecurity, self-doubt and inner conflict.‖  May highlights the 
role of mental pain, in particular, in the ―decomposition of a person‘s previously developed . . . 
life design (p. 302).  In her exposition of narrative analysis, Riessman (1993) similarly identifies 
―biographic disruption‖ often associated with chronic illness as prompting efforts to ―reconstruct 
a coherent self in narratives‖ (p. 219).  
In the case of depression, it appears that the intense pain can literally ―ramp up‖ 
individuals‘ already inherent need to interpret and explain what is going on.  Compared to when 
life is going well (when one arguably has less of a need to make sense), it appears this pain, when 
combined with striking confusion about its source, can lead some participants to even a 
desperation for answers.
14
 Other studies specific to depression have highlighted uncertainty as a 
tangible source of additional pain for both distressed individuals and their dear ones (Garfield et 
al., 2003; Lewis, 1995).  One survivor in another study noted, for instance, ―not knowing what it 
was making it twice as bad‖ (Badger & Nolan, 2007, p. 29).  In all these ways, confusion itself 
becomes an initial resource on which individuals may draw in the adoption of particular 
interpretations.   
 Beyond the personal pain, individual accounts clearly reflected a burden in the confusion 
experienced by surrounding family—i.e., ―It‘s hard for family and friends to understand that you 
really, really, really are not doing this intentionally‖ (16).  Associated with others‘ concerns, 
participants spoke of grappling with the debilitating pain stems primarily from their own messed 
up self.  This, in turn, appeared to further heighten the urgency for other explanations—further 
―ramping up‖ individuals‘ own need for answers.  As Lucy said about her early experience with 
                                                 
14
 The notable exceptions were those attempting to simply numb themselves or zone out to the pain or 
individuals with obvious reasons for the depression (abuse victims). 
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depression, ―You need a place to point your finger to . . it needs to go somewhere‖ (6).  This 
second level of confusion appears to have a significant influence–especially when family or 
friends are critical or blaming.  This helps explain further how an individual‘s desire for answers 
could become so great that even the possibility of a serious physical deficiency like a tumor can 
feel like a relief (4).   
   
2.  Friends and Family Offering Answers: “Let me help you . . .”  
 Grasping the role of confusion becomes an important backdrop to analyzing a second 
narrative resource identified in the study:  advice and suggestions from friends and family.  As 
noted previously, Rappaport (1998) has argued in his work on community narratives that 
individuals do not create their own personal story ―whole cloth‖ out of nothing, but instead draw 
on narratives available in the broader collective.  McAdams (1999) similarly notes ―a sense in 
which a life story is jointly authored, both by the person whose story it is and the culture within 
which the story is embedded‖ (p. 488-489).  As reflected in Sarah, Victoria, Kellie & Camille‘s 
accounts, surrounding friends and family often play an active role in sharing and instructing 
distressed individuals on potential explanations for their pain.  These kinds of instances of 
exchange constituted the most abundant category in the coding process, with 53 references across 
interviews.  Such exchanges appear often to be meaningful galvanizing moments in the adoption 
of a particular narrative of depression and its treatment.   
 The overall degree to individuals gave credence to counsel from family/friends varied 
widely.  On one side, some like Victoria and Sarah took a helpful friend or family member as a 
major guide—casting them as literal heroes in their story.  On the other side, individuals like Kyle 
and Esther saw family‘s intentions to help as intrusive and over-bearing, with Kyle describing 
having to learn to forgive their aggressive attempts at influencing his treatment decisions.    
As evident across accounts, ―community influence‖ is no monolithic entity—often 
representing competing, even contradictory advice.  Response to community influence 
subsequently also varied according to what specific advice was given.  Some who were 
encouraged towards medical treatment, for instance, responded favorably (Sarah), while others 
resisted and resented the pressure (Kyle).  Others who were encouraged away from medical 
treatment rejected this pressure and embraced medication even more (Elaine), while others were 
persuaded by such opposition (Kellie).   
 Among other things, this analysis has implications for understanding the larger interplay 
between personal and cultural narratives.  On one level, encounters with friends, family and 
medical professionals may be understood as moments for the potential transmission of prevailing 
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narratives.  Since participants varied in the degree to which they accepted surrounding views, 
however, it would be incorrect to portray this as some kind of linear effect.  Instead, as different 
possible narratives are voiced different friends or family members, individuals are presented with 
the interpretive raw material out of which they craft their own personal stories.  In this way, while 
some appeared to adopt a conventional biomedical narrative wholesale, others embraced only a 
part (e.g., liking diagnosis, but not medical treatment), while still others seemed to reject the same 
narrative entirely.   
 While moments of actual verbal conversation were the most common influences 
identified, observing others also appeared to exert an influence.   In a reference not shared 
previously, Jill said:      
When you have a friend or two or three . . . on Prozac too . . . you can feel like, ―Okay, 
I‘m not so bad,‖ you know.  If they‘re on it, I can be on it. . . . The biggest thing for me 
accepting it was knowing other people were on meds too that I knew. . . that made me 
more accepting of it. (7) 
 
 While personal acquaintances (talking or observing) seemed to exert the most palpable 
influence on individual interpretations, different kinds of media were referenced as well.    
 
3.  Biomedical Diagnosis and Explanation:  “It was such a relief. . .” 
 In addition to comments from family/friends, participants also mentioned interaction with 
medical professionals as significant in the formative understanding of their problem.   Against the 
backdrop of pain and confusion, the formal experience of receiving a diagnosis, in particular, is 
proposed as a third key narrative resource on which participants draw in the creation of their own 
understanding and overall story.   
 In their own interviewing study of women‘s use of the biomedical explanatory model, 
Schreiber and Hartrick (2002) found that all participants received understanding of the model 
initially from a physician.  In earlier chapters, this study examined variation in individual 
evaluations of biomedical diagnosis—from easy embrace, to ambivalence, to sharp rejection.  As 
noted in the literature review, ambivalence has been documented in other qualitative depression 
studies, with individuals varying in the degree to which medical diagnosis is experienced as 
implying more or less control over depression and more or less hope for recovery (Gammell & 
Stoppard, 1999; Karp, 1997; Lewis, 1995).  Here, we turn to consider implications of these 
diverging stances toward diagnosis for how participants‘ come to see and narrate their experience 
of depression overall.     
 First, it is worth highlighting one evident reason that biomedical explanation seems to be 
readily embraced as a part of individuals‘ narrative.  Simply put, the biomedical narrative 
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addresses and answers the very questions reviewed earlier as particularly confusing and painful 
(i.e., Why does this hurt so bad?  Why can‟t I overcome this?  Why does it come out of the blue?).  
Drew and colleagues (1999) document an association between the spontaneity, unpredictability 
and intransigence of symptom onset with the adoption of a biological narrative.  As reflected in 
the accounts of Camille, Jill, Elaine Kellie & Peter, participants expressed excitement at a 
concrete, physical explanation, as well as the promise of a tangible, physical solution.  More than 
simply offering an intellectual explanation, biological theories appear to address the emotional 
pain that results from thinking that the pain stems from one‘s own weakness.  Since a 
―medical/biological illness‖ has a currency as a concrete and material entity, it appears to 
legitimize the struggle with depression as a ―real thing.‖  Such explanations may thus provide 
crucial credibility to address others‘ confusion and establish a language for depression that 
communities can deal with.  This may explain the relief documented in other interviewing studies 
when individuals receive a depression diagnosis (Stoppard & Gammell, 2003) and specifically, 
when they come to see depression as primarily biological (Badger & Nolan, 2007; Ridge & 
Ziebland, 2006; Schreiber & Hartrick, 2002).   
 In addition to addressing personal confusion in a powerful way, formal medical diagnosis 
has been shown to often mark a significant change in how people come to talk about depression 
and see themselves overall (Gammell & Stoppard, 1999; Rogers, May & Oliver, 2001).  In their 
exploration of the depression experience of 43 women, Schreiber and Hartrick (2002) remark on 
the ―profoundly influential‖ occasion of individuals first hearing about the biomedical 
explanation for depression.  They describe how this encounter leads participants to question 
previous knowledge, and engage in ―ongoing process of revision to accommodate new 
information,‖ ultimately ―reformulating a new explanatory model,‖ which, at times ―completely 
substitutes‖ for their previous understanding (pp. 96-97).   
As reflected across interviews, these revisions can descend to the very level of identity.   
For some, diagnosis clearly provided some kind of reassurance for a stable new identity by 
explaining where their pain was coming from and outlining a course of action.  For others, 
however, the reverse effect was striking.  As reviewed in an earlier chapter, Lucy reflected, ―You 
feel like you lose yourself, almost.  Like a part of you dies when you‘re diagnosed. . . . .  like a 
grieving period realizing that the person that was faking it for so long--she wasn‘t real.‖  She 
continued, ―and she kind of did die and that we had to reinvent and restructure this new being, 
almost.  . . . Giving her the tools and the revenues, making sure she had insurance all the time . .  
it‘s hard.‖  Lucy concluded, ―[you] do feel a detachment from everything you thought you were 
when this becomes where you‘re at‖ (6).    
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 Biomedical explanation and abuse.  It was Lucy‘s story that also illustrated one of the 
most vivid consequences of biomedical explanation for individual narratives—an excerpt not 
reviewed to this point:  
When I was six, [my step-mother] locked me in the closet for three days, without food. . .  
I was scared of the dark when I was little.  And I remember screaming at first . . . and 
after a few hours, I was like so embarrassed because I had to go to the bathroom.  And 
my Dad was there, but he never opened the door.  And after three days, she let me out.  . . 
When the screaming went on longer than she would have liked, she, she taped my mouth 
and taped my hands behind my back and she hog-tied me . . like weird stuff.  And I was 
just like so embarrassed that I had gone to the bathroom in this closet. . . embarrassed 
they were going to open the door . . . I still see her in the corner of the closet just shaking 
and I look at her and I cry. . .  
 
 As reflected in the quote opening the introduction, Lucy described during this time, ―very 
bad beatings to the point of unconsciousness, ripped, broken and arms taken out of socket.‖  In 
the wake of these experiences, Lucy described starting to ―pull away at eight‖ and being taken by 
her real mother, who was unaware of the abuse happening with her father and step-mother, to an 
internal medicine doctor.  While still fearing to disclose the abuse, Lucy hoped her doctor would 
recognize what was happening:  ―I hoped that was how it would just eventually, just stop, you 
know--that they would just keep guessing  . . I don‘t know . . .  I just kept hoping that maybe my 
doctor would see through my lies . . of me going, ‗I‘m fine.‘‖  Although Lucy recalled ―there was 
always this feeling that something bad was going wrong with me,‖ she said, ―but they just never 
could figured it out.‖  Eventually the doctor put her on Prozac for depression.   
 Although expressing anger at doctors ―for allowing for so much . . . to go underneath the 
radar,‖ this event appeared to powerfully influence Lucy‘s narrative at a young age in fairly 
surprising ways.  Namely, Lucy began from this time to emphasize biological deficiency as the 
primary cause of her emotional struggles, including depression (6).    
 Shreiber and Hartrick (2002) propose one of the ―unintended consequences‖ of a 
biomedical narrative as ―shift[ing] attention away from the meaningful psychological, relational, 
or situational dynamics that women talked about within the context of their depression.‖  They 
suggest that prevailing biological explanations seem to often effectively drive out or ―render the 
situational factors‖ in a depression story ―irrelevant‖ in even severe cases (pp. 100-102).  
Speaking of the biochemical theory, Esther likewise said, ―a lot of times it drives out other things 
that might be going on‖ (14).   
 Interestingly enough, although medical discourse has been shown to be adopted more 
frequently when life stressors do not seem to be relevant (Gammel, 2004), the insight here is that 
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conventional medical discourse itself may deemphasize and minimize the seriousness of life 
stressors.  Chapter 8 explores the same inclination as a strategy for maintaining one‘s narrative.   
 Prevailing psychological models have been criticized for similar tendencies.  While 
proponents of the biopsychosocial model celebrate it as a framework that addresses all factors 
(Zuckerman, 1999), for instance, some have raised concern that it minimizes environmental 
factors in actual practice (McLaren, 1998).  Referring to the diathesis-stress model, as well, Drew 
and colleagues (1999), suggest that the importance of traumatic external event may be 
―downplayed since it is seen not as a cause, but as a trigger for depression (i.e., any one of 
hundreds of such events could serve as the trigger‖ (p. 192).   
In this section, we have considered implications of a biomedical diagnosis for 
individuals‘ views of their own pain, their identity and their surrounding life circumstances.  
Laying aside these personal consequences, we turn now to the implication most of interest to this 
study:  how individuals facing depression think of solutions.  As we continue exploration of 
resources relevant to particular narratives of depression and its treatment, the following 
discussion reveals dynamics especially connected with medication itself.  Since problem and 
solution definitions are intimately connected, once individuals settle on a certain explanation of 
the problem, certain solutions also become more or less amenable and agreeable.  Obviously, the 
embrace of a conventional biomedical explanation typically corresponds to embracing medical 
intervention as well--with biological explanation providing an initial and critical impetus for 
moving forward in treatment.  On the way to analyzing the embrace of solutions as another 
resource for narratives, it is first important to squarely examine an intervening state commonly 
mentioned by participants.   
 
4.  Personal Reluctance:  “I‟m just not sure about this. . .”   
 While a number of individuals embraced biomedical interventions readily, a greater 
number spoke of significant hesitancy both initially and throughout treatment.  Reluctance or 
resistance here refers to a reported hesitancy to receive medical diagnosis or its associated 
treatment.  Chapter 5 detailed the many aspects and nuances associated with this resistance 
among depression survivors—including changing resistance over time and distinct ways it was 
interpreted.  Depending on the participant, it varied in duration and intensity.  In multiple ways, 
resistance is here reviewed as another resource relevant to the adoption of particular narratives.   
  Across accounts, participants discussed multiple reasons underlying treatment 
resistance—from dulled creativity, to constraining one‘s sense of personal strength, to a desire to 
avoid dependency, to a dislike of drugs in general.  In his own research across fifty depression 
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narratives, Karp
15
 (2006) identified the response to treatment heard most often as ―ambivalence 
toward medications, of reluctance to rely on them, of movement from one drug or dose to 
another, and of uncertainty about the treatment‘s efficacy‖ (p. 21).  He goes on to highlight an 
assortment of queries evident in his interviewees:     
Must I take drugs for my pain? . . . How well are the drugs working?  Are the side-effects 
bearable?  Might other drugs or other doses work better?  Will drugs ever solve my 
problem?  How much do medical experts really know?  Should I stop taking my 
medication?  Who am I when I take mind-altering medications? (p. 18).   
 
 Two recent surveys of patient concerns corroborated such findings on a larger scale, 
documenting medication concerns that included dislike of adverse/side effects, feeling the drugs 
were not useful or effective, worries about addiction potential and long-term dependency in order 
to function and feeling like they were better (Manber, et al., 2003; other study cited in Holmes & 
Hudson, 2003).  
While such studies confirm hesitancies surrounding psychiatric medication, in particular, 
it is worth noting that such concerns are fairly common to any medication.  For 324 patients 
taking medication for four chronic illnesses (asthma, renal, cardiac, and oncology), Horne and 
Weinman (1999) note ―over a third (36%) reported strong concerns about the potential adverse 
effects of using their medication based on beliefs about the dangers of dependence or long-term 
effects‖ (p. 555).  Even so, compared with cardiac drugs, Benkert and colleagues (1997) 
document a particular level of distrust among the general public regarding psychotropic 
medications.  According to their study, psychiatric drugs were believed to involve significantly 
more severe side effects and prompted more fear of losing control.     
It is also worth noting that medication concerns vary according to certain individual 
characteristics.  Based on a questionnaire survey among 895 adult patients attending 20 general 
practices in England, significantly more men (67.4%) than women (54%) believed 
antidepressants to be ―addictive‖ (Churchhill et al., 2000).  A recent telephone survey of 829 
ethnically diverse patients meeting criteria for clinical depression in the prior year found that 
African Americans and Hispanics are both less likely than Caucasian individuals to embrace 
antidepressant medication (Cooper et al., 2003).  Most recently, a large-scale Internet survey 
measuring treatment preference, stigma and attitudes toward depression across 78,753 persons 
                                                 
15
 I discovered David Karp‘s work while in the middle of my own and have found in his insights and 
illustrations, in particular, both a counterpoint and corroborating voice in the analysis of depression 
narratives.   Because his sample of fifty individuals is so large and his questions so similar, I draw on his 
conclusions and examples extensively in what follows.  (As a long-time anti-depressant user in his own 
fight against depression, his fairness in examining both positive and negative aspects of the experience is 
also something I value).   
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with significant depressive symptoms confirmed the same pattern.  Compared to whites, African 
Americans, Asians/Pacific Islanders and Hispanics were all more likely to prefer other things like 
counseling and prayer to medications; ethnic minorities were also less likely to believe in the 
efficacy of medication overall, and more likely hold beliefs that antidepressants were addictive 
(Givens et al., 2007).   
Younger patients also report slightly more resistance than older individuals (Griffith, 
1990; Lorenc & Branthwaite, 1993).  Moses and Kirk (2005) note a consistent ambivalence 
towards medication in youth, with large numbers embracing medication and other large numbers 
resisting it for its side effects.  While resistance to medical treatment is fairly prevalent across 
demographics, it is thus disproportionally manifest in communities historically disenfranchised 
and oppressed:  women, children and ethnic minorities.    
Laying aside the source and demographics of resistance, we turn back to the primary 
issue of how resistance functions as a resource for individual narratives—that is, how those 
facing depression navigate such resistance and what it means for the formation of their overall 
story of depression and its treatment.  At a minimum, such resistance appears to function within a 
narrative like oppositional friction or turbulence, leading some to turn back and others to seek 
additional assurance.  Where it exists, resistance thus has to be overcome before individuals 
accepted initial treatment and/or its continuation.   
At first glance, whether the ―friction‖ of resistance is overcome appears to involve a 
simple cost/benefit decision based on actual effects.  Based on a survey of 81 primary care 
patients given maintenance antidepressant medications, however, Horne (2003) explored 
adherence to psychiatric treatment for depression in the context of medication beliefs—
suggesting that decisions about treatment depend on two main belief categories--―perceived need 
for the medication (necessity)‖ and the ―perceived potential for the medication to cause problems 
(concerns).‖   Logically, they hypothesized adherence would be greater among those whose 
beliefs about necessity outweighed beliefs about concerns related to medication (and vice versa).  
In an earlier study, Horne and Weinnman (1999) note that psychiatric patients were significantly 
less adherent than asthma and cardiac patients—a distinction partially explained by the fact their 
concerns about medication tended to outweigh their beliefs in its necessity.  They go on to 
suggest that patients facing asthma and cardiac disease, for instance, may see a stronger link 
between their medical treatment and the increase or reduction of symptoms than those receiving 
medical treatment for severe emotional problems.   
 Of significance to Horne‘s work is the evidence that resistance is a complex state 
involving more than simply whether treatment ―works‖ or not.  Indeed, they emphasized 
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medication beliefs as the strongest predictors of treatment adherence—exerting an influence 
beyond demographic factors (age, gender, and educational experience) and clinical factors (type 
of illness and number of prescribed medicines).  In other words, the degree to which treatment is 
interpreted as necessary and not, harmful or not, is the primary factor in whether individuals 
overcome hesitancies and resistance to persist in medical treatment for depression.   
 If anything, my own findings suggest that participant response to resistance is even more 
complex than Horne surmises.  In addition to the contributions of varied objective factors and 
personal characteristics, my interviews reflected evidence that judgments of levels of necessity 
and concern regarding treatment vary dramatically over time according to distinct experience, 
encounters and events.  Depending on how individuals respond to diverse prompts in the face of 
such reluctance, overall narratives of treatment appear to evolve considerably.  The remainder of 
this chapter explores nuances in this continuing process of narrative adoption.  In cases of such 
lingering reluctance, the following two additional narrative resources seem to be especially 
influential in individuals‘ ongoing movement to embrace biomedical treatment and narration.   
 
5.  Moments of Crisis:  “We‟ve just got to do something. . .”   
 As described in Chapter 4, individuals often recounted early moments of extreme pain or 
challenge in their early narrative of depression as influential in their decision process of what to 
do.  Beyond the intense need-to-explain associated with depression reviewed earlier, these rock-
bottom/climactic moments seem to ―ramp up‖ personal and collective urgency even further—
constituting an effective preface to some kind of decisive action.  In relation to the adoption of a 
particular narrative, these moments specifically appear in some cases to provide a concrete and 
compelling rationale needed to overcome personal resistance to some kind of formal treatment.  
This was most vividly reflected in Peter and Robert‘s reflections on crisis moments:  ―Things had 
gotten so bad for me that I said, ‗I‘ll do anything . . . I will do anything if you tell me that it will 
make me feel better‘ (10); ―And at that point my mom decided, she‘s like, ‗We have got to do 
something about this.  We‘ve got to‘‖ (9).  Jill and Elaine both commented on a similar urgency 
flowing from times of particular intensity and stress.   
 Karp (1997) describes similar moments among participants of ―not being able to live like 
this,‖ noting that even while resistance to medication often remains, ―the depth and persistence of 
their misery proves great enough‖ that influenced by others, individuals decide to move forward 
in treatment:  ―anything if you‘re depressed is better than being depressed.  I knew I had to do 
something‖ (p. 90-91).   
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Similar to community influence noted earlier, it is important to neither overstate nor 
oversimplify this narrative resource.  Rather than automatically causing this kind of readiness, 
crisis moments appear to significantly increase the thrust towards treatment--adding another 
influential factor to the complex process of simultaneously crafting one‘s narrative and making a 
decision about treatment.  If resistance functions like ―friction,‖ crisis moments may be seen as 
strong wind pushing and pulling in a certain direction.  Part of the thrust and pull of the moment, 
of course, are influential friends and family stepping into the crisis to again offer advice and 
counsel.  In the absence of these messages, it is unlikely that such crises would have such an 
impact on individual narratives.   
Against this backdrop, one specific message from surrounding relationships appears to be 
particularly influential.  As Kellie recounted, her brother emphasized medical treatment as a 
temporary attempt, ―[He said] ‗just try them for a certain amount of time,‘ just to see if it would 
help me while I was getting through that time.  It didn‘t mean I had to continue taking it for the 
rest of my life, but just for a time so I could get through whatever I needed to get through.‖  In 
another instance, he told Kellie, ―You can enjoy life now, even if you just take the medication for 
6 months, it would be worth it‖ (16). 
During Peter‘s crisis moment, he drew on the same narrative notion—―maybe I‘ll take it 
for six months and then I‘ll stop, you know--just something to get me over the hump‖ (10).  Even 
when the storm of crisis hits, some individuals appear to consent to medical treatment only with 
an understanding that it will be used in the short-term to ―kick-start‖ their recovery—accepting its 
use on this condition (see Badger & Nolan, 2007; Grime & Pollock 2003).  Karp (2006) notes, 
―whatever the particular route that leads people to medication, when drugs are first prescribed for 
them, they rarely foresee a permanent relationship. . . At this early point . . they may view their 
connection with medication as . . an association that will help them get past a difficult time in 
their lives (p. 73).   
While some are able to rely on medication for only a short-term, many of my participants  
spoke of being unable to get off like they had hoped (see Ch. 8).  Referring to the discrepancy 
between initial expectations and this eventual reality for many, Karp writes that an individual‘s 
first slow and ginger steps into a ―new world‖ of treatment is ―the beginning of a process of 
commitment that has far more wide-ranging implications than people can possibly see at the 
moment when they swallow the first pill prescribed for them‖ (p. 75).  To conclude this analysis 
of narrative resources, into this ―new world‖ we now go.        
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6.  Taking Medication:  “I felt like superwoman” // “I lost a part of myself . .”   
As reviewed above and in earlier chapters, arriving at a willingness to take medication is 
a journey for many, if not all.  For those who choose to accept medical treatment for depression, 
their subsequent experiences with drugs constitute a sixth and final narrative resource in the 
initial adoption and formation of their own particular narrative of what they are facing and what 
should be done about it.   
In Chapter 5, wide differences between reported effects across interviews were reviewed.  
While the range of these positive and negative experiences are real and worth exploration on their 
own right, the initial focus in this section goes beyond the effects per say, to how the effects 
appear to be framed and interpreted.  After examining how these interpretations are relevant to 
narrative adoption, this section concludes by reviewing a number of shifts to narratives that 
findings confirm as ensuing from initial medical treatment for depression. 
While some report little or no initially effect at all, the contrast between reports reviewed 
earlier was striking--―I can think clearly now‖ vs. ―I‘ve got cotton balls in my head‖; ―I feel like 
superwoman!‖ vs. ―I feel weirded out!‖; ―My life has never been better‖ vs. ―the eczema has 
never been worse.‖   
 In his study of life-story biographies, McAdams has identified two especially common 
patterns evident across accounts:  ―redemptive and contamination narrative sequences.‖  
Redemptive sequences are defined as accounts where ―an affectively negative or bad life-narrative 
scene is followed by an affectively positive or good outcome‖ with ―the good ultimately 
redeem[ing] or salvag[ing] the bad that precedes it.‖  These would include experiences of 
sacrifice, recovery, growth, learning, and improvement such as illness followed by a cure, and an 
estrangement followed by a reunion with a dear one.  Contamination sequences on the other 
hand, were defined as accounts where ―extremely good life narrative scenes suddenly, and 
sometimes dramatically, turn bad‖ (McAdams & Bowman, 2001).  Examples include 
victimization, betrayal, loss, or return of depression following a previous good period.   
These patterns seem to map on to many initial accounts of medication—both positive and 
negative.  On one hand, a salvation or redemptive narrative frames the encounter with medication 
almost like an evangelical speaks of conversion—i.e., life was bad, until that day I got on Prozac.  
In Elaine, Sarah, Debbie & Peter‘s reports of positive initial effects of medications, in particular, 
they framed the experience using terms of an ―absolute miracle‖ (2), a ―magic pill‖ creating a 
―superwoman‖ (8) and feeling like ―a million bucks‖ with a life that had ―never been better‖ (10); 
in each case, the initial impact of medication was portrayed as a dramatic redemption. 
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On the other hand, a contamination narrative packages the encounter with medication as a 
―horror story‖ (Karp, 1997, p. 94)—with doctors framed as literal villains and pharmaceutical 
companies something of an evil empire.  Correspondingly, Kyle portrayed the effects of 
medication as ―carbuncles and boils‖ that haven‘t been seen since the ―middle ages.‖  He went on 
to portray psychiatry as disinterested in true healing and affirmed, ―I am grateful to have found 
stability and to be free of psychiatry for the time being‖ (12).  Esther similarly described doctors 
from her previous experience as demeaning and even abusive in attempting to force her to take 
medication, as well as claiming they lied to her in minimizing side-effects (14).   
These diverging frames are also reflective of the broader rhetoric evident in societal 
discourse, discussed in the introduction—i.e., pharmaceutical companies and treatment advocates 
framing research and treatment progress as essentially a redemptive, ‗glory story‘ (Kramer, 
1997), while anti-psychiatry groups portray the effort as a conspiracy leading to great harm 
(Breggin,1991).  
While the specific way treatment effects are framed appears to be important for narratives 
across the duration of individuals‘ experiences (see Ch. 8), this initial ―first impression‖ of 
medication appears to leave an especially lasting impact.  Like the traumatic events that often 
galvanize a narrative justifying medical treatment, an initial effect that is received to be either 
dramatically wonderful or horrific appears to likewise cement the formation of a particular 
narrative relative to treatment.  Indeed, as examined in Chapter 8, references back to this initial 
encounter are a common feature of narratives.  When narrated positively, these initial treatment 
experiences seem to become a touchstone to which individuals return to reaffirm and reinforce 
their convictions when difficulties arise.  These kinds of positive frames for experiences 
subsequently reassure individuals about treatment and decrease fears—as Robert said that taking 
medication ―opened my eyes and made me realize that, ‗you know, this may be the right thing for 
you‘‖ (9).   
Not only do such experiences provide memories of positive emotion, they also appear to 
introduce particular new ideas.  Those with initially positive treatment encounters, for instance, 
are introduced to the idea that it is possible to effectively dissipate depression with the right 
medication.  In addition to taking heart in medical treatment, multiple participants confirmed that 
such an experience may likewise galvanize beliefs in depression‘s biological nature—a pattern 
reviewed extensively elsewhere.  Karp (1997) similarly related the account of a man whose ―taste 
of drug success solidified his commitment to a biomedical view of his illness‖ (p. 39).  
 In addition to influencing views of treatment and depression, the taking of medication has 
evident influence on one‘s narration of self and identity.  Peter spoke of the medication as making 
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his ideal self ―accessible,‖ with Sarah and Camille testifying to having ―found me‖ (4) and 
―feeling like me‖ (3) again.  Such effects parallel Moses and Kirk‘s (2005) ―psychosocial side 
effects‖ in consumers of medication reviewed earlier—i.e., increased self-confidence and the 
alleviation of guilt (pp. 392-393).  In his influential 1993 book, Listening to Prozac:  The 
landmark book about antidepressants and the remaking of the self, psychiatrist Peter Kramer 
recounts experiences of medication ―catapult[ing] people into new ways of behaving,‖ with 
transformative powers that ―went beyond treating illness to changing personality . . . outlook and 
self-image in quite fundamental ways‖ (xv, xviii).  Kramer goes on to document cases of 
individuals having dramatic and positive ―makeovers‖ after starting treatment and essentially 
rediscovering who they really were.   
In contrast to treatment effects that appear to positively impact individuals narratives, 
other accounts reflected a more ambiguous dynamic.  For some like Lucy and Jill, for instance, 
treatment prompted significant confusion about who they were.  This was corroborated 
particularly in several comments from Karp‘s (2006) study.  One woman said, ―I know I‘m better 
on medication . . . [but] there‘s been a persistent confusion about the real me since I started taking 
Prozac.‖ After expressing appreciation for vividly positive effects of medication in her life, a 
second interviewee reflected ―Would I be a completely different person?  And will I ever know 
that?  And can I ever say, ‗This is who I am‘ as long as I‘m on these?  That‘s my issue with 
drugs.‖  A third individual recounted:     
My therapist told me that the pills would make me ―more like me‖ . . . . I go back to her 
and I say, ―It‘s not happening.‖  You know, the pills take me away from me, they do 
something else.  The Lithium sort of organizes me, the Wellbutrin lifts me up, the 
Benadryl, puts me down.  But it‘s not me (pp. 19, 112- 113).   
 
Finally, reflecting the sentiment in Lucy‘s account of feeling ―like a part of you dies‖ 
when accepting biomedical explanation and treatment (6), the taking of medication can be 
experienced by some as deeply disruptive of one‘s sense of self.  Another Karp participant 
similarly reflected on his feelings upon starting medication for depression:  ―you‘re losing part of 
yourself . . . It was the fact of being altered.  Now I‘m no longer going to be who I was.‖  Karp 
identifies two key identity issues: ―What it means to feel like oneself‖ and ―whether one‘s ‗true‘ 
self is revealed or obscured by the pills one takes‖—noting that ―virtually everyone in my sample 
continued to question how psychotropic medications affect who they are at their core‖ (pp. 98, 
100, 107).  Based on interviews with 32 social work students and practitioners taking psychiatric 
medication, Davis-Berman and Pestello (2005a/b), explored the impact of taking medication on 
one‘s sense of self.  While documenting the development of a medicated self as complex and 
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varied, they found a ―small number of those who feel that medication led to an improved self, and 
the majority who felt damaged by their experience with medication, and expressed varying 
degrees of ambivalence about its use‖ (p. 283). 
 For better or worse, the experience of taking medication itself thus appears to be another 
major narrative resource on which participants draw in the initial adoption and creation of a 
particular story and narrative of their experience.  For those who adopt a positive narrative of 
treatment--through friction, wind or whatever the details—this narrative subsequently appears to 
carry a force of momentum that literally propels individuals forward through additional 
turbulence that arises (see Ch. 8).   
  
In summary, multiple resources upon which individual narrators may draw have been 
reviewed above.  Depending on the individual, varying contributors appear to be more or less 
salient in adopting a narrative.  Some individuals seem primarily influenced by a neighbor or 
friend—others by a doctor—in the adoption of their own narrative of the problem and solution.  
Others resist all persons and traumatic experiences in fidelity to a non-medical narrative.  Still 
others resist community influence, but when their own trauma hits, acquiesce to fully embrace a 
conventional medical narrative of both treatment and the problem itself.   
Overall, tangible resources such as interpersonal interactions and taking medication itself 
are argued to interrelate in important ways with resources that include states such as confusion, 
resistance and urgency.  Interpretive decisions thus occur against a backdrop of intense emotional 
states and regular influence from family and friends--ultimately galvanized for some by dramatic 
experiences with life crises or medical treatment itself.  Over time, this complex mixture of states 
and experiences fore-structures individuals‘ ongoing and evolving interpretations, decisions and 
further experiences in the crafting of their own unique narrative.     
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Chapter 7 
Breaking Down Stories:  
How Do Narratives Meaningfully Converge & Differ? 
 
 This chapter focuses on the question:  How do narratives meaningfully converge and 
differ?  In Chapter 3, basic structural comparisons between story content were made involving 
overall plot, protagonists, etc.  Building upon previous chapters, this chapter summarizes 
similarities and differences between stories in specific reference to key content issues.  In 
addition to further examining narratives in terms of medical treatment, this exploration also 
zooms out to consider several non-medical related aspects of depression narratives.   
Any two depression narratives may obviously vary in an enormous number of ways.  
Prior to interviews, several issues were selected as questions of particular interest for any 
depression narrative.  These included how individuals saw 1) the role of the body in depression; 
2) the role of personal agency in both depression and its recovery; 3) the role of medical 
treatment in recovery; 4) the precise nature of recovery from depression and 5) the role of 
friends/family in recovery.  Taken as a whole, a review of narratives along these five distinctions 
provides a good backdrop to understand what is going on content-wise across stories—i.e., 
similarities and differences.  For each issue, themes from this study will be examined against 
findings, arguments and text from other similar studies in the literature.   
 
1. Narrating the Body:  How is Biology Involved?   
 Varied participant responses to biomedical diagnosis were detailed in previous chapters.  
Related to and accompanying this experience, all but one participant spoke of a meaningful role 
for biology in their depression—albeit in different ways.  Indeed, even more interesting than 
whether they saw depression as biological, was how participants variously saw depression as 
biological.   
 On one hand, a number of participants spoke of depression as linked to a chemical 
imbalance.  Jill spoke of ―a brain chemical …that is not letting those neurons connect [like] you 
need, and so you don‘t function‖ (7); Victoria referred to ―a chemical in your brain that says you 
can‘t be happy and content‖ (5); Sarah shared her understanding of a ―chemical that says ‗okay 
… time to wake up get the kids off to school‘ and it will swim across the serotonin bridge . . . and 
when it gets there that enables you to get up‖ (4).  
 It is the neurochemistry of the brain, more than the body or even the brain as a whole, 
that receives the primary emphasis here.   As noted by other depression narrative researchers, the 
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chemical imbalance theory has become dominant across individual accounts (e.g. Schreiber & 
Hartrick, 2002; Stoppard & Gammell, 2003; Ridge & Ziebland, 2006; Karp, 2006).  When a 
particular narrative is shared by many people and institutionalized in policies and procedures, it 
may be called a ―dominant cultural narrative‖ (Rappaport, 1998).  
 Although not necessarily linked to a biochemical explanation, the degree to which the 
chemicals are here depicted as instrumentally
16
 related to emotions is striking—i.e., causing 
emotions in a unilateral way, independent of any other factor.  This same instrumental 
characteristic was evident in mentions of genetics as well (less frequent than brain chemistry, but 
also common):  ―Depression does have roots in genetics . . .  the same way people are born with 
physical limitations, sometimes they may be born with, uh, a physical limitation that affects them 
mentally‖ (9); ―I realize . . . that it probably is genetic most likely it ran in my family.  It wasn‘t 
caused by anything other than me being born to my particular parents‖ (10).  Such an 
instrumental frame of the brain and body generally may logically predispose an instrumental 
portrayal of external chemicals inserted into the brain as well.   
 A second characteristic salient to these accounts was the degree to which these biological 
deficits were depicted as largely permanent.  Victoria was later asked to elaborate on how she 
―defined depression?‖  ―Hmmm. . . it‘s that little glitch in my brain that‘s not producing the 
chemical that lets me be happy and content. I mean that‘s at least that‘s the way I look at it now‖ 
(5).  Jill said, ―You can‘t talk it out; it‟s chemical.  Talking it out or going for a jog isn‘t going to 
help the chemical imbalance that‘s going on‖ (7) [her emphasis].  Debbie similar recounted, ―it‘s 
a chemical imbalance--it‘s not gonna go away with . . you know; I can't--I‘m not one of those that 
could take [medication] for a couple of years and then be good for five years.  It‘s . . I‘m stuck‖ 
(8). 
A chemical imbalance is here portrayed as also a permanent condition—impervious to 
enduring change through therapy or exercise.  As Jill later elaborated:   
I‘m a firm believer in medication because I don‘t think, I mean, I think therapy is good, 
but it doesn‘t help if you‘re not calmed down, it doesn‘t, I mean . . . You can‟t talk it out; 
it‟s chemical! . . . I just, like I said, I don‘t . . you can‘t get better without medication.  
You can talk and talk and talk but you can‘t get better without, if your chemicals are 
messed up (emphatic) (7).  
 
The presumed permanency of this deficit is likely responsible for some of the tension 
seen at diagnosis.  Like this study, Stoppard and McMullen (2003) summarize the nature of relief 
                                                 
16
 Reflected in its noun form of ―instrument,‖ instrumental here refers to how tools are typically applied 
unilaterally to passive objects—i.e., ―indicat[ing] the inanimate, nonvolitional, immediate cause of the 
action expressed by a verb, as the rock broke the window” (Dictionary.com, 2008).   
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accompanying the experience of depression diagnosis for women interviewed:  ―Her feelings of 
distress and ill health are not her fault, she is not to blame (―there really is something wrong with 
me/‖It is not just in my head‖)—she has an illness called depression, which involves a chemical 
imbalance in her brain.‖  They go on to note, however, that ―this view of depression can also go 
hand-in-hand with the idea that one is flawed in some way or otherwise weak‖ (p. 3).   
To be clear, this prevailing biological portrayal certainly does not rule out other  
contributors.  Indeed, these same participants referenced above mentioned a significant role for 
surrounding life conditions in their depression.  Interestingly enough, these environmental 
conditions also appeared to be frequently portrayed in a unilateral, instrumental way, with 
environmental stressors portrayed as something of a ―trigger‖ to activate or aggravate underlying 
physiological deficiencies ( in turn, causing the negative mood).  After describing his conviction 
about genetics as the root of depression, Robert added, ―I don‘t think [however] that that‘s the 
whole deal as far as what causes it . . .certain events take place in one‘s life that, you know, kind 
of make those weaknesses express themselves‖ (9).  Echoes of the ―diathesis-stress‖ portrayal of 
illness were reflected in the way multiple participants spoke of the role of situational factors in 
their depression.   
 In terms of the biology, however, the chemical imbalance theory was the dominant 
explanation in this sample.  Some, however, expressed concerns at what they saw as an over-
focus on chemical imbalance in explaining depression, such as Kyle:  ―So you know, there‘s so 
many things . . . that can cause someone to be loopy, I mean the brain is such an amazing organ 
and it does . . get messed up sometimes.  But we kept on being fed these ―well. . it‘s a lack of 
serotonin.‖  Citing his review of the research, he added, ―Well now we‘re finding that we‘re not 
finding a lack of serotonin in the brains of the depressed. . . yet, the public still believes that‖ 
(12).  Speaking of the biochemical hypothesis, Esther remarked, ―I went in knowing that it just 
couldn‘t be that; it wasn‘t only that.  It couldn‘t be the whole . . only a chemical imbalance; it had 
to be more than that.‖  She added, ―I think a lot of the evidence. . is pretty lacking—people just 
seem to buy into it‖ (14).  In recent years, the primacy of biochemical explanation has indeed 
been questioned by a number of scientists, with many deciding that in terms of brain function, it 
must be more complex than a simple chemical imbalance (Valenstein, 1998; Lacasee & Leo, 
2005).   
 Other participants subsequently spoke of depression as linked to the body in another way.  
Rather than emphasize neurochemicals only, other participants emphasized relevant processes in 
the whole body.  After acknowledging the role of some kind of genetic predisposition, Kyle said, 
―There are hundreds of reasons why an individual or for that matter generations of individuals 
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from the family may have susceptibilities to.. . . depression.‖  He went on to say, ―they might be 
genetic, they might be susceptibilities, they might be allergens, abuse issues, there‘re so many 
issues it‘s not one thing--it‘s not like diabetes.‖  As noted in Chapter 5, participants spoke of a 
number of other physical conditions playing a role in depression, including hormonal problems 
(16), diabetes (13), obesity (11), surrounding toxic chemicals (12),  nutritional deficiencies (12),  
disrupted circadian rhythms (2, 12) and exercise (2).   
This broader emphasis is reflective of increasing attention to more complex portrayals of 
the neural underpinnings of depression.  Specific to the brain itself, the broader discourse reveals 
multiple processes of interest beyond neurochemistry.  Investigations into neural networks over 
recent decades, for instance, are pointing to their potential role in depression and other emotional 
problems (e.g., Siegle, 1999) and showing them to be remarkably plastic and changeable (Arbib 
& Amari, 2003).   
Notably, this view contrasts with both characteristics of the first portrayal above:  the 
instrumental relation between brain and emotions and its presumed permanency.  Rather than 
chemical deficits inevitably impairing functioning until/unless corrected, alternative portrayals 
highlight the changeability of the brain by more than pharmacological interventions.   After 
commenting on finding Lithium to initially be helpful in ―working to bring me down,‖ Kyle 
added, ―I think if I had been weaned off the Benzo and put in a nurturing environment . . . it 
would have done the same thing‖ (12).  For this view, then, environmental stressors become 
something more than a static trigger.  For instance, Kyle went on to say about his depression:   
If I, you know, if I go without sleep and start partying a lot and get over extended and 
stressed, yea . . I‘ll hit depression.‖ . . . I know the recipe for madness, I know I could 
bring myself another depression . .  .  I know that recipe.  I lose my sleep; I drink too 
much, um,. .  I get, I get involved in too many things, that‘s the recipe for madness for 
me. (12) 
 
Elaine reflected on her past care for her body in relation to depression:   
You‘re not gonna be able to let yourself get sleep deprived your whole life. You know 
you can‘t. You‘ve gotta kinda watch this and not think that you can go without sleep just 
because it feels like you could . . . (laughs) you can‘t do that to your brain for years on 
end. You can‘t not feed yourself. . . .You‘ve got to take care of your body because your 
body takes care of your brain. (2)
17
 
 
Well-worn neural networks, of course, cannot simply be ―zapped‖ like tumors with 
chemotherapy—nor does this imply a solution of simply ―choosing to be happy.‖  Yet this 
                                                 
17
 Since much of the text reflecting these distinctions was not reviewed in previous chapters, more new 
verbatim is included here than in Chapter 6.  The same is true of the following Chapter 8.     
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portrayal does appear to open up greater optimism about recovery.  Indeed, as maladaptive 
pathways are allowed to atrophy and individuals exercise new neural pathways, significant levels 
of recovery may be possible (see Rosenzweig & Bennett, 1996).  After learning about brain 
plasticity, my own sister Mary said, ―wow, that kind of makes me more hopeful I can do 
something that will help this change!‖  This portrayal also resonates with more sophisticated 
views of personal agency ebbing and flowing on a continuum, as reviewed later in this chapter.   
 
2. Narrating Agency:  Is Personal Choice Relevant to Any of This?   
A second distinction of interest relative to depression narrative content is the question of 
human agency.  The degree to which individual choice is seen as involved in depression (and its 
treatment) has significant implications for the ensuing experience of depression.  This is most 
evident in participants‘ recollection of comments from friends/family suggesting that the coming 
or going of depression (or happiness) is largely a free choice for each person to make.  Camille 
described challenges from people ―who think that you can just decide to be happy and snap out of 
it.‖  She added, ―I tell them, ‗do you think anybody would choose to live this way?  Don‘t you 
think if I could just snap out of it and decide to be happy I would have done that a long time 
ago?‘‖ (3).  Lucy similarly remarked, ―If I were to choose this as my illness—if anyone really 
truly believes this is the one I would have picked, you‘ve got to be kidding, honestly‖ (6).   
Unfortunately, this portrayal, here called ―radical agency,‖ appears fairly prevalent 
among the general public.  Based on the same survey of 984 adult surgery clients in England 
(91% response rate), just over one-third (35.7%) agreed with the statement that ―if you are 
depressed you have to pull yourself together‖ (Churchhill, et al., 2000).  Problematic implications 
of this particular narrative are obvious:  self-blame, discouragement, etc.  As described in Chapter 
4, this portrayal may heighten the actual burden of depression, as Kellie said, ―It‘s hard for family 
and friends to understand that you really, really, really are not doing this intentionally‖ (16).  
Kyle admitted to similar attitudes prior to his depression: 
You don‟t know what depression is until you have it.  And, uh, before I had my first 
depression, I believed that depression was a bunch of crap, you know, ―pull yourself up 
by the boot straps, quit feeling sorry for yourself, go into a damn cancer ward for kids 
and you‘ll see something to be depressed about, you know, what the hell do you have to 
be depressed about?‖ . . .  I didn‘t believe in it until it happened to me. (12) 
 
Clearly, those who voice this portrayal of agency may actually aggravate the paralysis of 
depression and potentially distance victims from critical community ties to a greater degree as 
individuals feel unsupported, harshly judged and misunderstood.      
 131 
Surely the greatest flaw of ―radical agency,‖ however, is how at odds it is with the reality 
of depression.  In nearly every narrative of depression, participants comment on real constraints 
and limitations on one‘s own agency.  From the beginning, participants spoke of coming clearly 
against their will and beyond their control—including one woman who spoke of ―getting it‖ 
during a stressful period like she had got a cold.  Peter recounted ―slipping‖ into a depression that 
eventually ―took hold‖ (10).  And Jill recollected her fear that depression would cause her to hurt 
herself, ―I always said ‗it takes over.‘  It takes over your personality, that‘s why I was afraid that I 
would take my own life . . . the depression might do it for me, and that scared me, scared me a 
lot‖ (7).  Kyle used images of violence to depict his depression:  ―it just really started to hit me 
hard . . .  I got smacked with my first depression . . . it threw me up high and, you know, I fell 
down, uh, and it was horrible depression‖ (12).   
As a final vivid illustration of these constraints, I turn to an outside account that had a  
significant impact on me in early graduate school—this, from the therapist and author, A. B. 
Curtis (2001):     
It had snowed a rare eighteen inches in Washington, D.C., and I love the snow.  The first 
few flakes of any snowstorm fall directly into my heart.  My husband and I are spending 
the weekend with another couple, our best friends.  Between us we have a gaggle of 
preteens who are busy building a snow fort outside, while we four adults are toasting our 
toes in front of a cheery fire, chatting cozily.  
The snow is still sifting down from a billowy gray sky that looks like it was painted long 
ago on Chinese silk.  A beautiful day.  A perfect day.  My husband throws back his head 
and laughs at his buddy‘s joke.  I too am smiling broadly.  Then the smile slides off my 
face as I feel my inner self suddenly give that downward jerk.  In a nanosecond 
everything good is gone.  I am submerging into that empty pain, sinking helplessly into 
myself, going further and further away from everybody.  Faster and faster I am sucked 
into that alternate universe of agonizing, utter loneliness called depression.  They don‘t 
notice.  They are laughing and passing me the cheese and crackers and they don‘t know I 
am no longer here.  I have gone to misery (pp. 40-41). 
 
In contrast to the previous portrayal, an admission of real constraints to agency can be a 
relief to those facing depression.  Where a community accepts these constraints, victims may feel 
supported, understood and judged fairly.  Given the human implications of competing portrayals, 
investigations of agency and severe emotional problems are becoming a subject of systematic 
study in recent years.  One of the sub-scales of the Perception of Depression Questionnaire 
(PDIQ) is ―Self-Efficacy, which reflects perceived controllability of the illness‖ (Manbera et al., 
2003).  Likewise, one of the five components of ―illness representations‖ identified by Leventhal 
and colleagues (1980) is ―controllability/cure (beliefs about the degree to which the disease is 
amenable to control or cure)‖ (as cited in Churchill, et al., 2001, p. 905).  And in a discourse 
analysis of ways of talking about mental health based on mental health service users in Ireland, 
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Speed (2006) identified ―intrinsically different ways of talking about mental illness‖ across the 
discourse, each alluding to ―different conceptions of agency on the part of the service user‖ (p. 
28).   
When taken to an extreme, agency may be de-emphasized completely.  Kellie spoke of 
her brother trying to help her realize that depression ―didn‘t have anything to do‖ with her efforts 
and that recovery didn‘t rely on her making any changes—telling her, ―I know you don‘t think 
you‘re doing all that you can but you really are!‖ (16).  Sarah spoke of her previous attempts to 
do anything to resist the onset of depression as naïve (4) and Victoria expressed gratitude for 
knowing that ―nothing could have been done‖:   
I guess the …it‘s the best shift in my thinking is knowing that this . . . wasn‘t something 
that I could have controlled.  I mean, the fact that I got depression . . there was nothing I 
could have done to keep me from getting it, you know?  I mean, it‘s not like if you don‘t 
smoke you won‘t get lung cancer, you know?  I mean, it‘s not that kind of a thing; you 
can‘t say, ―well it‘s because I ate the wrong thing or, you know, I got exposed to 
radiation or some, you know, some crazy thing like that; it couldn‘t be helped, you know. 
(5) 
 
In speaking of her seasonal depression, Camille similarly remarked on its inevitability in 
that ―every winter I would become depressed.‖  She continued, ―but then in the spring I‘d come 
out of it and one year I just didn‘t come out of it . . . it just had always gone away before and this 
time it didn‘t.  I couldn‘t live that way‖ (3).  This prompted her to seek treatment—―And so I 
called my regular doctor and he put me on Prozac and that worked great for a year and then it just 
quit working‖ (3).   
In this vignette, notably, both the coming and going of depression were experienced  
largely as happenings beyond any personal control—from depression that ―comes‖ and ―goes‖ to 
treatment that ―works‖ or ―quits working.‖  Similar to the discussion of brain chemicals and 
genes, both depression and its treatment may thus come to be framed overall as 
unilateral/instrumental experiences.  As a result, individuals may see themselves as having little 
potential of meaningfully impacting the going or coming of depression, except in relation to 
treatment itself—which, in turn, may be framed as largely a technical choice with unilateral 
consequences as well.  In their discourse analysis of representations of mental illness in Serbian 
newspapers, Bilic and Georgaca (2007) document one of the characteristics of the ―discourse of 
bio-medicalization‖ being ―people with mental health problems as passive sufferers of their 
condition‖ (p. 167).   
Some of this decreased sense of control may simply be related to the unpredictability of 
medical treatment.  Said one woman, ―Before that, every day I woke up I knew what I was going 
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to feel.  Once I started taking that drug, I didn‘t know.  I didn‘t know if I was going to wake up 
happy or if I was going to wake up sad, [or if] I was going to wake up angry.  I didn‘t know‖ 
(Karp, 2006, p. 29).   
After reviewing the literature examining learned helplessness within depression 
treatment, Moses and Kirk (2005) note a consistent link between psychiatric treatment and an 
external locus of control and decreased autonomy.  Feminist researchers such as Stoppard and 
Gamell (2003) have raised concerns with the impact of medical treatment and its implicit 
narrative on women‘s sense of empowerment—highlighting the minimal attention to social 
context, the strong deference to others‘ judgment, and the emphasis on elements outside of 
individual control.  Another individual admitted, ―There was a sort of deterioration of that resolve 
in me to get through anything when I started taking drugs.  I sort of felt like, ‗Well, gee, now that 
I‘m sick,. . . [it‘s] something that I don‘t have to fight through anymore.  There‘s a reason and it‘s 
not that I can‘t do something or I‘m too lazy or whatever‘.  But there was something in me that 
gave up the fight (Karp, 1997, p. 89).   
Regardless of the cause, this overall shift towards this disempowered state recalls 
Bruner‘s distinctions between ―agentic‖ and ―victimic‖ life plots.  Whereas agentic plots center 
around self-determination, confidence, active striving, and responsibility, victimic plots reflect a 
life depicted as ―as out of their control‖:   
In victimic life stories, the protagonist is shaped by conditions beyond his or her control.  
. . . the accomplishment or failure to achieve life goals depends on factors that are unable 
to be changed . . . The protagonist is oriented more toward avoiding negative possibilities 
than to actualizing positive possibilities.  Success in life is measured by what negative 
happenings did not occur or what one was able to prevent from occurring (cited in 
Polkinghorne, 1996, p. 302).  
  
Unfortunately, the attention this issue receives typically posits a debate or competition 
between ―choice‖ or ―no choice,‖ as if these were mutually exclusive options.  Among other 
things, this debate between extremes may prompt a further polarization in portrayals.  For 
instance, as illustrated in Chapter 4, one reason a biomedical diagnosis comes to be so relieving 
for some, is a context of having to defend against the idea that one has ―brought depression on 
yourself‖ (and need to simply ―pull yourself out of it‖).  Thus, the insistence on ―nothing I can 
do‖ may, in part, be prompted by the prevalence of ―it‟s your fault‖ blaming messages among 
friends or family.  Ultimately, this highlights the need for further research regarding a more 
moderate and sophisticated (alternative) articulation of agency avoiding the excesses of both 
preceding portrayals.    
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One possibility suggests that neither of these narratives is completely satisfactory, 
delineating the actual role of personal agency as something that ebbs and flows on a continuum 
(see Williams, 1992 on a ―human context for agency‖ and Charles Taylor on ―embodied agency‖ 
in Abbey, 2004, p. 3).  This allows discussion of a meaningful role for agency in the experience 
of depression and its treatment without lapsing into the problematic notion of depression being 
entirely a product of choice—either its coming or going.  Indeed, the same individuals who 
emphasized the overpowering experience of depression, emphasized choice in relation to 
behaviors that could indirectly impact depression.  Referring to health-related behaviors, Camille 
spoke of realizing, ―I could change even if nobody else did--that I had choices…and really that‘s 
like a shift from being a victim of the disease to saying, ―No more. There are things that I can do 
to change it‖ (3).  Sarah spoke of learning she had choice relative to her thinking:   
Before I went to counseling and Recovery inc, I just thought that whatever I thought was 
true, I didn‘t realize I had choices to make different thoughts go into my brain, so in 
learning that I now understand that I control everything within my own skin and this is 
recovery terms and that‘s called ―inner environment.‖ And everything outside of my own 
skin is called ―outer environment.‖  I can‘t control what you think, what happens with the 
person that . . . cuts in front of me [driving].  But I can control how I react to that. (4) 
 
In describing his recovery from depression, Peter emphasized the centrality of realizing 
his own personal power and agency in life generally—―I get to kind of shape myself in whatever 
image I see fit and it‘s great (laugh).‖  As key to his recovery, he went on to emphasize 
―confronting issues that had haunted me my whole life . . . so that I could be the person I wanted 
to be.‖  He added:  ―For me depression was a way of life, and now it‘s not anymore . . . so now 
when I look at things in my life, I realize . . I see many more possibilities, you know.  Depression 
was one possibility of many…it wasn‘t just ‗the way things were‘‖ (10).  Two of the most severe 
cases of depression reflected similar emphases on discovering agency.  Michelle spoke of a 
―turning point‖ in her recovery as admission to a unique in-patient treatment center during a 
suicidal period:  ―What I noticed was when you‘re in a psychiatric unit somebody unlocks the 
door, you step over the threshold and they lock the door behind you.‖  She continued, ―In [this 
center] they brought me down to this dorm like building where I would be staying and nobody 
locked the door.  And what that meant to me was that every minute that I was there, I was making 
a decision to participate in my recovery and I had the choice whether I wanted to stay or I wanted 
to go‖ (13). 
In a second account, Lucy, who had also related severe physical and sexual abuse as a  
child, reported the following key realization, ―You start learning ‗what is my part in this?‘ and 
‗how can I make my life better despite all the things I‘m going to have to overcome every day?‘‖ 
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She continued, ―We all need to be held accountable.  The time that I started getting better, I feel, 
is when I sat down with myself and looked at every minute of my life and I took my part in it and 
I held myself accountable for what was mine.‖  Lucy clarified:   
And that can be tricky, you know, because you don‘t want to take everything, right?  But 
until you hold yourself accountable for what was your part in it . . only then and then only 
can you become in charge of changing the future. . . . the minute you realize that you 
were an active part of your life .. is the minute that you realize ―I‘m still an active part in 
the progress that I can make in the future.‖. . . No one can define your quality of life. (6) 
 
 She concluded, ―So, I think that . . always hold people accountable .. but don‘t let them 
out of sights with it, you know—don‘t let them go into a dark hole, you know‖ (6).   
 From reacting to living situations, to general life orientations, to making personal 
changes, to approaching depression specifically, these individuals highlight new ways of acting in 
response to their situations as important in their recovery.  After detailing the shift from agentic 
to victimic plots following traumatic events, Polkinghorne (1996) goes on to detail the reverse:  a 
renewed sense of self-determination and agency accompanying the restoration of an agentic plot.   
 Some may justifiably feel uncomfortable with this portrayal—seeing in the allowance of 
any agency the tempting impulse to hold depression victims entirely responsible for a) their own 
pain and b) their recovery.  It is precisely for this reason that the foregoing analysis has 
juxtaposed portrayals of all, none, and some personal agency in relation to depression and its 
treatment—suggesting an implicit continuum on which agency can ebb or flow.   Without falling 
into either blaming or victimizing those facing depression, this third alternative seeks to clarify a 
meaningful and moderate place for personal choice and initiative.  In a context of violence or 
abuse, for instance, the truth that individuals do not ―bring on themselves the abuse‖ is not the 
same as saying ―there is nothing we can do to fight or prevent it.‖  Rather than ―making it go 
away‖ by simple choice, this role for agency entails doing what is necessary so the depression 
will dissipate over time.  As Kellie concluded, ―Well, things are just going to work out for me in 
time and I just have to try to do my part in the meantime‖ (16).   
 
3. Narrating Medication:  Is This Stuff Helping Me or Not?   
Among the general populace, it is commonly assumed that treatment either ―works‖ or 
―doesn‘t work‖—with results based on varied physiological effects.  That outcomes and 
biological changes can be interpreted or narrated in fundamentally different ways may still be a 
new idea for many.  Indeed, among my own sample, participants naturally took for granted their 
own current interpretations as reality. 
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Attention to diverging interpretations of the body, then, is unique in itself.  As Kleinman 
(1988), one of the early pioneers of this research area asserted, illness narratives ―tell us about the 
way cultural values and social relations shape how we perceive and monitor our bodies, label and 
categorize bodily symptoms, interpret complains in the particular context of our life situation‖ (p. 
xiii).   
 One of the greatest challenges for those facing depression is knowing when to attribute a 
particular state to medication versus some other condition.  For instance, while Sarah interpreted 
panic attacks as primarily coming from her own anxiety, Kyle attributed carbuncles and boils as 
primarily coming from the medication (see details in Chapter 5).  This confusion applies to 
positive instances as well.  Grime and Pollock (2003) cite one person as saying, ―I don‘t really 
know if they [medications] are working.  I just know I‘m getting better and I‘m wondering what‘s 
causing it‖ (p. 517).  Garfield and colleagues (2003) report one patient reflecting, ―Yes the 
medication has helped, but it‘s difficult to determine quite how much it‘s helped when you‘ve had 
a circumstance change as well‖ (p. 525).  
This difficulty of discerning the source of a particular state varies from situation  
to situation.  As Karp (2006) writes, ―Sometimes the connections between drug use and emotional 
changes are unclear.  In other cases, however, alterations in moods, feelings, and emotions are 
sufficiently intense after taking a medication that there is no mistaking cause (p. 111).   
This question has implications for identity as well.  Jill said of her confusion about the 
true effect medication treatment, ―I still wonder ‗who am I really?  What‘s my real personality?‘‖ 
(7).  Moses and Kirk (2005) quote a patient as saying, ―I need to know what is my personality and 
what is caused by the pill.  I don‘t know whether my feelings are what I feel or what the pill 
causes me to feel‖ (p. 391).  Naturally, whether a positive feeling hails from one‘s resolve or from 
Prozac may have much to say about one‘s self-image.   
Laying aside interpretations of the source of a particular state concurrent with 
medication, a second major question deserves further attention:  how to evaluate the worth of a 
particular state?  This question often occurs when the source of a particulate state is settled, while 
the worth of that state remains in question.  This may appear counter-intuitive, given the general 
inclination to speak of medication as either ―working or not.‖  Yet like other substances such as 
alcohol, whether its effect is experienced as ―positive‖ or ―negative‖ depends on more than 
merely metabolic differences or blood alcohol levels.  In the case of alcohol, obviously differing 
cultural interpretations of an inebriated state may differentiate between whether an individual is 
experienced (by others or oneself) as more or less ―exciting, fun and dynamic‖ when under the 
influence.   
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In like manner, the precise worth of an effect across a variety of substances is no obvious 
interpretative decision.  As reflected in earlier chapters, family may naturally disagree on how 
well a medication is working.  In Kyle‘s case, his mother and father differed sharply in their 
evaluations of medicine‘s impact on their son‘s bipolar symptoms.  Kyle went on to reflect on 
―who decides‖ when someone is feeling better or worse:   
You know, you can take that back to the lobotomy when Freeman was made man of the 
year for Time magazine, you know, by running around the country giving people 
lobotomies with an ice pick, I mean he performed these things in hotel rooms sometimes.  
And, you know, no one asked the patient if his life became better.  Often times, life 
became better for the people surrounding him, his family, her family, and the Kennedy‘s 
lobotomized their mildly retarded daughter because, uh, she was becoming sexually 
promiscuous. . . . So was life better for the people around me?  Well [when] I was on the 
medication compared to when I was, you know, hypomanic, ―yea‖ [better for my family]. 
But it wasn‘t better for me. (12)   
 
The answer to ―who decides,‖ of course, is ultimately and most typically thought to be 
professionals—both doctors and researchers.  In the popular view, science is often seen as 
reflecting monolithic agreement on solid and conclusive answers—with clear ―findings‖ 
establishing reality when it comes to medication effects.  On closer view, however, as noted in 
the introduction, there is a striking degree of general variation in conclusions regarding 
medication effects in the research community.  Where some argue medications are largely 
effective to alleviate emotional problems (Kramer, 1997), others conclude they are mostly 
ineffective or ―placebos‖ (Kirsch, Moore, Scoboria & Nicholls, 2002), while still others claim 
there are significant negative/iatrogenic effects being overlooked (Breggin & Cohen, 1999).  In 
cases of agreement on a particular negative state associated with medication, whether to call it a 
―side effect‖ (implying overall necessity and tolerability) or ―adverse effect‖ (implying the 
reverse), also varies across researchers (see Breggin & Cohen, 1999).  Depending on the general 
view, there are associated differences on whether populations are seen as over- or under-
medicated (Moses & Kirk, 2005).   
A final narrative distinction regarding medication worth mentioning is the scope of time 
in which effects are evaluated—short term vs. long term effects.  Participant comments about 
medications primarily centered on immediate emotional states, with only two individuals raised 
any concern with long-term effects.  While acknowledging some benefits of his anti-depressant 
medication, Kyle emphasized concerns with long-term impacts of other sleeping medication used 
in his treatment:  ―In the short run, I loved those sleeping pills [tranquilizers], I loved them. . . . a 
tranquilizer to cool someone out for just on short term, um, would be okay, but in the long run, I 
think there‘s always going to be a price to pay‖ (12).   Alternatively, Ridge and Ziebland (2006) 
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note an individual remarking, ―When people say to me, ‗Oh, I‘d be worried about the long term 
effects‘?  Well all right, let‘s say Seroxat is more likely to . . . take 5 years off the end of my life. 
I‘d say, ‗Well it‘s better than feeling f*ing awful now‘‖ (p. 1043). 
In the current research and professional discourse, there is clearly insufficient attention to 
longer-term outcomes for medication.  Given the limited number of formal studies of long-term 
outcomes (e.g., Ziere, et al., 2008; Williams, et al., 2008), additional research in these questions 
appears to be justified, including the application of qualitative studies as a formal part of the 
outcome research for psychiatric treatment (Crawford, et al., 2002).   
 
4. Narrating Recovery:  What Does it Mean to “Get Better” Anyway?   
Closely associated with distinct evaluations of how and whether a medication is working 
and the nature of a good treatment outcome is the question of ―what does it mean to get better 
anyway?‖  Participant views on this question were reviewed, ranging from emphasis on recovery 
as managing the depression and being able to function, to an emphasis on feeling joy again in life. 
Camille said:   
To me, knowing when you‘ve gotten better is when you‘re able to really laugh--and not 
only laugh on the outside but on the inside too--when you‘re able to find pleasure and 
joy.  And you know that that you can‘t be happy all the time and you‘re okay with that 
(3).   
 
In contrast, Daniel Fisher, President of the National Empowerment Center (2006/2007), 
writes of a ―rehabilitation‖ portrayal of recovery as ―recovery of function despite still having the 
permanent impairment of mental illness.‖ The metaphor here is a spinal chord injury, where with 
support, a person can once again function in society.  The impairment, however, remains 
permanent.  In a similar way, this view of recovery says that ―people can regain some social 
functioning, despite having symptoms, limitations, medication, and remaining mentally ill‖ (no 
page number).  Consistent with this view, several participants essentially saw recovery as 
essentially a matter of regaining basic functioning in life.    Other studies have documented a 
similar range of patient thoughts about recovery (see Ridge & Ziebland, 2006).   
 As with treatment effects, it is worth mentioning at this point that the way recovery is 
defined may have significant influence on those facing depression.   In the case of the two 
individuals reporting a lack of deep feelings, for instance, personal definitions of what it means to 
get better may determine whether this state is accepted to be ―as good as we can expect to manage 
for my condition‖ versus ―not good enough.‖  In their study of doctor and patient treatment 
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narratives for depression, Rogers, May and Oliver (2001) suggest that reports of client 
satisfaction may be linked, in part, to generally low expectations of treatment.   
Obviously many other questions remain.  Combined with previous reviews of recovery 
accounts and interpretations of prognosis, at a minimum, the foregoing analyses call for greater 
care in drawing rigid conclusions about whether recovery is possible and what recovery means—
even more so in offering them to others.  More directly, however, it might be proposed that 
different meanings of recovery deserve more attention than they have received in the research and 
popular literatures.  Presuming and asserting one universal definition (of recovery or a ―good 
outcome‖), while well-intentioned, may arguably constrain thoughtful deliberation on the topic.  
And while it certainly seems important to assert the reality and potential of recovery, it would be 
problematic if such a zealous proclamation obscured significant differences in ―what exactly 
recovery means?‖   
 
5. Narrating Community:  How Can Friends/Family Really Help?   
Another key issue in participant accounts of depression is the uncertainty among friends 
and family as to how to support individuals facing it.  As a community psychologist, I find myself 
interested in all aspects of community support and connection (or lack thereof) for those facing 
depression.  Holding this sense may be both especially important and especially difficult for those 
facing depression.  Hurst (1996) documents the ―profound betrayals‖ from close figures that often 
prompt a depressive spiral.  Regardless of its cause, those facing depression also often disconnect 
and isolate, even when social connection is earnestly desired (Karp, 1997)—hiding ill feelings 
and putting on a mask.  Reinforcing this silence and isolation are families not wanting to talk 
about the problem or simply not acknowledging it at all.  At the outset of the project, I aimed to 
understand how participants narrate their sense of community over the course of the depression—
including feelings of belonging, identity and emotional connection.   
 For those facing depression, it seems clear that friends and family are often experienced 
in very different ways.  On one hand, they are portrayed as primarily buffering against and 
fighting depression (the problem narrated as coming in spite of these relationships); these include 
examples of family and friends extending love, trust and unconditional support reviewed 
previously.  On the other hand, friends or family are portrayed as primarily contributing to the 
depression (the problem narrated as coming partially because of these relationships); these 
include examples of family and friends showing skepticism, being harshly judgmental and 
blaming, as well as being overly-forceful in recommendations--also reviewed previously.  In most 
accounts, participants spoke of a mixture of positive and negative instances.  Past chapters review 
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the role of friends and family to introduce particular depression explanations and associated 
interventions (Ch. 4), as well as positive support for individuals in the recovery process overall 
(Ch. 5).  In this section, we look specifically at the relationship difficulties during a depressive 
period for family, friends and individuals themselves.  Where previous chapters largely review 
bounded moments of interaction with family, this section elaborates and traces three broader 
patterns identified across narratives as barriers to authentic support—each especially relevant to 
circumstances when a family member has endured depression for a long period of time.  These 
include isolation/avoidance, over-involvement and ambivalence.   
A well-known pattern is the distance in relationships that may ensue from depression:   
You begin to feel (pause) just completely disconnected from your own life and from the 
people around you… I felt like I was in a place that no one else could reach…you know 
they don‟t know how I feel. . . they can‘t possibly understand (Peter/10) 
I think depression for me .. the word that always comes to mind is ―detachment,‖ when 
you become alone—it‘s the sad, the dark place.  But the biggest word, I think, is ―alone‖:  
how cut off from everything you either make yourself or they make themselves .. so 
alone, yeah—frightfully alone. (Lucy/6)   
 
Disconnection has been identified as a theme in both adolescent and adult narratives of 
depression (Hetherington & Stoppard, 2002).  While the isolation appears at time intrinsic to the 
depression itself, individuals also spoke of observing their actions pushing away loved ones:  
When you‘re dealing with depression, it is all about you.  I‘ve spent so many years trying 
to . . get well, physically and emotionally, that it has been all about me . . . in the midst of 
your illness, the world is only as big as you.  The only thing that you can understand is 
what you need or what you want and you have no comprehension that your episode has 
made somebody else late to work or caused them to have to take time off from work to 
drive you to a treatment or go pick you up. (Michelle/13) 
They [friends and family] stay away.  Um, I‘ve discovered . . . I became a very needy 
friend, which drives people away. . . you lose friends--not that they‘re not your friends 
anymore--they just don‘t . . . you know, you‘re just closed in.  (Jill/7) 
 
 Beyond the sadness of isolation, others spoke of another pain involved in having to rely 
on others—an intense desire that others not worry about them.  Lucy said, ―where there were 
people around that I could have gotten help from. . . I just started learning at how to become 
better at hiding what I was going through‖:     
I just learned how to read the people that wanted to help me, and how I could be what 
they [expected] . . how I could spend as little time as possible with them. . . . You learn 
how, with everybody around you just how to make it go away for their sake more . . . 
than to ever get better . . . completely, like to start working on it.  
 
 Lucy then explained her rationale for hiding the pain:   
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The thing is, that when you love people, and they love you, and you know that, I mean . . 
. you come to them at first, and you‘re like, ―this is where I‘m at and I can‘t do anything, 
please help.‖  And you see them working trying to do what they can, but you‘re not 
feeling better, you know, and you might even be getting worse.  And you just see that 
look of frustration, or, like, they don‘t know what else to do, and it‘s not they‘re mad at 
you.  It‘s just, you just see that look like ―god, I‘ve done everything,‖ you know, ―We‘ve 
worked on this for so long, why isn‘t it changing?‖  I mean, you just start feeling so awful 
and you don‘t want them to feel that, you know?  So instead of both of you feeling that. . 
. . eventually [I was]. . . like, ―no, I‘m fine‖. . . so, at least one of us isn‘t hurting, you 
know.  And a lot of people are doing that.  
 
In contrast, she reflected on her hope during her previous abuse that people would see 
through her attempt to be isolated:  ―I just kept hoping that maybe my doctor...would see through 
my lies, you know, of me going, ―I‘m fine.‖  When finally disclosing the abuse to her therapist, 
however, Lucy similarly recounted her deep ambivalence:   
When I finally opened up with the therapist, I was almost like, ―was it worth it?‖  Like . . 
. for so long, I have been able to suppress it and pretend it never happened. . . . was that 
worth it to not just let everyone else . . . just go on without knowing and I‘d be the only 
one hurting, you know?  Because I hate knowing now that I worry people, you know? . . . 
I almost think I should have just shut my mouth and kept going . . . because even though 
it hurt, it wasn‘t hurting everybody else. (6) 
  
 Kellie spoke similarly of her avoidance of conversation:   
I didn‘t really choose to talk about it a lot with friends because I know it‘s a depressing . . 
depression is a depressing subject, and I didn‘t want to, I don‘t know, I didn‘t want to 
subject them to that. I didn‘t want them to feel sorry for me and not know what to do. So, 
I can be a really good faker when I want to.  
 
 She added, ―people can sense when they‘re around you something is wrong, and I didn‘t 
want that, so I stopped going to you know . . . sport activities and things like that‖ (16).  Peter 
spoke of similar tactics, ―The first skill I acquired was how to keep people from asking questions. 
. . . just little misdirection:  ‗Oh, I‘m sick today, uh I got a cold today, oh man I didn‘t sleep at all 
last night.‘  Just give somebody an excuse to ride it off‖ (10).  He further described walking 
around ―with my sweatshirt on and my hood pulled down. . . . you‘d be amazed how easily a 
person can disappear if they want to . . . the right combination of clothing . . colors and keeping 
your head down, you can become a ghost and I did and I got very, very good at it‖ (10).   
 In addition to the personal pain of individual isolation, there is also pain reflected in 
surrounding loved ones.  This pattern is evident in accounts of other emotional problems as well.  
In the context of eating disorders, Tierney (2005) reports a parent‘s grief witnessing a child ―just 
deteriorating before our eyes‖ and their pain of uncertainty:  ―you sort of think, ‗what on earth is 
going to happen next with this?‘—[it‘s hard] not being able to plan anything‖ (p. 376).  In the 
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case of eating disorders, there is growing knowledge of ways that families and friends may 
support victims (Honey & Halse, 2005; Hall & Cohn, 1999; Sharkey-Orgnero, 1999; 
Vandereycken, 2005, Whitney et al., 2005).  Even so, this remains a difficult challenge.  Families 
may feel helpless in their efforts, perceiving ―any attempt to help on their part as unproductive,‖ 
as noted by parents who say, ―I try to do what I think is right at the time but it always seems so 
wrong‖ and ―Nothing you do or say makes a difference‖ (Whitney et al., 2005, p. 445).  Even 
with sincere desires to help, well-intentioned efforts can aggravate the situation (Rorty et al., 
1993).   
Returning to depression, the first way that communities appear to aggravate a problem is 
becoming over-involved:  checking in too frequently and encouraging treatment to a degree that 
is overbearing—a theme reflected in some accounts described in previous chapters.  The general 
literature around family therapy confirms that in crisis situations, family members often become 
involved in ways that are literally debilitating and defeating to the individual in crisis—including 
over-eager attempts to ―fix‖ a problem (Coyne, Wortman & Lehman, 1988).  This kind of 
―support‖ may obviously provoke difficulties even further, with documented linkages between 
the nature of family response and treatment outcomes (Whitney et al., 2005). 
This is clearly a challenging issue for caregivers—who can feel as if walking on egg-
shells, negotiating contradictory messages such as ―Treat me normal and don‘t worry, but don‟t 
pretend nothing is happening” // “I don‘t want to be around people . . but don‘t leave me alone.‖     
Lucy went on to give counsel to caregivers about being sensitive, but not too sensitive:   
Don‘t take anything personal that they say to you . . . I‘ve learned that they‘re at the point 
that they‘re just as scared and frustrated and they don‘t know what the hell is going on. . . 
. But on the other hand, don‘t take anything as trivial--everything they say you need to 
think about it.  . . . especially if it looks like they want to die. . . . On the other hand, you 
know, I‘m saying don‘t take it personally if they‘re attacking you—it‘s just, they‘re 
scared just like you. 
 
She acknowledged, ―And I know, it seems like you can‘t do both. . . . It‘s a very hard  
place to find‖ (6).  Although the challenge of finding the right way of helping is real, when 
families reach that point, there is evident power involved.  In contrast to entertaining, distracting, 
ignoring, pressuring, or trying to ―make things all better,‖ Chapter 5 recounted multiple instances 
of families being available, being interested, being concerned, being loving and being constant.  
In the context of eating disorders, Sharkey-Orgnero (1999) specifically describes family 
willingness to approach individuals with compassion, honesty and firmness as a turning point in 
individual progress.  More than simply ―hanging out,‖ being there calls for surrounding loved 
 143 
ones to remain proactive in honestly inquiring and gently encouraging in a way respectful of 
personal agency.   
Unfortunately, rather than seeking out this balanced way of helping, some families can 
simply grow weary of helping.  Elaine reflected:     
Well . . . it‘s been eight years and . . . I mean, it just gets old. They just don‘t wanna hear 
about it anymore (laughs) so I have tried to talk to them about it . . . I got my husband a 
book on, you know, living with somebody [who was depressed].  I had to read him 
everything that he‘s read out of it. He hasn‘t read it. He reads every night for an hour 
(laughs). (2)  
 
Coyne and colleagues (1988) detail how family may react with hostility and distance to 
an individual who appears to be refusing counsel, prompting a similar outcome of ―giving up‖ on 
a person in frustration.  Sarah reported that her husband ―didn‘t want me taking that time‖ to go 
to support group meetings and when she asked him to come with her said, ―oh that stuff isn‘t for 
him.‖  After being admitted to the hospital, she called to ask why he wasn‘t there:  ―How come 
you‘re not here and he says, ‗well Sarah, I talked with the doctors and they said there was nothing 
I could do‘‖ (4).  Camille said of her husband:  ―His solution was to not deal with it and so he‘d 
find excuses to be out of the home and which of course was just a vicious cycle‖ (3). 
Another kind of resignation can also occur after long years of struggle, when surrounding 
friends and family simply ―get used‖ to an individual living in pain, accepting that the person will 
always be that way.  Whether from fatigue, disinterest, or strategy, lack of involvement can 
obviously also impact the person facing depression.  Whereas over-involvement can fuel a 
worsening of the problem directly, this approach may intensify it by sheer inattention.  Such 
community distance may reinforce the inclination of victims to be isolated to an even to a greater 
degree.    
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Chapter 8 
Sustaining Interpretations of Depression and its Medical Treatment:   
How are Narratives Maintained Over Time? 
 
Given the formation or adoption of a particular narrative regarding depression and its 
treatment, how is that narrative maintained over time?  This chapter extends the previous 
exploration in Chapter 6 of how narratives arise and Chapter 7 of how they diverge in key 
interpretations and structure to examine how narratives are perpetuated over time.  Alongside the 
significant research attention currently being paid in compliance/adherence studies to the 
maintenance of treatment for depression, here we attend to the maintenance of treatment 
narratives associated with depression.   
While this analysis could justifiably consider a host of potential contributors, from the 
power of large institutions to the continuing role of particular narrative resources, the primary 
focus is to better understand what participants are doing and saying that appears to be 
contributing to the continuation of their particular narrative.  While narrators arguably continue 
drawing on resources for the maintenance of their story just as much as its initial adoption, once 
the narrative is formed, the real action seems to shift beyond these resources to what individuals 
actively do in relation to the narrative they have adopted.       
The umbrella term used to refer to these activities is narrative strategies.  Unlike the 
typical use of this term, ―strategy‖ does not here imply a conscious, deliberate process, nor does it 
suggest one that is largely cognitive.  Since humans typically embrace their own story as 
―reality,‖ in literally no case did participants appear to be aware of the potential role of these 
activities in the perpetuation and maintenance of their own ―narrative.‖  Regardless of limited 
awareness, activities identified below will be argued to have clear and evident implications for 
the continuation of particular narratives.    
A theoretical basis for attention to ―strategies‖ in the analysis of narratives is evident in 
the literature highlighting the purposive, functional characteristic of language.  As articulated by 
Drew and colleagues (1999) in their discourse analysis, this study also assumes that language is 
more than a ―neutral transmitter for relaying dispassionate descriptions of something that has 
occurred or was experienced.‖  ―Rather,‖ they continue, ―people organize their talk rhetorically; 
that is, they argue for a particular description of events or phenomena and struggle against other 
possible competing descriptions (e.g., one‘s constructions are constrained by how they are, or by 
anticipations about how they may be received by others).‖  Drew goes on to highlight the ―social 
actions being performed‖ in any unit of language (p. 193).  In Clark‘s (2008) compilation of 
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depression narrative analysis, there is emphasis on ―the work these stories do,‖ including 
―bringing meaning to sufferers, explaining depression, justifying therapies and treatments, and 
reducing the burden of shame.‖  She concludes, ―Thus, depression narratives have their work cut 
out for them.‖ 
As reflected in this latter comment, a second way to understand the significance of 
strategies for narrative maintenance is to examine their related implications for eventual action.  
Although strategies are being primarily analyzed here for their consequences for actual 
narratives, in most cases there are logical associations with or consequences for a particular 
behavior as well.  As Coffey and Atkinson (1996) note, ―Individual social actors recall and retell 
events or describe past experiences . . . in certain sorts of ways that account for, justify, excuse, or 
legitimate action or behavior (p. 100).  Correspondingly, while emphasizing the maintenance of 
treatment narratives associated with particular strategies, discussion below will naturally touch on 
related implications for treatment as well.     
To review, maintaining narratives is thus understood to rely on particular strategies 
reinforcing the way one ‗sees‘ oneself and is comfortable narrating oneself, as well as to resist 
other ways of ‗seeing‘ and narrating.  These include 1) Seeking reassurance from friends, family 
and doctors; 2) Affirming the evidence for a particular explanation; 3) Reframing past 
experiences to fit current conditions and convictions; 4) Looking to help others by sharing one‟s 
experience of treatment; 5) Persisting in medical treatment; 6) Reconciling difficulties concurrent 
with treatment; 7) Narrating life without medication; and 8) Defending one‟s narrative when it 
becomes challenged.  We first lay out a starting-point for this examination by recapitulating one 
critical emotional state that appears to frequently undergird a need to ―maintain‖ one‘s story in 
the first place.   
  
 Resistance reprise:  “I still don‟t know how I feel about this all . . .”  In Chapter 6, the 
function of treatment resistance as a resource for many participant narratives was likened to 
―friction‖ that raised dissonance in the receipt of medical help and thus required additional 
external ―force‖ to be overcome.  Surrounding encouragement, moments of crisis and positive 
initial effects of medication were all subsequently reviewed as narrative resources that helped 
individuals discount this resistance and gain conviction to move forward with treatment.   
 Laying aside its role in the formation of narratives, we here consider its relevance as a 
backdrop to the emphasis of this chapter, narrative maintenance.  As reviewed in Chapter 5, while 
such resistance and tension was relevant to many accounts, it obviously did not ―play out‖ 
consistently across stories.  Some followed this kind of resistance away from treatment, 
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decreasing dosages or stopping medication entirely.  In spite of having to move through and 
overcome fears of life without medication, these individuals (four in this study) ultimately 
concluded that they feel better pursuing a recovery without medications.   
 The rest of participants, however, (ten in this study) pushed through their resistance and 
hesitancies to persist in treatment.  For six of these participants (Camille, Sarah, Victoria, Robert, 
Peter & Robert), the momentum of early positive treatment experiences was great enough that no 
further mention of major resistance was made.  For the other four who likewise continued 
medical treatment, however, resistance appeared to continue and even increase (Elaine, Lucy, Jill 
& Debbie).  Rather than be carried forward in their narrative by the ―interpretive inertia‖ of 
experiences similar to the others, these four individuals recounted multiple ways in which they 
seemed to be working hard at persisting in both their treatment and the corresponding narrative 
that justified it.  It is in the context of this kind of continuing resistance that the question of 
narrative maintenance becomes especially interesting.  In the face of such lingering reluctance or 
hesitance about treatment, how do individuals hold on to their conviction and belief about moving 
forward?  As will be evident below, this question is relevant to more than just this vacillating sub-
set of participants.   
 
1. Accepting Monitoring:  “Have you taken your medication today?” 
As with the adoption of narratives initially, the maintenance of a particular story seems 
often to draw and rely on the ongoing encouragement of the surrounding community.  Accepting 
monitoring refers to a willingness to allow friends and family to reassure and help one ‗stay the 
course,‘ as it were.  A third of participants who had received medical treatment spoke of some 
kind of significant influence from surrounding relationships in their continued decisions about 
that treatment.   
As detailed in Chapter 5, doctors and other medical professionals appeared to play an 
especially significant role at this point in encouraging continued forward movement in a 
particular treatment (and its corresponding narrative).  Although there was significant variance in 
the amount of credibility and trust given to doctors, their influence across accounts was striking.  
As reviewed previously, Victoria had started considering tapering when, ―my doctor very wisely 
sat me down and scolded me and said, ‗You know, you will probably be on this medication for 
the rest of your life. And you have to come to terms with that . . . I don‘t think you‘re looking at 
this the right way.‘‖  The doctor went on to encourage her to be grateful that god brought medical 
treatment into her life so that she could have support to live a good life.  Victoria spoke of this as 
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a turning point as she took the advice to heart (7).  Sarah, Elaine & Debbie spoke of similar 
moments of influence.     
Especially for those facing continued personal treatment resistance, the role of these 
kinds of interactions appears critical.  In such cases, the surrounding community seem to become 
almost an extension of the treatment system in its monitoring and ensuring of compliance:  
―People keep telling me, . . . ‗Have you taken your medication today?‘ (laughs) . . . . People 
around you notice things‖ (8).  With a few exceptions (Kyle‘s mother, Sarah‘s husband), most 
friends and family mentioned across accounts voiced encouragement to continue medical 
treatment.  Sarah‘s neighbor and co-workers, for instance, encouraged her to continue trying 
medication and discouraged her from the temptation to attribute negative emotional states such as 
panic attacks and worsening mood to the medication itself.   
While some like Sarah and Victoria responded favorably to these efforts from friends and 
family, others like Kyle and Joan resisted their efforts and grew more concerned about medical 
treatment.  Alternatively, Kyle responded favorably to his mother‘s attempts to raise alternatives, 
while Sarah resisted these same efforts by her husband.  While most attention here examines the 
way community can reinforce a dominant biomedical narrative, similar dynamics thus appear to 
be at play in bolstering and maintaining a counter narrative.   
Since most family and friends appear unsurprisingly oriented to the ―dominant narrative‖ 
of treatment, for those with concerns about treatment, overall community encouragement can be 
experienced as critical and threatening.  With the exception of his mother, surrounding people 
confronted Kyle with significant concern and a message that he was being dangerously naïve.  He 
and Esther were subsequently both threatened with forced treatment when they resisted the 
counsel given them.  In both cases, this kind of interaction seemed to reinforce counter narratives 
deeply critical of psychiatry.  Across circumstances then, both assurances and hostility in 
surrounding interactions appear significant for the maintenance of (distinct) individual stories.   
 
2. Affirming the Evidence:  “It was great for me to have a picture of my brain . . .” 
While the foregoing interactions with others appeared critical, more often than not it 
appeared that participants were finding their own narrative momentum primarily independent of 
others.  Some of the most evident manifestations of this were the multiple ways that individuals 
reaffirmed the validity of their overall treatment narrative.  This second cluster of strategies 
included pursuing additional evidence for one‘s story and highlighting evidence of divine favor.   
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Pursuing additional scientific evidence.   Some narratives reflected ongoing efforts to 
learn and gather additional evidence supporting a particular story.  After recounting mental health 
classes she had taken, Debbie related, ―Once the internet came out, I just seemed to read 
everything and almost . . .overly learn about it.‖  She reported hearing about how ―they can look 
at the brain and see how things are formed and different areas and then be able to prescribe 
medication . . . I‘ve seen Dr. Phil or, you know, different shows that they‘ve had specials on 
that.‖ She asked me, the interviewer, ―Is that true or have you heard?‖   She then continued: 
I‘ve often thought, ‗now why can‘t I get into this? or why does it cost so much?‘ . . . I just 
wish there were a blood test, you know.  Maybe sometime down the road, they‘ll have 
genetics figured out of what exactly causes it. It‘s really hard to know . . . I don‘t know, 
I‘d like to donate my brain if they can learn (laughs) anything about it. (8) 
 
 Sarah concurred, saying, ―we need a blood test, like a diabetic that says ‗this is how much 
exactly you should be taking‘ . . . these are dreams, you know‖ (4).  After fighting with her 
husband about family finances during her depression bout, Camille recounted a trip out of state to 
secure a SPECT scan.  As reviewed in Chapter 4, she spoke of her excitement in getting the scan 
results back—―it showed . . there was an area that was just totally grey, meaning that there wasn‘t 
that . . that part of the brain had kind of shut down; and he explained to us that that part of the 
brain was the part that managed time . .[and] money.‖  She continued, ―all those kinds of things 
were controlled by that part of the brain that was not functioning (laughs). It was great for me to 
have a picture of my brain that showed, ―hey look! This isn‘t working‖ (3).   
 This kind of an initiative to seek and reach for additional evidence may thus function as a 
strategy to bolster one‘s narrative.  More than simply providing any explanation, the kind of 
evidence sought appears to reinforce a story that is personally comfortable to individuals.  In their 
analysis of depression discourse, Drew and colleagues (1999) note that individuals ―constructed 
themselves as blameless, competent and worthy,‖ actively seeking to exculpate themselves for 
having experienced depression.  They go on to highlight, ―energetic work done by participants to 
promote a positive self-view in their narratives‖ (pp. 201-202).   
The use of this strategy in maintaining a biomedical narrative may thus be additionally 
understood as a function of its continued resolution of added painful confusion about the 
fundamental nature of depression in the first place.  This seems especially true in the face of 
challenging side-effects, where a conventional biomedical narrative continues to offer compelling 
answers to hard questions about the depression itself.    
Since all participants spoke of times of seeking out and embracing certain studies, books 
or insights, it is important to clarify that the seeking of evidence is not unique to those adopting 
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the prevailing treatment narrative alone.  Kyle and Esther, for instance, both spoke of doing 
personal research on alternative perspectives and interventions.  In fact, a French study of 
psychotropic users found that ―looking for additional information‖ via doctors, media and 
exchanges with others was ―an act of autonomy‖ that among their sample was typically 
associated with non-compliant medical behavior:  ―Talking to other people and reading the 
information leaflets are more often done by non-observers [i.e., non-compliant patients]‖ 
(Baumann & Trincard, 2002, p. 389).  As elaborated later in this chapter, individuals from diverse 
views come to emphatically claim science as being ‗on their side.‘   
Although seeking additional evidence is thus a strategy common to the maintenance of 
diverse narratives of treatment, there is one unique characteristic that appears to differentiate 
some cases.  Beyond simply affirming the evidence, some participants appeared to have a habit of 
re-affirming the validity of their narrative repeatedly.  Jill and Debbie both commented on 
patterns of self-affirmation regarding their beliefs:  ―I wish I didn‘t have, you know . . . to have 
meds. . . . I had to just tell myself, you know, ‗It‘s okay.  You‘ll just be on these meds and it‘s 
okay to be on these.‘  You have to talk yourself into it, basically, you just have to talk yourself 
into it‖ (Jill/7).  Debbie added, ―I‘ve got to convince myself. I can convince others but accepting 
it myself, I just . . I struggle with that.‖  She then added, ―I have to keep telling myself it‘s a 
chemical imbalance‖ (8).   
In a study of Huntington disease narratives, Cox (2003) observed a similar phenomenon 
associated with a certain controversial procedure--―there is a continual need to renew and justify, 
if only to oneself, the ongoing commitment to a decision‖ (p. 274).  An especially intense need 
for more evidence thus seems to reflect battling against inclinations to the contrary.  For these 
individuals, a continued ―maintenance dose‖ of a justifying narrative appears to be required to 
move forward in conviction regarding their decision.     
 Attesting to divine guidance.  Some participants also pointed to spiritual experiences as 
another kind of evidence for their account.  In several instances, these references were about 
general support and comfort in facing and overcoming the problem.  Kellie and Peter, for 
instance, both spoke of recovery as stemming from God‘s intervention and love (10, 16).  
Victoria and Sarah both recounted touching experiences at their lowest points of darkness—
Victoria‘s through an inspired blessing (5) and Sarah‘s after pleading for help and feeling 
―Heavenly Father‘s arms just wrap around me‖ (4).  Even Lucy, who expressed some hostility 
towards religion generally, recounted what she believed to be a miraculous instance of an 
individual being prompted to return home right after she had slit her wrists (6).   
Clearly, faith is a powerful narrative resource for many individuals, with reference to it  
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a powerful strategy to maintain one‘s course and overall convictions, as in other instances.  In a 
few cases, however, participants went beyond general convictions of support to claims of God‘s 
specific guidance in relation to treatment decisions.  Victoria, for instance, went on recount 
recurring promptings to speak with the woman who first referred her to a psychiatrist.  It was 
after her doctor encouraged her to discard her hesitancies--―you should be thanking god that he 
has brought this medicine [so] that you can live a good life‖—that she embraced treatment 
enthusiastically.   
One morning, however, Victoria woke up paralyzed and completely unable to move.  As 
reviewed elsewhere, she attributed the terrifying state to random causes, rather than anything 
related to her treatment.  On this occasion, Victoria emphasized the blessing of encountering 
another doctor through this experience that turned out to be especially helpful to her.  In 
reflecting on that episode, she said, ―I just think that . . . [god put me in a place where I had no 
choice, and I would go where He wanted me to go to meet this just wonderful [man] . . I feel so 
blessed. . . . And I can‘t help but seeing all the way along, the Lord‘s hand in getting me through‖ 
(5).    
Both Sarah and Victoria went on to share a sense of calling and mission to educate others  
regarding treatment.  Victoria spoke of her amazement at the frequency of phone calls ―out of the 
blue‖ where an individual says, ―I know this is really weird, but you know, my doctor just said 
that I have depression and I just feel like something told me I should call and tell you that.‖  She 
added, ―when people . . . ask me about it, I feel like I always know what to say.‖  Like Sarah, 
Victoria emphasized her excitement at her sense of being used to help others.   
 
3.  Reframing the Past:  “I was a little naïve back then . .”     
  In addition to emphasizing and affirming past events and experiences as supportive of 
one‘s current narrative, several individuals commented critically regarding their past views in 
light of their current views and perspective.  In particular, when individuals embraced biomedical 
explanation/treatment, their interviews often reflected a criticizing and reframing of beliefs prior 
to their change of mind.  Reframing the past here refers to a reconsideration of earlier events and 
perspectives regarding treatment, depression itself and its purported causes.   
 Revising views of past depression experience.   Recollecting his views from an earlier 
period of facing depression, Peter said, ―I learned to live with it and . . . assumed that most people 
felt the way I did.‖  From his current vantage point of seeing depression as a primarily biomedical 
condition, he added, ―I didn‘t really understand what it was that I was dealing with‖ (10).  
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Accompanying this change in views over time, Peter also reported seeing his past experience with 
depression differently as well:   
I didn‘t realize until after I had gotten help how far back the depression went…like, I can 
remember it all the way back into childhood you know four five six years old…and until 
(pause) you know, that point in time, I didn‘t realize how far back it went. (10) 
 
Kellie‘s medical student brother encouraged her thinking in the same direction:    
He said he was concerned about me and he wanted me to maybe think about trying some 
medication. He said ―Kellie, You‘ve been depressed almost your whole life!‖ And, you 
know, he said, ―I remember you always, you know being in your room, and just always 
wanting to be by yourself.‖   
 
These comments impacted Kellie‘s own thoughts about her past views:     
I guess it took talking to him to make me look back and really look at . . . that depression. 
. . all during my, um, teenage years, I guess. I didn‘t realize this before, but talking with 
my brothers . . . has helped me realize some things.  Um, when I was younger I remember 
feeling depressed a lot. You know, feeling sad a lot, but I didn‘t really ever take it as 
anything serious because you know it was during that time where your hormones are 
crazy and you know you‘re changing, and I just figured, and I think my parents probably 
did too, that it was just all a part of growing up.  But as I look back on it . . . it really 
made me think; it made me look back . . . when I was younger and, ―yeah he‘s right, you 
know?‖ I didn‘t realize. . . . I just assumed that . . . I was just maybe a little bit more sad 
than most people and it was just something that I needed to learn to overcome . . . So, he 
helped me open my eyes in that respect . . . ―maybe there was an issue there.‖ (16) 
 
―I didn‘t realize this before, but . . talking with them has helped me realize some things.‖  
―As I look back on it . . he‘s right, you know?  . . . He helped me open my eyes . .‖  Kellie‘s quote 
was represented here in its entirety for its rich evidence of a significant amount of reframing 
going on.  Sarah similarly commented on misguided early beliefs about her pain as something 
other than chemical depression:  ―I just remember saying, ‗oh, Sarah you‘re just having a rough 
week, you know; it‘ll get better . . next week.‘  That was my way to make it through the week, 
you know, like, ‗Sarah, you know this will get better‘‖ (4).   
In each case, original views of depression were narrated as naïve and misleading 
compared to current views.   As stories evolve from initial emphases of ―it‘s just growing 
up/puberty/a rough week/a little bit more sad‖ to something biomedical and concrete, the contrast 
between the two stories thus appears to be leveraged as a strategy to reinforce and maintain the 
latter narrative.    
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Minimizing trauma and abuse.   In Chapter 6, particular interpretations of severe trauma 
and abuse were reviewed in relation to the adoption of a biomedical narrative.  Here, similar 
interpretations are reviewed as relevant to strategies upholding individuals‘ narratives.   
First, however, on a more general level participants often mentioned a wide variety of 
challenging environmental conditions and events that may have contributed to their emotional 
pain—from job loss and the stress of raising a family, to other health problems and actual abuse.  
Elaine, for example, described a time preceding her depression that included:  raising five 
children (all under the age of six), reversals in her husband‘s business and financial difficulty,  
having to move on three-days notice, having to start working outside of the home, having another 
baby and going back to school to take graduate level classes.  Accompanying this ―incredible, 
incredible, incredible amount of stress,‖ she described, ―I didn‘t sleep for a period of about 5 
years, more than three or four hours at a time.‖  It was during this period, that Elaine visited a 
doctor:  ―He went through a stress survey on it and told me that it was anxiety and depression that 
I was experiencing . . . [and] suggested Valium.‖  After resisting this suggestion, some additional 
stress lead Elaine to seek advice from a second doctor:  ―He explained that what I was 
experiencing was probably paralyzing anxiety and prescribed Xanax, [then] gave me a depression 
assessment . . . and . . . started me on Prozac‖ (2).  Reflective of her physician‘s response to her 
pain, Elaine‘s subsequent narrative literally centered around attaining the correct medication 
types and dosage levels.   
Elaine‘s account thus reflects the same basic pattern of abuse minimized in Lucy‘s 
account (see Ch. 7).  Indeed, while several others spoke of abuse as relevant to their depression, 
in each case its contribution was vague and inchoate—with an explicit focus on biological 
deficiency as the primary cause (Lucy, Jill & Debbie).   
Obviously, individuals and doctors look to biomedical explanation when it appears that 
emotional pain being experienced goes clearly beyond what seems merited by surrounding (even 
crazy) life circumstances.  As Chapter 6 detailed, this seems to be the basic reason that in many 
cases, an (internal) biological explanation takes priority over external explanations.  Furthermore, 
it seems important to point out that the basic relevance of both environmental and biological 
contributors is also commonly understood across participants.  In fact, most participants seemed 
to express a sophisticated understanding of the interplay between the body and external situations.  
Having said all this, these accounts corroborate other accounts of abuse victims to reflect a 
striking and unmistakable pattern of de-emphasizing surrounding life experiences.   
In Lucy‘s case, she became so passionate about psychiatric treatment that she 
volunteered to share her story to educate others about mental illness.  When doing so, Lucy 
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recounted avoiding mention of the past violence from her father:  ―Especially in my lectures, I 
don‘t go too much into my past, because, um . . . some people look at it and go, ‗well she was 
abused—that‘s all that‘s wrong with her.‘‖  She continued, ―No, [depression] might have come to 
the surface faster because of what happened to me, but this is something that can happen even if 
[abuse] doesn‘t‖ (6).  Notably, Lucy‘s quote reflects a desire to defend a conventional narrative of 
depression (i.e., emphasis on underlying diathesis, only brought to the ―surface‖ by varying levels 
of external trauma) as the explicit reason for which she, herself, minimized past abuse in her 
volunteer speeches.    
After describing another woman with a history of tragic accidents and abuse, Schreiber 
and Hartrick (2002) note how she explained away any connection to her depression during the 
interview:   
There was no consideration of the possibility that the past life trauma that she 
spontaneously related in her depression story may have contributed to her current 
depression. It seemed that the woman consciously turned away from exploring the 
complex web of depression that was revealed through her story and toward the more 
concise and concrete BEM [biomedical explanatory model] (pp. 100-102). 
 
It thus appears as if the active minimization of past abuse can, in some instances, be  
important to reinforcing and sustaining one‘s overarching narrative—i.e., keeping the focus on 
biomedical explanation.   
Alleging treatment concerns as having been naïve.  In addition to casting previous views 
of depression as times of relative ignorance, individuals also criticized previous views of 
treatment as reflecting similar naiveté.  Sarah went on to recollect prior worries about medical 
treatment:  ―[I thought] ‗No, no that can‘t be me, you know.  No, I‘m not a medicine taker.‘‖  She 
continued, ―I resisted and just [wanted to] be independent . . .  you know, ‗I‘ve done this before 
and I can do it on my own.‘‖  She went on to emphasize this period of refusing medication as 
corresponding with greater grief and pain, ―And it got worse and worse and worse. . . . My brain 
felt it was scrambled eggs . . . for me to make simple decisions, it overwhelmed me.‖  Ultimately, 
Sarah emphasized ―a wall of denial‖ relative to both biomedical diagnosis and treatment as 
largely responsible for her early pain (4).   
Referring to his own prior worries about potential negative effects of medical treatment,   
Peter suggested they were possibly related to the illness itself:  ―That‘s what I had in my mind, 
now again under the affects of the depression I was not thinking clearly, but that was what I had 
in my mind and so it really put me off for a long time‖ (10).   
Others like Kyle and Esther were similarly encouraged to see their concerns about 
treatment as reflecting denial and even manifesting the effects of sickness itself—an insinuation 
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that both rejected firmly.  Across cases, past treatment concerns were thus narrated as either valid 
or ignorant, depending on the current narrative espoused, in turn, I would argue, effectively 
bolstering that same narrative that seemed to direct the re-framing in the first place.    
 
4. Looking to Help Others:  “I think he probably has some kind of disorder . . “ 
Alongside instances of being supported and upheld by others in treatment, multiple 
participants spoke of their own interest in doing the same thing for others.  This striving to help 
educate and support others in treatment is reviewed as another strategy in maintaining narratives.  
Efforts range from noticing and cataloguing symptoms in others, to sharing one‘s own story, to 
actually encouraging treatment in others.   
Speculating about others‟ symptoms.  At the mildest level of outreach, individuals 
reported frequent reflection regarding potential signs and symptoms of depression in others.  
Debbie said, ―I think my daughter probably has..something‖ and added, ―for a long time we used 
to think it was in the water here. There are so many women in this neighborhood that are 
suffering different depressions . . . . and those are the ones I know about. I‘m sure there‘s other‘s 
that haven‘t said‖ (8).  Sarah noted similarly, ―Having been through my depression I pick up on . . 
. signs of people, you know, girlfriends or whoever‖ (4).  After describing his mother‘s panic 
attacks and agoraphobia, Peter said: 
My father--although he‘s never been he‘s never gone to any kind of psychologist--I think 
if he were to go he would probably have some sort of anxiety disorder…you know, he‘ll 
stay up late at night worrying about something he‘ll pace the floor uh you know…he may 
only sleep a few hours a night if there‘s a problem going on and it‘ll consume him. . . . 
and it goes on down the line I mean my grandfather was the same way. (10) 
 
As evident here, the highlighting of others‘ possible symptoms sometimes stretched back 
into one‘s own family history.  After mentioning an aunt with depression, Fern similarly 
speculated that it has ―probably runs in our family‖:  ―I remember my grandfather saying his 
mother was a person who was the most insecure person he had ever met.  I can see she probably 
experienced depression sometimes in her life‖ (11).  Jill reflected the most vivid illustration, 
highlighting potential evidence of many disorders in multiple branches of her family: 
Once I learn more about bipolar and how genetic it is, I look to my family and I think it‘s 
on my paternal side.  Um, like I said, my mom was neurotic and irrational and I don‘t 
know if that was a mental health problem or the result of her surgery, but my, my brother 
would have been diagnosed ADHD in this day and age. . . . After I got to know my 
father, he was very obsessive compulsive, (laughs) . . . and a little bit hyperactive, too:  
kind of a frenetic type of person, just always, you know, couldn‘t sit still, could not sit 
still. . . . And then his father, all I know about my grandfather--‗cause he died when I was 
about four--was that he was an alcoholic, which they say is a red flag.  Whether he was, 
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had some kind of mood disorder and it was self medicating or just had the addictive 
personality, I don‘t know. . . . (7) 
 
Beyond such speculation regarding others‘ symptoms—past and present--some spoke 
much about helping others in more direct ways, first, by calling for more education and second, 
by actively seeking to facilitate diagnosis and treatment.  Each is highlighted below.   
 
Calling for more public education.  While participants differed in what they viewed as 
the needed content of public education, most were insistent on the need for more extensive and 
frequent educational campaigns about depression.  Among participants, there were actually varied 
degrees of comfort in talking about depression—from some who were worried about being 
identified while sharing, to others who were regularly on the speaking circuit sharing their stories.  
At least five participants from diverse views (Sarah, Victoria, Lucy, Kyle & Esther) had been 
actively involved in sharing their stories as part of formal treatment advocacy efforts. Debbie 
spoke of her excitement at wanting everyone to learn what she had learned:  ―I want to be an 
advocate. I‘ve taken classes on . .  talking to others. . . I want everybody to understand it now.‖  
She continued, ―I tried to share my story with the people that I meet. . . My sisters. . .I‘ve talked 
to them and they‘ve gone in to get help (8). 
Kyle and Sarah each ended their accounts expressing interest in what they could do to 
help and reach out to others and mentioning their own advocacy work.  Once again, in spite of 
both claiming the banner of ―education,‖ their respective organizational affiliations reflect 
contradictory messages in respect to psychiatric medication (see websites for MindFreedom 
Support Coalition International and the National Alliance of the Mentally Ill). 
 In addition to reflecting an impulse to helping others, these calls for education and efforts 
to share and retell one‘s own story, once again, indicate another way individual narratives are 
strengthened and maintained (also reflecting well the previous strategy of ―affirming evidence‖).  
Indeed, the retelling of dramatic treatment experiences throughout communities and by 
institutions may be a major way that knowledge of narratives spread and becomes dominant.  
 
Facilitating others‟ diagnosis and treatment.  In addition to educating others, several 
people emphasized desires for facilitating treatment, including preventative screening efforts to 
get people on medication earlier.  Along these lines, several spoke of their efforts to facilitate the 
diagnosis and treatment of their own children, with three participants mentioning kids who were 
also taking medication. Speaking of her daughter, Camille further related: 
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My experience enabled me to recognize signs in her at a very young age and to seek help 
for her. She was diagnosed when she was eight years old, which from everything that I 
have read and heard is almost unheard of to catch it that early. 
*J:  So you just saw signs of it and got to a doctor; is that how it happened? 
Mmmhmm and at first he thought we were simply dealing with, uh, depression . . . Um I 
also took her to California to have a SPECT scan and there they told me . . . what is going 
on in her brain was bipolar, but it took her psychiatrist quite a bit longer to make that 
formal diagnosis. (3) 
 
It was Jill‘s account of seeking to help her sons, however, that was the most vivid 
reflection of the potential role of both educating others and facilitating their treatment in the 
maintenance of one‘s own narrative—especially when she asked her son to come in the room and 
verify details during the interview itself.  Before this happened, she had been recounting her sons‘ 
initial diagnoses and medical treatment.  After one son started to act violently on the medication, 
she related: 
They still hadn‘t properly diagnosed him.  One psychiatrist on the panel had mentioned in 
his notes ―possible bipolar‖ and that‘s when I grabbed that ball and ran with it.  And 
that‘s what it was.  But it took me a while to come to that. . . . It was me that had to go 
after ‗em, and after ‗em, and after ‗em, you know. I had researched it and, you know, I 
must have suggested to a psychiatrist several times ―Do you think he could be bipolar? . . 
. . . and finally several months down the road, she says ―well, it wouldn‘t hurt to just try 
[the mood-stabilizer] and see of anything happens.‖ (7) 
 
After her son began treatment, she subsequently began educating her son about his 
bipolar depression, as reviewed earlier:  ―I‘ve had to teach him that it‘s just like anybody else that 
has to take medication. . . . ‗your body needs this medication to function.  You have to take it‘ . . . 
From the beginning when he was diagnosed, I said ‗this is something for life; you‘ll have to be on 
these medications for the rest of your life.‘‖  Jill‘s son did not initially respond well:  ―He would 
just never want to take ‗em . . you know, he got mad at us, but as he‘s matured he‘s accepted it 
and he forgets, he has a hard time remembering.‖   
A second son was also placed on medication, but disliked it and eventually quit:    
They tried him on Ritalin . . . he just had that glazed over look, you know.  But it would 
calm his temper down.  And the summer before eighth grade he just begged me, ―can I 
just not be on it?‖  And I said ―well, we‘ll try it.‖  And he was strong willed enough that 
he could just tamp it down, get it under control of himself.  They say that can happen; it‘s 
rare. . . . He morphed around the age twelve to thirteen.  Like I said, we don‘t know how 
he did it, it‘s just that he‘s so strong willed and focused.   
 
 When I asked, ―So, those struggles with your oldest son have passed?‖ she responded, ―I 
know that before he [left home] he told a friend of mine that he still gets those feelings, he just 
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has to. . . . I mean we could ask him-―Terry, come here!‖  At this point, she called in her second 
son who had quit medication years ago:   
Do you still have any of the feelings you had when you would lose control, when you 
were younger?  Do you ever feel like you have to get a hold of yourself..or you‘ll lose it? 
*Terry:  No, actually, quite the opposite.  I, like, ever since they took me off the Ritalin, . 
. . it‘s rare that I ever actually ever get mad. . . . like I get frustrated with things but I‘ve 
never ever like gotten to the point of actually being mad at something.   
  
 Jill interjected, ―It‘s not a normal thing that you were able to get a hold of yourself like 
that.  We were just saying that year in seventh grade, you sort of morphed from someone with, 
you know, the anger all the time to what he is now. . .‖  
 Terry responded to his mother with some disagreement, ―Quite the opposite again.‖  I 
asked him, ―How would you explain the change?‖   
 He acknowledged, ―Yea, I used to get mad a lot.‖  Terry then emphasized again how the 
struggle ended after learning some new things, ―But, I don‘t know, things stopped really 
bothering me . . I guess I just realized that like everything‘s not, like earth-shakingly important so 
there‘s no reason to really, just like, to get so mad and out of control.    
 Jill interjected again, ―Well, it had to have been a real internal struggle that year; you may 
not remember how hard, I mean, for you to, to get a grip on it.‖  Terry again disagreed:    
I don‘t think so, ‗cause by the time you took me off [medication] I was asking you to take 
me off ‗cause I didn‘t like it anyway and I knew I‘d be able to take care of it myself.  So 
when you took me off, it wasn‘t…I don‘t remember it ever being a struggle.  I think the 
struggle was, like, with the medication because I didn‘t like it.  I was struggling with the 
side effects of it more than I was trying to control my own self.  
 
 Jill spoke somewhat defensively, ―Well it was the wrong medication for you. They just 
didn‘t have anything else; they didn‘t know what else to do.‖  She then challenged Terry a little, 
―[our neighbor] said you told her once that once in a while you still get those feelings that you‘re 
just able to….kind of push ‗em down and be alright.‖  Terry responded, ―I can‘t remember a time 
when I‘ve ever like, got to the point of like, being extremely mad at something.  Getting 
frustrated, but I don‘t ever remember getting, like, angry at things.  Nothings come up.‖ 
 Jill hastened to add, ―He couldn‘t even remember a lot. . . I remember sitting down with 
him and saying ‗this is what you were like when it was so difficult‘ and he didn‘t even remember 
a lot of it.‖ Terry responded, ―I just found that being positive is a much more, it‘s a happier way 
to live; I‘d just rather be positive, than be mad at something so I just don‘t let it bother me.  . . . I 
found out that that‘s something you can do to control yourself. 
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 ―Well . . not if you have a chemical imbalance‖ Jill retorted.  ―Yea, well maybe I did it 
natural,‖ said Terry.  Unable to let it go, Jill returned to emphasize improper diagnosis and 
medication types: 
They never were able to properly diagnose you.  You didn‘t fit any of the molds.  You 
didn‘t fit the ADHD mold, although he was kind of hyper. . . it was first grade when his 
teacher said ―I think that he needs some kind of medication.‖ . . . and Ritalin was really 
the only thing that they had at the time to even treat anything with and that was the wrong 
medication for him.  
 
 ―It has really bad side effects . .‖ Terry said.  ―It does,‖ Jill agreed (7).    
 This exchange is reproduced at length for how vividly it reflects this strategy of helping-
others-to-help-confirm-my-own-narrative in action.  In it, we see not only the mother‘s attempts 
to educate and help her sons—but the personal importance of doing so to suit her personal 
narrative.  Specifically, it was striking to see the extent to which this mother insisted on a 
particular way of interpreting her son‘s recovery.  After seeking confirmation from Terry that he 
still wrestled with severe emotions under the surface, her son denied this and attributed his 
improvement, in part, to getting off medication.  At this point, she interjected and insisted on his 
emotional improvement as some kind of random ―morphing‖ perhaps reflecting a unique level of 
willpower able to somehow manage severe emotional struggles without medication.  When Jill 
emphasized how hard it must have been for him to ―get a hold of himself‖ without medication, he 
again disagreed and asserted it was easy once he learned he had a choice.  He then suggested that 
the side-effects of the medication were a bigger challenge than struggling to control his behavior.  
After suggesting that he had been on the wrong medication, Jill insisted a third time that he had 
difficult feelings under the surface.  When he denied this once again, Jill insisted on his lack of 
clear memory of the true situation.   
In microcosm, this mother-son interaction illustrates and confirms the degree to which  
individual sharing can be connected to and reinforcing towards one‘s own individual narrative.  
In it, we see the personal importance for the mother to believe that the emotional struggle had 
continued at some level after stopping the medication.  Seemingly, the reports of her recovered 
son reflected enough of a contradiction of her own experience (and that of her unrecovered son), 
that it became necessary to narrate it as a ―rare case‖ of exceptionally strong willpower.  In the 
face of repeated denials and challenges by her son, Jill insisted on holding to her own story.  As 
further evidence of Jill‘s need to narrate others‘ according to her own story, the interview was 
later interrupted by her husband.  She introduced him and after complimenting him on his loving 
support to her during rough times, she said:  
They actually thought that he was depressed for awhile. 
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[Husband] No . .  you thought I was depressed for awhile. 
They put you on an anti-depressant for a couple… 
[Husband] Because you made them for a month and then I quit taking them and said ―this 
is stupid‖ and I never took it again (they both laugh) (7). 
 
Speculating about others‘ symptoms, re-telling one‘s story to others, and assisting them 
to receive a diagnosis and begin treatment are proposed as other related ways that individuals 
reinforce and affirm the validity of their own narrative of depression.   
 
5. Persisting in Treatment:   “I‟m a firm believer in medication. . .” 
 Alongside its influence on the formation of narratives, an individual‘s actual experience 
of treatment is proposed as having an equal or greater impact on how these narratives are 
maintained over time.  The decision to persist and adhere to medical treatment, in particular, is 
highlighted as another strategy in maintaining a conventional biomedical narrative.  
(Alternatively, the decision to cease treatment would disrupt the same narrative and contribute to 
forming another).       
On the most basic level, the ongoing presence of medication itself may function as 
continuing evidence that the biomedical explanation is accurate.  Just as early positive medication 
effects appeared to increase many participants‘ confidence in biological explanation overall, the 
continuing awareness of one‘s decision to take medications for emotional pain seems to act as a 
subtle and enduring reinforcement of the same justifying explanation.  For instance, several 
participants who expressed serious reservations about treatment nevertheless spoke at length 
about things such as recent doctor visits, the importance of finding the right dosage and their 
schedule for taking medication.  For these participants, the ongoing presence and taking of 
medication seemed to reinforce and spur the continued adherence to its treatment narrative, in a 
way not dissimilar to the reminders of surrounding friends and family.   
The role of treatment adherence as a maintenance strategy for narratives arguably goes 
deeper than external reminders, however, to its direct impact on interpretation itself.  Most 
basically, when a behavior (like medication taking) that corresponds to a particular narrative is 
perceived to be rewarded, it naturally reinforces not only the behavior, but the interpretation 
behind the behavior (like biomedical explanation).  A treatment experience evaluated positively 
will thus reinforce the justifying explanation for that treatment, in turn, making it more likely that 
an individual turns to both medication and its justifying biomedical etiology again.  In this way, 
once individuals gain an initial conviction regarding treatment, it may also color and shape 
subsequent judgments—acting as a backdrop out of which other treatment experiences, for better 
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or worse, are evaluated.  For instance, individuals who chose to medicate first symptoms seemed 
naturally more inclined to do the same with future difficulties (i.e., medicate the side-effects).  
Alternatively, individuals who resisted medicating first symptoms or ceased treatment seemed 
naturally inclined to do the same with future difficulties.   
As a final, most vivid example of interpretation being galvanized by treatment, once 
individuals initially attribute positive emotional change to the effects of medication, subsequent 
changes in emotional condition may be more readily and consistently credited to medication.  
This was evident in narratives where the effects of medication had come to be closely intertwined 
with major emotional issues generally.  In Jill‘s account, for instance, the taking of medication 
came to be seen as a natural response to a loved one‘s death—―And then when my dad died that 
year, then [my doctor] upped me a little bit to get me through that‖ (7).  In a similar vein, Victoria 
spoke of times when ―life doesn‘t make sense‖ as corresponding to times when she hadn‘t been 
faithful with the medication.  After so many years of taking medication, her interpretations 
reflected an imprint that extended even to deep issues of meaning, direction and purpose.  She 
continued, ―this has been times when they‘ve upped the medication . . . when I have gone in and I 
said, ‗I can‘t seem to find a direction I can‘t seem to prioritize and figure out what I need to do 
during the day,‘ you know. And umm that has usually been a symbol that we need to up the 
medication a little bit‖ (5).   
On multiple levels, then, persisting in medical treatment itself can bolster and reinforce 
both treatment maintenance and treatment-narrative maintenance.  Joining this strategy are two 
more medication-related dynamics described below.  It is when dramatic initial effects subside 
and difficult side-effects emerge that some of the most subtle and fascinating strategies for 
narrative maintenance can be observed.  The following sections take up two more related clusters 
of strategies—starting with the framing of difficult states concurrent with medical treatment, and 
moving to consider diverging frames for one‟s life without medication.   
 
6. Reconciling Difficulties Concurrent with Treatment. “You just have to deal with it, you know?” 
Earlier in this chapter, the telling of one‘s story of depression and its treatment was 
reviewed as an example of ―educating others‖ as a maintenance strategy.  Whether told or lived 
out, individual treatment narratives are here and in the remainder of the chapter dissected at closer 
view to consider constituent interpretations and affirmations that appear to be playing a role in 
their overall maintenance.  Like interpretation and narrative itself, these are held to be more than 
merely passive “beliefs‖—instead reflecting key constituents of practices that are ―lived and 
continuously accomplished‖ by those facing depression.     
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In this section, one of the primary impediments to treatment (and narrative) 
maintenance is examined:  difficult effects.  Alongside more common studies of how side-effects 
or adverse-effects are directly addressed by professionals or patients, this section examines how 
they are variously interpreted or narrated—in particular, how they are framed in ways that 
permits individual narratives to be perpetuated over time.  These specific ways include:  Holding 
to the memory of initial positive effects; Seeing mixed medical effects as acceptable; Narrating 
difficult medical effects as inevitable and necessary; Seeing difficulties as reflecting individual 
diversity or randomness; Seeing difficulties as coming from wrong medication types or dosage 
levels & Believing there is a right medication.  To conclude this section, a brief discussion will 
review apparent implications of these assumptions for how individuals subsequently respond to 
and endure difficult effects.   
 Holding to the memory of initial positive effects.  In Chapter 6, it was proposed that 
dramatic initial evaluations of medication may play a role in the adoption of a particular narrative.  
When difficult states arise concurrent with medication, this same resource may be referenced as 
part of a larger strategy to emphasize early memories of positive treatment impact for reassurance 
during tough periods.  Both Elaine and Debbie, for instance, although experiencing difficult side-
effects at the time of interview, referred back warmly to earlier experiences.  Debbie recounted, 
―You know, the magic part of my life was taking that Prozac. It just seemed to do everything. I 
had the energy; I was losing weight I could stay up (laughs) until 3 a.m. cleaning and everything 
was organized and it was just wonderful. It was like the superwoman I wanted to be.‖  After 
expressing some angst ―because I‘ve tried so many different medications‖ since that period, she 
almost wistfully acknowledged still wishing there would be another ―magic pill‖ like Prozac (8).   
Debbie‘s story is reflective of several others in relating years of searching for the right 
medication(s) to help her feel well after initial effects subside.  This kind of persistence arguably 
would not be possible without a positive initial memory that individuals could hold onto.  In this 
sense, the memory of dramatic initial effects may literally ―buffer‖ against future challenge.  Like 
a conversion or redemptive story, it may take on a remarkable personal staying or sticking 
power—helping people ―hold on‖ through turbulence and withstand rough times (see below, 
Cumulative implications of reconciling treatment difficulties).  
If memories of initial positive medication effects appear to frequently reinforce ongoing  
hope when treatment effects subside, this outcome does not necessarily seem to be the case.  A 
failure of treatment after early positive effects, for instance, might alternatively prompt worse 
hopelessness in one facing depression.  In Camille and Debbie‘s narratives, for instance, after 
each reporting initial treatment effects that were dramatically positive, they expressed particular 
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distress when these effects faded and attempts to duplicate them with higher dosages and 
additional drugs were unsuccessful.  After relating a similar story from one of his interviewees, 
Karp (2006) summarized the pattern, ―No doubt Mike‘s later disappointments with a wide array 
of drugs were deepened by their contrast with this early success.‖  He later spoke of the 
―unfathomable disappointment [individuals] feel when a medication that temporarily ‗cured‘ 
them simply stops working,‖ comparing it to the ―shock experienced when a lover suddenly 
leaves‖ (pp. 45, 82).   
Seeing mixed medical effects as acceptable.  Since all individuals dislike side-effects, it is 
overall judgments of benefits outweighing the downside that generally leads individuals to persist 
in any course of medication (see Ch. 6; Horne & Weinman, 1999).  While some participants 
strongly asserted the clear need for medication, alongside downsides emphasized as minimal 
(Sarah, Peter, Michelle), for others, the cost-benefit ratio just barely was enough.  In reference to 
her depression and psychotic symptoms, Lucy said the following about her current medication 
cocktail:  
I am on the right dose that I‟m okay with right now, but it‘s not perfect by any means. I 
still hear voices a lot of the time, but it‘s turned it down a notch. And I‘m not rapidly 
cycling . . . but I still do, you know what I mean?  So it‘s almost just like I‘ve settled.  It‘s 
not things are great, it just doesn‘t hurt as bad as it used to. (6) 
 
Narrating difficult medical effects as inevitable and necessary.  Beyond the rough 
distinction between beliefs of ―necessity‖ and ―concerns‖ described above, this study suggests 
that some specific nuances of belief and language may also influence treatment and its 
overarching narrative.  For instance, negative effects associated with a medication may be 
interpreted as ―side-effects‖ or ―adverse effects‖ depending on the original evaluation of 
medication itself (Breggin & Cohen, 1999).  In the former case, the emphasis is on effects that are 
tolerable and inevitable—i.e. ―all drugs having side-effects.‖  Camille said the following about 
memory loss she believed was possibly linked to her medical treatment:  ―You just deal with it. 
What else can you do? And I‘ve just figured well maybe those are parts of my life that I just don‘t 
wanna remember anyway, so it‘s okay.‖  When her family expressed frustration about this side-
effect as well, Camille responded similarly, ―I just I tell them . . . ―Um, I‘m sorry this is how it is 
and we all just have to learn to cope with it‖ (3).  By narrating uncomfortable effects in this way, 
they come to be experienced as both necessary and less ominous.   
Side-effects, of course, are not always narrated to be acceptable.  Accounts of Fern & 
Kyle both reflect decisions at some point that the effects they were experiencing were not okay.  
Karp recounts a poignant vignette of a man‘s experience after visiting his mother‘s grave site:   
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I heard something on the radio and it clearly reminded me of my mother, some early stuff 
that she would sing to me from the song ―Lightly like a Rose‖. . . . [it] immediately 
caught me.  And I listened to it.  I wanted to cry.  I just couldn‘t do it.  It was clear that 
the trough had been cut off.  And I knew, and I knew that it was the Prozac. . . . And I 
said, ―f* you, Prozac, I want to cry for my mom‖ (p. 109-110).   
 
Rather than use a frame of ―side-effects,‖ an effect seen as dangerous or intolerable may 
thus be framed as an ―adverse effect‖ (Breggin & Cohen, 1999).  In the latter case, the emphasis 
is on effects that are neither worth tolerating nor inevitable.   
Seeing difficulties as reflecting individual diversity or randomness.  Confusion in 
understanding the source of depression was reviewed previously.  When a medication is added to 
the picture, it naturally increases the complexity of explaining both positive and negative states:  
Was it the medication?  Was it my own biology?  Was it something else entirely?  A major theme 
of earlier chapters was the struggle to ascertain the precise source of negative (or positive) states 
arising concurrent with medical treatment.  In some cases, such as Kyle‘s negative reports of 
Lithium, negative effects were attributed to the medication itself.  In other cases like Sarah and 
Victoria, participants reach a conviction that certain negative effects were likely ensuing from 
sources other than the medical treatment for depression.  One popular alternative explanation for 
difficult states is emphasizing the sheer complexity and distinctiveness of individual situations 
and physiologies—as Kellie articulated, that ―everybody‘s situation is very unique‖ (16).  After 
being challenged by a woman who said medication hadn‘t helped her, Victoria responded, ―I 
mean, that‘s an easy one, because everybody is different. I have a friend who swears by Prozac; 
she wouldn‘t take anything else.  Well . . .  her make up is different, you know‖ (5).   
 While reflecting an undeniable and basic reality, this emphasis on diversity at times 
appears to function as a catch-all explanation for difficulties.  Camille referred to unique 
differences as justifying the need for doctors to experiment with medication--―And you go to 
doctors and everything is trial and error because every person is so different‖ (3).   
 Alongside diversity and uniqueness, a related narrative emphasis is randomness and/or 
mystery.  After Prozac helped her for a year, Camille recounted when it ceased to work.  After the 
doctor tried increasing the dosage and it didn‘t help, he explained, ―sometimes that just happens 
to people. . . we don‘t know why it happens; it just isn‘t effective anymore‖ (3).  As mentioned 
earlier, Victoria woke up paralyzed and completely unable to move.  Rather than attributing such 
difficulties to the medication directly, she emphasized it as coming out of the blue:  ―What it was, 
was that it was just some kind of freak thing where the nerve endings just, for some reason, just 
kind of locked everything up.‖ Her doctor‘s response further reassured her:  ―it‘s so rare, you 
know, that I really doubt that it will ever happen again‖ (5).  
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 Seeing difficulties as coming from wrong medication types or dosage levels.  As reflected 
in the discussion of side-effects earlier, even when negative state appears connected to treatment, 
it can be narrated in a way that preserves the centrality of medication (for narratives and practice).  
With acceptance of some degree of inevitable difficulties solidly rooted, critical attention goes 
elsewhere—starting with the details and particularities of treatment itself.  Rather than medication 
itself being to blame, it is the wrong amount or kind.  As reflected in these interviews, insufficient 
dosage levels or ―wrong medications‖ frequently receive the blame for discomfort and difficulty.  
Jill lamented her son‘s long-standing emotional difficulties as follows:  ―He‘s done better since 
he‘s been put on the right medications, all those years on the wrong medications‖ (7).  Others 
spoke of searching for years for the right treatment specifics; Elaine, for instance, summarized her 
―whole goal‖ as finding the right dosage level to be able to function better again (2). 
In a related interpretation, others assert difficult states as coming from inaccurate 
diagnosis.  Lucy, for instance, emphasized throughout her narrative that long years of painful 
emotion were principally caused by improper diagnosis (6).  And even after acknowledging that 
medication had been contributing to violent side-effects for her son, Jill remained focused on the 
misdiagnosed depression itself as her son‘s primary problem:  ―. . . they still hadn‘t properly 
diagnosed him‖ (7). 
Believing there is a right medication.  The flip side of the belief that problems come from  
a wrong medication or inaccurate dosage, of course, is the conviction that another, better 
medication could change that all.  Alongside the touchstone of looking back to positive earlier 
experiences is the evident influence of looking forward to positive visions of what can still 
happen with medications—i.e., the conviction that one day, a medication or combination of 
medications will be found that works (better or for a longer period of time).  This conviction was 
implicit in a number of participant narratives reflecting long journeys to find the right 
combination of medication types and dosages over the years (Elaine, Sarah, Peter, Michelle).   
In their own interviewing sample, Schreiber and Hartrick (2002) recount one woman who 
reported experiencing multiple childhood traumas prior to facing depression; after starting 
medical treatment, she subsequently ―spent her days researching new antidepressant medication 
on the Internet.‖  They conclude, ―Even women who described having little success in spite of 
having taken a variety of antidepressants continued to hold out hope that they would eventually 
find a medication that would ameliorate their depression (p. 96; 100-102).  Karp (2006) suggests 
that ―the search for the ‗right‘ drug is analogous to the search for Mr. or Ms. Right‖:  ―Just as 
people hold out hope of finding the perfect mate despite repeated disappointments, those 
suffering from depression often remain convinced that there‘s an ideal drug for them‖ (p. 75-76).   
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 Cumulative implications of reconciling treatment difficulties.  When individuals interpret 
difficult effects as necessary side-effects, temporary reflections of wrong prescriptions or random 
unfortunate occurrences, the single or joint operation of these convictions may arguably have 
consequences for treatment choices and experience.   
One of the most perplexing dynamics I observed across interviews was the degree to 
which individuals persisted through side-effects that appeared gut-wrenching to me.  Jill, for 
instance, recounted the decision she and her husband felt forced to make between continuing 
sexual intimacy and continuing treatment:    
My husband and I had to sit down and make the decision of ―do we want me to be well?‖ 
. . . and he decided that he‘d rather have me [emotionally] function. . . . and so that‘s just 
something we‘ve had to deal with which hasn‘t been good; he‘s just basically taken an 
oath of celibacy. (7) 
 
Others spoke of significant weight gain (Lucy), memory loss (Camille), heart pain 
(Robert) and financial debt from medical payments (Victoria).  Jill went on to speak of her first 
son still facing bipolar depression—recounting a time when his treatment on Risperdal, Adderall 
and another medication were ―working too hard on his heart.  His heart was beating so fast and 
pushing such a large fast velocity through the heart it was causing a murmur‖ (7).  Even so, Jill 
spoke of this as an inevitable part of his necessary treatment.   Individual willingness to continue 
treatment in the face of tremendous difficulties can be, at times, remarkable.   
Such willingness to endure and persist through such difficulties over long periods of time 
is here proposed to ensue, in part, from the effect of this series of beliefs and convictions 
described above.  When taken together, these interpretations constitute a strategy of 
systematically minimizing uncomfortable states and difficulties concurrent with medication.   
The surprising degree to which individuals, at times, tolerate and overlook painful side 
effects is reflected in other studies as well.  As one example, Karp (2006) interviewed one man 
who described working with his doctor for forty weeks trying to find the right medication: ―I was 
willing to put up with feeling like nauseated to the point of just about throwing up for about two 
weeks and staying sick in bed trying to adjust to the Prozac.‖  After stopping Prozac, he described 
―working my way through the SSRIs‖:  ―Then I get into Paxil.  Paxil has me nauseated . . . I 
stayed on it for a while . . . the first eight hours after I take a Paxil I am sick, really sick.  The 
second eight hours . . . I‘m sick and shaky . . . . Then after eight hours of being sick and shaky I 
start getting a little bit of relief‖ (p. 41).   
Such persistence, of course, relies on more than treatment narratives.  Karp goes on to 
argue that long years of enduring treatment side-effects may not happen without commitment to a 
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particular narrative of the biological cause itself—noting that the ―unflinching commitment to 
biomedical solutions‖ is ―nearly always the backdrop for years of experimentation with a series of 
medications‖; ―To stick with drug experiments virtually requires the belief that your biology is 
bad‖ (pp. 39, 77; see Ch. 7). 
 
7. Narrating Life Without Medication: “What happens if I stop taking these?” 
           In addition to particular convictions about difficult effects, participants also reflected on 
multiple aspects of what life would be like without medication:  How would I face depression 
alone?  Is there anything else that can help?  Is improvement without meds even possible?  Would 
depression come back if I taper?  These interpretations and beliefs regarding life after treatment 
are proposed as likewise relevant to the process of maintaining one‘s overall narrative of 
depression and its treatment.  These beliefs include:  Seeing life without medical treatment as 
equivalent to „facing depression alone‟; Assuming alternatives are not viable; Narrating 
complete recovery as unlikely & Narrating tapering difficulties as a „return of the depression.‟  
After reviewing the nature of these specific interpretations, I conclude this section reviewing a 
strategy overarching many of these assumptions:  Confiding in physicians. 
 
 Seeing life without medical treatment as equivalent to „facing depression alone.‟  
Independent from considerations of treatment, the dread of depression coming back was reflected 
across multiple accounts (Elaine, Kellie, Robert, Lucy).  Since it is to medication that most 
participants turned for relief, naturally they associate its presence with safety from depression and 
its absence with a return.  For this reason, even when acknowledging problems with psychiatric 
treatment, many individuals insisted that life would be worse without them.  Camille said, ―I‘d 
really like to be off the meds, but the person off the meds is scary‖ (2).   Reflecting on an 
imagined future without medications, Jill remarked, ―I‘m grateful that I was born in this day and 
age where I could get the medication that I need so that I wouldn‘t be locked up in the attic 
somewhere, or indisposed all the time (laughs)‖ (7).  In this way, a fear of depression comes to 
correspond very closely to a fear of one‘s life without medication.   
Said another way, life without medication may thus come to be narrated as literally 
equivalent to facing depression alone—a scary proposition, indeed.  The role of this kind of fear 
in treatment compliance has been documented by others as well (Carder, Vuckovic & Green, 
2003; Grime & Pollock, 2003).  Another interviewing study cited an individual as saying, ―you‘re 
afraid everything will go wrong if you don‘t take your medicine‖ (Knudsen et al, 2002, p. 933).  
In a French study of psychotropic users, Baumann and Trincard (2002) point towards ―the feeling 
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of fear‖ as functioning to ―put taking the medication into perspective‖ and specifically countering 
the ―guilt from non-observance‖ (p. 389).  The fear associated with not taking medication seems 
to effectively overwhelm the guilt some may feel in taking them.   
 Karp (1997) elaborates the point in an interview where he asked a patient, ―Can you see 
yourself getting off this medication?‖:    
I really don‘t want to because I‘m afraid.  I don‘t really have any side effects other than 
the upset stomach, the appetite fluctuation, and the sexual dysfunction which I can live 
with.  [Recently] I said [to my psychiatrist], ―Well, I can‘t tell the difference [between] 
being on it or not being on it.‖  And she said, ―Well, if you stopped taking it . . you would 
notice it because you would fall back into the depression.‖  That‘s how you‘d know that 
it was working.  So I said, ―Well I don‘t want that because there‘s nothing worse than not 
being able to sleep, not being able to eat, and not being able to function‖ (p. 99-100).  
 
Rather than the benefits of treatment, it is here the threat of its discontinuation that  
functions to reinforce compliance.  Although very real to individuals, these combined analyses 
raise the striking possibility that such fears may be neither natural nor inevitable.  Like other 
heightened feelings among participants of urgency, excitement or accusation reviewed in earlier 
chapters, fears of a foreboding future may likewise be ensuing largely from a particular narrative 
or interpretation of experience.   
 
Assuming alternatives are not viable.   Implicit to the assertion that life without  
medication is equivalent to facing depression alone, of course, is the assumption that medical 
treatment is the one and only legitimate way to address the problem—i.e., that there are no viable 
alternatives.    While alternative treatment options remain a common desire among distressed 
individuals (Carder, Vuckovic & Green, 2003), other research confirms that they have remained 
minimized and obscure to those facing depression (Badger & Nolan, 2007; Rogers, May & 
Oliver, 2001).  In Sarah‘s account, for instance, suggestions to exercise or improve her diet were 
received as a naïve expression of her husband‘s misunderstanding of depression:   
He didn‘t understand; there wasn‘t the education about , you know, depression.  He‘d 
thought . . . ―you‘re not eating right.  You‘re not getting enough rest or . . . You need to 
exercise, Sarah.  C‘mon get up and go jogging with me.‖  That was there was no way . . . 
so I had that turmoil, you know; so I had his lack of . . . understanding depression. (4) 
 
As reflected here, Schreiber and Hartrick (2002) suggest that the dominant biomedical 
narrative may indirectly discount alternatives.  Badger and Nolan (2007) document doctors 
directly discouraging the same.  Other narratives similarly confirm that a conviction of the 
necessity of medication may underlie a disbelief in alternatives.  As Jill said, ―You can‘t get 
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better without medication.  You can talk and talk and talk but you can‘t get better without, if your 
chemicals are messed up‖ (7). 
This kind of skepticism regarding improvement without medication arguably undergirds  
the aforementioned assumption that the alternative to medication is ―suffering alone‖—
positioning ―getting medical help‖ against ―going it alone.‖  Schreiber & Hartrick (2002) note 
that interview participants ―seemed to equate the term treatment with medical intervention‖ (p. 
94).  As one Kellie‘s brother counseled, ―you can have a good quality life now [with medication], 
you don‘t just have to suffer through and wait for time to pass and just think that you can do it all 
on your own.  You can enjoy life now‖ (16).  Once again, as reflected here, accepting medical 
treatment is positioned against ―suffering through‖ and ―doing it all on your own.‖   
That there are implications of these views seems clear—for both individuals and their 
caregivers.  One man, in explaining his continued treatment efforts in spite of side effects, said, ―I 
didn‘t know of any other way‖ (Karp, 2006, p. 71).  These kinds of assumptions may help explain 
the force behind individuals‘ eventual reconciliation with the idea of treatment:  ―Just a couple 
years ago, I just faced it that I‘m just always gonna have to have something‖ (8).  As a result of 
this dichotomy, surrounding friends and family may be more inclined to see rejecting medicine as 
rejecting recovery, thus predisposing family to be more resistant to any change in a course of 
treatment.  This perhaps explains, in part, why Kyle‘s parents were upset and his wife threatened 
to leave him when he decided to begin tapering:  they saw no alternative way for him to recover.  
Narrating complete recovery as unlikely.  Independent of both diverging views regarding  
alternatives and medication are those related to overall recovery itself.  Among the interpretations 
reviewed in previous chapters is a belief that fully overcoming depression may be a naïve goal—a 
view voiced by multiple participants.  Gammell and Stoppard (1999) described women hoping 
that depression would not re-occur, but generally believing depression was ―something they had 
to live with‖ (p. 120).  Ridge and Ziebland (2006) found that a ―language of recovery‖ was not 
readily available to patients in the UK national health service—highlighting ―anti-recovery‖ tales 
of people being ―perpetually trapped in mental illness‖ (p. 1041).  For those participants in this 
study who came to believe recovery was possible, the moment of hearing about this possibility 
often appeared to be significant turning point in their narratives.   
Limited accessibility of recovery language may have subtle, but significant consequences 
for individual improvement.  However, since all professional helpers logically speak of some kind 
of recovery, it may be more accurate to say that it is different ways of talking about recovery, 
such as reviewed in Chapter 7, that matter more for those facing depression.  Depending on the 
exact portrayal of recovery, individuals may come to be satisfied or not with their current state.  
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Some may simply come to accept wherever they find themselves as the best possible state given 
the illness--―I‘m not well, but I‘m better than I would be without [medications]‖ (p. 67).   
Consequences, however, go deeper than merely acquiescing to treatment.  Several 
participants defined depression as ―hopelessness‖—such as Kyle, ―When you‘re depressed, 
you‘re not going to get better.  You don‟t think you are going to get better. . .  No hope‖ (12).  
For individuals already facing the hopelessness of depression, it is more than ironic to consider 
the personal effect of being told they cannot recover:   
My initial diagnosis--they said this is something permanent. This isn‘t something that 
you‘ll ever not have. (Elaine/2) 
[I was told] ―It‘s a lifetime illness . . . you got to stay on your meds.‖ (Kyle/12)   
This doctor told my family that I would never be able to live independently again. 
(Michelle/13) 
 
While there is wide acknowledgment of hopelessness naturally coming from depression 
itself, there is much less attention to the subtle way that certain treatment narratives may literally 
and tragically reinforce this message and feeling as well.  At the time of final revisions for this 
thesis, the author was invited to give a public presentation on depression at a local Kiwanis club, 
where he discussed competing narratives of recovery.  Following the presentation, a woman 
approached him and related with some emotion the long struggle with bipolar depression of one 
of her best friends, a Mormon mother of several small children.  Three months ago, during a visit 
to her psychiatrist regarding some medication problems, she was told that depression would 
probably be life-long and that her anti-psychotic treatment would likely be a permanent need. 
This mother came home, wrote a letter to her family, and killed herself.  While any suicide is 
tragic, what is arguably more disturbing is the likely way her suicide would be narrated by most 
involved, including the psychiatrist:  ―isn‘t bipolar depression a terrible illness?‖   
When one can see an endpoint to the pain, it often seems possible to get through almost 
anything, as Camille said, ―The important thing is that I know that it won‘t last forever.  Before I 
had no hope.  I couldn‘t see a light at the end of the tunnel‖ (3).  When the very person offering 
―help‖ affirms that one‘s condition is life-long, however, the logical consequence is deepened 
hopelessness.  Rather than trapped by the disorder itself, these individuals may arguably be 
equally confined by the sheer lack of any alternative way to think about the future.   
 Not incidentally, it is worth noting that a ―recovery movement‖ in mental health is 
becoming increasingly embraced (Fisher, 2007), with growing evidence and documented 
possibilities of full recovery from severe depression (see Curtis, 2001; Fisher, 2007; Ridge & 
Ziebland, 2006; Shreiber, 1996).   
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Narrating tapering difficulties as a „return of the depression.‟   For some, the kinds of  
assumptions detailed above may prevent them from ever considering stopping medication.  A 
recent qualitative study of 16 anti-depressant users was entitled, ―Better safe than sorry--why 
patients prefer to stop using selective serotonin reuptake inhibitor (SSRI) antidepressants but are 
afraid to do so.‖  This study explored some of the dilemmas involved in stopping these drugs and 
specifically ―why these dilemmas tend to be solved by continuing rather than stopping.‖  The 
authors conclude that ―the fear and uncertainty about stopping without sufficient guidance were 
stronger than the fear and uncertainty about continuing [treatment]‖—prompting the choice of 
being ―safe‖ rather than ―sorry‖ (Verbeek-heida & Mathot, 2006).   
While this seems to be the most typical trend, many others still choose to attempt tapering 
in spite of their fears.  Karp notes that ―after years of drug-taking, most of those I interviewed 
longed to know who they would be in the absence of the drugs.  Even those who felt well, even 
cured, on their medications often fiddled with dosage levels and considered stopping their 
medication altogether‖ (p. 117).   
Three quarters of participants who started medication reported passing through periods of 
experimenting and tapering, albeit with distinct outcomes.  According to Dr. David Fassler, 
studies illustrate approximately one quarter of those taking anti-depressants stop within three 
months, with overall compliance less than 50% by six months (as cited in Tanner, 2008).  As 
reflected above, the prevailing fear with tapering is a return of depression—understandably 
viewed as the major barrier.  Less acknowledged, however, is another subtle interpretive strategy 
that may play an even larger role in the tapering process.   
During this process, individuals naturally come to feel emotional shifts.  As this occurs, 
individuals may interpret any turbulence in distinct ways.  For instance, Lucy said, ―the couple 
times I tried to get off—‗just not gonna happen.‘ And you see the side effects of getting off and 
nobody likes me and I myself don‘t like me when I get off the medication‖ (8).  A recent 
newspaper article recounted another individual‘s attempts to taper associated with her resistance-- 
"I was so eager to consider myself well and to go off of it.‖  The article continued:  ―but each 
time she stopped, debilitating depression including suicidal thoughts would return‖—prompting 
her to give up the attempt (Tanner, The Associated Press; 2/20/08).   
Considering an emergence of emotions during tapering as a return of depression is a 
natural impulse—and consistent with other strategies reviewed above.  Most, including everyone 
in my sample, seem to take this interpretation for granted.  Others seem to struggle with the 
question.  Speaking of his own period to taper off medications, Karp (2006) writes, ―throughout 
this time I vascillated, often within minutes and throughout the days and nights, about the wisdom 
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of my decision to stop taking medication.  I could not distinguish the effects of stopping the drugs 
from a ferocious return of my mental illness (p. 6). 
Beyond the more obvious, physiological barriers to tapering, I would argue that to a large 
degree it is the particular interpretation laid on top of these concrete challenges that potentially 
makes the greatest impact on the process and outcome of tapering.  A recent study reflecting one 
of the ―most methodologically rigorous pieces of research into people‘s experiences of coming 
off psychiatric drugs,‖ drew on both quantitative and qualitative data via interviews and 
questionnaires with 204 individuals who had made efforts to come off psychotropic medications 
(Read, 2005; cited in Holmes & Hudson, 200X). In addition to finding that ―over half of the 
sample had difficulties in coming off medication,‖ they noted that ―many withdrawal reactions 
mirrored psychiatric symptoms/disorders‖ (p. 1).  In light of this, Glenmullen (2005), a doctor at 
Harvard Medical School, recently decried the wide-spread interpretation of difficulties 
accompanying a tapering of psychiatric medication as automatically meaning the original 
condition is returning:   
Many doctors have not been taught that [negative symptoms experienced] shortly after 
lowering the dose of an antidepressant are drug-induced withdrawal phenomena.  Doctors 
and patients who are unaware of antidepressant withdrawal can mistake the symptoms for 
a return of the patient's original psychiatric condition, leading to years of additional 
unnecessary treatment (p.1).   
 
Glenmullen goes on to explain that with a decrease in any medication, there are  
withdrawal effects in normal humans as the body adjusts to the absence of the chemical. 
Withdrawal effects came to the attention of researchers in the mid 1990s and have now been 
observed with all major classes of antidepressants--66% of patients stopping Paxil, 60% stopping 
Zoloft and 78% stopping Effexor. These effects may be even worse than the original condition, 
including, ―depressed mood, low energy, crying uncontrollably, anxiety, insomnia, irritability, 
agitation, impulsivity, hallucinations, or suicidal and violent urges. . . . disabling dizziness, 
imbalance, nausea, vomiting, flu-like aches and pains, sweating, headaches, tremors, burning 
sensations, or electric shock-like ‗zaps‘ in the brain‖ (p. 7).  Awareness of these withdrawal 
symptoms is crucial, Glenmullen argues, in understanding how they can mimic the original 
psychiatric conditions.  From his own practice, Glenmullen recounts a woman‘s earlier effort to 
get off Zoloft as part of making a ―fresh start‖ in life.  As difficult emotions returned, the woman 
rushed to her previous doctor in a panic:  ―I guess my doctor . . didn‘t know about withdrawal.  
Instead, he confirmed my worst fear:  That I was a hopeless case because I quickly became 
depressed and anxious again without the drug‖ (p. 2). 
The impact of the experience may be enhanced when individuals subsequently find relief  
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on medication.  Returning to Karp‘s struggle to taper, he continued ―my resolve to complete the 
experiment was most severely tested‖ ultimately describing its dissolution during a weekend of 
particular difficulty:  ―At that moment I knew my decision to stop the medication had failed, and I 
took some Klonopin.  That night, I slept better than I had in weeks.  The relief was enormous‖ (p. 
6-7).  For those who endure similar periods of testing and find a return to medication bringing 
relief, the impact on personal interpretations of treatment is obvious.     
A failed tapering effort may thus lead individuals to conclude that their biological 
deficiency was even worse than realized and that medication is needed even more than previously 
assumed.  The student in the article above concluded, ―If I've learned anything from this journey, 
it's that medication really works for me‖ (Tanner, The Associated Press; 2/20/08).  
 Glenmullen notes:  
Being caught in the antidepressant catch-22 needlessly exposes patients—often for years-
-to the side effects and long-term risks of psychiatric medication.  In many instances, not 
only is the drug restarted, the dose is increased and additional drugs are added to "treat" 
withdrawal that has been mistaken for depressive relapse.  In the process, patients get the 
false impression that their psychiatric conditions and prognoses are far worse than they 
actually are (p. 5). 
 
In contrast, when negative states associated with tapering are understood to likely involve 
withdrawal effects, in many cases people can ―ride out‖ temporary effects and eventually be fine 
without medication.  The remainder of his book details a personalized, gradual tapering program 
designed to reduce the severity of withdrawal effects.  There are growing resources and books 
with good recommendations about withdrawing safely from medication (Glenmullen, 2005; 
Breggin & Cohen, 1999; Harper, 2008).    
 Overarching strategy:  Confiding in physicians.  The foregoing three clusters of 
strategies each reflect particular ways of approaching or narrating medical treatment, its difficult 
effects and its absence.  While helpful to parse out distinct assumptions and beliefs in this area 
relevant to the maintenance of individual narratives, it would be a mistake at this point not to 
again highlight the relationship context in which these beliefs are maintained.  Just as certain 
beliefs appear to arise largely from the significant influence of surrounding friends, family and 
medical professionals—these ways of approaching treatment described above appear to be 
sustained to a significant degree by individuals‘ trust in others, especially in this case, medical 
professionals.  When difficult effects arise, it is to the doctors that individuals typically go for 
answers and assurance.   
As highlighted in other places, the impact of these interactions with a doctor in a critical 
moment can be dramatic, with their counsel a turning point in many accounts.  Whether or not 
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such advice is embraced or rejected, however, depends on an individual choice to trust the 
doctor—proposed here as an overarching strategy in maintaining one‘s treatment narrative, 
perhaps mediated by beliefs reviewed above.  Conversely, distrust and wariness is an important 
factor of disrupting a conventional biomedical narrative and forming another.   
In addition to a certain deference often given to any helper in society, that associated with 
medical doctors appears to be of a particularly powerful kind—perhaps linked with the promise 
of alleviating quickly our pain.  In addition to assurances, I would suggest the certainty of doctors 
themselves as also influential in eliciting patient confidence.  Indeed, if these evaluations about 
medications were challenging for participants in my study, by and large they didn‘t appear to be a 
struggle for their doctors.  The reported certainty and boldness of doctors in trying diverse 
combinations of psychiatric medications was striking.  Even when a person‘s reaction to a first 
medication was very negative, the belief in psycho-tropics appeared, in this sample, to literally 
never be questioned as the primary solution by doctors, with the next step typically assumed to be 
trying another dosage or drug type.   
This level of professional certainty may prove to be an even larger factor in the 
maintenance of treatment (narratives) than is now realized—especially in light of the reluctance 
towards medication depicted earlier.  Indeed, one large survey of 403 primary care patients across 
five practices found that higher percentages of patients trust their doctors than they trust the 
medication they offer (Brody, Khaliq &Thompson, 1997).  In the face of such treatment distrust, 
it seems obvious that the interpersonal trust in doctors alone may be a significant factor in 
overcoming fears to press on.   
The source of this kind of certainty is important to consider.  In one relevant study, for 
instance, Lacasse & Gomory (2003) examined 71 psychopathology course syllabi from 58 
different graduate schools of social work to determine whether contrasting viewpoints on the 
nature of mental disorder, reliability and validity of diagnosis and drug treatment were evident.  
The authors concluded there was ―little evidence that graduate psychopathology courses cover 
viewpoints other than the most conventional and institutional--that of biomedical psychiatry,‖ 
noting that ―a small handful of secondary (textbooks) . . . provide the majority of the mental 
health content in these courses‖ (p. 383).  In light of its potential importance, more studies are 
needed on the discourse of medical doctors and other professionals in the context of tremendous 
trust given them by patients.   
Of course, this trust varies individual to individual.  Kyle referred to his doctors‘  
prescription decisions as a ―crapshoot‖ (12), while Esther felt belittled and demeaned by her 
interactions (14).  From Karp‘s (2006) study, one man describes his doctor as follows:   
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I‘m saying, ―This guy doesn‘t know what the hell he‘s doing.‖  I thought he was 
experimenting with me.  And he thought he knew everything.  He wasn‘t listening to me 
when I told him Prozac worked (p. 56).   
 
 For some like Kyle and Esther, medical professionals attempt to force treatment in the 
face of such resistance—an action that seems to typically reinforce an anger and rejection of a 
biomedical narrative even more.   After recounting being ―forced‖ to take Prozac during the time 
she was being abused as a child, Lucy expressed anger at this doctor ―for allowing for so much . . 
. to go underneath the radar,‖ linking that, in part, to his level of confidence—―Doctors who feel 
that they are god‖ (6).   
It seems clear that the level of trust in medical professionals varies dramatically by  
region as well.  In a 2002 study by Express Scripts, a prescription benefit firm, prescription orders 
were tabulated across states.  Utah ranked 7
th
 in total prescriptions overall and 1
st
 in anti-
depressant prescriptions (Walch, 2006).  While critics of the Church of Jesus Christ pounced on 
the finding as solid evidence of the psychological oppression of Mormonism,
18
 this simple 
correlation conflicts with other evidence of lower suicide rates and less depression among active 
Mormons (e.g., Jensen, Jensen & Wiederhold, 1993; Hilton, Fellingham & Lyon, 2002;) and a 
recent Gallup poll ranking Utah as number one for well-being among the 50 states--a full point 
ahead of runner-up Hawaii (Arave, 2009).
 19
  From my own experience as a resident of Utah, I 
would point to the high level of trust in authorities cultivated among Mormons (similar to 
conservative religious people generally), as the most compelling explanation for high prescription 
rates.  Just as Latter-day Saints trust their priesthood and auxiliary leaders to guide them in 
beneficial ways, they are more likely to trust other authorities, in this case doctors, to do the 
same.  Judd (1999) suggests that it is Utah‘s higher rate of education per capita that leads them 
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 According to a 2004 report to the Utah Office of Planning, Utah is 62% Mormon, with estimates of 42% 
of those being ‗active‘ church-going members.    
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 A more comprehensive explanation would not discount the role of religious faith, but would address it in 
a more sophisticated and complex way.  For instance, Utah consumes less alcohol and illegal drugs than 
any other state, raising the possibility that non self-medicating residents may have more need for ―legal‖ 
resource for emotional issues (Judd, 1999).  Also, drawing on Allport‘s distinction between intrinsic and 
extrinsic religiosity, Bergin and colleagues (1987) have conducted research that confirms religiosity‘s 
relationship to mental health depends on the specific way individuals are religious, with intrinsically 
committed/motivated individuals more mentally healthy, on average, and extrinsically committed (means-
to-an-end/utilitarian), less mentally healthy. (Hearkening back to William James‘ statement that there 
health and unhealthy ways of being religious).  One recent study that showed active Mormon young men 
less likely to commit suicide than the national average, corroborated this point in showing that inactive 
Mormons were more likely and at greater risk for suicide (Hilton et al., 2002).  Although interpretations of 
this point might vary dramatically, I take it to be, at a minimum, a third possibility in explaining of the 
higher anti-depressant rate in Utah—i.e., members who are extrinsically committed or those who have 
rejected the church entirely are likely to be more depressed than the national average.   
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towards seek professional help for emotional problems, rather than seek to self-medicate or 
address it in other ways.      
 Where a cultural respect for authority exists, this may conceivably even override the kind 
of lack of trust noted earlier.  After her doctor prescribed Valium, Elaine recollected her response,  
I thought he was crazy because, I thought Valium was something that would calm me 
down and I said to myself--but not to him because I didn‘t want to challenge authority—
―now I don‘t need anything to calm me down anymore; I can‘t [even] get out of bed!‖ (2) 
 
Speaking of her response to advice from a professional friend to start medications, Kellie  
recounted similar hesitancy:  ―I resisted. And maybe I shouldn‘t have, but I did. I couldn‘t help it, 
I just resisted it. . . . I didn‘t want him to feel that I was rejecting his ideas, you know, because I 
held his opinions and ideas in very high esteem‖ (16).   
Sarah spoke of her attempts at ―trying you know to be my own doctor‖ as dangerous and 
naïve--eventually learning to ―not be smarter than the doctors‖ (4).  Elaine similarly confessed to 
previously thinking she ―knew more than the doctor did‖ and also spoke of ―learning to not be 
smarter‖ (2).  As a mirror image opposite, Kyle came to question ―just tak[ing] the doctors‘ word 
for it and do[ing] whatever they say to do‖ (12) and emphasized the importance of personally 
researching possible treatments before starting.  Esther reached the same conclusion after finding 
more side-effects in her internet research that her doctor had conveyed (14).     
 
8. Defending One‟s Narrative:  “They just don‟t get it! . .”       
 Many of the strategies reviewed above--emphasizing, highlighting, elaborating, sharing 
and testifying of a particular narrative--are proactive, on-the-offense strategies of reinforcing and 
maintaining one‘s story.  In the opposite direction, individual accounts also reflect more reactive, 
defensive strategies and postures that address what appears to be threatening to one‘s own view.  
In contrast to agreeable input which naturally reinforces one‘s preferred narrative, disagreeable 
input may either galvanize or weaken an individual‘s commitment to the same.     
For those who withstand opposition, they may go on to frame challenges as false, 
mistaken and even dangerous or harmful.  Elaine, Jill and Sarah spoke critically of those who 
challenged their treatment.  This kind of a response to challenge may arguably become a critical 
reinforcement to one‘s story. For Victoria, to illustrate, being questioned and challenged was 
evidence of her narrative‘s validity as she emphasized feeling inspired to know how to respond 
(5).  While opposition appeared to strengthen convictions for many, for others such critique 
appeared to play a role in their ongoing hesitancy.  Elaine noted ―I‘ve been challenged plenty,‖ 
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and added, ―I guess if I didn‘t have so many people that I felt like…kind of look down on me for 
taking the medication, I might feel a little different‖ (2). 
Framing opposition as ignorance.  As indicated earlier in this chapter, individuals may 
often re-frame previous doubts and skepticism as having been naïve and ignorant.  As reviewed 
elsewhere, others who retain doubts about treatment often find their concerns eliciting the same 
response.  In attempting non-medical alternatives, for instance, Kyle spoke of a sense from others 
that ―I‘m in denial‖ (12).  Esther spoke of doctors‘ response to her own treatment concerns:  
―Some would just flat out tell me . . .‗You don‘t know what you‘re talking about.  Of course, 
you‘re mentally ill and you‘re in denial that you‘re mentally ill‘‖ (14).   
Overall, such instances reflect a larger strategy at play.  Namely, in response to treatment 
concerns, individuals, friends/family and doctors often appear to insist on their own narrative as 
certain, obvious and proven—in turn, casting alternative views as naïve and ignorant to some 
degree.  In the context of ―narrative asymmetries‖ where individuals are challenged to make 
sense of ―enigmatic and frustrating situations,‖ Ochs & Capps (1996) note that ―narrators 
alternate between two fundamental tendencies—either to cultivate a dialogue between diverse 
understandings or to lay down one coherent, correct solution to the problem‖ (p. 32).   
From the latter standpoint, the truth about one‘s own view (and others‘) is fairly certain 
and established—with ambiguities and complexities in the research dismissed as insignificant.  
Across accounts, a line is effectively drawn between people ―getting it‖ or not; ―people who 
know‖ or an individual who ―just doesn‘t get it‖ (4).  Once again, this rhetorical strategy was 
evident in participants from diverse views—with both proponents and critics of medical treatment 
in the study speaking of science as ―on their side‖ with the findings ―very clearly‖ justifying their 
position.  
Such distinctions were evident in particular aspects of narratives as well.  For instance, 
Several raised questions about the scientific validity of prevailing biomedical explanations, with 
Kyle calling them ―diagnonsense.‖  In contrast, others, including Sarah, Victoria and Camille, 
spoke of the scientific validity of prevailing biomedical explanations as an established fact.  For 
the latter group, the questions were assumed to have largely been settled.   
 Beyond the interview evidence, one need not look far to discover prominent examples of 
such certitude.  The medical compliance literature, for instance, asserts antidepressant treatment 
as indubitably effective—attributing patient concerns and reluctance as reflecting basic 
irrationality or ignorance (Dwight-Johnson, et al., 2000; Löwe et al., 2006).  Concerns may be 
thus downplayed as illusory:  ―It is of interest that concerns about medication arose from 
(potentially mistaken) beliefs that regular usage could result in long-term adverse effects or 
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dependence‖ (Horne & Weinman, 1999, p. 564).  Many research teams thus hint at the notion that 
not wanting treatment reflects an implicit ignorance or lack of knowledge.     
Dwight-Johnson and colleagues (2000) raise associated practical questions such as, 
―should practitioners honor a patient's autonomy in declining or deferring care for depression, 
especially when this choice may be associated with poverty or lack of knowledge?‖  They go on 
to emphasize ―an important role for patient education‖ in ―promoting informed decision making‖ 
and call for more research examining the potential of education in ―motivating depressed patients 
to seek active treatment‖ and ―shift[ing] patient preferences‖ (pp. 532-533).   
 As mentioned earlier, similar certitude is found in studies critical of medical treatment 
(Breggin & Cohen, 1999).  In both cases, certainty about one conclusion or the other may 
―trickle-down‖ to professionals and patients alike, with little difficulty evident until encountering 
someone with the opposite conclusion, who is similarly certain.  Ultimately, for all involved, this 
portrayal reinforces ―sharing the truth‖ as the primary issue—justifying a sense of a cause, 
mission or crusade associated with education and advocacy, noted earlier.   Unsurprisingly, those 
participants most involved in education (both proponents and critics of psychiatry) were also 
those who seemed most convicted that the clear and indubitable truth was in their possession.    
Seeing questions and concerns as stigmatizing.  One way to defend one‘s narrative is 
thus to insist on the certitude of one‘s view and suggest that alternative views are ignorant and 
uneducated.  A second associated defensive posture is reflected in suggestions that treatment 
resistance reflects an unfortunate prejudice or stigma against depression.   
While many expressed concerned with public stigma, they attributed it to very different 
sources.  For instance, Kyle spoke of stigma as ensuing from the receipt of a questionable 
diagnostic ―label‖—emphasizing public fears as an unfortunate byproduct of a misguided 
psychiatric practice.  Sarah, on the other hand, emphasized stigma as ensuing from misguided 
fears of uneducated citizens.  From her perspectives, Kyle‘s own criticisms of medication would 
likely be seen as a reflection of such stigma.   
Of course, it is important to recognize a kind of opposition that clearly deserves to be 
decried for its belligerence.  As related elsewhere, participants spoke of being called lazy (3) and 
blamed (2) for facing depression.  Elaine said ―I‘ve been challenged many times; they wanna 
know who said it and when and in what book and how many research studies backed it up‖ (2).  
Lucy said:  ―It‘s amazing how low you can feel when someone you love keeps saying ‗so when 
you getting off that medication?‘‖ (6).  While overbearing and blaming comments clearly need to 
be condemned, it appears that this kind of harsh questioning can prompt some to see any question 
or critique of their treatment narrative to be attacking and stigmatizing.    
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In a op-ed during a recent ―Mental Health Month,‖ a medical doctor lambasted the 
editor for publishing an article that had explored critiques of medication (May, 2007 
―Sensationalist Reporting Fuels Stigmas‖; The Modesto Bee) and proposing the newspaper would 
―do well to highlight the many advances in mental illness treatment and real hope of recovery, 
instead of perpetuating stigma.‖  After asserting tremendous recovery rates associated with 
medication, he claimed that any critique of this view reflected distortions from prejudice, rather 
than valid concerns.  He concluded by addressing critics in this way:  ―unfortunately, the stigma 
of mental illness extends to its treatment, and side effects of psychiatric drugs tend to be 
exaggerated in the public's mind compared with other medications‖ (Lewis, 2007).  Accusations 
of ―exaggeration‖ and ―stigma‖ may thus automatically be made toward those raising questions.  
An emphasis on stigma may further reinforce calls for conventional public education about 
mental illness to counter the presumed ignorance shrouding such critique.   
A final strategy for maintaining narratives is therefore interpreting any questioning of a 
biomedical narrative as stigmatizing; this may contribute to the defense of one‘s narrative as 
questions are automatically framed as an ―attack.‖  For instance, Jill criticized Tom Cruise, one 
well-known challenger to psychiatry, as stigmatizing, ―I‘d like him to come and live in my shoes 
for a while.  . . . people like him have no business passing judgment like that.  That‘s what sets it 
back, that‘s what sets us back . . . he doesn‘t know what he‘s talking about‖ (7).  In contrast, Kyle 
saw Tom Cruise as raising valid concerns, ―They crucified him.  But in fact what he said had 
some basis of truth, you know.  Um, and he wasn‟t trying to just knock down Brook Shields.  He 
was saying we need to wake up and look at other alternatives.  We need to look at root causes . . 
you know, what causes post-partum depression?‖ (12).     
He then raised specific concern that opposition to medication was automatically  
interpreted as coming from the scientology religion—and suggested that legitimate scientific 
critiques were not being given a fair hearing.  Speaking of researcher David Healy, who had 
explored the link between suicide and violence, he noted, ―because of that he‘s been banned from 
all sorts of universities; you know, he‘s lost appointments, so that‘s, he's honest, I mean he‘s 
saying it the way it is‖ (12).  Once again, however, the emphasis on resistance as inherently 
stigmatizing, may lead any critic or challenger to be cast as dangerous and fanatic.   
In the same manner, individual reluctance and resistance to treatment may be attributed 
to external reluctance.  Debbie, who spoke of struggling to convince herself to continue treatment 
explained, ―I think if you know . . . if things were different, if people around the universe would 
accept it more, I think it would be easier to handle and accept‖ (8).  Not everyone attributes 
personal resistance to external stigma, of course, with some suggesting resistance as reflective of 
 179 
genuine problems with the medication itself.  Overall, however, it is arguably more common for 
explanations of resistance to be portrayed as reflective of external prejudice against a biomedical 
view of depression and its treatment.  
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Chapter 9 
Conclusion:  “So What?” 
 
This study began with curiosity as to why views of medical treatment for depression 
varied so sharply and so widely among those facing depression and other stakeholders 
(researchers, helping professionals):  “Prozac saved my life” vs. “Prozac ruined my life.”  From 
the beginning, the hypothesis has been that there had to be something more than sheer metabolic 
differences in drug effects or researcher bias in outcome studies at play—something in addition to 
these other variables that could be contributing to the process by which individuals reach very 
different conclusions.    
As documented in the foregoing chapters, depending on how and what individuals come 
to think about depression and its treatment, they may have distinct experiences arguably leading 
them to arrive at very different places in terms of treatment and recovery (and their associated 
conclusions).  Like a virtual reality ―choose your own adventure novel‖ or ―murder mystery 
play,‖ significant shifts in individual journeys are evident moment by moment.  Rather than 
reflecting inevitable destinations, these individual journeys are here proposed to be meaningfully 
prompted, bolstered and reinforced by distinct interpretations and overall narratives.  Indeed, 
beyond simply a random, free choice of ―what to do‖ or ―where to go from here,‖ these ongoing 
trajectory adjustments seem to be inescapably mediated by one‘s received way of explaining or 
narrating the problem of depression (Ch. 4) and ensuing way of approaching potential solutions 
(Ch. 5).  Beyond variation in physiology, community and other objective factors, this analysis 
suggests that narratives may, in fact, be substantial, even ―driving‖ forces behind both the ensuing 
treatment experience and ultimate conclusions reached by those facing depression.    
The process and manner by which this influence was exerted was divided between 
analyses of the ―adoption‖ and ―maintenance‖ of narratives.  First, an array of narrative resources 
was examined as foregrounding for the initial formation and adoption of unique stories regarding 
depression and its treatment (Ch. 6).  As anticipated, the opportunity to examine diverse ―expert‖ 
narratives close-up has permitted many insights on how individuals negotiate the complex terrain 
of conflicting prompts and resources on the surrounding landscape of any depression experience--
from intense states of confusion, resistance and urgency to influential moments with surrounding 
friends, family and the medication itself.  Depending on particular interpretations and decisions 
made along the way, individual trajectories may subsequently diverge sharply over time and 
reach distinct places in terms of both outcomes and conclusions (interpretations/narratives).  In 
addition to distinctions in general structure (Ch. 3), ensuing stories meaningfully vary across 
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multiple key issues, including how physiological conditions, personal agency, and medication 
itself are narrated (Ch. 7).   
Although referring to the ―choose-your-own-adventure‖ adolescent novels above, this 
metaphor is not entirely accurate.  Throughout the process of narrative adoption, while individual 
agency may be implicit, persons clearly do not often seem aware of all their options.  In an 
examination of the relevance of narrative in complex decision-making processes, Cox (2003) 
notes that decision-making is ―seldom a completely conscious, rational . . process,‖ with the 
degree to which choices are consciously experienced as a decision varying widely:  ―choices are 
always hedged in by constraints; we are not free to decide upon just any course of action nor are 
we ever positioned in such way that we can see what the full range of choices might consist of‖ 
(pp. 262, 273).  It was the surprising limitations on open exploration and choice itself in my home 
community that prompted this study in the first place.   
 After arriving at a particular narrative, to be sure, the story isn‘t over.  Across a wide 
range of strategies, a great deal of attention and energy appears to be directed toward the ongoing 
maintenance and perpetuation of individual stories (Ch. 8).  In terms of understanding what 
underlies divergent and passionate perspectives regarding treatment, this process appears to be at 
least as important as that involved in forming the initial stories.   
In spite of some attention to surrounding influence from friends, family and doctors, the 
lasting impression throughout these chapters may have been that adopting and maintaining a story 
were intra-psychic, subjective processes occurring largely ‗in the heads‘ of those facing 
depression.  If that was the case, logically, ensuing proposals and implications for practice would 
also primarily center around mental processes.  Although this study‘s methods naturally directed 
primary attention to patterns in interpretation and narrative, it is worth mentioning that from the 
beginning these terms were defined as explicitly linked to practice—i.e., narrative as a kind of 
―holistic interpretive practice that is lived and continuously accomplished moment-by-moment‖ 
(see Ch. 1).  It is thus how this lived practice of narrating comes to be initially set in motion 
(adopted) and sustained over time (maintained) that this study has focused its examination.  
Implications of these insights for additional community practices will be reviewed below.    
Like any study, this one has limitations in scope and purpose, therefore pointing naturally 
towards other research that could illuminate beyond the boundaries of its own claims.  For 
instance, how do narratives of anxiety, eating disorders, ADHD and schizophrenia arise and play 
out in individual experiences?  Are the dynamics of creation and maintenance similar or are there 
meaningful differences?  Moving beyond narrative questions, the way the adoption and 
maintenance of narratives are embedded within particular settings, institutions and communities 
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would be helpful to better understand.  How do individual communities variously reinforce or 
oppose the adoption of particular narratives of depression and its treatment?  How are distinct 
narratives either sustained or disrupted over time within these same settings?  How may the 
dynamics of each process meaningfully differ across varied communities?  Could the differing 
prescription rates in a given community be related to distinctive trends in narrative adoption and 
maintenance?  More specifically, could the relatively high concentration of mental health 
advocacy organizations like NAMI and CHADD
20
 within a particular locale cultivate an 
atmosphere where the adoption of biomedical narratives is especially prevalent and likely?    
 
Three Proposals: 
Laying aside these additional questions, we turn to the ultimate consequences of this 
study‘s findings—aka ―so what?‖  If, in fact, the dynamics of these practices are central forces in 
guiding individual experiences and the conclusions they reach, what is the significance of this for 
actual lives and practice?  More specifically, what are the implications of these findings for other 
practices, especially for professional and informal care-giving and for the heroic survival efforts 
of those facing depression themselves?  In light of these general conclusions, the following three 
implications are proposed: 
 
1. Deliberation before education:    First, ongoing disagreement across multiple key 
questions suggests a shift in how stakeholders engage across differences (or not).  As noted in 
Chapter 8, it is currently common for individuals involved in fighting emotional problems to 
present their own position as certain while portraying alternatives as deeply flawed.  Through 
both advocacy and education, primary energies of competing organizations have been invested in 
disseminating these messages in broad campaigns to convince others of the established ―truth‖ 
about depression and other severe emotional problems, in turn ―debunking‖ alternative views as 
misguided or simply ―biased.‖  When actual exchange occurs, it is more often than not combative 
and hostile—reflecting the same aggressive tactics, this time turned on each other.    
Even researchers who have turned to invest their energies in understanding attitudes of  
those facing depression have often done so as part of a larger agenda of overcoming obstacles and 
―barriers to treatment‖ (e.g., Benkert, et al., 1997; Jorm, et al., 2005).  A favorable interpretation 
of this treatment is thus typically assumed in many studies, and not generally questioned against 
                                                 
20
 NAMI (National Alliance of the Mentally Ill) and CHADD (Children and Adults with Attention 
Deficit/Hyperactivity Disorder) are two of the premiere mental health organizations in the nation.  
Although active across the nation, they are well-known to have an especially strong presence in the state of 
Utah.   
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alternative interpretations in any serious or rigorous fashion.   A factor analysis of a national 
survey of nearly 4,000 Australian adults noted a striking discrepancy between professionals and 
the general public in views on a wide range of interventions—with psychological and lifestyle 
interventions favored over the medical ones (Jorm et al., 2005).  Rather than discuss how doctors 
might encourage and facilitate public willingness to make lifestyle and psychological changes as 
well, however, the researchers highlight the alarming need to help better persuade the public of 
the importance of medical treatment:  ―Educational campaigns to improve public knowledge 
about treatments will need to take account of these pre-existing belief systems‖ (p. 877).  Aikens 
and colleagues (2005) similarly call for patient ―education about symptom course, medication 
response lag, the rationale of maintenance treatment, and the link between early discontinuation 
and subsequent decline (p. 28). With a few notable exceptions (Karp, 1996/2006; Stoppard & 
McMullen, 2003), much of the research focused on perceptions or attitudes about treatment thus 
presumes one interpretation as obvious reality. 
Perhaps the most unfortunate aspect of this scenario is its categorical denial of the 
existence of more than one thoughtful, viable perspective about emotional problems.  On a 
general level, this frame may arguably stifle open discussion and thereby feed an increasing 
polarization of views described earlier, as individuals only talk to others who agree with them 
(Bishop, 2008).  In addition, this position may effectively dissuade those facing depression to 
critically explore different interpretations of their own experience.  Instead, the message to 
distressed individuals becomes to simply ―accept the truth‖ about emotional problems and reject 
others views as potentially dangerous.  As Gattuso and colleagues (2005) note:     
Depression literacy strategies tend to adopt rather unsophisticated one way models of 
communication in which individuals are supposed to ―absorb‖ correct health messages 
when they circulate within the popular media. . . . People who refuse to take up the expert 
view of depression as illness can only be seen as non-compliant, ignorant or, in the 
dominant discourse, illiterate (p. 1640).  
 
       To be clear, if or when an indubitable truth becomes apparent on any issue, proclaiming 
and disseminating it is surely the right and sensible approach.  However, as long as ideas remain 
so tentative and contested across views, it seems necessary to reign in or question the massive 
educational campaigns underway (from diverse perspectives).  Indeed, if there is one thing that 
can be acknowledged without controversy, it is that there are significantly different perspectives 
evident on a host of questions and at multiple levels (survivors, caregivers, professionals and 
researchers).  In spite of positive intentions among advocates and educators, the presence of 
serious unresolved issues suggests that declaring one view as the view (―reality‖) may only 
further confuse the situation—especially for those in distress.     
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In place of such advocacy and educational campaigns, a viable practical alternative is 
possible.  Deliberation is a formal practice involving individuals from multiple, conflicting 
perspectives coming together to compare, weigh and carefully consider different views, 
interpretations and options.  The primary purpose of doing so is not to persuade, but to 
collaborate on genuinely seeking better collective understanding and potentially a wiser course of 
ultimate action (Heierbacher, 2007).  As illustrated by the foregoing accounts, interpretive 
differences are deep-set enough that more open, joint exploration of key issues could be 
extremely productive.   Since particular views across these issues have implications for how 
problems are both experienced and addressed, the well-being of people‘s actual lives are at stake.  
(Incidentally, this became my answer to why there was such emotional intensity and resentment 
in these conversations:  ideas matter for actual lives.)  A discourse shift towards greater 
deliberation may thus potentially lead to tremendous consequences for good on all sides.     
Clearly, a more deliberative practice would require significant change on the part of the 
many involved in fighting depression.  Those researchers, practitioners or patients in the ―anti-
psychiatry‖ camp, for instance, would need to take greater care to avoid automatically inscribing 
malevolent, power-seeking motives to those offering psychiatric treatment.  In addition to seeing 
genuine intentions to help, this camp may take care to not deny the experiences of those reporting 
significant help from psychiatric medication and consider more carefully the influence of difficult 
interpretive issues in the process of evaluating treatment.  Likewise, for those who feel positively 
about medication, they might also find opportunities to hear out those who see otherwise—being 
careful to not automatically write-off negative experiences and critique as ―fanatical.‖  Many 
thoughtful concerns have been raised in relation to psychiatric treatment that have yet to be 
adequately addressed (from any party).  On this note, it is worth recognizing that greater 
deliberation across deep difference serves no single agenda; instead, it calls on all involved to 
slow down educational campaigns and intervention efforts in order to think more together.  As a 
result, deeper collective knowledge and a more powerful collaboration across viewpoints may 
potentially ensue.     
Of course, if such an exchange were merely about semantics or subjectivities, it might 
matter little.  As illustrated in this thesis, however, since distinct narratives contribute to the literal 
creation or expression of remarkably divergent experiences, the process and product of such a 
deliberation may matter a great deal—especially for individuals actually facing depression.  
Indeed, this study indirectly highlights the provocative possibility that particular narratives of 
depression may contribute tangibly to the problem itself.  For instance, individuals may be 
socialized to be victims of feelings in general and the body specifically; further, individuals may 
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be led to believe the depression is permanent with no full recovery.   In this way, they may be led 
overall to a passive place of feeling inevitably hijacked by depression and waiting on meds to 
work:  helpless and largely powerless.  A prevailing narrative of depression may also predispose 
distance and deterioration in relationships above and beyond the impact of depression itself.  In 
all these ways, individuals may face bondage not simply to depression alone, but to a particular 
way of thinking about depression.  There are multiple ways we contribute to and reinforce 
depression unawares by the way we approach and talk about it.  Implications of narratives may 
thus be seen as constituting part of the conglomerate burden of depression, with certain 
interpretive distinctions literally prolonging the suffering and interfering with the healing process 
(Schreiber & Hartrick, 2002).   
Based on the foregoing, this is no simple matter, since both medical diagnosis and 
treatment may be experienced as alternatively relieving/liberating and burdening/disempowering 
depending on the situation.  Previous chapters have explored how many have embraced biological 
explanation as a tangible way of explaining the real constraints on agency for those facing 
depression (Lewis, 1995).  From this view, a portrayal of disease is relieving and disburdening.  
On the other hand, others have raised concerns with portraying depression as primarily an internal 
disease (Gammell & Stoppard, 1999), highlighting the way severe external conditions such as 
poverty or abuse may be minimized by these prevailing problem definitions (Shreiber, 1996; 
Shreiber & Hartrick, 2002).  From this view, a disease portrayal can be pathologizing and 
disempowering.   
The crucial point, once again, is whether those reflecting these kinds of differences can 
come together to discuss and collaborate.  As long as proponents of these diverging views work 
separately, respective inquiry and interventions are more likely to emphasize their own position 
as the only feasible option.  In contrast, a joint exploration/deliberation between views may lead 
to innovative insights.  For instance, those physiological accounts which acknowledge neural 
plasticity may explain real constraints on personal agency without denying either the centrality of 
surrounding circumstances or a meaningful degree of individual choice within these conditions 
(Curtis, 2001).   
 From such a vantage point of diverse stakeholders, we may thus come to consider other 
innovative views of depression itself.  Drew (1999), for instance, cites Yardley‘s notion that 
psychopathology can be seen as an ―intersubjective phenomenon, constantly negotiated and 
redefined by sufferers and their immediate contacts.‖  Depression experience may subsequently 
be understood as ―continually constructed and reconstructed moment by moment through 
linguistic and social practices and self-conscious reflection‖ (p. 194).  Greater consideration may 
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thus be given to eastern narratives of emotional challenges, as well, that depict ―mind-weather‖ or 
―mental events‖ that one must pass through, rather than true representations of self or identity 
(Ridge & Ziebland, 2006; Segal, Williams & Teasdale, 2001; see also Maisel, Epston & Borden, 
2005).  By opening up the discourse beyond exclusive portrayals of biological vulnerabilities 
triggered by externals, deliberation may expedite an empowering understanding of body, context 
and choice that avoids both victimizing and victim-blaming.   
 Once again, if distinct narratives truly undergird the prolonging of depression to any 
degree, this would also suggest that recovery from such hopelessness is likewise intimately 
connected to particular interpretations of both what is happening and what may be expected in the 
future.  After noting the limited availability of a ―language of recovery‖ for patients, Ridge and 
Ziebland (2006) went on to describe people adopting narratives of lasting and long-term recovery, 
concluding that the establishment of ―hopeful and authentic life narratives‖ as a key to longer 
term recovery (p. 1052). 
 Further insights such as these, to emphasize, are only possible with open exchange and 
exploration of differing views.  In a current climate where many assume that the nature of 
depression is largely a settled issue, the existence of this kind of a dialogue itself cannot be taken 
for granted.    
The choice is evident.  In the face of different views, should individuals fight and 
minimize each other‘s claims on the truth, or learn to listen and explore and talk and consider 
together?  As Ochs and Capps (1996) highlight, narrators in ambiguous situations may choose 
―either to cultivate a dialogue between diverse understandings or to lay down one coherent, 
correct solution to the problem‖ (p. 32).   
 
2. Deliberation for all: While acknowledging its potential, some may assume such 
deliberation is primarily appropriate for researchers and practitioners.  It becomes important to 
thus emphasize that critical exploration is not a luxury reserved for doctors, psychologists or 
academics.  Given the striking contrast in treatment evaluations, in particular, individuals facing 
depression deserve to be fully informed of ongoing disagreements and competing viewpoints.  
Indeed, distressed individuals themselves are arguably most in need of such critical exploration.  
Once again, this is at odds with popular wisdom that people facing emotional problems simply 
need to be educated correctly, so as to pursue the appropriate treatment.   
Naturally, this also suggests some change in the role of professionals.  In addition to 
offering guidance at times, therapists and doctors may seek more regularly to help individuals 
think for themselves about different views and options (see implication #3).  This may be a 
 187 
particular challenge for doctors with typically limited time and expectations for ―talk‖ (Rogers, 
May & Oliver, 2001).  Likewise, researchers may seek ways of presenting findings in a way that 
may better facilitate collective thinking about an issue (Schwandt, 1996).  
For some individuals, this proposition may be viewed as concerning.  Recently, in 
discussing my belief in a need to trust individuals to think critically and deliberate about key 
issues, a medical doctor friend suggested that it could be ―dangerous‖ to get patients thinking 
about such questions and that the full complexity and multiple perspectives involved issues that 
―only trained medical professionals‖ could address adequately.  There are undoubtedly important 
precautions that should be exercised when opening up the ‗universe of alternatives‘ to those 
facing these problems (e.g., not simply offering alternative narratives without ensuring 
corresponding resources and support).  In spike of potential risks, this view would argue that 
keeping alternative views from these individuals entails a greater risk (e.g., never finding the 
approach to treatment that is a best fit for that individual).  Ultimately, this approach emphasizes 
the inherent capacity of those facing emotional problems to think for themselves, however 
embattled or atrophied these capacities may currently be.   
In both cases, this would entail honestly and fairly acknowledging criticisms of one‘s 
own position—as well as viable alternatives.  Failure to do so naturally leads to a constrained 
deliberation.  As noted earlier, Grime and Pollock (2003) documented frequent complaints of not 
being warned about psychological dependency of anti-depressant medication.  Rather than 
understand how anti-depressants could become a constant need, these individuals began with 
expectations of medication as merely a ―kick-start‖ to recovery.  It appears a casual discussion of 
side effects or ―risks and benefits‖ is not sufficient to make possible authentic critical exploration 
among patients.   In contrast, an open discussion of competing scholarly views on medication 
(including those who warn medication could make things significantly worse) may ensure that 
patients are both fully informed of differing views and able to give a genuinely informed consent 
(or dissent).  The same holds true for preserving authentic exploration of other key issues 
explored earlier—such as the source of positive or negative states coinciding with new 
medication and competing definitions of recovery.  In the case of a negative state arising 
concurrent with a particular medication, rather than assuming only physical aspects are relevant, 
this approach may potentially encourage a more comprehensive intervention.  Namely, before 
simply prescribing a different dosage or new medications, professionals may essentially help 
patients ―try out‖ different interpretive lenses—i.e., Are we sure we know where these effects are 
coming from?  How are we defining good and bad?  Could drugs be the problem here?  Likewise, 
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individuals may be supported in thinking about recovery on their own terms (Grime & Pollock 
2003).   
 Implicit in this point is the understanding that there are multiple ways of intervening on 
these questions that are equally well intentioned.  Rather than assume they need to deliver 
solutions in a confusing situation (i.e., ―Here is the answer‖), alternatively, they can approach 
competing solutions as something to explore together—helping clients to think through questions 
for themselves.   
 If not with the help of medical professionals, individuals may obviously seek support and 
direction in other settings as well.  As hinted by several participants, the internet provides a rich 
resource from which to gather multiple perspectives on an issue.  Beyond mere individual 
education, however, over recent decades mutual help and support groups have developed from 
multiple perspectives.  While psychiatry advocacy organizations like NAMI offer these kinds of 
support groups, there are others that provide alternative views—e.g., Recovery International 
(www.recovery-inc.org/) and Grow (www.grow.net.au/igrow/index.php).  Rather than centering 
curriculum and support around biomedical causes and treatments, these groups highlight 
community support and life lessons relevant to severe emotional problems.  Indeed, given the 
ongoing controversies about medication, Recovery International has a policy of neutrality on the 
issue of medication—respecting individuals‘ rights to either choose or decline medication.  From 
the author‘s own experience, this is not necessarily the case with other support groups.   
 In a relevant study comparing support offered from distinct groups to those facing severe 
emotional problems, Kloos (2000) argued that ―treatment program ideology, structure, and praxis 
provide resources for meaning-making in the form of worldviews, social roles, convincing 
narrative explanations, and expectations for residents that setting members use to create a sense 
of purpose and identity.‖  By examining differences in the practice and discourse of a community 
mental health center and a mutual help group respectively, Kloos highlighted meaningful 
differences in both the program narratives and the patient behavior they cultivated.  From his 
summary, the traditional mental health support emphasized ―addressing residents' problems, 
providing the ‗best professional care‘ available, taking medication, and assisting them to fit into a 
community setting.‖  In contrast, he noted that the other organization emphasized ―distributed 
leadership, mutual support, personal growth, and community building.‖  He concluded:   
These setting differences appear to influence the process and the content of residents' 
meaning-making in terms of thematic content (e.g., differential importance of medication, 
of social roles, and of relationships for rehabilitation), how they view themselves and 
 189 
others, how they organize their narrative accounts, and their views of the future (p. 
abstract). 
 
The precise nature of community support offered, then, may play a critical role in  
whether individuals are able to deliberate on these issues.  This, in turn, may have implications 
for the degree of choice and agency allowed to those facing depression.   
 
3. Maximizing choice for those facing depression:  In addition to critical exploration, the 
existence of widely diverging views points towards another need:  authentic choice in treatment.  
 The importance of preserving individual choice in the course of treatment has been 
emphasized by a growing chorus of researchers, practitioners and clients (Ridge & Ziebland, 
2006; Sangster, 2005; Schreiber, 1996).  The degree to which one has been able to exercise 
personal choice during treatment is seen by some as key to their recovery (Badger & Nolan, 
2007).  Of course, the degree to which they have personal choice is closely related to whether 
individuals are genuinely able to explore different perspectives.  Indeed, in the end, my answer to 
why deep set convictions came to exist was there was little consideration of any other viable 
interpretation.  When a narrative is unchallenged by any other viable narrative, it becomes simply 
accepted as reality.  The impact of such an unquestioned narrative was suggested on multiple 
occasions.  Perhaps the most dramatic example was tapering efforts where concurrent emotional 
difficulties were seemingly automatically interpreted or narrated as evidence that the biological 
deficiency was even worse than realized.  In each case, an alternative interpretation simply was 
not available.    
While authentic choice often depends on doctors and patients sharing information 
honestly, unfortunately, there is evidence that doctors often emphasize treatment benefits without 
adequately acknowledging possible harms or risks (Pound et al., 2005).  A recent study of 
physician communication in the Archive of Internal Medicine indicated that only 35% of patients 
reported doctors discussing adverse side effects with them in the context of general treatment 
(Tarn, et al., 2006).   
By surfacing subtle distinctions between competing narratives more clearly, it has been 
one of my hopes that the extent and strength of collective exploration can expand.  As contrasting 
narratives come to be seen as narratives, I ultimately hope the decision-making process can 
increasingly come to more fully be under individuals‘ own control.  Rather than dragged down 
certain narrative pathways, individuals may be aware and dictate which direction they want to go.  
Rather than fear alternative views, individuals may be open to considering all their options.  
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Rather than presume answers are certain, families and professionals may likewise be open to 
learning from different perspectives.  Whether in conversation with open doctors or exploring on 
the internet, facilitating a transparent exploration of different perspectives—including regarding 
the risks and benefits of medication--may thus indirectly contribute to personal empowerment.    
In addition to critical exploration, authentic choice also requires the presence of viable 
options from which to choose.  Unfortunately, like contrasting viewpoints, actual alternatives to 
dominant treatment options have often remained obscure to those facing depression (Badger & 
Nolan, 2007; Rogers, May & Oliver, 2001).  Like deliberation, the capacity to choose goes 
beyond the theoretical existence of alternative narratives to whether or not tangible resources and 
community supports reflecting these alternatives are actually accessible to individuals and 
families.  Indeed, while alternatives are a common desire among distressed individuals (Carder, 
Vuckovic & Green, 2003), their consideration can be both indirectly precluded by a dominant 
biomedical narrative (Schreiber & Hartrick, 2002) and directly discouraged by professionals 
(Badger & Nolan, 2007).  In turn, where no viable alternatives are understood to exist, even 
extreme detrimental possibilities may be acceptable.  
Rather than dismiss alternatives, professionals need to acknowledge the potential of 
multiple avenues of recovery beyond medication.  In this way, individuals may be facilitated to 
make their own choices.  Such an emphasis does not imply that simple agency underlies the 
ongoing pain of depression nor that individuals ought to ―just choose‖ to feel happy again.  
Instead, support may be extended for individuals to exercise whatever agency they have within 
the bounds of current constraints.  As individuals wrestle with recovery, this degree of choice 
may ebb and flow—with a potential of ultimately growing stronger.  Even at the lowest points, 
however, respecting and maximizing the personal choice of individuals regarding treatment is 
crucial (Sangster, 2005).  In cases of treatment non-adherence, Grime and Pollock (2003) argue 
for moving beyond additional patient education to achieve unilateral ―compliance‖—to a growing 
movement towards a more bilateral professional-patient relationship known as ―concordance‖ 
(see also Garfield et al., 2003).  The aim here is to inform and empower individuals to make their 
own decisions.    People deserve to see different perspectives on issues and be aware of 
alternative narratives so they may choose for themselves.   
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Appendix A:  Recruitment Protocol and Flyer 
  
1) Explanation of the research to the person:  ―I am beginning my dissertation research this month 
investigating depression.  As you know, depression is a problem increasing in severity in our 
communities.  My research aims to document personal experiences of fighting depression in order 
to help us understand better how to treat it.  I hope to interview 15-20 people to gather their 
accounts of depression.  Interviews will last 60-90 minutes.   I am interested in talking with 
anyone with experience in fighting depression.  Do you know anyone that may have a story to 
share?  Would you be willing to contact them for me?‖  
2) Preparation of the person for contacting others:  ―I would ask you to do two things in 
contacting this person.  First, briefly explain the research aims and methods—what the study is 
seeking to understand and what involvement would entail [Read flyer out loud to the person].  
Next, I would ask you to personally invite them to participate in the study and leave this flyer 
with them‖ (see below).    
3) Follow up with the person:  After this preparation, I left several flyers with the individual and 
asked if I could call them back in a week to follow up.   
4) Ongoing snowballing recruitment:  After individuals are interviewed, I similarly invited them 
to contact other persons they know who are potential participants.    
 
“Seeking participants:  Depression study.   
Do you have a story?    
Critical issues in fighting depression as communities can be better addressed with further in-
depth research.  Help to expand  knowledge of depression by participating in an interview at a 
location and time convenient to you.  Involvement will be confidential and $10 will be given to 
each participant as a small token of appreciation.   
 
If you have experienced depression in any degree now or in your past, please contact:   217-766-
2471 or 801-451-6221   
(also--jzhess@uiuc.edu) 
 
Thank you!  
Jacob Hess, PhD Candidate  
University of Illinois, Urbana-Champaign” 
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Appendix B: Additional Plans in Case of Distress During Interview 
   
First, the interviewer will take steps to actively promote participant well-being 
throughout the interview--monitoring comfort levels and the pace of the interview, as well as 
suggesting that a question be skipped if needed.   
Second, at the earliest indication of any degree of serious distress, the interview would be 
terminated by the primary investigator.  This will be done in a way sensitive to the participant 
with the following basic script:  ―One of my important goals as a researcher is to avoid any 
significant distress or discomfort during the interview.  Because of this, I would recommend we 
not continue the interview.  I can assure you this will in no way hurt the research project and I 
would still like to offer you a small token of my appreciation for your participation today.  Is this 
okay?‖  If the participant wants to continue, I would only do so in the absence of serious distress.  
Otherwise, I would insist on stopping, offer the full amount of 10$ in appreciation for what they 
contributed and ensure there is no concern about 'failing' or disappointing the investigation.   
(Note:  While care with initial recruiting protocol will ideally screen out any participant 
experiencing such significant distress, these steps and plans are in place as a secondary precaution 
when that initial protocol fails to detect someone not stable enough for inclusion in the research.)  
Third, at this point, the interviewer--an advanced graduate student in clinical/community 
psychology with some education in psychological assessment--would ask the following two 
questions to assess the seriousness of the distress (at a most basic level):   
--Have you been experiencing any increased difficulty with your depression lately?   
--Are there any recent experiences that have aggravated your condition?     
Fourth, if responses indicate significant challenges in recent experience or increasing 
level of depression, I will recommend immediate contact with a health care professional or some 
other support in their community—for additional assessment and assistance.  If they have no 
previous contact or have interest in additional resources, I will provide information on the 
following resources as well as any additional resources that appear to be relevant:   
Utah interviews:   
--Davis Behavioral Health, 801-451-7799; Emergency Services available 24-hours/day 7 days a 
week 801-773-7060.  
--NAMI (National Alliance of the Mentally Ill) Support Groups, Crisis Intervention and Mentors:   
David County:  Rob & Julianna Morrow Rob.morrow@brooks.com (801) 558-7518 (home) 1st & 
3rd Wednesday. @ 7:00 p.m. Bountiful, IHC Center Lobby corner of 400 N. & Main St., 
Bountiful, UT 84010  
Ogden/Weber County:   Dan Robinson danr@browning.com  (801) 544-1194 ext.302  
(801) 710-6127  1st and 3rd Thursday @ 7:00 pm South Ogden Sr. Citizens Center, 580 39th St. 
Ogden , UT 84403  
Salt Lake City:  Sal Ventura ventura@xmission.com (801) 243-6105 day; (801) 537-6377 
evening 2nd & 4th Wednesday @ 7:00 p.m. Alliance House, 1724 S Main St Salt Lake City , UT 
84115  
Utah County:  Grover Jenson Groverjenson@hotmail.com (801) 225-3855   2nd & 4th Tuesday 
@ 7:00 p.m. Utah State Hospital , Heninger, 1300 E Center St. Provo UT 84606  
Illinois interviews:   
--Psychological Services Center 505 E. Green St.Champaign, IL 61820  Voice:  217-333-0041 24 
hour crisis line—217-359-4141 (The Psychological Services Center offers a variety of 
psychological services from individual consultation. The Center is equipped to deliver an array of 
psychological assessments. Services are available through self-referral, physician referral and/or 
agency referral. Faculty and student-therapists in clinical and counseling psychology staff the 
Center. Services are provided on a fee basis). 
--NAMI (National Alliance of the Mentally Ill) Support Groups, Crisis Intervention and Mentors:   
Champaign:  Stefanie Griffin (217)352-2064  61824-1514 
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Bloomington: Faye Townsend (309) 828-0530  61701-5323 
Fifth, while the interview will not be allowed to continue in the presence of serious 
distress, there are plans for the extreme case.  If suicide risk becomes apparent, the investigator 
would follow the basic standards for mandatory reporting of suicide risk across both states.  
Namely, in the extreme case that this was necessary, the investigator would break confidentiality 
to inform individuals in the person‘s community about the suicide risk.  This would be done, if 
possible, with the consent of the person, as well as his/her assistance in identifying a member of 
their community to contact.  As noted in a previous section, while not trained as a clinician, the 
investigator has received specific training in assessment for suicide risk as part of his graduate 
training in a clinical/community psychology program.  In the case that any interview experiences 
such challenges, the investigator would immediately consult and report to dissertation chair, Dr. 
Wendy Heller, a clinical psychologist—as well as reporting the ‗adverse event‘ to the IRB office 
and to our psychology department executive officer.  Any further action for the participant‘s well-
being would be made at the time, as well as modifications and improvements to the recruiting 
protocol and/or interviewing schedule.       
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Appendix C:  Informed Consent 
 
UNIVERSITY OF ILLINOIS 
AT URBANA-CHAMPAIGN 
 
Jacob Hess is a graduate student in the psychology department at the University of Illinois under 
the supervision of Dr. Wendy Heller.  He is beginning this research project aiming to better 
understand personal experiences of depression in order to improve the way communities may 
respond to this problem.  You were selected as a possible participant because of your experience 
with depression.  Interview participants must be 18 years of age or older.  If you decide to 
participate, you would be one of 15-20 participants in the study.  Participation would involve one 
conversation in person at a location convenient to you.  This interview would be tape-recorded 
and last between 60 to 90 minutes.  If any follow-up questions are needed, they would happen 
over the phone no longer than one month following the first interview.  Your participation in this 
project would be strictly voluntary and you could refuse to participate or discontinue participation 
at any time during the project without penalty.  Doing so will have no effect on your future 
relations with the University of Illinois.  No research risks are anticipated in the study beyond the 
possible discomfort of talking about events associated with mental and emotional health.  For this 
reason, if you chose to participate, you should feel comfortable skipping any questions you would 
prefer not to answer.  Recordings made during these interviews would be kept confidential and 
secure in a locked office when not in direct possession of the investigator.  Files will be coded 
numerically, with an identity key kept separately.  Any publication, report or presentation of 
research that may result from this inquiry would not identify you or any other participant.  In an 
instance, however, where there is any indication an individual may harm self or others, it would 
become necessary to break confidentiality.  As a small token of appreciation for your 
participation, you will be offered $10.  No additional direct benefits are anticipated, although the 
research is hoped to benefit society more generally.  You may request a copy of research reports 
at a later date.          
 
If you are not comfortable with documentation of these discussions or have any other concerns or 
questions about this research please contact Jacob Hess directly at 217-766-2471 
(jzhess@uiuc.edu) or Wendy Heller (w-heller@uiuc.edu).  If you have questions about your 
rights as a research participant in UIUC-approved research you can contact the Institutional 
Review Board Office at the University of Illinois by phone (217-333-2670) or email 
(irb@uiuc.edu).  You will be given a copy of this consent form for your records.   
 
I have read and understand this consent document and agree to participate in the procedures as 
outlined above--including allowing the interview to be audio recorded for use in the research 
project.   
 
Signed _______________________________________________ Date _____________ 
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Appendix D:  Interviewing Schedule 
 
The final schedule of questions used in the interview are listed below: 
Main question—open ended experience:  The focus of this interview is on understanding your 
experience of depression.  Let me start by asking you to tell me about your experience in general.  
[General probes about experience—clarification questions, what happened next?] 
 
Formation/adoption of narration probes (depending on what is shared initially, these questions 
may be used as needed to prompt further elaboration of their narration):  To help me better 
understand your story, I‘d like to ask you to say more about some particular events and features.     
--What has been your experience with family during this time?  How has your family responded 
through this experience?   
--How about your friends?     
--What has been your experience with professional help during this time?   
--How was your experience with MDs?     
--Did you see a psychiatrist?  What was your experience like?     
--Were you ever prescribed drugs?  What was your experience with psychiatric drugs? 
--Can you tell me about experience with counselors or psychologists?    
--Was your experience ever impacted by something you read?   
--Was your experience ever impacted by something you saw on television—news, feature stories, 
etc?   
--Did you ever hear a story from an acquaintance that impacted your experience?   
--If you had to pick an event that most impacted how you make sense of your experience, what 
would it be?    
 
Nature of narration („content‟) probes:  If we could, I‘d like to zoom in some more specifics of 
how you think about this experience.   
--Narrated beginning:  How would you say your experience with depression began?   
--Narration of the nature of depression:  How do you define depression?  What is it?   
Has your understanding of depression changed through this experience?  How?   
--Narrated attributions of change:  In your story, you discussed both times of improvement and 
deterioration.  How do you explain what basically lead to improvements?  How do you explain 
what most basically led to times of worsening in your experience with depression?   
--Narrations of the nature of improvement:  What is your own definition of ―getting better‖ from 
depression?  How do you talk about a permanent improvement, if at all?  How does someone 
know when this happens?   
--Narrated experience with medication:  What is your personal definition of when a medication 
has worked?  How did you response to any uncomfortable effects?  Did taking medication affect 
your relationships with friends or family?    
--Narrations of community:  You talked about your family and friends already.  Of any person, 
whom have you turned to the most for support?  Have your relationships changed through this 
experiences?  How?   
 
Nature of narration (“process/structure”) probes:   
--Life chapters:  You‘ve already described much of your experience—thank you.  I would like to 
ask you to return to this experience and help me understand the sequence of your story by 
framing it like chapters in a book.  What would each of the main chapters be?  You may have as 
many or as few chapters as you like, but I would suggest dividing your story into at least 2 or 3 
chapters and at most about 7. If you can, give each chapter a name and review briefly the contents 
and plot summary for each chapter. 
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--Theme:  Looking back over the story of your experience once again can you discern a central 
theme, message, or idea that runs throughout it all?  Please explain. 
 
Maintenance of narration probes:   
--You have shared current understandings of this experience.  Have your understandings changed 
over time?  (That is, did you used to believe something different about your depression?)  How 
has your thinking changed?  [*This question is more relevant to understanding how the narration 
arises—but, if used, would fit better at this point in the interview] 
--We discussed events that may have contributed to your experience.  Has your current 
understanding of depression ever been challenged (for instance, by something you heard or 
someone you know)?   
 
Other:  What else should I know about your experience in order to understand your story? 
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Table 1:  Meaning and frequency count of interviewing nodes.  My own sub-
organization of nodes is also evident below, with ―Arriving‖ prefacing any node which targeted 
evidence of a narrative‘s creation/arising, ―Continuing‖ prefacing any node which targeted 
evidence of a narrative‘s maintenance and the actual constitution of narratives divided between 
―Depression‖ (problem definition‖) and ―S‖ (―Solution definition‖):   
 
 
Coding node Meaning of the node  Coding 
References 
(Number of 
times text 
was placed 
in the code) 
Sources 
Coded 
(Number of 
separate 
interviews 
placed in 
code) 
1) Arriving through community 
challenge 
Any comments on instances of being challenged by others in 
their view of depression. 
28 10 
2) Arriving through community 
wisdom 
Any comments on instances of being helped and taught by 
others about depression. 
53 12 
3) Arriving through medical 
events 
Comments on important medication experiences or 
encounters with doctors or other medical professionals. 
35 10 
4) Arriving through terrifying 
events 
Comments on climactic or dramatic events important in 
their story of depression. 
19 9 
 5) Continuing in spite of them Comments that speak to moving forward in one‘s 
understanding in spite of being attacked by others 
(―Maintaining story via defense‖)   
6 5 
6) Continuing in these ways Comments that speak to moving forward in one‘s 
understanding independently (―Maintaining story via 
offense.‖) 
18 8 
7) Depression basic--what is it? Comments on the definition or nature of depression 32 14 
8) Depression-biology involved 
or not 
Comments on the role of biology in their depression 
(genetics, biochemicals, hormones, other physical 
conditions, etc.) 
34 15 
9) Depression-General increase Comments about the increase in depression 5 5 
10) Depression-identity Comments about one‘s identity in relation to depression 8 3 
11) Depression relative to other 
sorrow 
Instances of participants comparing their depression with 
others‘ sorrow (or their own previous encounters with a 
―normal sorrow‖) 
3 3 
12) Depression temporal origin Comments on how depression initially emerged 12 6 
13) Depression-where it came 
from 
Comments on the source or origin of depression 53 15 
14) Participation-against my will Comments on depression indicating it was outside of their 
control. 
25 10 
15) Participation-my 
participation 
Comments on depression suggesting their choice was 
relevant. 
12 7 
16) S--Change me or not change 
me 
Instances where individuals reflected on whether personal 
changes were necessary to recovery 
4 2 
17) S--Counselors Comments on professional therapists or counselors 45 12 
18) S--Depression coming back Comments on the possibility of depression returning 9 6 
19) S—doctors Comments on encounters with or feelings about medical 
professionals—primary care doctors, psychiatrists, etc. 
11 5 
20) S--getting better . . how Descriptions of how individuals got better 36 11 
21) S--getting better . . meaning Comments on what ―getting better‖ meant to individuals 16 9 
22) S--med side-effects Comments about side-effects associated with medication 39 12 
23) S-meds for how long Comments about the duration of time individuals were on 10 6 
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medication 
24) S--meds going off . . what 
like 
Comments on the experience of tapering off of medication 4 2 
25) S--meds not working Comments on instances when meds were not working 13 9 
26) S--meds resisting and/or 
tapering 
Comments reflecting resistance or a desire to taper 33 10 
27) S--meds working Comments on instances when meds were working 40 12 
28) S--pharmacy practice Comments on details of their medical management over 
time 
21 10 
29) S--what I think of medicine . 
. what they are doing 
Comments on how individuals perceive the medication to be 
working 
13 6 
30) Theme Comments on the overall ―theme‖ of participants‘ 
experience (the final question) 
11 10 
Average code frequency 
 
 22 average 8.5 average 
Range of code frequency  (4-53) (3-15) 
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2006 - 2007  Assistant, Psychological Services Center, University of Illinois Training 
Clinic 
Clinical supervisor:  Elaine Shpungin, Ph.D.  
 
2004 - 2005   Group Supervisor, Juvenile Detention Center, Urbana Illinois 
Clinical supervisor:  Carol Diener, Ph.D.  
 
1999 - 2000 Human Service Worker, Vantage Point Youth Services, Provo, Utah 
 
SERVICE AND LEADERSHIP EXPERIENCE   
 
2005 - Present Ad hoc Reviewer, Preventive Medicine 
 
2007 Volunteer Member, Planning committee for the 2008 biennial conference 
of the National Coalition of Dialogue and Deliberation, October 3-5, 2008 
in Austin, Texas.  
 
2003 - 2007  Volunteer, Committee preparing and publishing department newsletter, 
    ―Inclinations‖   
 
2006 Volunteer, Midwest Eco Conference Planning Committee, Saugatuck, 
Michigan 
 
2005  Participant, Planning Committee, 10
th
 Biennial Conference of the Society 
for Community Research and Action.   
 
2001  Chair, Program/Profile Committee for the Students for International 
Development Hunger Banquet at BYU. 
 
1999 - 2000 Mentor, Slate Canyon Mentor Program with Robert, chair of recruiting for 
the program.   
 
1998 - 1999 Big brother, Access Big Brother/Big Sister Program with Eric & Emily. 
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1998 - 1999 President, BYU chapter of Psi Chi, the psychology honors society. 
Constructed Psi-Chi Website at BYU. 
 
1998 Volunteer, Utah County Crisis Line. 
 
1992 Eagle Scout, Boy Scouts of America.  Organizing a project to install a 
bench, paint and clean up a local camping area. 
 
PROFESSIONAL AFFILIATIONS 
 
2006 - Present National Coalition for Dialogue and Deliberation, NCDD, Member 
[www.thataway.org] 
 
2006 - Present  American Psychological Association, Student Affiliate  
 
2006 - Present  Society for Theoretical and Philosophical Psychology (APA Division 
24), Student Member 
 
2003 - Present  Society for Community Research and Action, SCRA (APA Division 
27), Student Member 
